data_1bwe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bwe _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.456 ' H1 ' ' CD2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 118.351 -0.833 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -105.23 153.86 21.01 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.641 0.655 . . . . 0.0 110.17 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 t -138.13 145.83 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.746 0.818 . . . . 0.0 110.764 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -60.81 165.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.237 1.815 . . . . 0.0 111.536 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 p -151.93 168.67 24.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.994 0.918 . . . . 0.0 109.094 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -8.52 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 128.506 2.722 . . . . 0.0 116.336 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 -21.39 71.91 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 121.487 1.567 . . . . 0.0 113.541 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.18 -30.34 71.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.756 0.822 . . . . 0.0 112.177 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.21 90.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.598 0.713 . . . . 0.0 110.385 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.11 60.8 0.67 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.941 1.734 . . . . 0.0 109.92 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t 39.56 73.03 0.12 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.158 1.783 . . . . 0.0 114.307 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 68.94 48.5 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.57 1.148 . . . . 0.0 113.053 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.19 152.42 40.8 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.75 40.12 0.89 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.795 0.725 . . . . 0.0 112.125 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 m -83.89 -37.35 22.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 112.205 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 p -70.04 -13.73 62.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.272 1.429 . . . . 0.0 113.215 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.26 153.85 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 112.431 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 75.86 -40.29 0.4 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.834 2.053 . . . . 0.0 113.038 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.65 -29.11 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.705 -0.622 . . . . 0.0 110.156 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.0 t -65.63 126.58 91.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.949 0.5 . . . . 0.0 110.103 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -39.72 -37.44 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 126.377 4.718 . . . . 0.0 115.407 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.0 m -126.54 21.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.822 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t70 33.2 51.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.702 2.001 . . . . 0.0 113.668 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.5 p -94.57 42.34 1.09 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.298 1.039 . . . . 0.0 110.922 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 132.32 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 173.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -133.51 142.13 48.08 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -167.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -83.52 125.15 31.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.309 -0.87 . . . . 0.0 111.627 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.82 -55.07 2.48 Favored Glycine 0 CA--C 1.525 0.69 1 N-CA-C 103.047 -4.021 . . . . 0.0 103.047 166.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -60.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.195 2.198 . . . . 0.0 106.614 168.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.4 -29.17 69.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.266 1.826 . . . . 0.0 114.787 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.18 177.5 11.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.343 0.657 . . . . 0.0 109.476 -168.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.87 116.03 28.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.233 1.013 . . . . 0.0 108.699 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -94.88 119.62 33.74 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 130.441 3.497 . . . . 0.0 109.388 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.7 mt -81.33 130.13 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 118.878 0.763 . . . . 0.0 109.839 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.39 111.64 18.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.01 -30.98 92.86 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-N 120.98 1.386 . . . . 0.0 111.273 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -79.1 -23.63 43.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -92.1 -32.84 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.276 0.489 . . . . 0.0 110.978 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.56 123.56 16.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.979 0.809 . . . . 0.0 111.45 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.8 pt -89.46 21.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 50.75 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.37 2.268 . . . . 0.0 113.089 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.0 148.41 31.67 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.944 -0.472 . . . . 0.0 110.951 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.72 51.75 4.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.191 -0.943 . . . . 0.0 113.08 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.67 -76.99 0.59 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.363 1.082 . . . . 0.0 111.633 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -47.96 -48.8 31.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.598 1.159 . . . . 0.0 112.497 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.5 -46.55 83.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.171 0.896 . . . . 0.0 111.562 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.14 74.86 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.486 -0.759 . . . . 0.0 110.538 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -74.81 -38.26 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.094 0.557 . . . . 0.0 111.45 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.4 t -64.27 112.41 7.59 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.227 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.48 20.88 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.207 2.604 . . . . 0.0 113.087 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.39 -30.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.103 1.761 . . . . 0.0 109.354 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 t 62.27 81.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 0.0 109.894 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.32 -9.92 0.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -79.82 92.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -109.36 164.57 12.36 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.1 0.96 . . . . 0.0 108.894 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' CD2' ' H1 ' ' A' ' 1' ' ' ALA . 5.1 t-80 -62.5 146.94 50.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.855 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -40.96 64.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.113 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -73.35 -38.91 65.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -53.76 124.53 43.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.667 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 144.95 52.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.103 2.535 . . . . 0.0 112.191 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -41.49 -47.36 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 128.933 2.893 . . . . 0.0 112.676 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.59 -44.41 26.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.049 0.94 . . . . 0.0 111.063 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -96.71 -6.73 35.73 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.173 1.389 . . . . 0.0 112.424 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -57.99 -22.38 49.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.562 1.528 . . . . 0.0 110.231 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.01 -43.08 40.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.701 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -64.35 -35.06 79.63 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.6 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.35 -46.12 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -56.91 -46.58 81.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.115 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -46.42 90.62 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.427 -0.796 . . . . 0.0 111.631 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -61.59 -40.0 93.22 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.051 0.94 . . . . 0.0 111.357 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -57.22 -61.86 2.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -52.96 -50.42 64.13 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 128.122 2.569 . . . . 0.0 112.529 -170.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -37.46 -46.35 0.8 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 125.57 1.548 . . . . 0.0 113.432 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -111.39 -3.21 15.33 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.789 0.681 . . . . 0.0 111.447 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -36.67 25.05 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.939 0.791 . . . . 0.0 110.31 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' NZ ' ' OXT' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.464 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -100.8 147.58 25.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.413 0.685 . . . . 0.0 111.128 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.64 142.29 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.845 1.258 . . . . 0.0 110.708 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.88 168.57 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 125.772 1.629 . . . . 0.0 110.904 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 p -145.02 171.65 14.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -9.82 -61.22 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 128.661 2.785 . . . . 0.0 116.164 169.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.59 -15.42 45.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 121.991 1.747 . . . . 0.0 113.635 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.37 -26.09 63.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.851 0.86 . . . . 0.0 112.742 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.15 115.95 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.95 130.31 1.34 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -169.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -60.06 119.57 8.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.957 0.503 . . . . 0.0 112.026 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 36.22 50.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.492 1.917 . . . . 0.0 113.376 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.24 -50.85 72.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.673 0.789 . . . . 0.0 112.616 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.95 -136.01 0.86 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.918 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m 62.7 45.34 5.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.856 1.263 . . . . 0.0 111.878 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 p -176.51 -28.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.162 2.985 . . . . 0.0 109.138 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.75 -44.87 51.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.22 1.008 . . . . 0.0 110.469 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.34 0.3 3.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.399 1.88 . . . . 0.0 114.175 -169.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.03 -16.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.277 1.031 . . . . 0.0 113.136 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -75.36 126.15 88.05 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 119.751 1.16 . . . . 0.0 111.624 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -62.11 141.24 87.88 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.565 2.177 . . . . 0.0 109.227 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.287 11.6 m 45.17 37.09 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 114.217 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 35.92 49.1 0.56 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.335 2.654 . . . . 0.0 114.17 168.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -85.89 30.14 0.68 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.058 -1.027 . . . . 0.0 112.643 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 142.13 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -141.55 156.8 45.69 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.086 1.354 . . . . 0.0 107.849 -170.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -91.53 134.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 118.888 0.767 . . . . 0.0 111.254 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.54 -46.96 7.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 104.987 -3.245 . . . . 0.0 104.987 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -175.56 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.245 2.618 . . . . 0.0 104.284 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -98.21 54.1 1.09 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.901 1.81 . . . . 0.0 108.94 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.71 137.37 0.2 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 -169.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -102.37 168.41 9.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.889 0.743 . . . . 0.0 109.663 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -146.44 119.82 9.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.192 1.797 . . . . 0.0 107.797 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.38 130.76 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -73.33 114.64 33.38 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -30.85 52.42 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.619 0.879 . . . . 0.0 111.1 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -83.07 -28.43 29.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.279 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.52 -27.63 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.397 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -59.45 120.99 10.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.497 1.044 . . . . 0.0 110.945 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 pt -96.14 34.03 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 27.2 m-20 46.17 42.31 9.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.574 1.549 . . . . 0.0 113.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -23.21 60.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.244 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.75 -138.94 20.9 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.531 1.062 . . . . 0.0 110.934 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.17 -67.51 0.25 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.689 1.596 . . . . 0.0 111.95 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 p -47.98 -50.64 26.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.888 1.275 . . . . 0.0 110.412 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -43.92 -41.25 5.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.714 2.005 . . . . 0.0 113.815 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.47 -34.87 21.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.162 0.985 . . . . 0.0 110.064 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -79.18 -25.57 12.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.94 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -59.84 111.97 4.67 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.413 1.006 . . . . 0.0 108.49 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.12 49.53 3.26 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.857 3.038 . . . . 0.0 110.117 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -169.35 -35.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 128.232 2.613 . . . . 0.0 107.74 -168.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 58.0 58.14 3.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 110.045 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.75 -17.57 50.54 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.665 1.186 . . . . 0.0 110.873 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -77.66 125.42 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.48 170.47 15.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.421 ' CD2' ' H1 ' ' A' ' 1' ' ' ALA . 6.7 t-80 -65.62 146.35 54.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -48.69 -44.12 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.174 0.512 . . . . 0.0 112.058 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.32 -40.22 77.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.177 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -78.96 -34.13 44.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 111.56 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.96 126.55 59.89 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.95 145.5 62.45 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.118 2.545 . . . . 0.0 112.469 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.6 mp0 -40.91 -45.69 2.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.62 3.168 . . . . 0.0 113.811 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.45 -44.68 12.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.914 0.864 . . . . 0.0 111.093 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -101.26 0.06 36.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.475 1.91 . . . . 0.0 112.945 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 28.3 mmtm -59.27 -21.42 59.61 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.593 1.542 . . . . 0.0 109.456 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 p -50.46 -49.03 56.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.713 1.205 . . . . 0.0 109.896 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -61.91 -35.91 79.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.053 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.45 -50.65 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -54.29 -41.69 69.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.623 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -66.84 -45.58 77.77 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.2 -42.16 94.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.276 1.43 . . . . 0.0 110.587 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -55.76 29.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.84 -48.97 69.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.738 2.815 . . . . 0.0 113.987 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -31.66 -48.92 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.09 1.756 . . . . 0.0 114.942 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -117.12 1.72 12.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.746 0.818 . . . . 0.0 111.985 -170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -40.21 13.24 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.822 0.737 . . . . 0.0 110.814 -169.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.567 2.347 . . . . 0.0 104.682 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.57 150.21 31.67 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.477 0.581 . . . . 0.0 110.612 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.2 140.01 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.287 0.635 . . . . 0.0 111.661 -174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.04 144.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 125.331 1.452 . . . . 0.0 109.93 172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 p -133.65 168.4 18.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 110.332 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 9.5 tt0 -15.49 -57.65 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 129.107 2.963 . . . . 0.0 116.484 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.26 -21.32 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 CA-C-N 121.774 1.669 . . . . 0.0 114.325 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.7 -32.65 72.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.733 0.697 . . . . 0.0 112.246 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -65.34 86.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.982 0.896 . . . . 0.0 109.943 -172.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 53.11 0.57 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 127.191 2.329 . . . . 0.0 108.256 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.298 12.2 t 53.28 -153.61 0.25 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.624 1.97 . . . . 0.0 113.939 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -73.77 66.96 1.14 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.324 1.45 . . . . 0.0 112.276 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.27 -57.54 8.57 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.722 1.609 . . . . 0.0 111.083 170.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.55 43.93 16.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.476 1.51 . . . . 0.0 112.924 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -98.54 -42.11 7.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.355 0.662 . . . . 0.0 111.564 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -74.28 67.96 1.45 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.006 0.908 . . . . 0.0 108.696 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.43 163.6 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.938 2.095 . . . . 0.0 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 40.93 39.24 0.79 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.627 1.971 . . . . 0.0 114.403 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.61 -39.74 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.423 1.089 . . . . 0.0 111.217 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -65.58 124.98 88.8 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 121.922 -0.486 . . . . 0.0 110.934 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.73 -42.78 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.624 1 C-N-CA 126.012 4.475 . . . . 0.0 115.533 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.5 27.77 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.415 0.686 . . . . 0.0 111.411 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 58.99 -173.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p 124.28 -2.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 130.702 3.601 . . . . 0.0 111.985 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -89.22 115.57 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.708 0.803 . . . . 0.0 109.149 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -134.52 172.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.528 1.531 . . . . 0.0 108.815 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -114.72 177.52 4.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.689 0.757 . . . . 0.0 109.673 168.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.8 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 124.608 1.099 . . . . 0.0 110.692 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -128.94 -94.78 0.42 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.3 58.25 1.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.411 1.101 . . . . 0.0 108.95 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -175.22 2.78 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 128.685 2.794 . . . . 0.0 105.786 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -111.56 159.09 18.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.286 0.494 . . . . 0.0 110.947 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.12 130.86 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.724 2.81 . . . . 0.0 104.444 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -106.06 126.39 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -66.95 114.6 18.73 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 118.022 -1.471 . . . . 0.0 107.516 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.32 -28.46 22.54 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.854 1.703 . . . . 0.0 110.0 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -81.26 -28.77 34.61 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.08 -38.45 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.875 0.761 . . . . 0.0 111.27 169.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.8 t -55.13 124.94 18.52 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 111.838 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 pt -95.23 37.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.111 0.964 . . . . 0.0 111.617 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 38.57 60.33 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.182 2.193 . . . . 0.0 113.691 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 -20.98 16.32 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.1 -132.34 11.4 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.89 -70.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.458 1.503 . . . . 0.0 112.042 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.6 p -48.73 -47.3 41.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.711 1.205 . . . . 0.0 111.197 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.66 -42.64 79.33 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.653 -0.654 . . . . 0.0 111.755 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.74 75.83 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.499 -0.751 . . . . 0.0 110.337 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.72 -40.84 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.596 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -59.55 112.15 4.84 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 119.072 0.851 . . . . 0.0 109.464 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.67 11.66 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.909 2.406 . . . . 0.0 112.862 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -117.14 -26.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 127.679 2.392 . . . . 0.0 108.843 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m 54.39 76.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.483 1.513 . . . . 0.0 111.18 -169.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 6.58 5.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.154 1.382 . . . . 0.0 112.719 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.43 80.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -95.99 162.84 13.39 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -59.35 149.14 29.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.947 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -50.39 -42.42 53.46 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -80.82 -21.59 40.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 119.279 -0.969 . . . . 0.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -71.48 -33.3 69.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -58.36 126.75 79.66 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 119.252 -0.404 . . . . 0.0 109.911 171.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.73 153.17 57.94 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.656 2.904 . . . . 0.0 113.156 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -45.61 -45.12 13.63 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 129.968 3.307 . . . . 0.0 112.747 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -48.79 -46.2 41.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.894 0.878 . . . . 0.0 110.889 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 6' ' ' GLU . 46.8 m0 -97.06 -1.19 45.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 0.0 112.525 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -54.46 -27.98 41.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.565 1.075 . . . . 0.0 109.324 169.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -45.86 -46.95 16.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.626 1.17 . . . . 0.0 110.8 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -64.25 -34.36 77.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.766 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.35 -47.55 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 120.698 1.59 . . . . 0.0 107.183 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -57.63 -44.07 85.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -60.56 -51.15 70.63 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 118.682 0.674 . . . . 0.0 111.211 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -56.36 -38.93 72.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.382 1.073 . . . . 0.0 110.733 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -63.28 -58.68 6.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.53 1.132 . . . . 0.0 109.859 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.85 -47.15 87.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.658 2.383 . . . . 0.0 112.936 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.65 -46.32 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.093 1.357 . . . . 0.0 113.954 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.77 3.24 24.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.666 0.786 . . . . 0.0 112.193 -171.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 -60.08 1.93 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.507 1.523 . . . . 0.0 107.913 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.643 3.177 . . . . 0.0 112.738 -174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.209 0.052 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -92.24 136.04 33.52 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.63 142.05 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.473 0.709 . . . . 0.0 110.776 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -65.64 158.26 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 126.728 2.011 . . . . 0.0 110.656 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.7 p -144.9 156.26 43.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.33 0.514 . . . . 0.0 111.687 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.351 3.7 tt0 6.87 -72.05 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 130.108 3.363 . . . . 0.0 117.58 169.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -52.95 -26.17 30.62 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.693 1.998 . . . . 0.0 114.905 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -58.46 -36.39 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.699 0.8 . . . . 0.0 112.058 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.07 144.23 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.069 0.462 . . . . 0.0 111.06 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.38 37.87 2.75 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 125.465 1.507 . . . . 0.0 111.315 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -166.87 129.11 1.74 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -70.89 88.01 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.87 167.9 20.52 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.841 0.856 . . . . 0.0 110.939 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.03 71.69 0.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.843 1.657 . . . . 0.0 107.12 173.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.3 m -141.99 -59.0 0.47 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.743 -0.598 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.43 72.63 0.98 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.076 0.941 . . . . 0.0 108.962 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.3 152.56 15.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 108.72 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 62.97 -12.77 0.08 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.28 -24.45 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 120.822 -1.174 . . . . 0.0 110.884 -170.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.71 126.48 92.65 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 122.775 0.43 . . . . 0.0 110.619 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.32 -43.89 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 126.485 4.79 . . . . 0.0 115.975 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.34 7.1 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.868 0.867 . . . . 0.0 112.146 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.2 t0 65.87 149.87 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 111.539 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.9 m -163.06 -102.09 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.509 1.923 . . . . 0.0 106.209 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.255 2.2 pp 13.78 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.785 3.234 . . . . 0.0 116.474 169.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -103.4 138.7 39.79 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.487 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 32.6 mt-10 -76.57 131.84 39.16 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 120.775 -1.203 . . . . 0.0 112.661 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.84 8.63 Favored Glycine 0 CA--C 1.532 1.099 1 N-CA-C 102.886 -4.085 . . . . 0.0 102.886 165.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.44 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.236 3.014 . . . . 0.0 104.286 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.15 -35.88 74.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.661 -0.649 . . . . 0.0 111.584 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.68 146.87 46.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.227 1.411 . . . . 0.0 110.411 -169.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 27' ' ' GLU . 96.9 m-85 -80.44 150.95 29.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.94 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -119.68 114.55 22.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 129.808 3.243 . . . . 0.0 105.554 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -83.95 116.88 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.9 109.07 1.27 Allowed Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 126.868 2.067 . . . . 0.0 111.659 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -67.78 -26.98 38.2 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.039 1.16 . . . . 0.0 111.685 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.15 -41.87 85.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.798 0.839 . . . . 0.0 109.852 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -92.94 -38.31 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.663 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.12 120.01 7.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.107 0.867 . . . . 0.0 111.278 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 pt -89.87 35.58 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.155 0.982 . . . . 0.0 111.572 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.52 60.05 3.04 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.36 1.464 . . . . 0.0 112.905 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.13 -164.75 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.065 0.946 . . . . 0.0 109.03 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.42 -112.15 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 168.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.72 -67.29 0.14 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 126.292 1.837 . . . . 0.0 112.665 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.5 p -62.17 -49.06 77.34 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 137.21 58.22 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 168.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 84.47 -22.24 0.22 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.015 2.526 . . . . 0.0 111.873 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.7 -34.22 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.44 ' C ' ' H ' ' A' ' 51' ' ' VAL . 22.8 t -62.89 116.76 26.53 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.15 26.78 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.41 2.74 . . . . 0.0 113.03 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.7 m -141.5 -27.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 128.393 2.677 . . . . 0.0 108.331 -172.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.9 m 54.14 62.93 2.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.693 1.197 . . . . 0.0 111.288 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.1 -7.36 45.77 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.276 1.031 . . . . 0.0 111.128 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.4 mt -83.05 124.67 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -134.58 168.51 18.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -64.08 143.51 57.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.517 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.41 -40.82 51.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.33 -38.49 89.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.372 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -77.28 -31.54 54.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.043 -169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.47 125.38 52.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.635 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.79 144.34 55.0 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.045 2.497 . . . . 0.0 112.043 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -41.91 -47.13 4.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 128.995 2.918 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -46.99 -45.36 20.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.138 0.975 . . . . 0.0 110.863 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -96.72 -4.51 40.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.752 1.621 . . . . 0.0 112.528 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -60.89 -17.2 49.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.156 1.344 . . . . 0.0 109.841 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -51.52 -42.6 61.87 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.628 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -67.82 -31.2 70.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.29 -0.881 . . . . 0.0 111.752 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.77 -45.67 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -55.85 -48.98 74.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.71 0.404 . . . . 0.0 110.032 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.59 73.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.248 0.476 . . . . 0.0 110.497 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.61 -39.61 68.06 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 124.021 0.826 . . . . 0.0 110.568 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -56.15 19.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -50.97 -43.18 60.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.868 2.067 . . . . 0.0 112.526 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -43.84 -44.71 7.03 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.756 0.66 . . . . 0.0 112.151 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -107.95 21.47 17.35 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 111.139 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -132.67 74.51 1.58 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 169.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -169.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.447 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.28 144.98 26.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.103 0.961 . . . . 0.0 110.248 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.85 144.05 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.273 1.029 . . . . 0.0 111.296 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.73 142.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.489 1.515 . . . . 0.0 109.553 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 p -131.42 165.47 23.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.038 0.535 . . . . 0.0 110.237 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -12.21 -58.33 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 129.587 3.155 . . . . 0.0 116.568 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.72 -20.65 69.82 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 CA-C-N 122.115 1.791 . . . . 0.0 114.06 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -62.73 -33.3 74.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.64 0.655 . . . . 0.0 111.532 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.31 3.9 mp -70.58 95.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.965 0.888 . . . . 0.0 112.168 -168.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 151.6 23.34 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 103.784 -3.726 . . . . 0.0 103.784 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -48.07 125.14 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.393 1.877 . . . . 0.0 112.789 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 18.31 72.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.41 2.684 . . . . 0.0 116.037 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -51.01 -58.63 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.577 1.951 . . . . 0.0 112.342 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.0 42.45 32.25 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.265 1.426 . . . . 0.0 113.318 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -103.06 -51.13 3.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.257 0.623 . . . . 0.0 111.583 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 p -75.27 69.66 2.12 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.96 0.886 . . . . 0.0 109.416 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.9 156.44 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.972 1.709 . . . . 0.0 109.324 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 40.76 58.47 2.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.857 . . . . 0.0 112.79 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 p -160.39 -37.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -72.62 141.34 82.46 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -37.29 -36.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.623 4.215 . . . . 0.0 115.575 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.02 29.82 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.297 31.1 m-20 21.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.576 2.351 . . . . 0.0 114.751 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.3 p -86.17 41.58 0.94 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.235 1.014 . . . . 0.0 110.415 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 pp -109.41 126.88 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.864 1.666 . . . . 0.0 108.422 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -141.56 145.46 35.13 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 124.226 1.011 . . . . 0.0 109.991 -169.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.6 115.96 7.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.786 169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.87 -59.32 4.07 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.04 -2.424 . . . . 0.0 107.04 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -124.12 -69.24 0.82 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -128.08 -37.58 1.87 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.538 1.135 . . . . 0.0 113.18 172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' CD ' ' H ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -87.02 160.2 18.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.986 2.914 . . . . 0.0 110.551 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -76.38 124.9 28.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.613 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 159.07 16.47 Favored 'General case' 0 N--CA 1.444 -0.729 1 C-N-CA 131.835 4.054 . . . . 0.0 104.962 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -116.29 137.19 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.203 1.001 . . . . 0.0 108.369 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 38.5 t0 -78.24 112.4 25.54 Favored Pre-proline 0 C--N 1.341 0.222 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 167.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.94 -30.9 67.35 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.052 1.168 . . . . 0.0 110.585 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -80.44 -22.94 40.66 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.477 -0.764 . . . . 0.0 110.223 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -90.03 -29.28 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.47 0.577 . . . . 0.0 111.009 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.6 t -58.52 128.92 39.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.477 1.035 . . . . 0.0 110.568 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 pt -98.31 36.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.342 1.057 . . . . 0.0 111.473 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.442 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 7.6 m-20 42.8 57.32 3.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.96 1.704 . . . . 0.0 112.11 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -176.73 4.3 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.042 0.537 . . . . 0.0 111.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.13 69.16 0.23 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.96 162.39 28.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.019 1.727 . . . . 0.0 106.634 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.27 1.9 p 77.75 -54.76 0.52 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.854 2.862 . . . . 0.0 111.264 -170.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -52.89 15.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.866 0.866 . . . . 0.0 111.998 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.16 62.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.461 1.105 . . . . 0.0 112.025 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.11 -38.2 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.826 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.5 t -61.55 110.37 3.06 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.763 0.71 . . . . 0.0 109.371 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.02 -0.04 6.55 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.999 1.799 . . . . 0.0 112.653 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.19 -23.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.82 1.648 . . . . 0.0 109.837 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 t 60.46 56.97 2.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 110.888 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.95 -22.47 21.94 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.915 0.886 . . . . 0.0 111.062 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -78.68 119.11 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -128.43 167.13 17.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 4.3 t-80 -68.93 144.45 54.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -51.74 -40.99 61.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.18 60.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -82.49 -34.2 28.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.922 0.783 . . . . 0.0 109.814 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.44 127.81 90.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.13 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.98 148.64 37.81 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.546 2.831 . . . . 0.0 112.571 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -51.4 -43.78 62.03 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.865 1.266 . . . . 0.0 111.492 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -41.47 -44.76 2.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.996 1.319 . . . . 0.0 111.267 172.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.41 -1.31 31.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.447 1.499 . . . . 0.0 112.586 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -61.37 -19.45 61.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.473 1.488 . . . . 0.0 110.317 169.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -51.44 -45.02 62.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.339 1.055 . . . . 0.0 109.268 167.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.57 -33.99 77.19 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.678 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.09 -47.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 120.616 1.553 . . . . 0.0 107.691 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -52.9 -49.85 65.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.925 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -46.46 88.76 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.707 -0.62 . . . . 0.0 111.872 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -57.8 -43.06 85.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.095 1.358 . . . . 0.0 110.589 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -58.68 -60.92 3.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.11 -51.15 62.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.435 2.694 . . . . 0.0 112.001 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -48.46 0.21 Allowed 'General case' 0 C--N 1.337 0.055 0 C-N-CA 126.152 1.781 . . . . 0.0 114.139 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.57 -4.17 14.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.56 0.744 . . . . 0.0 111.296 -170.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -89.77 -37.24 14.66 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.487 -1.244 . . . . 0.0 107.904 -172.074 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.441 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 119.886 -0.102 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -92.18 146.19 23.91 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.019 0.528 . . . . 0.0 110.245 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.01 143.02 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.013 . . . . 0.0 111.169 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.87 142.26 14.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 126.869 2.068 . . . . 0.0 109.052 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.3 p -133.96 166.43 22.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.059 0.544 . . . . 0.0 111.628 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.282 3.0 tt0 -8.77 -61.4 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 129.776 3.23 . . . . 0.0 116.642 172.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -20.03 44.61 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 122.56 1.95 . . . . 0.0 114.619 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 t -61.04 -36.44 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.595 0.634 . . . . 0.0 112.523 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.267 8.6 mt -40.04 113.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.129 0.972 . . . . 0.0 112.066 -169.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.37 130.41 1.41 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -53.82 99.65 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.627 1.571 . . . . 0.0 115.107 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 46.66 56.03 7.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.381 1.873 . . . . 0.0 112.332 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -62.17 95.67 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.451 1.1 . . . . 0.0 110.463 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.41 78.21 9.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 m -128.89 -59.48 1.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.169 0.588 . . . . 0.0 110.876 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 p -74.22 66.71 1.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.79 0.805 . . . . 0.0 109.162 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -120.49 -124.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 109.936 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.6 pm0 -68.52 21.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.68 -27.2 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.158 1.383 . . . . 0.0 109.332 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -67.68 124.05 88.37 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.944 -0.473 . . . . 0.0 110.168 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.99 -45.1 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 125.285 3.99 . . . . 0.0 114.67 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.22 13.61 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.367 -170.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 65.2 t0 59.88 111.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.645 1.578 . . . . 0.0 112.241 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 78.7 m -135.57 4.1 3.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.939 172.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.53 113.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 111.409 -167.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.13 167.08 19.72 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.755 1.222 . . . . 0.0 109.325 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -106.99 177.2 4.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 168.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.38 -43.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -129.77 -97.28 0.36 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -144.08 53.8 1.29 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 123.42 1.581 . . . . 0.0 110.564 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -178.85 6.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.999 2.92 . . . . 0.0 105.022 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.39 164.16 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.56 118.48 16.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.489 2.316 . . . . 0.0 106.177 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.3 mt -90.09 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 113.76 14.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.232 1.378 . . . . 0.0 107.807 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.82 -30.83 40.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.789 1.66 . . . . 0.0 110.582 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -82.82 -28.06 30.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.772 0.829 . . . . 0.0 109.272 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 t -85.38 -31.46 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.752 0.706 . . . . 0.0 111.163 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -58.02 129.89 44.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.387 0.994 . . . . 0.0 111.327 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.7 pt -103.52 33.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.564 1.146 . . . . 0.0 111.391 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.441 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 31.2 m-20 46.0 42.68 9.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.967 1.707 . . . . 0.0 113.478 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -23.57 60.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.276 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.69 -141.26 23.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.59 1.09 . . . . 0.0 111.15 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.52 -66.72 0.25 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.132 1.373 . . . . 0.0 111.117 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -49.93 -49.75 48.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.636 1.174 . . . . 0.0 110.352 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -53.97 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.775 2.03 . . . . 0.0 113.096 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.86 65.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.014 0.526 . . . . 0.0 110.568 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.06 -37.81 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.917 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -68.46 108.51 2.93 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 119.934 1.243 . . . . 0.0 108.834 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.64 11.35 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.633 2.222 . . . . 0.0 113.129 -172.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.07 -26.0 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.588 2.355 . . . . 0.0 108.535 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.35 58.92 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.592 0.757 . . . . 0.0 110.51 -170.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.29 -11.69 58.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.744 0.817 . . . . 0.0 111.186 171.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.03 127.37 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.6 1.56 . . . . 0.0 107.276 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -134.83 168.71 18.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -65.78 144.33 56.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -52.93 -39.02 62.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.41 -40.86 79.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.814 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -77.48 -31.32 53.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.518 0.727 . . . . 0.0 110.523 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.22 127.05 69.81 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.695 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 144.84 50.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.163 2.576 . . . . 0.0 112.35 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -43.64 -45.57 6.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 128.734 2.814 . . . . 0.0 112.662 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.21 -48.84 23.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 0.0 110.506 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -90.9 -7.92 50.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.905 1.282 . . . . 0.0 112.456 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -58.05 -21.99 47.99 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 120.629 1.559 . . . . 0.0 110.028 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -49.3 -43.9 43.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.519 -0.738 . . . . 0.0 110.466 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -65.73 -33.57 76.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.504 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.89 -46.04 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 120.906 1.684 . . . . 0.0 107.247 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -56.89 -44.18 82.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.723 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.62 -50.7 72.47 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.352 0.524 . . . . 0.0 111.227 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -57.69 -39.77 77.91 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -60.67 -58.31 9.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.236 1.014 . . . . 0.0 109.003 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.79 -42.2 95.23 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 127.625 2.37 . . . . 0.0 112.957 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.96 -46.26 2.03 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.776 1.23 . . . . 0.0 113.367 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.61 5.47 31.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.649 0.779 . . . . 0.0 111.794 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -170.2 2.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.419 1.887 . . . . 0.0 106.218 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 C-N-CA 128.891 2.877 . . . . 0.0 103.877 168.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 111.331 0.122 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -100.1 143.37 30.39 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.444 1.098 . . . . 0.0 109.132 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.06 145.69 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.38 129.94 44.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 127.601 2.36 . . . . 0.0 107.391 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -110.0 -84.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.961 0.904 . . . . 0.0 112.322 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.95 -63.48 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.394 1.878 . . . . 0.0 113.728 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.79 86.0 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.883 1.722 . . . . 0.0 109.9 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 177.68 -44.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.197 2.599 . . . . 0.0 107.489 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.65 131.35 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.653 0.781 . . . . 0.0 110.944 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.65 72.49 0.02 OUTLIER Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.492 0.568 . . . . 0.0 113.016 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 61.44 -59.4 0.1 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.575 2.75 . . . . 0.0 116.346 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -166.45 148.39 6.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.218 0.917 . . . . 0.0 109.095 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 t -149.94 166.74 28.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.684 1.594 . . . . 0.0 106.953 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -145.83 176.79 9.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.153 2.581 . . . . 0.0 104.038 168.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 49.0 m 117.26 -66.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.334 2.254 . . . . 0.0 109.144 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -74.16 33.19 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.498 -0.751 . . . . 0.0 111.057 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.9 -75.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 O-C-N 120.723 -1.236 . . . . 0.0 108.42 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.09 28.28 0.06 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.22 1.808 . . . . 0.0 115.144 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -130.58 -27.38 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.701 1.2 . . . . 0.0 112.186 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.55 125.73 91.15 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 119.344 0.975 . . . . 0.0 112.267 -169.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.9 121.7 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.911 2.407 . . . . 0.0 108.835 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t 76.25 24.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 111.314 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 36.87 40.69 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.486 2.314 . . . . 0.0 115.067 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.02 44.48 1.18 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 120.672 -1.267 . . . . 0.0 111.176 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.57 122.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.76 2.024 . . . . 0.0 106.14 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.63 143.02 50.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.238 1.415 . . . . 0.0 111.551 -167.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -76.06 135.31 39.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.63 38.23 3.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 105.977 -2.849 . . . . 0.0 105.977 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 65.72 -64.23 0.2 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.756 3.222 . . . . 0.0 110.189 -169.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.41 -27.29 66.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 112.6 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 172.19 18.66 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -91.85 151.35 20.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 125.39 15.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.624 2.77 . . . . 0.0 108.736 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -76.79 142.22 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.763 0.825 . . . . 0.0 109.288 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -80.72 108.92 11.21 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -74.9 -3.14 13.46 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.797 1.665 . . . . 0.0 113.263 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.44 -38.19 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.0 -33.07 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.762 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 t -55.53 123.39 13.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.227 0.921 . . . . 0.0 111.149 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 pt -88.75 35.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.176 0.99 . . . . 0.0 111.672 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.2 m-20 44.83 48.21 9.09 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.325 1.45 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.48 178.22 7.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.08 103.25 0.76 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.45 -56.67 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.08 0.94 . . . . 0.0 111.675 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.3 p -63.51 -43.02 98.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.699 0.8 . . . . 0.0 109.819 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.11 137.14 40.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.59 -0.694 . . . . 0.0 110.023 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.59 -18.33 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.199 1.4 . . . . 0.0 113.052 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.69 -36.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 t -62.76 118.1 38.44 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.33 -23.69 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.101 1.868 . . . . 0.0 112.025 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.39 -22.73 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.139 0.975 . . . . 0.0 110.569 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.6 m 54.05 51.52 14.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.661 1.184 . . . . 0.0 111.87 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.46 -19.64 30.96 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.961 0.904 . . . . 0.0 111.624 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.02 117.72 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -128.87 164.89 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.047 0.939 . . . . 0.0 108.793 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.54 144.89 55.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.07 -40.36 61.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.373 0.606 . . . . 0.0 112.456 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.91 -40.92 77.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.996 1.318 . . . . 0.0 111.854 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -80.09 -36.71 35.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.791 1.237 . . . . 0.0 110.234 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.27 126.41 36.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.493 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.18 144.56 37.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.228 2.618 . . . . 0.0 112.39 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -43.38 -45.87 6.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.407 2.683 . . . . 0.0 112.188 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -46.11 -43.98 15.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.271 1.029 . . . . 0.0 111.245 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -98.6 -6.39 30.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.37 1.868 . . . . 0.0 112.711 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -58.83 -22.32 58.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.437 1.472 . . . . 0.0 110.532 170.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 p -50.41 -44.75 55.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.618 167.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.06 -30.5 70.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.94 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.14 -48.26 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 120.89 1.677 . . . . 0.0 106.81 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -55.87 -47.76 76.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.125 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.37 -46.63 87.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.283 0.492 . . . . 0.0 111.713 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -56.55 -43.08 79.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.056 1.342 . . . . 0.0 109.794 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -61.38 -58.01 9.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 123.109 1.433 . . . . 0.0 108.335 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.36 -39.79 73.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.955 2.102 . . . . 0.0 112.933 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -38.88 -53.73 1.69 Allowed 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.684 1.194 . . . . 0.0 111.61 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.39 -29.55 11.97 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.43 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.7 78.34 4.2 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.431 -1.747 . . . . 0.0 108.02 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -95.96 135.56 37.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.4 t -134.66 139.3 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.035 0.534 . . . . 0.0 110.844 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.49 170.0 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.497 1.919 . . . . 0.0 110.54 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 p -140.74 -107.96 0.15 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -120.86 -54.39 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.4 -23.22 54.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.771 1.647 . . . . 0.0 111.935 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -53.32 -39.61 64.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 112.973 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.13 125.25 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.82 -147.0 4.63 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-O 123.203 1.446 . . . . 0.0 110.931 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 p -89.04 64.35 7.06 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 126.135 1.774 . . . . 0.0 109.429 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.87 0.48 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.919 0.888 . . . . 0.0 110.246 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.16 146.99 52.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.565 0.346 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.03 90.01 1.79 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.491 1.516 . . . . 0.0 107.507 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.4 m -144.14 -55.12 0.36 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.562 -0.711 . . . . 0.0 111.062 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.19 70.54 0.83 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.924 0.868 . . . . 0.0 109.523 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.1 -117.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.545 1.538 . . . . 0.0 108.613 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.02 7.48 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.361 1.864 . . . . 0.0 115.291 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.39 -25.4 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 110.102 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.2 t -69.34 126.09 92.43 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.04 0.382 . . . . 0.0 110.31 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -42.42 -38.21 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.738 4.292 . . . . 0.0 114.543 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -124.47 24.73 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 111.193 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t0 39.29 62.54 1.12 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.559 1.544 . . . . 0.0 113.152 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.1 p -125.17 51.82 1.65 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.523 0.729 . . . . 0.0 110.994 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.56 127.37 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.925 2.09 . . . . 0.0 106.462 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.93 133.45 30.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 119.796 1.18 . . . . 0.0 113.987 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.42 146.86 32.56 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.788 -1.195 . . . . 0.0 112.336 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.18 -50.1 0.43 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -54.67 0.82 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.513 1.525 . . . . 0.0 110.212 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -141.16 -49.66 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.908 2.483 . . . . 0.0 110.813 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.1 137.49 37.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.785 -0.572 . . . . 0.0 111.394 -168.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -75.21 102.14 4.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.838 0.828 . . . . 0.0 109.15 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.65 113.31 3.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.925 2.49 . . . . 0.0 106.911 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mt -78.59 130.96 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.12 119.68 71.63 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.754 0.706 . . . . 0.0 109.254 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.29 -27.05 16.84 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 121.706 1.604 . . . . 0.0 112.56 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -42.6 60.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.14 -33.34 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.795 -0.622 . . . . 0.0 112.243 -172.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -61.55 116.86 5.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.133 1.333 . . . . 0.0 110.998 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -83.23 35.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.974 0.91 . . . . 0.0 111.853 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.39 49.69 6.07 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.654 1.982 . . . . 0.0 113.259 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -161.81 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.609 0.764 . . . . 0.0 109.508 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.6 -125.49 4.46 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.88 -67.51 0.26 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 127.662 2.385 . . . . 0.0 110.408 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.3 p -56.61 -46.56 80.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.103 0.561 . . . . 0.0 110.242 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -44.92 78.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.144 0.978 . . . . 0.0 112.878 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.13 72.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.05 0.54 . . . . 0.0 110.655 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.7 -38.17 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.882 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 51' ' ' VAL . 13.9 t -59.86 114.7 10.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.4 18.91 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.242 2.628 . . . . 0.0 113.139 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.9 m -133.08 -25.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.85 2.86 . . . . 0.0 108.295 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 m 53.2 58.39 5.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.623 1.169 . . . . 0.0 111.242 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.71 -12.6 55.62 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.719 1.208 . . . . 0.0 111.322 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.81 128.5 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.02 170.5 15.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -58.49 143.31 46.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.22 -40.49 58.9 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -74.69 -26.5 59.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.376 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -71.04 -28.9 64.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.65 124.6 73.3 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.12 -0.467 . . . . 0.0 109.753 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.9 149.15 71.79 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.039 3.159 . . . . 0.0 112.573 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -44.26 -44.91 8.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.578 3.151 . . . . 0.0 113.772 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -48.05 -39.83 21.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.466 0.706 . . . . 0.0 111.472 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -105.79 -1.42 24.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.533 1.933 . . . . 0.0 112.66 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -57.83 -22.51 48.06 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.035 1.288 . . . . 0.0 109.336 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.93 -46.37 31.92 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.303 1.441 . . . . 0.0 110.221 168.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.32 -35.18 80.04 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.506 -0.746 . . . . 0.0 110.788 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.63 -37.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.781 1.173 . . . . 0.0 108.39 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -62.71 -46.89 86.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.171 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.5 -49.33 78.19 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.575 -0.703 . . . . 0.0 110.238 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -45.84 -44.7 14.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 127.612 2.365 . . . . 0.0 111.552 169.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -59.51 4.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.56 -44.48 62.73 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.522 1.929 . . . . 0.0 111.524 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -43.2 -42.81 4.39 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -115.51 19.73 15.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.153 0.581 . . . . 0.0 110.855 -174.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 77.99 1.5 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -113.43 142.04 46.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.51 144.38 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.321 1.048 . . . . 0.0 111.815 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.51 161.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.961 2.105 . . . . 0.0 110.916 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 p -148.96 163.73 36.62 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.623 0.725 . . . . 0.0 111.899 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.255 2.8 tt0 -15.1 -62.21 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.805 3.242 . . . . 0.0 116.838 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.53 -25.71 79.87 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 CA-C-N 122.008 1.753 . . . . 0.0 113.451 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -12.3 60.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.352 0.661 . . . . 0.0 111.612 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.09 85.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.268 -0.895 . . . . 0.0 109.204 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.04 58.42 0.57 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.22 1.39 . . . . 0.0 110.131 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.311 14.5 t 38.1 115.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.503 3.121 . . . . 0.0 116.728 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 61.97 -62.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.751 2.021 . . . . 0.0 114.075 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.6 t 66.01 -63.92 0.22 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.859 2.064 . . . . 0.0 112.396 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.94 24.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.004 1.722 . . . . 0.0 113.42 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.0 m -97.31 -48.68 5.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.675 0.39 . . . . 0.0 110.998 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -73.51 71.82 1.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.807 0.813 . . . . 0.0 109.137 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 152.78 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.763 1.625 . . . . 0.0 109.745 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 48.46 21.29 0.37 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.85 -16.92 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.456 0.703 . . . . 0.0 111.718 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -71.98 131.73 85.32 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -172.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -45.44 -37.23 14.37 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.026 3.817 . . . . 0.0 115.084 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 -15.06 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.959 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 t0 99.2 162.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.341 2.657 . . . . 0.0 108.951 -171.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.8 p 154.96 -9.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.608 2.763 . . . . 0.0 112.708 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.91 100.16 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.625 1.102 . . . . 0.0 110.253 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.96 142.52 45.56 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.128 0.971 . . . . 0.0 111.749 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.95 98.59 3.07 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.663 -1.273 . . . . 0.0 111.806 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.43 68.51 2.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 69.91 -59.9 0.49 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 130.066 3.346 . . . . 0.0 111.509 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -141.71 33.52 1.61 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.968 0.89 . . . . 0.0 112.235 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -166.05 140.27 4.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -80.13 114.99 19.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.07 117.93 35.67 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.953 2.501 . . . . 0.0 106.004 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.91 123.19 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.402 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 35.8 t0 -67.47 113.92 16.6 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.309 0.959 . . . . 0.0 108.589 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -61.24 -32.47 90.44 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.801 1.667 . . . . 0.0 110.699 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -77.12 -28.18 54.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -172.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.06 -32.97 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.171 0.441 . . . . 0.0 110.836 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 t -59.54 104.42 0.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.051 0.842 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.7 pt -78.82 46.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.936 -1.103 . . . . 0.0 111.262 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.37 -110.67 0.53 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.265 1.426 . . . . 0.0 109.401 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.83 -45.74 0.49 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.68 1.592 . . . . 0.0 114.386 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.42 -122.82 6.09 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.84 -75.09 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.9 1.28 . . . . 0.0 112.179 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -51.18 -43.46 61.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.201 1.0 . . . . 0.0 110.417 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -48.27 -59.92 3.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.224 1.41 . . . . 0.0 110.511 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.89 74.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.995 0.518 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 t -64.81 -36.54 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.894 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.7 t -63.83 114.3 13.03 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.15 46.09 2.14 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.352 2.702 . . . . 0.0 110.97 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -164.19 -29.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.739 2.415 . . . . 0.0 109.536 -169.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 m 57.59 58.55 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 110.315 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.59 -20.87 38.91 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.221 1.008 . . . . 0.0 110.673 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.87 116.39 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.1 166.85 12.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -54.26 -39.65 67.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -52.49 -43.63 65.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.073 0.949 . . . . 0.0 112.222 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.57 -34.33 53.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.406 1.082 . . . . 0.0 110.38 -169.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.26 124.17 59.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 118.213 -0.899 . . . . 0.0 109.57 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.67 146.12 56.09 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.01 2.474 . . . . 0.0 112.399 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.5 mp0 -41.75 -44.67 3.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -46.73 -44.01 18.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.592 0.757 . . . . 0.0 110.931 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -101.55 -1.65 32.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.375 1.87 . . . . 0.0 113.246 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.5 mmtm -57.91 -23.96 55.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.454 1.479 . . . . 0.0 108.92 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 p -48.18 -45.36 33.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.717 1.207 . . . . 0.0 110.623 168.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.33 -35.83 82.15 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 121.395 -0.815 . . . . 0.0 111.305 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -46.26 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.76 -44.81 73.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.384 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.39 -45.85 78.62 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.359 0.527 . . . . 0.0 112.047 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -59.61 -41.34 90.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.565 1.146 . . . . 0.0 111.135 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -58.42 -61.21 2.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -52.69 -52.47 55.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.864 2.466 . . . . 0.0 113.359 -170.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -34.99 -47.99 0.39 Allowed 'General case' 0 C--O 1.228 -0.07 0 O-C-N 125.427 1.705 . . . . 0.0 113.466 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.97 -2.84 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.705 0.628 . . . . 0.0 111.894 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.61 -34.1 40.94 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.035 0.834 . . . . 0.0 111.038 -173.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -110.35 149.08 30.73 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 117.964 0.347 . . . . 0.0 110.374 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -128.34 139.05 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.179 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.62 140.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 126.553 1.941 . . . . 0.0 107.833 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -129.79 172.44 11.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.163 0.585 . . . . 0.0 111.102 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -12.71 -59.59 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 129.408 3.083 . . . . 0.0 115.946 171.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.4 -17.74 59.25 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.894 1.712 . . . . 0.0 114.206 -173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.69 -31.82 73.22 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.139 0.882 . . . . 0.0 111.659 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -54.14 101.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.988 -169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.71 54.42 0.08 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.286 7.1 t 54.99 -160.09 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.134 1.774 . . . . 0.0 113.763 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -77.24 67.02 3.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.347 1.459 . . . . 0.0 111.189 -171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.32 -49.42 77.08 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.27 1.428 . . . . 0.0 110.989 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.86 -127.44 0.75 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.057 0.943 . . . . 0.0 109.329 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 m 75.98 -57.17 0.57 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.209 2.203 . . . . 0.0 110.853 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -57.21 -37.16 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.0 t -54.64 -62.21 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.062 0.945 . . . . 0.0 111.491 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -64.28 6.84 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -168.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.21 -12.06 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.975 1.261 . . . . 0.0 113.418 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.4 t -69.63 130.02 90.84 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.795 1.18 . . . . 0.0 110.7 -171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -57.12 -29.5 83.49 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.947 3.098 . . . . 0.0 113.749 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.4 67.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.214 0.606 . . . . 0.0 109.43 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 6.96 64.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 130.752 3.621 . . . . 0.0 115.354 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 p -116.33 37.51 3.69 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.561 0.744 . . . . 0.0 110.394 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.16 123.51 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 128.056 2.542 . . . . 0.0 105.485 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.32 165.12 25.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.367 1.867 . . . . 0.0 108.643 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -90.41 160.83 15.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.649 0.659 . . . . 0.0 110.351 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 68.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.3 84.01 0.16 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.853 2.061 . . . . 0.0 109.318 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.274 1.1 m-20 47.33 41.43 12.3 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.929 2.092 . . . . 0.0 114.875 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 160.18 28.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.768 2.827 . . . . 0.0 104.195 168.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -102.1 164.07 11.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 123.158 0.287 . . . . 0.0 110.637 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.31 148.62 41.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 106.958 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.2 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.82 123.42 89.2 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 119.621 1.101 . . . . 0.0 109.553 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.87 -28.25 16.78 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.348 1.365 . . . . 0.0 112.961 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -27.46 18.27 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.857 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -81.84 -29.58 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.816 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.32 118.61 9.58 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.428 1.013 . . . . 0.0 110.4 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 pt -88.74 32.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 123.673 0.789 . . . . 0.0 111.336 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 1.6 t70 42.3 52.52 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.953 2.101 . . . . 0.0 111.103 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.5 p -74.35 -44.73 51.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -168.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.85 86.09 1.25 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.64 -59.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.715 0.806 . . . . 0.0 110.65 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -54.97 -48.17 73.6 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.057 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -48.96 70.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.207 1.003 . . . . 0.0 111.422 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.63 77.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.272 0.629 . . . . 0.0 111.768 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.74 2.4 6.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 117.809 -1.091 . . . . 0.0 113.482 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' VAL . 12.9 t -87.44 102.33 3.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.05 15.59 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.694 2.929 . . . . 0.0 113.112 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.5 m -119.07 -27.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 129.624 3.17 . . . . 0.0 107.343 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 56.83 58.15 4.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.85 1.26 . . . . 0.0 110.15 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -20.1 33.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.187 0.995 . . . . 0.0 110.466 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.75 121.83 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -135.82 168.83 18.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -64.89 142.79 58.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -47.3 -43.91 22.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.09 -39.88 79.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.72 0.808 . . . . 0.0 111.538 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -77.06 -38.9 51.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.56 1.144 . . . . 0.0 110.681 -168.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.88 122.68 14.29 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.191 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.97 146.61 46.46 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.299 2.666 . . . . 0.0 112.668 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.4 mp0 -41.47 -45.5 3.21 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.512 3.125 . . . . 0.0 113.735 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -46.31 -44.73 16.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.851 0.834 . . . . 0.0 110.894 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.93 -0.43 39.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.315 1.846 . . . . 0.0 112.83 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.0 mmtm -59.21 -22.44 61.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.621 1.555 . . . . 0.0 109.341 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 p -48.46 -46.1 37.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.441 1.096 . . . . 0.0 109.764 168.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -62.55 -34.45 76.97 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.322 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.4 -35.53 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 120.849 1.659 . . . . 0.0 109.403 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -62.69 -50.14 72.3 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -48.05 83.51 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.192 0.597 . . . . 0.0 111.384 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -42.25 -47.93 4.84 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 129.591 3.156 . . . . 0.0 112.368 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -61.36 1.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.33 -31.0 65.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.301 1.84 . . . . 0.0 113.616 -170.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.36 17.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.202 0.601 . . . . 0.0 111.828 174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -113.31 -33.25 6.01 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.251 0.621 . . . . 0.0 110.747 -170.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.75 140.9 33.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.67 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -103.92 145.92 29.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.586 0.754 . . . . 0.0 108.981 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t -132.36 141.93 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.276 1.031 . . . . 0.0 111.37 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.72 139.8 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.341 1.856 . . . . 0.0 109.177 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.2 p -126.95 174.36 8.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.736 0.815 . . . . 0.0 111.289 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -12.91 -59.62 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.957 2.903 . . . . 0.0 115.577 169.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.09 -12.48 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 121.181 1.458 . . . . 0.0 114.23 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -70.23 -33.86 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.075 0.852 . . . . 0.0 111.951 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.41 127.65 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.527 0.603 . . . . 0.0 109.753 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.6 48.7 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m 52.15 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 116.241 168.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm 73.9 -64.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.742 2.817 . . . . 0.0 113.247 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 t 60.71 -67.36 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.237 1.415 . . . . 0.0 112.165 -170.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.51 34.32 6.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.364 1.866 . . . . 0.0 113.339 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 m -89.9 -47.72 7.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 111.227 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 p -72.92 69.99 0.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.724 0.773 . . . . 0.0 109.36 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.71 -96.48 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.553 1.141 . . . . 0.0 109.594 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.51 24.71 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.699 1.599 . . . . 0.0 115.133 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.01 -25.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.479 1.512 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.11 121.79 86.03 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.254 0.933 . . . . 0.0 110.765 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.2 -38.17 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 125.261 3.974 . . . . 0.0 114.148 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -116.16 18.77 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.953 0.901 . . . . 0.0 111.804 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t0 42.9 52.25 5.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.699 1.2 . . . . 0.0 112.658 172.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.9 p -107.42 26.95 9.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.765 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.29 126.7 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.364 1.466 . . . . 0.0 109.09 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -136.77 170.28 16.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.892 1.677 . . . . 0.0 107.868 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -100.52 156.74 17.12 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 122.146 0.974 . . . . 0.0 113.209 169.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.87 73.54 0.45 Allowed Glycine 0 N--CA 1.444 -0.77 1 N-CA-C 102.848 -4.101 . . . . 0.0 102.848 167.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 61.98 -66.58 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 131.206 3.803 . . . . 0.0 112.59 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -102.56 -21.14 14.23 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.295 1.438 . . . . 0.0 112.452 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.75 163.68 31.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.221 -169.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -81.41 164.36 22.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 123.574 0.546 . . . . 0.0 110.27 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -143.77 120.6 11.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.516 2.326 . . . . 0.0 106.114 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.09 134.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.433 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 32.3 t0 -77.47 112.33 23.22 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 168.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.11 -28.33 41.1 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.74 1.626 . . . . 0.0 110.768 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -78.61 -25.42 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.4 t -89.61 -36.44 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 118.694 0.679 . . . . 0.0 111.868 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.3 t -55.08 136.52 48.04 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.62 1.1 . . . . 0.0 110.722 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.64 38.4 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.476 1.111 . . . . 0.0 111.408 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 44.53 55.47 5.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.438 1.495 . . . . 0.0 112.198 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -159.66 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.705 0.402 . . . . 0.0 111.358 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.47 109.42 0.59 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 169.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -168.63 -66.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.706 1.202 . . . . 0.0 110.094 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.0 p -54.74 -44.44 73.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.99 0.916 . . . . 0.0 111.159 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -50.94 70.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.158 0.583 . . . . 0.0 111.972 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.66 78.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.031 0.532 . . . . 0.0 110.889 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.07 -37.09 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.836 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 t -73.5 106.97 2.77 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 108.706 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.17 -14.0 41.65 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.615 1.544 . . . . 0.0 111.805 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.26 -21.53 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.283 1.433 . . . . 0.0 109.974 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 53.48 58.85 4.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.254 1.022 . . . . 0.0 110.987 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.98 46.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.854 0.862 . . . . 0.0 110.551 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.82 125.08 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.82 167.59 20.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.13 145.4 55.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -48.84 -46.41 42.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.508 0.671 . . . . 0.0 111.048 174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.8 -38.11 60.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.012 1.725 . . . . 0.0 111.109 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -82.77 -41.25 19.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.284 1.034 . . . . 0.0 110.437 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.26 121.81 27.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.752 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.31 147.69 54.73 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.403 2.735 . . . . 0.0 112.531 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -39.98 -46.6 2.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.517 3.127 . . . . 0.0 113.399 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -45.53 -43.72 12.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.699 0.8 . . . . 0.0 111.148 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -102.11 -0.49 33.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.524 1.93 . . . . 0.0 113.08 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -57.9 -25.76 61.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.86 1.663 . . . . 0.0 109.23 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -46.87 -46.41 21.01 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.029 1.332 . . . . 0.0 110.272 168.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -64.31 -34.89 79.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.656 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.66 -47.11 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 120.869 1.668 . . . . 0.0 106.952 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -58.75 -43.69 90.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.956 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -64.1 -44.39 92.46 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.367 0.531 . . . . 0.0 111.766 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -59.11 -43.0 91.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.675 1.59 . . . . 0.0 110.497 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -56.7 -60.13 4.01 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.86 -42.06 88.51 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.132 2.573 . . . . 0.0 112.651 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -37.41 -50.41 1.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 112.276 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.18 -21.58 13.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 -170.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -78.91 81.62 5.17 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 170.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.964 -1.493 . . . . 0.0 108.376 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.418 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.79 141.05 33.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.947 0.499 . . . . 0.0 109.998 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.39 143.26 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.836 0.855 . . . . 0.0 110.264 -173.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.08 161.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 110.552 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 p -148.49 174.55 11.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.015 0.926 . . . . 0.0 109.198 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -10.2 -61.71 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 128.661 2.785 . . . . 0.0 116.071 170.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.85 -17.16 58.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 CA-C-N 121.494 1.569 . . . . 0.0 113.694 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.67 -31.24 72.15 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.741 0.701 . . . . 0.0 112.03 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.17 91.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.806 0.812 . . . . 0.0 110.14 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.89 85.43 0.16 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.092 2.282 . . . . 0.0 107.639 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.287 6.5 t -6.85 99.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.466 2.706 . . . . 0.0 117.096 -172.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp 56.09 41.62 29.35 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.486 2.314 . . . . 0.0 113.108 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -46.36 -52.11 13.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.741 1.617 . . . . 0.0 112.472 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.04 -121.58 0.72 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.81 0.844 . . . . 0.0 109.229 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m 68.86 -57.38 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.056 1.743 . . . . 0.0 111.634 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.3 p -70.21 64.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 0.0 108.671 169.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.36 152.36 21.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 126.053 1.741 . . . . 0.0 108.0 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 61.12 -10.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.982 2.215 . . . . 0.0 116.982 173.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m -90.55 -24.62 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.812 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -72.76 125.52 91.15 Favored Pre-proline 0 CA--C 1.538 0.512 0 O-C-N 122.211 -0.306 . . . . 0.0 110.19 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.15 -31.54 55.44 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.278 3.318 . . . . 0.0 113.531 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.17 19.92 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.89 0.876 . . . . 0.0 111.853 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.6 t70 41.23 56.39 3.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.065 1.346 . . . . 0.0 113.202 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -110.85 36.19 3.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.681 0.793 . . . . 0.0 111.006 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 131.96 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 106.713 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -142.1 174.65 10.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.815 1.646 . . . . 0.0 107.749 -169.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -107.94 160.39 15.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.117 0.96 . . . . 0.0 113.095 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.36 67.65 0.56 Allowed Glycine 0 N--CA 1.445 -0.716 1 N-CA-C 102.732 -4.147 . . . . 0.0 102.732 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 64.41 -63.22 0.17 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 131.096 3.758 . . . . 0.0 112.631 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -101.74 -20.5 14.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 112.57 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.45 162.81 38.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.12 -0.987 . . . . 0.0 108.62 -169.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -85.05 162.72 19.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.75 0.656 . . . . 0.0 110.911 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -145.19 131.45 19.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.789 2.436 . . . . 0.0 106.495 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.82 129.31 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 13.3 t0 -69.13 113.95 20.06 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.327 0.967 . . . . 0.0 109.192 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -28.94 71.1 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.385 1.39 . . . . 0.0 112.304 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -31.48 23.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.092 -0.48 . . . . 0.0 109.763 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.74 -28.29 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.247 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -58.94 119.53 7.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.946 1.248 . . . . 0.0 111.09 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 pt -91.65 33.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.103 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 27.9 m-20 43.92 58.98 3.35 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.015 1.326 . . . . 0.0 112.592 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.94 -173.86 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.98 172.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.58 104.4 0.8 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -163.03 -75.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.243 1.017 . . . . 0.0 110.025 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.4 p -50.83 -44.39 59.3 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.601 1.161 . . . . 0.0 112.365 -172.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -39.14 90.54 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.544 -0.722 . . . . 0.0 111.658 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.01 -36.92 67.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.812 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.0 t -65.86 -43.23 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.948 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 t -58.65 112.95 5.67 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 119.272 0.942 . . . . 0.0 108.665 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.28 42.35 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.621 2.881 . . . . 0.0 111.08 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.1 -34.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 128.979 2.911 . . . . 0.0 107.8 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m 57.13 59.85 3.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.276 1.031 . . . . 0.0 110.085 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.65 -23.99 56.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.476 1.51 . . . . 0.0 109.873 169.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.94 116.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.402 1.481 . . . . 0.0 107.008 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -122.87 166.45 15.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.82 145.39 52.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -44.05 62.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.615 -0.678 . . . . 0.0 111.995 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.49 -16.7 63.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.246 1.019 . . . . 0.0 112.597 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -80.8 -38.51 28.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.83 121.07 62.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.822 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -54.03 148.6 38.44 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.717 2.945 . . . . 0.0 112.119 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -52.88 -41.43 64.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.679 1.191 . . . . 0.0 110.728 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -44.34 -47.92 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.067 1.347 . . . . 0.0 111.292 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -95.9 -8.56 33.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.694 1.198 . . . . 0.0 112.08 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -59.95 -16.79 32.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 119.524 1.056 . . . . 0.0 110.869 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -50.56 -47.57 57.73 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.624 -0.673 . . . . 0.0 109.427 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -63.63 -37.34 86.95 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 121.651 -0.656 . . . . 0.0 111.18 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -45.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -55.89 -45.03 78.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -64.07 -45.89 86.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.605 0.639 . . . . 0.0 112.202 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -55.69 -41.58 73.96 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.417 1.487 . . . . 0.0 110.876 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -63.78 -58.44 6.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.1 -46.04 75.5 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.058 1.743 . . . . 0.0 112.833 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -34.76 -53.5 0.55 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.729 1.212 . . . . 0.0 112.298 -173.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -106.71 1.7 25.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 124.438 1.087 . . . . 0.0 112.315 -170.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 11.8 mptt -102.72 -8.65 20.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.778 0.717 . . . . 0.0 112.667 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -119.7 152.42 37.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.42 0.555 . . . . 0.0 109.704 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.9 140.6 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.976 0.911 . . . . 0.0 110.613 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 127.344 2.257 . . . . 0.0 107.968 169.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -113.75 -89.97 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -134.46 -52.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -167.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.67 -25.16 74.19 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.935 1.757 . . . . 0.0 113.529 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.12 -37.32 66.74 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.832 0.853 . . . . 0.0 112.294 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.292 3.6 mp -69.01 96.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 122.181 0.991 . . . . 0.0 112.574 -168.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.3 -171.89 14.58 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 103.471 -3.852 . . . . 0.0 103.471 169.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.95 105.33 1.97 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.561 1.944 . . . . 0.0 111.789 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm 62.58 -63.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.638 2.375 . . . . 0.0 115.528 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t 66.03 -89.42 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.827 2.051 . . . . 0.0 112.093 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 96.54 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.341 2.657 . . . . 0.0 108.68 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m 73.92 -57.66 0.61 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.406 2.282 . . . . 0.0 111.584 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.52 -24.47 61.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.34 1.056 . . . . 0.0 111.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.26 7.9 p -72.55 -52.19 24.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 O-C-N 121.345 -0.847 . . . . 0.0 112.27 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -74.13 17.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.46 -20.51 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.68 129.25 94.29 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 120.476 1.489 . . . . 0.0 109.711 -172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.01 -42.32 25.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.801 3.667 . . . . 0.0 113.3 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.72 110.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -31.01 120.25 0.21 Allowed 'General case' 0 C--O 1.23 0.077 0 C-N-CA 126.101 1.76 . . . . 0.0 114.686 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.7 m -133.7 16.93 3.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 108.036 168.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.62 110.99 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -115.92 145.75 42.64 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -166.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.82 78.08 3.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 122.483 1.135 . . . . 0.0 108.861 169.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.66 97.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.26 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -125.0 -74.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.751 1.221 . . . . 0.0 107.803 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -135.71 -39.25 0.72 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.144 0.978 . . . . 0.0 113.12 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 170.88 8.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.488 1.915 . . . . 0.0 108.954 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.02 127.19 32.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.86 -172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -109.19 117.18 33.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.849 3.26 . . . . 0.0 106.976 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 129.09 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.88 0.764 . . . . 0.0 109.487 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.14 112.91 26.23 Favored Pre-proline 0 C--O 1.232 0.181 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.8 -29.74 50.32 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.41 1.407 . . . . 0.0 111.203 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -82.63 -29.64 29.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.293 0.637 . . . . 0.0 109.608 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.94 -33.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.562 0.619 . . . . 0.0 110.932 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.9 t -52.07 120.66 5.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.323 0.965 . . . . 0.0 111.436 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.58 35.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.738 0.815 . . . . 0.0 112.112 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.465 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 45.04 50.08 9.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 0.0 113.496 176.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.31 -167.51 1.8 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.55 101.02 0.44 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 169.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.7 -76.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.094 0.947 . . . . 0.0 110.042 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.2 p -48.16 -46.06 34.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.759 1.224 . . . . 0.0 111.844 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -50.9 71.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.956 0.902 . . . . 0.0 112.18 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.34 70.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.15 0.58 . . . . 0.0 110.828 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 t -69.65 -38.81 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.236 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.4 t -57.73 111.67 3.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.753 1.16 . . . . 0.0 109.67 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 -14.26 41.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.501 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.91 -22.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.265 1.426 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m 53.16 57.25 6.47 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 111.258 -171.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.97 -19.85 29.8 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 111.444 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.99 127.99 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 124.989 1.316 . . . . 0.0 107.649 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -139.65 168.45 19.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.21 148.21 52.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -53.28 -42.8 66.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.76 -23.22 60.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.819 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.58 -35.87 52.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.19 125.26 70.12 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.631 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.82 141.91 64.46 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.442 2.761 . . . . 0.0 112.148 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' CD ' ' HZ1' ' A' ' 65' ' ' LYS . 2.2 mp0 -35.37 -51.3 0.59 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.403 2.681 . . . . 0.0 113.461 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.48 -46.89 14.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.953 0.882 . . . . 0.0 110.617 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -95.18 -3.13 48.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.464 1.506 . . . . 0.0 112.629 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 36.3 mttp -60.34 -22.53 63.34 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.531 1.514 . . . . 0.0 110.119 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -48.58 -41.75 31.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.317 0.647 . . . . 0.0 110.294 167.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -68.44 -32.49 72.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.245 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.84 -46.84 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 121.135 1.789 . . . . 0.0 107.365 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.08 -49.12 72.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.017 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -63.71 -43.25 97.15 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -61.32 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.489 1.515 . . . . 0.0 110.297 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -57.23 13.41 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.32 -42.38 99.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 128.375 2.67 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -37.15 -51.84 1.01 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.414 1.086 . . . . 0.0 112.836 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.34 4.14 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.795 0.838 . . . . 0.0 111.503 -170.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 80.63 1.33 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.032 -1.937 . . . . 0.0 107.365 -169.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.484 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -90.18 161.59 15.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.195 0.521 . . . . 0.0 111.294 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.19 149.58 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.339 1.055 . . . . 0.0 110.794 -172.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.45 138.71 25.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.979 1.312 . . . . 0.0 109.196 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -128.79 170.84 12.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 111.939 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.25 7.8 tt0 -12.25 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 129.756 3.222 . . . . 0.0 116.657 171.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.66 -19.74 54.66 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 122.559 1.95 . . . . 0.0 114.572 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -68.07 -29.1 67.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.071 0.851 . . . . 0.0 111.895 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.7 mt -44.18 110.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.3 0 C-N-CA 124.576 1.15 . . . . 0.0 113.188 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 38.47 0.07 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.9 m 57.51 -83.63 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.954 2.101 . . . . 0.0 113.258 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -124.86 110.46 14.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.601 0.761 . . . . 0.0 109.556 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -129.76 163.82 25.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.446 2.299 . . . . 0.0 105.242 170.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.71 -130.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.6 m 73.6 -68.17 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.601 2.36 . . . . 0.0 110.569 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 p -59.57 -28.44 67.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.826 0.451 . . . . 0.0 110.392 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.58 -66.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.39 1.076 . . . . 0.0 111.846 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -76.95 38.68 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.782 1.233 . . . . 0.0 113.839 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.45 -33.48 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.17 0.988 . . . . 0.0 113.195 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.03 122.6 73.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 120.064 1.302 . . . . 0.0 112.305 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.73 -31.06 91.5 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.841 3.028 . . . . 0.0 112.842 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.9 16.6 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.332 0.653 . . . . 0.0 112.237 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.8 t0 44.2 56.37 4.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.225 . . . . 0.0 112.405 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.7 p -115.63 32.42 6.08 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.563 0.745 . . . . 0.0 110.943 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.68 114.99 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.572 2.349 . . . . 0.0 107.818 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -128.75 173.8 10.01 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 126.198 1.799 . . . . 0.0 109.72 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -119.89 165.2 14.93 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.009 1.323 . . . . 0.0 113.925 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -128.68 13.67 6.13 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.821 1.677 . . . . 0.0 110.571 167.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 73.9 12.48 4.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.958 2.503 . . . . 0.0 112.774 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -123.54 -48.35 1.94 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 128.789 2.836 . . . . 0.0 109.611 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.83 176.25 10.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.032 2.133 . . . . 0.0 105.371 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.52 166.65 19.11 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.197 0.522 . . . . 0.0 110.269 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -145.39 109.67 4.92 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.767 2.027 . . . . 0.0 107.184 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.89 133.09 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -74.54 111.49 13.21 Favored Pre-proline 0 C--N 1.343 0.301 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 167.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -58.38 -33.53 97.9 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.111 1.207 . . . . 0.0 111.591 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -80.26 -29.83 38.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.705 -0.622 . . . . 0.0 110.599 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.3 -30.68 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.68 125.02 20.4 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.042 0.837 . . . . 0.0 111.308 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 pt -99.05 32.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.258 1.023 . . . . 0.0 111.347 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 26.3 m-20 46.4 41.7 9.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.78 1.632 . . . . 0.0 113.691 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -21.92 59.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.287 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.44 -139.23 25.33 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.847 1.213 . . . . 0.0 110.682 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.48 -60.55 0.5 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.836 2.054 . . . . 0.0 111.409 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -52.31 -40.46 61.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.911 0.884 . . . . 0.0 111.374 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -46.19 80.73 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.768 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.49 76.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.359 0.663 . . . . 0.0 110.292 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.4 -37.76 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.147 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 t -61.21 116.15 18.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.01 1.277 . . . . 0.0 108.103 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.89 -19.83 49.43 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.1 1.867 . . . . 0.0 112.777 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.27 -19.09 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.305 1.442 . . . . 0.0 110.235 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.0 m 51.9 58.36 5.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.359 1.064 . . . . 0.0 111.137 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.17 -13.4 59.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.071 0.948 . . . . 0.0 111.596 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.11 129.81 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.82 179.45 6.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.428 ' CD2' ' H1 ' ' A' ' 1' ' ' ALA . 7.8 t-80 -79.51 145.35 33.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -48.31 -42.47 31.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.02 -39.82 87.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.223 0.535 . . . . 0.0 112.274 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -76.88 -32.41 57.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.517 -168.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.72 128.89 80.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.083 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.79 143.55 47.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.157 2.571 . . . . 0.0 112.4 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -44.05 -44.93 7.75 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.603 2.761 . . . . 0.0 112.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -46.77 -47.73 20.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.086 0.954 . . . . 0.0 110.843 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -93.17 -6.2 48.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.402 1.481 . . . . 0.0 112.301 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -59.85 -16.04 25.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.273 1.397 . . . . 0.0 110.869 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 p -52.73 -47.35 67.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.064 -1.022 . . . . 0.0 108.998 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -65.76 -30.16 70.77 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.355 -0.831 . . . . 0.0 111.621 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.04 -49.85 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -54.32 -41.87 69.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.421 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -49.98 66.75 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.624 0.647 . . . . 0.0 112.351 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.22 -42.18 69.51 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.371 1.468 . . . . 0.0 109.71 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -58.55 7.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.1 -44.38 83.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.887 2.475 . . . . 0.0 112.923 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -38.28 -50.99 1.49 Allowed 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.383 1.073 . . . . 0.0 112.664 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -102.74 -15.08 16.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 111.483 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 73.82 8.64 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 116.429 -1.748 . . . . 0.0 107.601 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -108.27 145.21 34.69 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.317 1.447 . . . . 0.0 110.864 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.09 140.54 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.714 1.206 . . . . 0.0 111.51 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -37.92 71.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 C-N-CA 126.123 1.769 . . . . 0.0 112.133 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p 63.36 -108.08 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.712 2.405 . . . . 0.0 114.24 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.92 -52.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -167.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.75 77.64 2.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.014 1.81 . . . . 0.0 111.077 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -178.03 -41.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.238 2.615 . . . . 0.0 108.026 -170.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.94 143.75 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 124.116 0.966 . . . . 0.0 113.024 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.59 32.98 58.89 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 124.954 1.264 . . . . 0.0 112.146 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -161.47 103.24 1.22 Allowed 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.253 1.421 . . . . 0.0 108.097 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -53.16 -39.11 63.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.091 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.9 t 66.71 -68.14 0.15 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 113.756 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.09 42.2 28.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.767 1.627 . . . . 0.0 112.472 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.4 m -100.51 -50.15 3.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.287 0.635 . . . . 0.0 111.228 171.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.3 p -75.16 68.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.762 0.791 . . . . 0.0 109.766 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.95 151.43 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.903 1.681 . . . . 0.0 109.043 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 59.01 29.74 19.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.701 1.6 . . . . 0.0 111.899 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.35 -38.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.366 1.066 . . . . 0.0 111.498 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.11 131.56 93.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.423 0.689 . . . . 0.0 110.201 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -45.95 -36.63 16.0 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 125.274 3.983 . . . . 0.0 114.229 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.71 19.48 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.051 0.94 . . . . 0.0 111.405 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 40.64 44.25 1.77 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 113.316 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.4 p -90.2 46.73 1.37 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.291 1.037 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.63 125.74 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.063 1.745 . . . . 0.0 106.564 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -133.8 166.57 22.34 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 124.791 1.237 . . . . 0.0 107.882 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -98.48 140.75 32.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 120.206 1.366 . . . . 0.0 112.096 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.79 -50.61 4.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 166.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 175.33 -74.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.516 3.126 . . . . 0.0 105.008 168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.32 10.23 7.41 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.057 1.343 . . . . 0.0 113.023 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.84 153.23 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.08 161.99 22.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.857 0.723 . . . . 0.0 110.233 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -134.53 111.89 10.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.861 2.865 . . . . 0.0 105.325 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.52 138.57 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.421 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 21.0 t0 -78.9 108.16 7.59 Favored Pre-proline 0 N--CA 1.464 0.268 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -76.67 -3.31 13.64 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.319 1.346 . . . . 0.0 112.479 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.89 -38.36 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 109.983 169.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.86 -31.19 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 t -57.19 131.18 49.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.243 0.929 . . . . 0.0 111.211 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.2 pt -103.99 37.19 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.669 1.187 . . . . 0.0 111.53 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 28.0 m-20 52.23 37.06 21.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.393 1.477 . . . . 0.0 114.017 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -20.81 39.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.49 -140.45 24.42 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.03 -57.06 0.57 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 127.359 2.264 . . . . 0.0 111.386 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.2 -37.15 71.76 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.615 0.766 . . . . 0.0 111.188 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -43.28 86.14 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.3 -0.875 . . . . 0.0 110.912 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.17 84.01 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.861 0.464 . . . . 0.0 110.683 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.6 t -67.35 -40.29 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.043 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -58.38 115.62 12.13 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.95 61.44 7.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.952 3.101 . . . . 0.0 109.14 -172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 174.93 -36.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.813 2.445 . . . . 0.0 108.593 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m 58.31 53.88 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.086 0.954 . . . . 0.0 110.864 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.285 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.25 121.43 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -118.26 164.13 15.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -71.69 147.28 47.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.79 -36.96 70.48 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.265 1.031 . . . . 0.0 113.183 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.51 -46.21 66.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.307 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -76.48 -36.44 57.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.616 1.167 . . . . 0.0 110.927 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -52.46 122.14 24.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.5 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.03 147.32 64.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.3 2.667 . . . . 0.0 112.81 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 4.6 mp0 -39.69 -47.06 1.96 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.831 3.252 . . . . 0.0 113.537 174.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.06 -43.42 14.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.769 0.828 . . . . 0.0 111.11 172.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -102.13 -1.68 30.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.617 1.967 . . . . 0.0 112.87 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.5 mmtm -55.52 -28.81 56.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.588 1.54 . . . . 0.0 109.501 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 p -48.78 -45.49 40.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.054 1.342 . . . . 0.0 111.566 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -67.81 -32.68 73.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.549 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.94 -47.67 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 120.73 1.605 . . . . 0.0 108.283 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -49.99 -53.67 25.02 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.62 93.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.763 0.256 . . . . 0.0 111.204 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.535 0.734 . . . . 0.0 111.111 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -62.85 -57.89 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.934 1.35 . . . . 0.0 109.202 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -59.64 -38.98 82.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.848 2.859 . . . . 0.0 112.25 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -37.33 -57.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 171.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -97.48 -31.58 12.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.806 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -76.56 81.38 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.998 -1.477 . . . . 0.0 108.007 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -101.47 136.71 40.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.934 1.294 . . . . 0.0 108.604 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.7 142.75 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.367 0.667 . . . . 0.0 111.219 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.11 157.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.187 1.795 . . . . 0.0 111.179 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -145.77 160.08 42.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.341 3.6 tt0 1.2 -66.14 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 130.068 3.347 . . . . 0.0 117.445 169.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.04 -25.71 55.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 122.76 2.021 . . . . 0.0 114.633 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 t -57.29 -33.98 68.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 112.177 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.63 83.44 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.646 0.736 . . . . 0.0 111.032 -169.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.88 65.11 0.6 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.148 1.832 . . . . 0.0 108.876 171.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.256 14.2 t 50.13 -156.42 0.1 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.919 1.688 . . . . 0.0 112.435 -175.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -77.4 100.72 6.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.942 0.877 . . . . 0.0 110.56 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.62 177.62 8.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.149 1.78 . . . . 0.0 109.687 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.42 134.33 12.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m 156.42 -68.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.348 2.259 . . . . 0.0 107.412 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.89 40.29 0.24 Allowed 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.564 -0.71 . . . . 0.0 110.876 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.71 -73.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.069 0 O-C-N 120.548 -1.345 . . . . 0.0 107.988 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -80.85 41.5 0.58 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.88 -35.7 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.35 127.91 93.34 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.378 0.99 . . . . 0.0 110.925 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.96 -36.4 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.945 3.763 . . . . 0.0 114.218 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.75 45.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.802 0.841 . . . . 0.0 111.213 -169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 55.62 -115.18 0.91 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.049 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.16 -19.64 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.78 103.26 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.95 1.3 . . . . 0.0 109.824 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.27 142.63 47.29 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.632 1.173 . . . . 0.0 111.823 -169.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -75.8 77.72 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.601 1.091 . . . . 0.0 109.369 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.97 -43.02 96.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.666 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -111.55 -120.72 0.29 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -101.16 -8.79 21.91 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 111.071 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.36 161.87 28.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.425 2.69 . . . . 0.0 108.536 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.49 120.99 25.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.348 0.659 . . . . 0.0 112.255 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 124.14 47.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.441 3.096 . . . . 0.0 106.421 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt -89.34 125.33 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 118.125 -0.94 . . . . 0.0 108.516 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 36.1 t0 -70.24 113.44 17.97 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 120.134 1.334 . . . . 0.0 108.417 169.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -61.9 -31.85 84.86 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 121.277 1.318 . . . . 0.0 110.975 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -79.86 -21.14 44.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.871 -0.518 . . . . 0.0 110.369 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -88.09 -37.55 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.334 0.516 . . . . 0.0 110.706 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.08 148.18 36.73 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.807 0.731 . . . . 0.0 111.207 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 pt -122.62 38.46 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.255 1.422 . . . . 0.0 111.017 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 46.94 39.69 7.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.323 1.849 . . . . 0.0 112.615 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.17 159.0 32.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.829 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.44 63.65 4.38 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.03 174.33 15.38 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 124.373 1.069 . . . . 0.0 108.233 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.283 4.8 p 66.39 -56.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.387 2.275 . . . . 0.0 111.644 -169.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -66.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.992 0.917 . . . . 0.0 111.67 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.83 64.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.261 0.624 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.63 -35.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.555 0.742 . . . . 0.0 109.484 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -60.74 114.07 9.33 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 -2.5 7.72 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.299 2.0 . . . . 0.0 113.026 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -108.8 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.242 1.817 . . . . 0.0 109.894 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.3 m 52.48 55.28 9.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.054 0.942 . . . . 0.0 111.563 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.36 -16.17 50.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 111.058 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.98 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -133.75 167.66 20.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.59 145.15 56.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.58 171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.5 -41.03 65.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.42 -31.42 72.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.806 0.843 . . . . 0.0 110.885 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -81.45 -36.74 29.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.439 0.695 . . . . 0.0 109.945 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -48.92 127.5 14.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.339 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.01 142.51 64.95 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 0.0 112.125 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -41.66 -45.78 3.52 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.755 2.822 . . . . 0.0 112.784 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -47.68 -46.13 28.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.141 0.976 . . . . 0.0 110.882 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -96.19 -6.58 37.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.494 1.518 . . . . 0.0 112.578 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -58.87 -19.9 46.14 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.26 1.391 . . . . 0.0 110.422 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -49.84 -46.71 51.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.705 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -62.7 -35.83 80.97 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.171 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.66 -45.59 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.717 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -65.27 -46.5 80.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.365 0.529 . . . . 0.0 111.654 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -58.24 -42.54 86.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 110.885 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -57.81 -61.64 2.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.719 1.208 . . . . 0.0 108.028 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -52.25 -51.74 56.65 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.801 2.44 . . . . 0.0 113.054 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -50.92 0.29 Allowed 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.175 1.79 . . . . 0.0 113.695 -175.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -110.02 -1.14 17.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.715 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.53 -34.31 41.25 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.165 0.893 . . . . 0.0 111.162 -174.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -109.56 142.62 40.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.027 1.331 . . . . 0.0 109.746 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.07 141.04 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.462 1.105 . . . . 0.0 110.705 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -48.37 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 128.433 2.693 . . . . 0.0 114.316 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p 61.19 -165.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.66 1.584 . . . . 0.0 114.065 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.05 -48.93 59.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 129.446 3.099 . . . . 0.0 115.726 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.09 -22.4 74.16 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 CA-C-N 121.322 1.508 . . . . 0.0 113.327 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -58.33 -34.08 70.23 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.444 0.697 . . . . 0.0 112.026 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -71.14 84.15 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.683 0.754 . . . . 0.0 110.814 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.15 58.28 0.7 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.597 2.046 . . . . 0.0 108.608 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.266 14.5 t 49.23 -150.01 0.2 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.022 1.729 . . . . 0.0 113.025 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 16.2 mmtm -66.56 81.62 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.936 1.695 . . . . 0.0 112.157 -172.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.7 t -66.22 151.37 47.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.995 0.918 . . . . 0.0 109.598 169.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.44 44.19 2.31 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.263 1.025 . . . . 0.0 109.508 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -150.49 144.15 25.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.386 5.7 p 74.01 49.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.657 2.383 . . . . 0.0 108.466 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 -43.28 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.624 1.97 . . . . 0.0 109.246 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.07 27.04 2.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.756 2.822 . . . . 0.0 113.498 -168.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.5 -37.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -168.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 t -59.34 123.66 71.27 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.698 1.135 . . . . 0.0 112.535 -168.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.93 -47.21 19.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 1 C-N-CA 125.318 4.012 . . . . 0.0 113.144 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -133.65 84.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -17.37 112.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.984 2.114 . . . . 0.0 114.544 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m -121.97 1.14 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.135 1.374 . . . . 0.0 109.94 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.14 106.4 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.222 0.919 . . . . 0.0 112.433 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -125.95 144.28 50.75 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.081 0.953 . . . . 0.0 110.191 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 12' ' ' LYS . 56.8 mt-10 -74.39 118.39 17.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 120.157 1.344 . . . . 0.0 111.93 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.66 75.08 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 104.781 -3.327 . . . . 0.0 104.781 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 71.94 -47.83 0.67 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.602 2.761 . . . . 0.0 112.152 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.01 -12.5 1.46 Allowed 'General case' 0 C--N 1.34 0.181 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.04 34.52 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.06 135.83 49.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 109.989 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 128.74 54.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.066 3.346 . . . . 0.0 104.545 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.0 mt -93.48 124.86 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.78 116.04 33.88 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.056 1.298 . . . . 0.0 108.201 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.91 -20.35 17.17 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.959 1.773 . . . . 0.0 111.605 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -88.39 -30.68 19.32 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.58 -38.6 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.41 171.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.43 146.28 51.86 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.528 0.604 . . . . 0.0 111.352 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.1 pt -120.79 37.9 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.264 1.426 . . . . 0.0 111.098 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.88 42.44 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.724 1.61 . . . . 0.0 111.752 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 161.51 28.92 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.889 -0.507 . . . . 0.0 111.483 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.6 61.19 3.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.98 156.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.257 1.5 p 78.35 -55.68 0.48 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.855 2.462 . . . . 0.0 109.953 -169.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -59.26 0.88 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.859 1.664 . . . . 0.0 113.827 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.64 -10.16 57.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.958 . . . . 0.0 112.494 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.08 -37.26 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.64 0.655 . . . . 0.0 109.447 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.95 114.91 9.51 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.21 -7.64 17.96 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.445 2.097 . . . . 0.0 112.616 -174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.33 -20.47 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.536 1.534 . . . . 0.0 109.865 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m 54.35 51.98 13.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 111.318 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.64 34.76 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.8 mt -64.69 120.88 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -130.64 164.25 25.4 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -65.87 150.08 49.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.99 -43.89 60.78 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -66.05 -29.89 70.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.282 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -82.56 -37.09 25.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.282 0.633 . . . . 0.0 109.887 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -50.89 128.96 28.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.371 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.57 148.15 45.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.17 2.58 . . . . 0.0 113.471 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -45.71 -44.61 13.71 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 129.164 2.986 . . . . 0.0 112.881 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -48.43 -44.45 35.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 111.003 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -97.06 -0.27 47.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.104 1.361 . . . . 0.0 112.441 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -55.42 -29.7 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.777 1.171 . . . . 0.0 108.906 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.19 -44.97 11.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.44 1.096 . . . . 0.0 111.557 169.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -66.39 -34.74 78.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.801 -1.095 . . . . 0.0 111.667 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.12 -43.99 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 120.712 1.596 . . . . 0.0 107.133 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -51.43 69.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -59.19 -42.11 90.09 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.128 -0.982 . . . . 0.0 112.231 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -60.45 -44.16 96.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.138 1.775 . . . . 0.0 110.649 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.05 -55.92 27.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.188 0.995 . . . . 0.0 109.178 174.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.11 -42.02 94.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 129.111 2.964 . . . . 0.0 114.043 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.95 -53.81 0.76 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.705 1.202 . . . . 0.0 112.984 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.2 4.3 31.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.008 0.923 . . . . 0.0 111.497 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 79.85 1.25 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 CA-C-O 116.064 -1.922 . . . . 0.0 107.463 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.436 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -103.73 143.06 33.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.279 1.032 . . . . 0.0 110.043 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.36 138.15 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.205 1.002 . . . . 0.0 110.814 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.34 151.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.935 1.694 . . . . 0.0 109.833 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.2 p -138.81 160.17 40.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.923 -0.486 . . . . 0.0 110.574 172.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.331 4.9 tt0 -1.28 -64.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 130.192 3.397 . . . . 0.0 117.418 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.63 -25.42 41.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 122.864 2.059 . . . . 0.0 114.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 -35.83 68.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.795 0.838 . . . . 0.0 112.261 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.273 3.5 mp -70.31 89.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.747 0.784 . . . . 0.0 112.205 -168.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.4 47.44 0.71 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.621 1.581 . . . . 0.0 110.986 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.363 0.9 OUTLIER 51.56 118.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.472 2.709 . . . . 0.0 118.075 174.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? 68.09 -63.33 0.33 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.476 2.71 . . . . 0.0 112.588 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t 64.11 -66.3 0.12 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.158 1.783 . . . . 0.0 112.966 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.07 47.79 11.52 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 112.406 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.0 m -110.92 -56.37 2.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.303 0.641 . . . . 0.0 110.703 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -72.95 75.33 1.18 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.993 0.901 . . . . 0.0 109.263 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 m -115.56 -140.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 110.116 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -67.73 17.79 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.65 -28.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -62.41 127.98 90.68 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.52 -34.3 71.85 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.482 3.454 . . . . 0.0 114.637 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.56 24.44 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 122.576 0.351 . . . . 0.0 111.449 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 62.94 -176.28 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.192 0.597 . . . . 0.0 109.454 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.2 p 122.18 -5.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.976 3.71 . . . . 0.0 111.923 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.2 110.84 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.37 141.81 50.97 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 109.877 -170.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.98 113.71 9.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 120.175 1.352 . . . . 0.0 109.823 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.34 64.58 3.76 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 170.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 65.5 -59.11 0.29 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 129.811 3.245 . . . . 0.0 111.163 -172.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.48 -54.29 4.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.535 0.734 . . . . 0.0 112.072 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.8 166.49 24.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.588 1.155 . . . . 0.0 110.215 -169.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.82 133.39 50.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.645 0.736 . . . . 0.0 110.695 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 131.19 53.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 131.002 3.721 . . . . 0.0 104.586 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.1 mt -99.5 128.41 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.45 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 36.4 t0 -74.66 111.85 14.93 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 120.037 1.29 . . . . 0.0 107.697 168.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.72 -29.61 69.01 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.563 1.509 . . . . 0.0 111.041 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.27 -24.38 40.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.71 -0.619 . . . . 0.0 110.22 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.06 -35.7 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.5 0.591 . . . . 0.0 110.74 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.2 t -54.71 129.88 38.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.03 0.832 . . . . 0.0 110.743 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.02 35.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 111.378 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 2.3 m-20 48.55 37.64 9.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.166 1.787 . . . . 0.0 113.082 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -23.79 46.14 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.55 -141.73 21.39 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.357 0.98 . . . . 0.0 111.772 -169.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.48 -65.01 0.36 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.919 2.088 . . . . 0.0 113.026 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -46.87 -42.37 17.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.61 1.164 . . . . 0.0 109.803 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -40.88 -44.62 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.188 2.195 . . . . 0.0 114.426 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 -28.17 16.63 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 110.19 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -63.42 -38.49 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 119.068 -0.492 . . . . 0.0 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.442 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.1 t -61.23 113.0 6.76 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.47 29.68 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.448 2.766 . . . . 0.0 112.74 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.1 m -146.15 -29.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 129.42 3.088 . . . . 0.0 108.056 -173.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m 55.54 57.93 4.95 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.503 1.121 . . . . 0.0 110.759 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.51 57.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.819 1.248 . . . . 0.0 110.745 170.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mt -80.85 124.79 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -128.31 167.57 16.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.39 146.24 54.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.46 -36.47 69.11 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.424 1.107 . . . . 0.0 112.882 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.64 -44.14 76.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.132 171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -78.32 -34.65 48.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.329 1.452 . . . . 0.0 112.022 -168.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -50.0 124.31 16.8 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.508 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 143.66 67.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.989 2.459 . . . . 0.0 112.114 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -42.77 -46.89 5.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 128.867 2.867 . . . . 0.0 112.462 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -46.38 -45.14 17.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.14 0.976 . . . . 0.0 110.878 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -97.96 0.49 46.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.702 1.601 . . . . 0.0 112.411 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -61.3 -19.21 61.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.23 1.377 . . . . 0.0 110.781 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -54.07 -42.75 69.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.098 0.959 . . . . 0.0 110.167 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -64.83 -36.62 84.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.064 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 mt -60.36 -44.76 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 120.756 1.616 . . . . 0.0 109.047 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -54.13 -48.22 71.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.427 173.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -61.47 -45.06 95.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.465 0.575 . . . . 0.0 112.064 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -58.89 -43.55 91.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.581 1.152 . . . . 0.0 110.904 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -58.13 -60.46 3.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.893 1.277 . . . . 0.0 107.655 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.14 -51.05 63.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.569 2.748 . . . . 0.0 112.942 -171.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -32.68 -49.6 0.23 Allowed 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 126.581 1.952 . . . . 0.0 113.472 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -114.08 -0.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.804 0.69 . . . . 0.0 111.768 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.45 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.11 -34.31 43.56 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.184 0.902 . . . . 0.0 110.873 -174.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.385 0 CA-C-O 115.684 -2.103 . . . . 0.0 106.35 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.429 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -97.46 138.91 34.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.401 0.68 . . . . 0.0 109.177 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.42 140.79 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.751 0.786 . . . . 0.0 111.097 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -75.93 152.56 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.686 3.194 . . . . 0.0 111.054 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -146.47 166.71 25.6 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.713 0.405 . . . . 0.0 111.27 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.272 58.4 tt0 -16.2 -60.05 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 129.002 2.921 . . . . 0.0 116.147 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.07 -18.03 41.3 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 121.691 1.64 . . . . 0.0 115.12 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 t -62.36 -40.62 97.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.771 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.86 118.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.024 0.375 . . . . 0.0 110.354 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.42 76.3 0.06 OUTLIER Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.315 3.1 t 64.39 -49.36 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.286 2.634 . . . . 0.0 116.181 170.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 -60.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.981 1.264 . . . . 0.0 111.102 176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.6 -71.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.522 1.929 . . . . 0.0 114.965 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.18 -123.25 0.49 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 109.337 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m 72.29 -55.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.957 2.103 . . . . 0.0 112.783 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.13 -47.98 82.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.389 1.076 . . . . 0.0 110.634 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.79 -41.61 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 O-C-N 121.434 -0.791 . . . . 0.0 112.418 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -68.19 -7.31 29.13 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.63 -22.95 3.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 120.02 1.282 . . . . 0.0 113.665 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -61.87 128.93 91.24 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.45 1.023 . . . . 0.0 110.973 -172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.29 -41.62 13.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 1 C-N-CA 125.327 4.018 . . . . 0.0 114.312 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.18 57.71 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.905 0.882 . . . . 0.0 109.769 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -4.23 104.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.939 2.096 . . . . 0.0 114.689 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -132.14 29.77 4.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.305 171.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.51 113.79 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 -169.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -136.76 140.59 42.68 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -165.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -68.13 160.69 28.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.522 -1.361 . . . . 0.0 112.767 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.63 -52.99 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -112.92 -63.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.586 1.554 . . . . 0.0 109.712 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.8 -54.49 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 109.007 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 145.25 56.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.516 2.327 . . . . 0.0 111.008 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -86.2 102.69 14.14 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 111.746 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -54.41 110.5 0.63 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.839 2.856 . . . . 0.0 108.505 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -82.97 115.27 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.83 117.22 30.08 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.686 1.13 . . . . 0.0 108.544 171.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.88 -24.82 20.66 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 121.493 1.462 . . . . 0.0 112.085 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -36.51 34.18 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.68 -32.02 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.309 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.2 t -59.64 124.22 19.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.215 0.916 . . . . 0.0 110.539 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.91 36.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.998 0.919 . . . . 0.0 111.706 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.429 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 9.1 m-20 39.1 61.9 1.2 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.086 1.755 . . . . 0.0 112.609 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.92 -163.19 1.02 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.862 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 101.87 0.41 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.74 -65.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.06 1.344 . . . . 0.0 110.786 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.1 p -60.37 -52.41 65.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.495 0.718 . . . . 0.0 111.262 -172.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -54.8 24.11 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.757 0.823 . . . . 0.0 111.306 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.98 66.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.02 0.528 . . . . 0.0 112.003 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -41.31 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.349 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.0 t -58.35 111.7 3.93 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.001 0.819 . . . . 0.0 108.877 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.1 22.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.439 2.759 . . . . 0.0 113.038 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -135.09 -28.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 129.871 3.268 . . . . 0.0 107.616 -177.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 54.35 59.53 4.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.623 1.169 . . . . 0.0 110.39 -172.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.14 44.94 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.349 1.06 . . . . 0.0 110.214 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.1 mt -77.67 125.51 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -131.94 171.32 13.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.87 147.18 50.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.141 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -49.11 -41.72 36.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.14 -40.28 89.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.452 0.701 . . . . 0.0 111.461 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -78.79 -34.91 45.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.177 0.991 . . . . 0.0 110.855 -168.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.87 123.99 26.68 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.389 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.76 144.69 53.22 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.066 2.511 . . . . 0.0 112.119 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -41.8 -46.51 3.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.78 2.832 . . . . 0.0 112.497 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -46.89 -46.02 20.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.194 0.997 . . . . 0.0 110.995 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -96.35 -3.02 44.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.713 1.605 . . . . 0.0 112.359 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -61.11 -17.74 54.26 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.478 1.49 . . . . 0.0 110.23 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -51.63 -44.74 63.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.851 0.86 . . . . 0.0 109.189 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -64.79 -32.62 74.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.665 -1.159 . . . . 0.0 111.817 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.72 -47.25 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 121.127 1.785 . . . . 0.0 107.917 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -52.72 -53.99 39.97 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -43.05 99.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.547 0.213 . . . . 0.0 111.082 -171.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.05 -39.17 85.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 111.545 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -51.24 63.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.061 0.934 . . . . 0.0 109.348 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 61.2 t0 -68.86 -47.97 64.63 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.283 2.633 . . . . 0.0 112.54 -169.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -31.11 -56.27 0.23 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.991 1.716 . . . . 0.0 113.053 -175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -98.97 -3.42 35.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.978 0.911 . . . . 0.0 112.543 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -104.02 78.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.063 0.945 . . . . 0.0 109.749 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 127.769 2.427 . . . . 0.0 105.872 168.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.455 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -112.27 156.34 22.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.893 0.77 . . . . 0.0 110.625 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.26 143.43 40.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.846 1.658 . . . . 0.0 109.167 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.19 135.6 25.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.561 1.144 . . . . 0.0 108.666 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 p -127.88 170.78 12.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.222 1.009 . . . . 0.0 111.08 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -14.09 -56.85 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 129.628 3.171 . . . . 0.0 116.553 172.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.49 -21.33 61.18 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 122.25 1.839 . . . . 0.0 114.147 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.53 -27.04 68.69 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.84 0.745 . . . . 0.0 112.094 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.02 79.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.811 0.844 . . . . 0.0 110.969 -170.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.67 0.79 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.236 1.874 . . . . 0.0 108.571 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.331 14.6 t 46.83 88.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.326 2.251 . . . . 0.0 114.603 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 73.8 -61.2 0.5 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.703 2.001 . . . . 0.0 114.347 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 t 61.61 -68.6 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 0.0 113.217 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.01 35.01 8.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.399 1.879 . . . . 0.0 114.455 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -106.06 14.69 27.46 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -121.92 54.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.3 -45.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.407 -0.808 . . . . 0.0 111.104 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.84 10.5 1.4 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.183 2.193 . . . . 0.0 114.001 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.64 -24.79 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -70.6 124.53 91.06 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 119.595 1.089 . . . . 0.0 111.198 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.24 -26.76 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.804 3.003 . . . . 0.0 113.161 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.98 38.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.396 0.679 . . . . 0.0 110.004 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 29.97 42.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.079 2.551 . . . . 0.0 116.361 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.1 p -92.18 36.02 0.99 Allowed 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.092 -1.005 . . . . 0.0 110.746 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 120.32 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 126.313 1.845 . . . . 0.0 108.062 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -137.12 171.06 15.06 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.039 1.335 . . . . 0.0 109.607 -169.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.18 172.01 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 119.387 0.994 . . . . 0.0 110.217 168.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.49 -53.9 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.259 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -139.64 58.38 1.61 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.355 0.662 . . . . 0.0 109.27 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 45.76 37.36 3.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.172 1.789 . . . . 0.0 112.578 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 154.25 38.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 172.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -76.41 163.21 27.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.669 0.606 . . . . 0.0 110.707 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.45 110.37 5.63 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 106.057 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.11 132.23 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 76' ' ' LYS . 17.8 t0 -75.81 112.95 22.62 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 167.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.06 -28.97 48.82 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.826 1.684 . . . . 0.0 110.672 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.03 -27.93 29.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.784 0.834 . . . . 0.0 109.804 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.2 t -85.5 -32.27 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.836 0.743 . . . . 0.0 111.122 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.4 t -56.13 130.43 44.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.09 0.859 . . . . 0.0 111.152 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 pt -102.44 35.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.3 1.04 . . . . 0.0 111.184 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 7.1 m-20 50.65 32.19 6.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.24 1.816 . . . . 0.0 114.636 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -23.08 62.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.13 -132.53 11.27 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -168.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.83 -68.25 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.749 1.62 . . . . 0.0 113.098 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -48.84 -49.99 36.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.324 1.05 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -48.47 -56.2 8.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.255 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.0 68.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.16 0.584 . . . . 0.0 112.465 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.98 -7.73 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.982 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -82.79 111.29 28.38 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.51 41.64 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.237 2.624 . . . . 0.0 111.727 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.7 -27.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 128.346 2.658 . . . . 0.0 109.2 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 55.65 60.18 3.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.847 0.859 . . . . 0.0 110.025 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.55 -25.07 41.75 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.25 1.02 . . . . 0.0 110.169 170.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.9 mt -72.7 117.47 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -127.81 165.16 20.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.29 150.19 40.33 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -54.67 -40.44 69.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.677 -0.64 . . . . 0.0 112.69 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.98 -24.17 63.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.426 -0.796 . . . . 0.0 111.032 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.88 -45.32 43.66 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.915 0.325 . . . . 0.0 110.167 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.0 t -52.69 123.75 32.14 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.792 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.85 149.32 61.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.924 2.416 . . . . 0.0 112.606 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -42.66 -46.25 4.97 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 129.698 3.199 . . . . 0.0 112.258 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.54 -40.44 12.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.11 0.964 . . . . 0.0 111.767 172.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -106.08 7.77 31.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.857 1.663 . . . . 0.0 112.482 -176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -57.89 -27.37 63.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.403 1.001 . . . . 0.0 110.038 170.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -49.28 -44.53 44.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.165 1.386 . . . . 0.0 111.051 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -67.98 -33.02 73.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.68 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.99 -48.18 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 120.803 1.638 . . . . 0.0 108.124 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -53.29 -50.52 64.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -62.8 -43.27 99.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 0.541 . . . . 0.0 111.968 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -58.69 -44.18 90.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.039 1.335 . . . . 0.0 110.763 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -55.55 33.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.163 0.985 . . . . 0.0 109.041 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.68 -45.7 93.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.982 2.513 . . . . 0.0 112.402 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.05 -50.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 113.463 -171.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.2 4.66 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.282 1.033 . . . . 0.0 111.983 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -108.22 73.41 0.88 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.685 1.194 . . . . 0.0 109.135 -175.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.142 0 C-N-CA 127.63 2.372 . . . . 0.0 105.916 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.456 ' H1 ' ' CD2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 118.351 -0.833 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -105.23 153.86 21.01 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.641 0.655 . . . . 0.0 110.17 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 t -138.13 145.83 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.746 0.818 . . . . 0.0 110.764 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -60.81 165.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.237 1.815 . . . . 0.0 111.536 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 p -151.93 168.67 24.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.994 0.918 . . . . 0.0 109.094 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -8.52 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 128.506 2.722 . . . . 0.0 116.336 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 -21.39 71.91 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 121.487 1.567 . . . . 0.0 113.541 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.18 -30.34 71.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.756 0.822 . . . . 0.0 112.177 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.21 90.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.598 0.713 . . . . 0.0 110.385 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.11 60.8 0.67 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.941 1.734 . . . . 0.0 109.92 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t 39.56 73.03 0.12 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.158 1.783 . . . . 0.0 114.307 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 68.94 48.5 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.57 1.148 . . . . 0.0 113.053 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.19 152.42 40.8 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.75 40.12 0.89 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.795 0.725 . . . . 0.0 112.125 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 m -83.89 -37.35 22.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 112.205 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 p -70.04 -13.73 62.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.272 1.429 . . . . 0.0 113.215 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.26 153.85 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 112.431 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 75.86 -40.29 0.4 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.834 2.053 . . . . 0.0 113.038 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.65 -29.11 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.705 -0.622 . . . . 0.0 110.156 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.0 t -65.63 126.58 91.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.949 0.5 . . . . 0.0 110.103 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -39.72 -37.44 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 126.377 4.718 . . . . 0.0 115.407 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.0 m -126.54 21.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.822 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t70 33.2 51.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.702 2.001 . . . . 0.0 113.668 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.5 p -94.57 42.34 1.09 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.298 1.039 . . . . 0.0 110.922 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 132.32 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 173.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -133.51 142.13 48.08 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -167.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -83.52 125.15 31.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.309 -0.87 . . . . 0.0 111.627 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.82 -55.07 2.48 Favored Glycine 0 CA--C 1.525 0.69 1 N-CA-C 103.047 -4.021 . . . . 0.0 103.047 166.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -60.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.195 2.198 . . . . 0.0 106.614 168.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.4 -29.17 69.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.266 1.826 . . . . 0.0 114.787 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.18 177.5 11.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.343 0.657 . . . . 0.0 109.476 -168.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.87 116.03 28.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.233 1.013 . . . . 0.0 108.699 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -94.88 119.62 33.74 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 130.441 3.497 . . . . 0.0 109.388 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.7 mt -81.33 130.13 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 118.878 0.763 . . . . 0.0 109.839 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.39 111.64 18.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.01 -30.98 92.86 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-N 120.98 1.386 . . . . 0.0 111.273 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -79.1 -23.63 43.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -92.1 -32.84 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.276 0.489 . . . . 0.0 110.978 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.56 123.56 16.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.979 0.809 . . . . 0.0 111.45 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.8 pt -89.46 21.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 50.75 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.37 2.268 . . . . 0.0 113.089 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.0 148.41 31.67 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.944 -0.472 . . . . 0.0 110.951 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.72 51.75 4.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.191 -0.943 . . . . 0.0 113.08 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.67 -76.99 0.59 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.363 1.082 . . . . 0.0 111.633 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -47.96 -48.8 31.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.598 1.159 . . . . 0.0 112.497 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.5 -46.55 83.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.171 0.896 . . . . 0.0 111.562 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.14 74.86 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.486 -0.759 . . . . 0.0 110.538 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -74.81 -38.26 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.094 0.557 . . . . 0.0 111.45 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.4 t -64.27 112.41 7.59 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.227 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.48 20.88 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.207 2.604 . . . . 0.0 113.087 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.39 -30.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.103 1.761 . . . . 0.0 109.354 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 t 62.27 81.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 0.0 109.894 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.32 -9.92 0.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -79.82 92.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -109.36 164.57 12.36 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.1 0.96 . . . . 0.0 108.894 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' CD2' ' H1 ' ' A' ' 1' ' ' ALA . 5.1 t-80 -62.5 146.94 50.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.855 175.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -40.96 64.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.113 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -73.35 -38.91 65.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -53.76 124.53 43.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.667 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 144.95 52.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.103 2.535 . . . . 0.0 112.191 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -41.49 -47.36 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 128.933 2.893 . . . . 0.0 112.676 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.59 -44.41 26.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.049 0.94 . . . . 0.0 111.063 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -96.71 -6.73 35.73 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.173 1.389 . . . . 0.0 112.424 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -57.99 -22.38 49.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.562 1.528 . . . . 0.0 110.231 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.01 -43.08 40.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.701 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -64.35 -35.06 79.63 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.6 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.35 -46.12 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -56.91 -46.58 81.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.115 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -46.42 90.62 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.427 -0.796 . . . . 0.0 111.631 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -61.59 -40.0 93.22 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.051 0.94 . . . . 0.0 111.357 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -57.22 -61.86 2.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -52.96 -50.42 64.13 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 128.122 2.569 . . . . 0.0 112.529 -170.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -37.46 -46.35 0.8 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 125.57 1.548 . . . . 0.0 113.432 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -111.39 -3.21 15.33 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.789 0.681 . . . . 0.0 111.447 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -36.67 25.05 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.939 0.791 . . . . 0.0 110.31 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' NZ ' ' OXT' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -100.8 147.58 25.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.413 0.685 . . . . 0.0 111.128 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.64 142.29 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.845 1.258 . . . . 0.0 110.708 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.88 168.57 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 125.772 1.629 . . . . 0.0 110.904 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 p -145.02 171.65 14.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -9.82 -61.22 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 128.661 2.785 . . . . 0.0 116.164 169.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.59 -15.42 45.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 121.991 1.747 . . . . 0.0 113.635 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HA ' ' S1 ' ' A' ' 78' ' ' SF4 . 15.2 t -70.37 -26.09 63.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.851 0.86 . . . . 0.0 112.742 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.15 115.95 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.95 130.31 1.34 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -169.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -60.06 119.57 8.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.957 0.503 . . . . 0.0 112.026 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 36.22 50.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.492 1.917 . . . . 0.0 113.376 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.24 -50.85 72.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.673 0.789 . . . . 0.0 112.616 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.95 -136.01 0.86 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.918 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m 62.7 45.34 5.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.856 1.263 . . . . 0.0 111.878 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 p -176.51 -28.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.162 2.985 . . . . 0.0 109.138 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.75 -44.87 51.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.22 1.008 . . . . 0.0 110.469 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.34 0.3 3.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.399 1.88 . . . . 0.0 114.175 -169.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.03 -16.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.277 1.031 . . . . 0.0 113.136 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -75.36 126.15 88.05 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 119.751 1.16 . . . . 0.0 111.624 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -62.11 141.24 87.88 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.565 2.177 . . . . 0.0 109.227 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.287 11.6 m 45.17 37.09 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 114.217 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 35.92 49.1 0.56 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.335 2.654 . . . . 0.0 114.17 168.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -85.89 30.14 0.68 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.058 -1.027 . . . . 0.0 112.643 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.44 142.13 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -141.55 156.8 45.69 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.086 1.354 . . . . 0.0 107.849 -170.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -91.53 134.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 118.888 0.767 . . . . 0.0 111.254 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.54 -46.96 7.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 104.987 -3.245 . . . . 0.0 104.987 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -175.56 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.245 2.618 . . . . 0.0 104.284 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -98.21 54.1 1.09 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.901 1.81 . . . . 0.0 108.94 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.71 137.37 0.2 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 -169.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -102.37 168.41 9.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.889 0.743 . . . . 0.0 109.663 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -146.44 119.82 9.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.192 1.797 . . . . 0.0 107.797 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.38 130.76 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -73.33 114.64 33.38 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -30.85 52.42 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.619 0.879 . . . . 0.0 111.1 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -83.07 -28.43 29.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.279 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.52 -27.63 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.397 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -59.45 120.99 10.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.497 1.044 . . . . 0.0 110.945 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 pt -96.14 34.03 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 27.2 m-20 46.17 42.31 9.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.574 1.549 . . . . 0.0 113.282 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -23.21 60.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.244 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.75 -138.94 20.9 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.531 1.062 . . . . 0.0 110.934 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.17 -67.51 0.25 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.689 1.596 . . . . 0.0 111.95 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 p -47.98 -50.64 26.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.888 1.275 . . . . 0.0 110.412 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -43.92 -41.25 5.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.714 2.005 . . . . 0.0 113.815 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.47 -34.87 21.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.162 0.985 . . . . 0.0 110.064 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -79.18 -25.57 12.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.94 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -59.84 111.97 4.67 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.413 1.006 . . . . 0.0 108.49 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.12 49.53 3.26 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.857 3.038 . . . . 0.0 110.117 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -169.35 -35.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 128.232 2.613 . . . . 0.0 107.74 -168.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 58.0 58.14 3.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 110.045 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.75 -17.57 50.54 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.665 1.186 . . . . 0.0 110.873 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -77.66 125.42 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.48 170.47 15.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.421 ' CD2' ' H1 ' ' A' ' 1' ' ' ALA . 6.7 t-80 -65.62 146.35 54.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -48.69 -44.12 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.174 0.512 . . . . 0.0 112.058 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.32 -40.22 77.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.177 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -78.96 -34.13 44.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 111.56 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.96 126.55 59.89 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.95 145.5 62.45 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.118 2.545 . . . . 0.0 112.469 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.6 mp0 -40.91 -45.69 2.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.62 3.168 . . . . 0.0 113.811 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.45 -44.68 12.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.914 0.864 . . . . 0.0 111.093 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -101.26 0.06 36.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.475 1.91 . . . . 0.0 112.945 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 28.3 mmtm -59.27 -21.42 59.61 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.593 1.542 . . . . 0.0 109.456 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 p -50.46 -49.03 56.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.713 1.205 . . . . 0.0 109.896 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -61.91 -35.91 79.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.053 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.45 -50.65 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -54.29 -41.69 69.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.623 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -66.84 -45.58 77.77 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.2 -42.16 94.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.276 1.43 . . . . 0.0 110.587 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -55.76 29.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.84 -48.97 69.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.738 2.815 . . . . 0.0 113.987 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -31.66 -48.92 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.09 1.756 . . . . 0.0 114.942 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -117.12 1.72 12.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.746 0.818 . . . . 0.0 111.985 -170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -40.21 13.24 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.822 0.737 . . . . 0.0 110.814 -169.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.567 2.347 . . . . 0.0 104.682 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . 0.422 ' S1 ' ' HA ' ' A' ' 8' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.57 150.21 31.67 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.477 0.581 . . . . 0.0 110.612 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.2 140.01 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.287 0.635 . . . . 0.0 111.661 -174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.04 144.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 125.331 1.452 . . . . 0.0 109.93 172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 p -133.65 168.4 18.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 110.332 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 64' ' ' TRP . 9.5 tt0 -15.49 -57.65 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 129.107 2.963 . . . . 0.0 116.484 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.26 -21.32 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 CA-C-N 121.774 1.669 . . . . 0.0 114.325 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.7 -32.65 72.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.733 0.697 . . . . 0.0 112.246 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -65.34 86.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.982 0.896 . . . . 0.0 109.943 -172.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 53.11 0.57 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 127.191 2.329 . . . . 0.0 108.256 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.298 12.2 t 53.28 -153.61 0.25 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.624 1.97 . . . . 0.0 113.939 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -73.77 66.96 1.14 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.324 1.45 . . . . 0.0 112.276 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.27 -57.54 8.57 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.722 1.609 . . . . 0.0 111.083 170.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.55 43.93 16.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.476 1.51 . . . . 0.0 112.924 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -98.54 -42.11 7.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.355 0.662 . . . . 0.0 111.564 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -74.28 67.96 1.45 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.006 0.908 . . . . 0.0 108.696 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.43 163.6 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.938 2.095 . . . . 0.0 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 40.93 39.24 0.79 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.627 1.971 . . . . 0.0 114.403 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.61 -39.74 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.423 1.089 . . . . 0.0 111.217 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -65.58 124.98 88.8 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 121.922 -0.486 . . . . 0.0 110.934 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.73 -42.78 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.624 1 C-N-CA 126.012 4.475 . . . . 0.0 115.533 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.5 27.77 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.415 0.686 . . . . 0.0 111.411 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 58.99 -173.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p 124.28 -2.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 130.702 3.601 . . . . 0.0 111.985 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -89.22 115.57 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.708 0.803 . . . . 0.0 109.149 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -134.52 172.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.528 1.531 . . . . 0.0 108.815 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -114.72 177.52 4.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.689 0.757 . . . . 0.0 109.673 168.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.8 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 124.608 1.099 . . . . 0.0 110.692 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -128.94 -94.78 0.42 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.3 58.25 1.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.411 1.101 . . . . 0.0 108.95 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -175.22 2.78 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 128.685 2.794 . . . . 0.0 105.786 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -111.56 159.09 18.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.286 0.494 . . . . 0.0 110.947 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.12 130.86 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.724 2.81 . . . . 0.0 104.444 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -106.06 126.39 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -66.95 114.6 18.73 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 118.022 -1.471 . . . . 0.0 107.516 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.32 -28.46 22.54 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.854 1.703 . . . . 0.0 110.0 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -81.26 -28.77 34.61 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.08 -38.45 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.875 0.761 . . . . 0.0 111.27 169.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.8 t -55.13 124.94 18.52 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 111.838 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 pt -95.23 37.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.111 0.964 . . . . 0.0 111.617 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 38.57 60.33 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.182 2.193 . . . . 0.0 113.691 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 -20.98 16.32 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.1 -132.34 11.4 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.89 -70.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.458 1.503 . . . . 0.0 112.042 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.6 p -48.73 -47.3 41.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.711 1.205 . . . . 0.0 111.197 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.66 -42.64 79.33 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.653 -0.654 . . . . 0.0 111.755 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.74 75.83 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.499 -0.751 . . . . 0.0 110.337 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.72 -40.84 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.596 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -59.55 112.15 4.84 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 119.072 0.851 . . . . 0.0 109.464 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.67 11.66 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.909 2.406 . . . . 0.0 112.862 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -117.14 -26.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 127.679 2.392 . . . . 0.0 108.843 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m 54.39 76.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.483 1.513 . . . . 0.0 111.18 -169.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 6.58 5.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.154 1.382 . . . . 0.0 112.719 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.43 80.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -95.99 162.84 13.39 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -59.35 149.14 29.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.947 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -50.39 -42.42 53.46 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -80.82 -21.59 40.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 119.279 -0.969 . . . . 0.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -71.48 -33.3 69.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -58.36 126.75 79.66 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 119.252 -0.404 . . . . 0.0 109.911 171.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.73 153.17 57.94 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.656 2.904 . . . . 0.0 113.156 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -45.61 -45.12 13.63 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 129.968 3.307 . . . . 0.0 112.747 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -48.79 -46.2 41.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.894 0.878 . . . . 0.0 110.889 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 6' ' ' GLU . 46.8 m0 -97.06 -1.19 45.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 0.0 112.525 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -54.46 -27.98 41.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.565 1.075 . . . . 0.0 109.324 169.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -45.86 -46.95 16.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.626 1.17 . . . . 0.0 110.8 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -64.25 -34.36 77.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.766 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.35 -47.55 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 120.698 1.59 . . . . 0.0 107.183 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -57.63 -44.07 85.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -60.56 -51.15 70.63 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 118.682 0.674 . . . . 0.0 111.211 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -56.36 -38.93 72.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.382 1.073 . . . . 0.0 110.733 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -63.28 -58.68 6.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.53 1.132 . . . . 0.0 109.859 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.85 -47.15 87.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.658 2.383 . . . . 0.0 112.936 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.65 -46.32 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.093 1.357 . . . . 0.0 113.954 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.77 3.24 24.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.666 0.786 . . . . 0.0 112.193 -171.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 -60.08 1.93 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.507 1.523 . . . . 0.0 107.913 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.643 3.177 . . . . 0.0 112.738 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.209 0.052 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -92.24 136.04 33.52 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.63 142.05 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.473 0.709 . . . . 0.0 110.776 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -65.64 158.26 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 126.728 2.011 . . . . 0.0 110.656 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.7 p -144.9 156.26 43.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.33 0.514 . . . . 0.0 111.687 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.351 3.7 tt0 6.87 -72.05 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 130.108 3.363 . . . . 0.0 117.58 169.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -52.95 -26.17 30.62 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.693 1.998 . . . . 0.0 114.905 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -58.46 -36.39 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.699 0.8 . . . . 0.0 112.058 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.07 144.23 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.069 0.462 . . . . 0.0 111.06 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.38 37.87 2.75 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 125.465 1.507 . . . . 0.0 111.315 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -166.87 129.11 1.74 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -70.89 88.01 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.87 167.9 20.52 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.841 0.856 . . . . 0.0 110.939 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.03 71.69 0.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.843 1.657 . . . . 0.0 107.12 173.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.3 m -141.99 -59.0 0.47 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.743 -0.598 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.43 72.63 0.98 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.076 0.941 . . . . 0.0 108.962 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.3 152.56 15.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 108.72 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 62.97 -12.77 0.08 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.28 -24.45 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 120.822 -1.174 . . . . 0.0 110.884 -170.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.71 126.48 92.65 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 122.775 0.43 . . . . 0.0 110.619 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.32 -43.89 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 126.485 4.79 . . . . 0.0 115.975 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.34 7.1 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.868 0.867 . . . . 0.0 112.146 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.2 t0 65.87 149.87 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 111.539 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.9 m -163.06 -102.09 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.509 1.923 . . . . 0.0 106.209 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.255 2.2 pp 13.78 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.785 3.234 . . . . 0.0 116.474 169.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -103.4 138.7 39.79 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.487 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 32.6 mt-10 -76.57 131.84 39.16 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 120.775 -1.203 . . . . 0.0 112.661 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.84 8.63 Favored Glycine 0 CA--C 1.532 1.099 1 N-CA-C 102.886 -4.085 . . . . 0.0 102.886 165.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.44 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.236 3.014 . . . . 0.0 104.286 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.15 -35.88 74.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.661 -0.649 . . . . 0.0 111.584 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.68 146.87 46.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.227 1.411 . . . . 0.0 110.411 -169.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 27' ' ' GLU . 96.9 m-85 -80.44 150.95 29.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.94 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -119.68 114.55 22.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 129.808 3.243 . . . . 0.0 105.554 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -83.95 116.88 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.9 109.07 1.27 Allowed Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 126.868 2.067 . . . . 0.0 111.659 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -67.78 -26.98 38.2 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.039 1.16 . . . . 0.0 111.685 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.15 -41.87 85.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.798 0.839 . . . . 0.0 109.852 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -92.94 -38.31 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.663 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.12 120.01 7.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.107 0.867 . . . . 0.0 111.278 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 pt -89.87 35.58 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.155 0.982 . . . . 0.0 111.572 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.52 60.05 3.04 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.36 1.464 . . . . 0.0 112.905 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.13 -164.75 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.065 0.946 . . . . 0.0 109.03 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.42 -112.15 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 168.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.72 -67.29 0.14 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 126.292 1.837 . . . . 0.0 112.665 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.5 p -62.17 -49.06 77.34 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 137.21 58.22 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 168.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 84.47 -22.24 0.22 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.015 2.526 . . . . 0.0 111.873 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.7 -34.22 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.44 ' C ' ' H ' ' A' ' 51' ' ' VAL . 22.8 t -62.89 116.76 26.53 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.15 26.78 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.41 2.74 . . . . 0.0 113.03 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.7 m -141.5 -27.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 128.393 2.677 . . . . 0.0 108.331 -172.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.9 m 54.14 62.93 2.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.693 1.197 . . . . 0.0 111.288 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.1 -7.36 45.77 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.276 1.031 . . . . 0.0 111.128 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.4 mt -83.05 124.67 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -134.58 168.51 18.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -64.08 143.51 57.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.517 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.41 -40.82 51.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.33 -38.49 89.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.372 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -77.28 -31.54 54.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.043 -169.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.47 125.38 52.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.635 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.79 144.34 55.0 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.045 2.497 . . . . 0.0 112.043 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -41.91 -47.13 4.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 128.995 2.918 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -46.99 -45.36 20.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.138 0.975 . . . . 0.0 110.863 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -96.72 -4.51 40.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.752 1.621 . . . . 0.0 112.528 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -60.89 -17.2 49.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.156 1.344 . . . . 0.0 109.841 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -51.52 -42.6 61.87 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.628 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -67.82 -31.2 70.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.29 -0.881 . . . . 0.0 111.752 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.77 -45.67 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -55.85 -48.98 74.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.71 0.404 . . . . 0.0 110.032 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.59 73.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.248 0.476 . . . . 0.0 110.497 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.61 -39.61 68.06 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 124.021 0.826 . . . . 0.0 110.568 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -56.15 19.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -50.97 -43.18 60.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.868 2.067 . . . . 0.0 112.526 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -43.84 -44.71 7.03 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.756 0.66 . . . . 0.0 112.151 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -107.95 21.47 17.35 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 111.139 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -132.67 74.51 1.58 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 169.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -169.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.28 144.98 26.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.103 0.961 . . . . 0.0 110.248 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.85 144.05 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.273 1.029 . . . . 0.0 111.296 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.73 142.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.489 1.515 . . . . 0.0 109.553 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 p -131.42 165.47 23.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.038 0.535 . . . . 0.0 110.237 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -12.21 -58.33 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 129.587 3.155 . . . . 0.0 116.568 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.72 -20.65 69.82 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 CA-C-N 122.115 1.791 . . . . 0.0 114.06 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -62.73 -33.3 74.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.64 0.655 . . . . 0.0 111.532 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.31 3.9 mp -70.58 95.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.965 0.888 . . . . 0.0 112.168 -168.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 151.6 23.34 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 103.784 -3.726 . . . . 0.0 103.784 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -48.07 125.14 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.393 1.877 . . . . 0.0 112.789 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 18.31 72.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.41 2.684 . . . . 0.0 116.037 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -51.01 -58.63 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.577 1.951 . . . . 0.0 112.342 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.0 42.45 32.25 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.265 1.426 . . . . 0.0 113.318 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -103.06 -51.13 3.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.257 0.623 . . . . 0.0 111.583 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 p -75.27 69.66 2.12 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.96 0.886 . . . . 0.0 109.416 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.9 156.44 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.972 1.709 . . . . 0.0 109.324 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 40.76 58.47 2.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.857 . . . . 0.0 112.79 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 p -160.39 -37.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -72.62 141.34 82.46 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -37.29 -36.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.623 4.215 . . . . 0.0 115.575 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.02 29.82 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.297 31.1 m-20 21.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.576 2.351 . . . . 0.0 114.751 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.3 p -86.17 41.58 0.94 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.235 1.014 . . . . 0.0 110.415 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 pp -109.41 126.88 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.864 1.666 . . . . 0.0 108.422 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -141.56 145.46 35.13 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 124.226 1.011 . . . . 0.0 109.991 -169.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.6 115.96 7.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.786 169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.87 -59.32 4.07 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.04 -2.424 . . . . 0.0 107.04 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -124.12 -69.24 0.82 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -128.08 -37.58 1.87 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.538 1.135 . . . . 0.0 113.18 172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' CD ' ' H ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -87.02 160.2 18.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.986 2.914 . . . . 0.0 110.551 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -76.38 124.9 28.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.613 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 159.07 16.47 Favored 'General case' 0 N--CA 1.444 -0.729 1 C-N-CA 131.835 4.054 . . . . 0.0 104.962 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -116.29 137.19 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.203 1.001 . . . . 0.0 108.369 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 38.5 t0 -78.24 112.4 25.54 Favored Pre-proline 0 C--N 1.341 0.222 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 167.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.94 -30.9 67.35 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.052 1.168 . . . . 0.0 110.585 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -80.44 -22.94 40.66 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.477 -0.764 . . . . 0.0 110.223 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -90.03 -29.28 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.47 0.577 . . . . 0.0 111.009 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.6 t -58.52 128.92 39.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.477 1.035 . . . . 0.0 110.568 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 pt -98.31 36.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.342 1.057 . . . . 0.0 111.473 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 7.6 m-20 42.8 57.32 3.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.96 1.704 . . . . 0.0 112.11 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -176.73 4.3 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.042 0.537 . . . . 0.0 111.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.13 69.16 0.23 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.96 162.39 28.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.019 1.727 . . . . 0.0 106.634 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.27 1.9 p 77.75 -54.76 0.52 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.854 2.862 . . . . 0.0 111.264 -170.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -52.89 15.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.866 0.866 . . . . 0.0 111.998 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.16 62.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.461 1.105 . . . . 0.0 112.025 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.11 -38.2 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.826 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.5 t -61.55 110.37 3.06 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.763 0.71 . . . . 0.0 109.371 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.02 -0.04 6.55 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.999 1.799 . . . . 0.0 112.653 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.19 -23.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.82 1.648 . . . . 0.0 109.837 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 t 60.46 56.97 2.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 110.888 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.95 -22.47 21.94 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.915 0.886 . . . . 0.0 111.062 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -78.68 119.11 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -128.43 167.13 17.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 4.3 t-80 -68.93 144.45 54.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -51.74 -40.99 61.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.18 60.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -82.49 -34.2 28.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.922 0.783 . . . . 0.0 109.814 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.44 127.81 90.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.13 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.98 148.64 37.81 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.546 2.831 . . . . 0.0 112.571 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -51.4 -43.78 62.03 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.865 1.266 . . . . 0.0 111.492 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -41.47 -44.76 2.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.996 1.319 . . . . 0.0 111.267 172.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.41 -1.31 31.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.447 1.499 . . . . 0.0 112.586 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -61.37 -19.45 61.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.473 1.488 . . . . 0.0 110.317 169.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -51.44 -45.02 62.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.339 1.055 . . . . 0.0 109.268 167.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.57 -33.99 77.19 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.678 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.09 -47.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 120.616 1.553 . . . . 0.0 107.691 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -52.9 -49.85 65.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.925 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -46.46 88.76 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.707 -0.62 . . . . 0.0 111.872 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -57.8 -43.06 85.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.095 1.358 . . . . 0.0 110.589 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -58.68 -60.92 3.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.11 -51.15 62.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.435 2.694 . . . . 0.0 112.001 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -48.46 0.21 Allowed 'General case' 0 C--N 1.337 0.055 0 C-N-CA 126.152 1.781 . . . . 0.0 114.139 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.57 -4.17 14.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.56 0.744 . . . . 0.0 111.296 -170.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -89.77 -37.24 14.66 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.487 -1.244 . . . . 0.0 107.904 -172.074 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 119.886 -0.102 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -92.18 146.19 23.91 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.019 0.528 . . . . 0.0 110.245 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.01 143.02 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.013 . . . . 0.0 111.169 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.87 142.26 14.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 126.869 2.068 . . . . 0.0 109.052 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.3 p -133.96 166.43 22.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.059 0.544 . . . . 0.0 111.628 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.282 3.0 tt0 -8.77 -61.4 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 129.776 3.23 . . . . 0.0 116.642 172.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -20.03 44.61 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 122.56 1.95 . . . . 0.0 114.619 -176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 t -61.04 -36.44 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.595 0.634 . . . . 0.0 112.523 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.267 8.6 mt -40.04 113.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.129 0.972 . . . . 0.0 112.066 -169.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.37 130.41 1.41 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -53.82 99.65 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.627 1.571 . . . . 0.0 115.107 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 46.66 56.03 7.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.381 1.873 . . . . 0.0 112.332 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -62.17 95.67 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.451 1.1 . . . . 0.0 110.463 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.41 78.21 9.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 m -128.89 -59.48 1.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.169 0.588 . . . . 0.0 110.876 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 p -74.22 66.71 1.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.79 0.805 . . . . 0.0 109.162 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -120.49 -124.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 109.936 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.6 pm0 -68.52 21.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.68 -27.2 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.158 1.383 . . . . 0.0 109.332 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -67.68 124.05 88.37 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.944 -0.473 . . . . 0.0 110.168 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.99 -45.1 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 125.285 3.99 . . . . 0.0 114.67 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.22 13.61 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.367 -170.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 65.2 t0 59.88 111.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.645 1.578 . . . . 0.0 112.241 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 78.7 m -135.57 4.1 3.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.939 172.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.53 113.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 111.409 -167.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.13 167.08 19.72 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.755 1.222 . . . . 0.0 109.325 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -106.99 177.2 4.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 168.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.38 -43.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -129.77 -97.28 0.36 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -144.08 53.8 1.29 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 123.42 1.581 . . . . 0.0 110.564 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -178.85 6.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.999 2.92 . . . . 0.0 105.022 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.39 164.16 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.56 118.48 16.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.489 2.316 . . . . 0.0 106.177 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.3 mt -90.09 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 113.76 14.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.232 1.378 . . . . 0.0 107.807 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.82 -30.83 40.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.789 1.66 . . . . 0.0 110.582 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -82.82 -28.06 30.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.772 0.829 . . . . 0.0 109.272 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 t -85.38 -31.46 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.752 0.706 . . . . 0.0 111.163 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -58.02 129.89 44.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.387 0.994 . . . . 0.0 111.327 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.7 pt -103.52 33.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.564 1.146 . . . . 0.0 111.391 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.441 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 31.2 m-20 46.0 42.68 9.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.967 1.707 . . . . 0.0 113.478 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -23.57 60.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.276 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.69 -141.26 23.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.59 1.09 . . . . 0.0 111.15 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.52 -66.72 0.25 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.132 1.373 . . . . 0.0 111.117 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -49.93 -49.75 48.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.636 1.174 . . . . 0.0 110.352 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -53.97 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.775 2.03 . . . . 0.0 113.096 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.86 65.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.014 0.526 . . . . 0.0 110.568 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.06 -37.81 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.917 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -68.46 108.51 2.93 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 119.934 1.243 . . . . 0.0 108.834 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.64 11.35 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.633 2.222 . . . . 0.0 113.129 -172.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.07 -26.0 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.588 2.355 . . . . 0.0 108.535 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.35 58.92 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.592 0.757 . . . . 0.0 110.51 -170.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.29 -11.69 58.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.744 0.817 . . . . 0.0 111.186 171.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.03 127.37 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.6 1.56 . . . . 0.0 107.276 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -134.83 168.71 18.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -65.78 144.33 56.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -52.93 -39.02 62.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.41 -40.86 79.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.814 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -77.48 -31.32 53.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.518 0.727 . . . . 0.0 110.523 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.22 127.05 69.81 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.695 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 144.84 50.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.163 2.576 . . . . 0.0 112.35 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -43.64 -45.57 6.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 128.734 2.814 . . . . 0.0 112.662 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.21 -48.84 23.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 0.0 110.506 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -90.9 -7.92 50.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.905 1.282 . . . . 0.0 112.456 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -58.05 -21.99 47.99 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 120.629 1.559 . . . . 0.0 110.028 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -49.3 -43.9 43.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.519 -0.738 . . . . 0.0 110.466 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -65.73 -33.57 76.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.504 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.89 -46.04 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 120.906 1.684 . . . . 0.0 107.247 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -56.89 -44.18 82.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.723 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.62 -50.7 72.47 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.352 0.524 . . . . 0.0 111.227 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -57.69 -39.77 77.91 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -60.67 -58.31 9.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.236 1.014 . . . . 0.0 109.003 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.79 -42.2 95.23 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 127.625 2.37 . . . . 0.0 112.957 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.96 -46.26 2.03 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.776 1.23 . . . . 0.0 113.367 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.61 5.47 31.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.649 0.779 . . . . 0.0 111.794 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -170.2 2.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.419 1.887 . . . . 0.0 106.218 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 C-N-CA 128.891 2.877 . . . . 0.0 103.877 168.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 111.331 0.122 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -100.1 143.37 30.39 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.444 1.098 . . . . 0.0 109.132 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.06 145.69 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.38 129.94 44.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 127.601 2.36 . . . . 0.0 107.391 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -110.0 -84.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.961 0.904 . . . . 0.0 112.322 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.95 -63.48 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.394 1.878 . . . . 0.0 113.728 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.79 86.0 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.883 1.722 . . . . 0.0 109.9 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 177.68 -44.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.197 2.599 . . . . 0.0 107.489 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.65 131.35 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.653 0.781 . . . . 0.0 110.944 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.65 72.49 0.02 OUTLIER Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.492 0.568 . . . . 0.0 113.016 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 61.44 -59.4 0.1 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.575 2.75 . . . . 0.0 116.346 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -166.45 148.39 6.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.218 0.917 . . . . 0.0 109.095 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 t -149.94 166.74 28.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.684 1.594 . . . . 0.0 106.953 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -145.83 176.79 9.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.153 2.581 . . . . 0.0 104.038 168.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 49.0 m 117.26 -66.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.334 2.254 . . . . 0.0 109.144 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -74.16 33.19 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.498 -0.751 . . . . 0.0 111.057 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.9 -75.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 O-C-N 120.723 -1.236 . . . . 0.0 108.42 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.09 28.28 0.06 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.22 1.808 . . . . 0.0 115.144 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -130.58 -27.38 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.701 1.2 . . . . 0.0 112.186 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.55 125.73 91.15 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 119.344 0.975 . . . . 0.0 112.267 -169.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.9 121.7 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.911 2.407 . . . . 0.0 108.835 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t 76.25 24.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 111.314 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 36.87 40.69 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.486 2.314 . . . . 0.0 115.067 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.02 44.48 1.18 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 120.672 -1.267 . . . . 0.0 111.176 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.57 122.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.76 2.024 . . . . 0.0 106.14 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.63 143.02 50.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.238 1.415 . . . . 0.0 111.551 -167.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -76.06 135.31 39.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.63 38.23 3.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 105.977 -2.849 . . . . 0.0 105.977 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 65.72 -64.23 0.2 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.756 3.222 . . . . 0.0 110.189 -169.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.41 -27.29 66.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 112.6 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 172.19 18.66 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -91.85 151.35 20.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 125.39 15.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.624 2.77 . . . . 0.0 108.736 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -76.79 142.22 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.763 0.825 . . . . 0.0 109.288 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -80.72 108.92 11.21 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -74.9 -3.14 13.46 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.797 1.665 . . . . 0.0 113.263 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.44 -38.19 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.0 -33.07 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.762 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 t -55.53 123.39 13.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.227 0.921 . . . . 0.0 111.149 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 pt -88.75 35.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.176 0.99 . . . . 0.0 111.672 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.2 m-20 44.83 48.21 9.09 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.325 1.45 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.48 178.22 7.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.08 103.25 0.76 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.45 -56.67 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.08 0.94 . . . . 0.0 111.675 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.3 p -63.51 -43.02 98.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.699 0.8 . . . . 0.0 109.819 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.11 137.14 40.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.59 -0.694 . . . . 0.0 110.023 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.59 -18.33 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.199 1.4 . . . . 0.0 113.052 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.69 -36.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 t -62.76 118.1 38.44 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.33 -23.69 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.101 1.868 . . . . 0.0 112.025 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.39 -22.73 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.139 0.975 . . . . 0.0 110.569 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.6 m 54.05 51.52 14.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.661 1.184 . . . . 0.0 111.87 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.46 -19.64 30.96 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.961 0.904 . . . . 0.0 111.624 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.02 117.72 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -128.87 164.89 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.047 0.939 . . . . 0.0 108.793 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.54 144.89 55.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.07 -40.36 61.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.373 0.606 . . . . 0.0 112.456 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.91 -40.92 77.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.996 1.318 . . . . 0.0 111.854 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -80.09 -36.71 35.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.791 1.237 . . . . 0.0 110.234 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.27 126.41 36.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.493 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.18 144.56 37.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.228 2.618 . . . . 0.0 112.39 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -43.38 -45.87 6.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.407 2.683 . . . . 0.0 112.188 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -46.11 -43.98 15.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.271 1.029 . . . . 0.0 111.245 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -98.6 -6.39 30.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.37 1.868 . . . . 0.0 112.711 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -58.83 -22.32 58.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.437 1.472 . . . . 0.0 110.532 170.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 p -50.41 -44.75 55.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.618 167.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.06 -30.5 70.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.94 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.14 -48.26 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 120.89 1.677 . . . . 0.0 106.81 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -55.87 -47.76 76.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.125 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.37 -46.63 87.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.283 0.492 . . . . 0.0 111.713 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -56.55 -43.08 79.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.056 1.342 . . . . 0.0 109.794 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -61.38 -58.01 9.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 123.109 1.433 . . . . 0.0 108.335 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.36 -39.79 73.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.955 2.102 . . . . 0.0 112.933 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -38.88 -53.73 1.69 Allowed 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.684 1.194 . . . . 0.0 111.61 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.39 -29.55 11.97 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.43 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.7 78.34 4.2 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.431 -1.747 . . . . 0.0 108.02 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -95.96 135.56 37.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.4 t -134.66 139.3 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.035 0.534 . . . . 0.0 110.844 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.49 170.0 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.497 1.919 . . . . 0.0 110.54 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 p -140.74 -107.96 0.15 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -120.86 -54.39 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.4 -23.22 54.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.771 1.647 . . . . 0.0 111.935 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -53.32 -39.61 64.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 112.973 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.13 125.25 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.82 -147.0 4.63 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-O 123.203 1.446 . . . . 0.0 110.931 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 p -89.04 64.35 7.06 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 126.135 1.774 . . . . 0.0 109.429 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.87 0.48 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.919 0.888 . . . . 0.0 110.246 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.16 146.99 52.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.565 0.346 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.03 90.01 1.79 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.491 1.516 . . . . 0.0 107.507 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.4 m -144.14 -55.12 0.36 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.562 -0.711 . . . . 0.0 111.062 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.19 70.54 0.83 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.924 0.868 . . . . 0.0 109.523 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.1 -117.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.545 1.538 . . . . 0.0 108.613 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.02 7.48 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.361 1.864 . . . . 0.0 115.291 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.39 -25.4 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 110.102 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.2 t -69.34 126.09 92.43 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.04 0.382 . . . . 0.0 110.31 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -42.42 -38.21 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.738 4.292 . . . . 0.0 114.543 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -124.47 24.73 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 111.193 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t0 39.29 62.54 1.12 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.559 1.544 . . . . 0.0 113.152 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.1 p -125.17 51.82 1.65 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.523 0.729 . . . . 0.0 110.994 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.56 127.37 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.925 2.09 . . . . 0.0 106.462 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.93 133.45 30.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 119.796 1.18 . . . . 0.0 113.987 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.42 146.86 32.56 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.788 -1.195 . . . . 0.0 112.336 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.18 -50.1 0.43 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -54.67 0.82 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.513 1.525 . . . . 0.0 110.212 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -141.16 -49.66 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.908 2.483 . . . . 0.0 110.813 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.1 137.49 37.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.785 -0.572 . . . . 0.0 111.394 -168.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -75.21 102.14 4.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.838 0.828 . . . . 0.0 109.15 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.65 113.31 3.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.925 2.49 . . . . 0.0 106.911 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mt -78.59 130.96 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.12 119.68 71.63 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.754 0.706 . . . . 0.0 109.254 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.29 -27.05 16.84 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 121.706 1.604 . . . . 0.0 112.56 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -42.6 60.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.14 -33.34 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.795 -0.622 . . . . 0.0 112.243 -172.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -61.55 116.86 5.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.133 1.333 . . . . 0.0 110.998 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -83.23 35.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.974 0.91 . . . . 0.0 111.853 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.39 49.69 6.07 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.654 1.982 . . . . 0.0 113.259 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -161.81 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.609 0.764 . . . . 0.0 109.508 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.6 -125.49 4.46 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.88 -67.51 0.26 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 127.662 2.385 . . . . 0.0 110.408 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.3 p -56.61 -46.56 80.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.103 0.561 . . . . 0.0 110.242 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -44.92 78.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.144 0.978 . . . . 0.0 112.878 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.13 72.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.05 0.54 . . . . 0.0 110.655 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.7 -38.17 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.882 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 51' ' ' VAL . 13.9 t -59.86 114.7 10.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.4 18.91 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.242 2.628 . . . . 0.0 113.139 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.9 m -133.08 -25.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.85 2.86 . . . . 0.0 108.295 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 m 53.2 58.39 5.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.623 1.169 . . . . 0.0 111.242 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.71 -12.6 55.62 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.719 1.208 . . . . 0.0 111.322 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.81 128.5 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.02 170.5 15.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -58.49 143.31 46.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.22 -40.49 58.9 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -74.69 -26.5 59.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.376 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -71.04 -28.9 64.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.65 124.6 73.3 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.12 -0.467 . . . . 0.0 109.753 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.9 149.15 71.79 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.039 3.159 . . . . 0.0 112.573 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -44.26 -44.91 8.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.578 3.151 . . . . 0.0 113.772 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -48.05 -39.83 21.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.466 0.706 . . . . 0.0 111.472 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -105.79 -1.42 24.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.533 1.933 . . . . 0.0 112.66 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.3 mmtm -57.83 -22.51 48.06 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.035 1.288 . . . . 0.0 109.336 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.93 -46.37 31.92 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.303 1.441 . . . . 0.0 110.221 168.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.32 -35.18 80.04 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.506 -0.746 . . . . 0.0 110.788 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.63 -37.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.781 1.173 . . . . 0.0 108.39 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -62.71 -46.89 86.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.171 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.5 -49.33 78.19 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.575 -0.703 . . . . 0.0 110.238 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -45.84 -44.7 14.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 127.612 2.365 . . . . 0.0 111.552 169.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -59.51 4.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.56 -44.48 62.73 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.522 1.929 . . . . 0.0 111.524 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -43.2 -42.81 4.39 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -115.51 19.73 15.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.153 0.581 . . . . 0.0 110.855 -174.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 77.99 1.5 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -113.43 142.04 46.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.51 144.38 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.321 1.048 . . . . 0.0 111.815 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.51 161.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.961 2.105 . . . . 0.0 110.916 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 p -148.96 163.73 36.62 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.623 0.725 . . . . 0.0 111.899 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.255 2.8 tt0 -15.1 -62.21 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.805 3.242 . . . . 0.0 116.838 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.53 -25.71 79.87 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 CA-C-N 122.008 1.753 . . . . 0.0 113.451 -173.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -12.3 60.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.352 0.661 . . . . 0.0 111.612 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.09 85.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.268 -0.895 . . . . 0.0 109.204 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.04 58.42 0.57 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.22 1.39 . . . . 0.0 110.131 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.311 14.5 t 38.1 115.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.503 3.121 . . . . 0.0 116.728 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 61.97 -62.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.751 2.021 . . . . 0.0 114.075 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.6 t 66.01 -63.92 0.22 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.859 2.064 . . . . 0.0 112.396 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.94 24.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.004 1.722 . . . . 0.0 113.42 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.0 m -97.31 -48.68 5.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.675 0.39 . . . . 0.0 110.998 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -73.51 71.82 1.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.807 0.813 . . . . 0.0 109.137 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 152.78 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.763 1.625 . . . . 0.0 109.745 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 48.46 21.29 0.37 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.85 -16.92 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.456 0.703 . . . . 0.0 111.718 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -71.98 131.73 85.32 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -172.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -45.44 -37.23 14.37 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.026 3.817 . . . . 0.0 115.084 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 -15.06 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.959 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 t0 99.2 162.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.341 2.657 . . . . 0.0 108.951 -171.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.8 p 154.96 -9.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.608 2.763 . . . . 0.0 112.708 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.91 100.16 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.625 1.102 . . . . 0.0 110.253 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.96 142.52 45.56 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.128 0.971 . . . . 0.0 111.749 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.95 98.59 3.07 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.663 -1.273 . . . . 0.0 111.806 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.43 68.51 2.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 69.91 -59.9 0.49 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 130.066 3.346 . . . . 0.0 111.509 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -141.71 33.52 1.61 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.968 0.89 . . . . 0.0 112.235 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -166.05 140.27 4.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -80.13 114.99 19.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.07 117.93 35.67 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.953 2.501 . . . . 0.0 106.004 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.91 123.19 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.402 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 35.8 t0 -67.47 113.92 16.6 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.309 0.959 . . . . 0.0 108.589 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -61.24 -32.47 90.44 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.801 1.667 . . . . 0.0 110.699 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -77.12 -28.18 54.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -172.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.06 -32.97 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.171 0.441 . . . . 0.0 110.836 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 t -59.54 104.42 0.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.051 0.842 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.7 pt -78.82 46.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.936 -1.103 . . . . 0.0 111.262 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.37 -110.67 0.53 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.265 1.426 . . . . 0.0 109.401 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.83 -45.74 0.49 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.68 1.592 . . . . 0.0 114.386 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.42 -122.82 6.09 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.84 -75.09 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.9 1.28 . . . . 0.0 112.179 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -51.18 -43.46 61.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.201 1.0 . . . . 0.0 110.417 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -48.27 -59.92 3.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.224 1.41 . . . . 0.0 110.511 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.89 74.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.995 0.518 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 t -64.81 -36.54 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.894 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.7 t -63.83 114.3 13.03 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.15 46.09 2.14 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.352 2.702 . . . . 0.0 110.97 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -164.19 -29.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.739 2.415 . . . . 0.0 109.536 -169.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 m 57.59 58.55 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 110.315 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.59 -20.87 38.91 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.221 1.008 . . . . 0.0 110.673 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.87 116.39 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.1 166.85 12.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -54.26 -39.65 67.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -52.49 -43.63 65.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.073 0.949 . . . . 0.0 112.222 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.57 -34.33 53.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.406 1.082 . . . . 0.0 110.38 -169.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.26 124.17 59.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 118.213 -0.899 . . . . 0.0 109.57 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.67 146.12 56.09 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.01 2.474 . . . . 0.0 112.399 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.5 mp0 -41.75 -44.67 3.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -46.73 -44.01 18.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.592 0.757 . . . . 0.0 110.931 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -101.55 -1.65 32.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.375 1.87 . . . . 0.0 113.246 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.5 mmtm -57.91 -23.96 55.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.454 1.479 . . . . 0.0 108.92 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 p -48.18 -45.36 33.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.717 1.207 . . . . 0.0 110.623 168.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.33 -35.83 82.15 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 121.395 -0.815 . . . . 0.0 111.305 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -46.26 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.76 -44.81 73.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.384 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.39 -45.85 78.62 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.359 0.527 . . . . 0.0 112.047 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -59.61 -41.34 90.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.565 1.146 . . . . 0.0 111.135 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -58.42 -61.21 2.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -52.69 -52.47 55.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.864 2.466 . . . . 0.0 113.359 -170.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -34.99 -47.99 0.39 Allowed 'General case' 0 C--O 1.228 -0.07 0 O-C-N 125.427 1.705 . . . . 0.0 113.466 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.97 -2.84 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.705 0.628 . . . . 0.0 111.894 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.61 -34.1 40.94 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.035 0.834 . . . . 0.0 111.038 -173.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -110.35 149.08 30.73 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 117.964 0.347 . . . . 0.0 110.374 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -128.34 139.05 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.179 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.62 140.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 126.553 1.941 . . . . 0.0 107.833 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -129.79 172.44 11.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.163 0.585 . . . . 0.0 111.102 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -12.71 -59.59 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 129.408 3.083 . . . . 0.0 115.946 171.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.4 -17.74 59.25 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.894 1.712 . . . . 0.0 114.206 -173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.69 -31.82 73.22 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.139 0.882 . . . . 0.0 111.659 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.9 mt -54.14 101.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.988 -169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.71 54.42 0.08 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.286 7.1 t 54.99 -160.09 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.134 1.774 . . . . 0.0 113.763 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -77.24 67.02 3.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.347 1.459 . . . . 0.0 111.189 -171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.32 -49.42 77.08 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.27 1.428 . . . . 0.0 110.989 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.86 -127.44 0.75 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.057 0.943 . . . . 0.0 109.329 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 m 75.98 -57.17 0.57 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.209 2.203 . . . . 0.0 110.853 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -57.21 -37.16 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.0 t -54.64 -62.21 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.062 0.945 . . . . 0.0 111.491 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -64.28 6.84 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -168.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.21 -12.06 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.975 1.261 . . . . 0.0 113.418 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.4 t -69.63 130.02 90.84 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.795 1.18 . . . . 0.0 110.7 -171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -57.12 -29.5 83.49 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.947 3.098 . . . . 0.0 113.749 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.4 67.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.214 0.606 . . . . 0.0 109.43 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 6.96 64.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 130.752 3.621 . . . . 0.0 115.354 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 p -116.33 37.51 3.69 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.561 0.744 . . . . 0.0 110.394 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.16 123.51 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 128.056 2.542 . . . . 0.0 105.485 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.32 165.12 25.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.367 1.867 . . . . 0.0 108.643 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -90.41 160.83 15.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.649 0.659 . . . . 0.0 110.351 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 68.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.3 84.01 0.16 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.853 2.061 . . . . 0.0 109.318 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.274 1.1 m-20 47.33 41.43 12.3 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.929 2.092 . . . . 0.0 114.875 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 160.18 28.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.768 2.827 . . . . 0.0 104.195 168.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -102.1 164.07 11.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 123.158 0.287 . . . . 0.0 110.637 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.31 148.62 41.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 106.958 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.2 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.82 123.42 89.2 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 119.621 1.101 . . . . 0.0 109.553 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.87 -28.25 16.78 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.348 1.365 . . . . 0.0 112.961 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -27.46 18.27 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.857 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -81.84 -29.58 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.816 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.32 118.61 9.58 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.428 1.013 . . . . 0.0 110.4 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 pt -88.74 32.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 123.673 0.789 . . . . 0.0 111.336 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 1.6 t70 42.3 52.52 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.953 2.101 . . . . 0.0 111.103 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.5 p -74.35 -44.73 51.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -168.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.85 86.09 1.25 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.64 -59.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.715 0.806 . . . . 0.0 110.65 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -54.97 -48.17 73.6 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.057 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -48.96 70.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.207 1.003 . . . . 0.0 111.422 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.63 77.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.272 0.629 . . . . 0.0 111.768 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.74 2.4 6.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 117.809 -1.091 . . . . 0.0 113.482 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' VAL . 12.9 t -87.44 102.33 3.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.05 15.59 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.694 2.929 . . . . 0.0 113.112 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.5 m -119.07 -27.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 129.624 3.17 . . . . 0.0 107.343 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 56.83 58.15 4.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.85 1.26 . . . . 0.0 110.15 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -20.1 33.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.187 0.995 . . . . 0.0 110.466 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.75 121.83 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -135.82 168.83 18.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -64.89 142.79 58.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -47.3 -43.91 22.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.09 -39.88 79.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.72 0.808 . . . . 0.0 111.538 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -77.06 -38.9 51.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.56 1.144 . . . . 0.0 110.681 -168.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.88 122.68 14.29 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.191 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.97 146.61 46.46 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.299 2.666 . . . . 0.0 112.668 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.4 mp0 -41.47 -45.5 3.21 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.512 3.125 . . . . 0.0 113.735 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -46.31 -44.73 16.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.851 0.834 . . . . 0.0 110.894 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.93 -0.43 39.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.315 1.846 . . . . 0.0 112.83 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.0 mmtm -59.21 -22.44 61.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.621 1.555 . . . . 0.0 109.341 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 p -48.46 -46.1 37.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.441 1.096 . . . . 0.0 109.764 168.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -62.55 -34.45 76.97 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.322 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.4 -35.53 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 120.849 1.659 . . . . 0.0 109.403 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -62.69 -50.14 72.3 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -48.05 83.51 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.192 0.597 . . . . 0.0 111.384 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -42.25 -47.93 4.84 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 129.591 3.156 . . . . 0.0 112.368 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -61.36 1.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.33 -31.0 65.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.301 1.84 . . . . 0.0 113.616 -170.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.36 17.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.202 0.601 . . . . 0.0 111.828 174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -113.31 -33.25 6.01 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.251 0.621 . . . . 0.0 110.747 -170.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.75 140.9 33.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.67 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -103.92 145.92 29.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.586 0.754 . . . . 0.0 108.981 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t -132.36 141.93 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.276 1.031 . . . . 0.0 111.37 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.72 139.8 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.341 1.856 . . . . 0.0 109.177 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.2 p -126.95 174.36 8.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.736 0.815 . . . . 0.0 111.289 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -12.91 -59.62 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.957 2.903 . . . . 0.0 115.577 169.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.09 -12.48 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 121.181 1.458 . . . . 0.0 114.23 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -70.23 -33.86 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.075 0.852 . . . . 0.0 111.951 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.41 127.65 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.527 0.603 . . . . 0.0 109.753 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.6 48.7 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.7 m 52.15 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 116.241 168.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm 73.9 -64.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.742 2.817 . . . . 0.0 113.247 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 t 60.71 -67.36 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.237 1.415 . . . . 0.0 112.165 -170.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.51 34.32 6.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.364 1.866 . . . . 0.0 113.339 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 m -89.9 -47.72 7.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 111.227 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 p -72.92 69.99 0.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.724 0.773 . . . . 0.0 109.36 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.71 -96.48 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.553 1.141 . . . . 0.0 109.594 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.51 24.71 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.699 1.599 . . . . 0.0 115.133 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.01 -25.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.479 1.512 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.11 121.79 86.03 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.254 0.933 . . . . 0.0 110.765 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.2 -38.17 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 125.261 3.974 . . . . 0.0 114.148 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -116.16 18.77 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.953 0.901 . . . . 0.0 111.804 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t0 42.9 52.25 5.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.699 1.2 . . . . 0.0 112.658 172.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.9 p -107.42 26.95 9.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.765 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.29 126.7 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.364 1.466 . . . . 0.0 109.09 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -136.77 170.28 16.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.892 1.677 . . . . 0.0 107.868 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -100.52 156.74 17.12 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 122.146 0.974 . . . . 0.0 113.209 169.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.87 73.54 0.45 Allowed Glycine 0 N--CA 1.444 -0.77 1 N-CA-C 102.848 -4.101 . . . . 0.0 102.848 167.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 61.98 -66.58 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 131.206 3.803 . . . . 0.0 112.59 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -102.56 -21.14 14.23 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.295 1.438 . . . . 0.0 112.452 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.75 163.68 31.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.221 -169.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -81.41 164.36 22.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 123.574 0.546 . . . . 0.0 110.27 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -143.77 120.6 11.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.516 2.326 . . . . 0.0 106.114 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.09 134.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.433 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 32.3 t0 -77.47 112.33 23.22 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 168.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.11 -28.33 41.1 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.74 1.626 . . . . 0.0 110.768 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -78.61 -25.42 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.4 t -89.61 -36.44 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 118.694 0.679 . . . . 0.0 111.868 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.3 t -55.08 136.52 48.04 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.62 1.1 . . . . 0.0 110.722 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.64 38.4 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.476 1.111 . . . . 0.0 111.408 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 44.53 55.47 5.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.438 1.495 . . . . 0.0 112.198 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -159.66 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.705 0.402 . . . . 0.0 111.358 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.47 109.42 0.59 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 169.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -168.63 -66.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.706 1.202 . . . . 0.0 110.094 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.0 p -54.74 -44.44 73.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.99 0.916 . . . . 0.0 111.159 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -50.94 70.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.158 0.583 . . . . 0.0 111.972 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.66 78.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.031 0.532 . . . . 0.0 110.889 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.07 -37.09 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.836 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 t -73.5 106.97 2.77 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 108.706 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.17 -14.0 41.65 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.615 1.544 . . . . 0.0 111.805 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.26 -21.53 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.283 1.433 . . . . 0.0 109.974 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 53.48 58.85 4.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.254 1.022 . . . . 0.0 110.987 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.98 46.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.854 0.862 . . . . 0.0 110.551 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.82 125.08 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.82 167.59 20.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.13 145.4 55.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -48.84 -46.41 42.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.508 0.671 . . . . 0.0 111.048 174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.8 -38.11 60.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.012 1.725 . . . . 0.0 111.109 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -82.77 -41.25 19.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.284 1.034 . . . . 0.0 110.437 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.26 121.81 27.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.752 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.31 147.69 54.73 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.403 2.735 . . . . 0.0 112.531 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -39.98 -46.6 2.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.517 3.127 . . . . 0.0 113.399 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -45.53 -43.72 12.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.699 0.8 . . . . 0.0 111.148 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -102.11 -0.49 33.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.524 1.93 . . . . 0.0 113.08 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -57.9 -25.76 61.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.86 1.663 . . . . 0.0 109.23 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -46.87 -46.41 21.01 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.029 1.332 . . . . 0.0 110.272 168.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -64.31 -34.89 79.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.656 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.66 -47.11 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 120.869 1.668 . . . . 0.0 106.952 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -58.75 -43.69 90.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.956 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -64.1 -44.39 92.46 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.367 0.531 . . . . 0.0 111.766 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -59.11 -43.0 91.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.675 1.59 . . . . 0.0 110.497 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -56.7 -60.13 4.01 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.86 -42.06 88.51 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.132 2.573 . . . . 0.0 112.651 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -37.41 -50.41 1.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 112.276 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.18 -21.58 13.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 -170.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -78.91 81.62 5.17 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 170.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.964 -1.493 . . . . 0.0 108.376 -174.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.79 141.05 33.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.947 0.499 . . . . 0.0 109.998 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.39 143.26 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.836 0.855 . . . . 0.0 110.264 -173.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.08 161.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 110.552 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 p -148.49 174.55 11.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.015 0.926 . . . . 0.0 109.198 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -10.2 -61.71 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 128.661 2.785 . . . . 0.0 116.071 170.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.85 -17.16 58.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 CA-C-N 121.494 1.569 . . . . 0.0 113.694 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.67 -31.24 72.15 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.741 0.701 . . . . 0.0 112.03 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.17 91.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.806 0.812 . . . . 0.0 110.14 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.89 85.43 0.16 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.092 2.282 . . . . 0.0 107.639 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.287 6.5 t -6.85 99.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.466 2.706 . . . . 0.0 117.096 -172.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp 56.09 41.62 29.35 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.486 2.314 . . . . 0.0 113.108 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -46.36 -52.11 13.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.741 1.617 . . . . 0.0 112.472 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.04 -121.58 0.72 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.81 0.844 . . . . 0.0 109.229 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m 68.86 -57.38 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.056 1.743 . . . . 0.0 111.634 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.3 p -70.21 64.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 0.0 108.671 169.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.36 152.36 21.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 126.053 1.741 . . . . 0.0 108.0 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 61.12 -10.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.982 2.215 . . . . 0.0 116.982 173.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m -90.55 -24.62 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.812 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -72.76 125.52 91.15 Favored Pre-proline 0 CA--C 1.538 0.512 0 O-C-N 122.211 -0.306 . . . . 0.0 110.19 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.15 -31.54 55.44 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.278 3.318 . . . . 0.0 113.531 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.17 19.92 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.89 0.876 . . . . 0.0 111.853 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.6 t70 41.23 56.39 3.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.065 1.346 . . . . 0.0 113.202 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -110.85 36.19 3.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.681 0.793 . . . . 0.0 111.006 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.41 131.96 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 106.713 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -142.1 174.65 10.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.815 1.646 . . . . 0.0 107.749 -169.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -107.94 160.39 15.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.117 0.96 . . . . 0.0 113.095 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.36 67.65 0.56 Allowed Glycine 0 N--CA 1.445 -0.716 1 N-CA-C 102.732 -4.147 . . . . 0.0 102.732 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 64.41 -63.22 0.17 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 131.096 3.758 . . . . 0.0 112.631 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -101.74 -20.5 14.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 112.57 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.45 162.81 38.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.12 -0.987 . . . . 0.0 108.62 -169.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -85.05 162.72 19.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.75 0.656 . . . . 0.0 110.911 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -145.19 131.45 19.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.789 2.436 . . . . 0.0 106.495 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.82 129.31 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 13.3 t0 -69.13 113.95 20.06 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.327 0.967 . . . . 0.0 109.192 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -28.94 71.1 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.385 1.39 . . . . 0.0 112.304 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -31.48 23.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.092 -0.48 . . . . 0.0 109.763 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.74 -28.29 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.247 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -58.94 119.53 7.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.946 1.248 . . . . 0.0 111.09 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 pt -91.65 33.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.103 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 27.9 m-20 43.92 58.98 3.35 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.015 1.326 . . . . 0.0 112.592 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.94 -173.86 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.98 172.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.58 104.4 0.8 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -163.03 -75.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.243 1.017 . . . . 0.0 110.025 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.4 p -50.83 -44.39 59.3 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.601 1.161 . . . . 0.0 112.365 -172.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -39.14 90.54 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.544 -0.722 . . . . 0.0 111.658 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.01 -36.92 67.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.812 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.0 t -65.86 -43.23 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.948 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 t -58.65 112.95 5.67 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 119.272 0.942 . . . . 0.0 108.665 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.28 42.35 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.621 2.881 . . . . 0.0 111.08 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.1 -34.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 128.979 2.911 . . . . 0.0 107.8 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m 57.13 59.85 3.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.276 1.031 . . . . 0.0 110.085 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.65 -23.99 56.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.476 1.51 . . . . 0.0 109.873 169.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.94 116.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.402 1.481 . . . . 0.0 107.008 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -122.87 166.45 15.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.82 145.39 52.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -44.05 62.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.615 -0.678 . . . . 0.0 111.995 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.49 -16.7 63.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.246 1.019 . . . . 0.0 112.597 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -80.8 -38.51 28.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.83 121.07 62.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.822 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -54.03 148.6 38.44 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.717 2.945 . . . . 0.0 112.119 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -52.88 -41.43 64.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.679 1.191 . . . . 0.0 110.728 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -44.34 -47.92 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.067 1.347 . . . . 0.0 111.292 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -95.9 -8.56 33.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.694 1.198 . . . . 0.0 112.08 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -59.95 -16.79 32.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 119.524 1.056 . . . . 0.0 110.869 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -50.56 -47.57 57.73 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.624 -0.673 . . . . 0.0 109.427 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -63.63 -37.34 86.95 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 121.651 -0.656 . . . . 0.0 111.18 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -45.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -55.89 -45.03 78.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -64.07 -45.89 86.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.605 0.639 . . . . 0.0 112.202 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -55.69 -41.58 73.96 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.417 1.487 . . . . 0.0 110.876 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -63.78 -58.44 6.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.1 -46.04 75.5 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.058 1.743 . . . . 0.0 112.833 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -34.76 -53.5 0.55 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.729 1.212 . . . . 0.0 112.298 -173.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -106.71 1.7 25.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 124.438 1.087 . . . . 0.0 112.315 -170.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 11.8 mptt -102.72 -8.65 20.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.778 0.717 . . . . 0.0 112.667 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -119.7 152.42 37.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.42 0.555 . . . . 0.0 109.704 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.9 140.6 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.976 0.911 . . . . 0.0 110.613 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 127.344 2.257 . . . . 0.0 107.968 169.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -113.75 -89.97 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -134.46 -52.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -167.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.67 -25.16 74.19 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.935 1.757 . . . . 0.0 113.529 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.12 -37.32 66.74 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.832 0.853 . . . . 0.0 112.294 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.292 3.6 mp -69.01 96.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 122.181 0.991 . . . . 0.0 112.574 -168.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.3 -171.89 14.58 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 103.471 -3.852 . . . . 0.0 103.471 169.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.95 105.33 1.97 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.561 1.944 . . . . 0.0 111.789 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm 62.58 -63.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.638 2.375 . . . . 0.0 115.528 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t 66.03 -89.42 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.827 2.051 . . . . 0.0 112.093 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 96.54 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.341 2.657 . . . . 0.0 108.68 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m 73.92 -57.66 0.61 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.406 2.282 . . . . 0.0 111.584 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.52 -24.47 61.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.34 1.056 . . . . 0.0 111.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.26 7.9 p -72.55 -52.19 24.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 O-C-N 121.345 -0.847 . . . . 0.0 112.27 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -74.13 17.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.46 -20.51 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.68 129.25 94.29 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 120.476 1.489 . . . . 0.0 109.711 -172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.01 -42.32 25.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.801 3.667 . . . . 0.0 113.3 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.72 110.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -31.01 120.25 0.21 Allowed 'General case' 0 C--O 1.23 0.077 0 C-N-CA 126.101 1.76 . . . . 0.0 114.686 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.7 m -133.7 16.93 3.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 108.036 168.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.62 110.99 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -115.92 145.75 42.64 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -166.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.82 78.08 3.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 122.483 1.135 . . . . 0.0 108.861 169.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.66 97.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.26 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -125.0 -74.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.751 1.221 . . . . 0.0 107.803 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -135.71 -39.25 0.72 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.144 0.978 . . . . 0.0 113.12 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 170.88 8.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.488 1.915 . . . . 0.0 108.954 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.02 127.19 32.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.86 -172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -109.19 117.18 33.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.849 3.26 . . . . 0.0 106.976 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 129.09 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.88 0.764 . . . . 0.0 109.487 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.14 112.91 26.23 Favored Pre-proline 0 C--O 1.232 0.181 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.8 -29.74 50.32 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.41 1.407 . . . . 0.0 111.203 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -82.63 -29.64 29.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.293 0.637 . . . . 0.0 109.608 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.94 -33.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.562 0.619 . . . . 0.0 110.932 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.9 t -52.07 120.66 5.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.323 0.965 . . . . 0.0 111.436 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.58 35.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.738 0.815 . . . . 0.0 112.112 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.465 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 45.04 50.08 9.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 0.0 113.496 176.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.31 -167.51 1.8 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.55 101.02 0.44 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 169.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.7 -76.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.094 0.947 . . . . 0.0 110.042 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.2 p -48.16 -46.06 34.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.759 1.224 . . . . 0.0 111.844 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -50.9 71.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.956 0.902 . . . . 0.0 112.18 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.34 70.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.15 0.58 . . . . 0.0 110.828 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 t -69.65 -38.81 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.236 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.4 t -57.73 111.67 3.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.753 1.16 . . . . 0.0 109.67 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 -14.26 41.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.501 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.91 -22.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.265 1.426 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m 53.16 57.25 6.47 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 111.258 -171.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.97 -19.85 29.8 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 111.444 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.99 127.99 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 124.989 1.316 . . . . 0.0 107.649 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -139.65 168.45 19.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.21 148.21 52.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -53.28 -42.8 66.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.76 -23.22 60.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.819 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.58 -35.87 52.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.19 125.26 70.12 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.631 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.82 141.91 64.46 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.442 2.761 . . . . 0.0 112.148 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' CD ' ' HZ1' ' A' ' 65' ' ' LYS . 2.2 mp0 -35.37 -51.3 0.59 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.403 2.681 . . . . 0.0 113.461 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.48 -46.89 14.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.953 0.882 . . . . 0.0 110.617 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -95.18 -3.13 48.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.464 1.506 . . . . 0.0 112.629 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 36.3 mttp -60.34 -22.53 63.34 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.531 1.514 . . . . 0.0 110.119 169.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -48.58 -41.75 31.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.317 0.647 . . . . 0.0 110.294 167.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -68.44 -32.49 72.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.245 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.84 -46.84 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 121.135 1.789 . . . . 0.0 107.365 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.08 -49.12 72.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.017 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -63.71 -43.25 97.15 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -61.32 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.489 1.515 . . . . 0.0 110.297 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -57.23 13.41 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.32 -42.38 99.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 128.375 2.67 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -37.15 -51.84 1.01 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.414 1.086 . . . . 0.0 112.836 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.34 4.14 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.795 0.838 . . . . 0.0 111.503 -170.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 80.63 1.33 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.032 -1.937 . . . . 0.0 107.365 -169.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.484 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -90.18 161.59 15.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.195 0.521 . . . . 0.0 111.294 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.19 149.58 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.339 1.055 . . . . 0.0 110.794 -172.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.45 138.71 25.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.979 1.312 . . . . 0.0 109.196 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -128.79 170.84 12.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 111.939 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.25 7.8 tt0 -12.25 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 129.756 3.222 . . . . 0.0 116.657 171.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.66 -19.74 54.66 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 122.559 1.95 . . . . 0.0 114.572 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -68.07 -29.1 67.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.071 0.851 . . . . 0.0 111.895 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.7 mt -44.18 110.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.3 0 C-N-CA 124.576 1.15 . . . . 0.0 113.188 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 38.47 0.07 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.9 m 57.51 -83.63 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.954 2.101 . . . . 0.0 113.258 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -124.86 110.46 14.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.601 0.761 . . . . 0.0 109.556 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -129.76 163.82 25.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.446 2.299 . . . . 0.0 105.242 170.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.71 -130.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.6 m 73.6 -68.17 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.601 2.36 . . . . 0.0 110.569 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 p -59.57 -28.44 67.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.826 0.451 . . . . 0.0 110.392 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.58 -66.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.39 1.076 . . . . 0.0 111.846 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -76.95 38.68 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.782 1.233 . . . . 0.0 113.839 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.45 -33.48 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.17 0.988 . . . . 0.0 113.195 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.03 122.6 73.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 120.064 1.302 . . . . 0.0 112.305 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.73 -31.06 91.5 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.841 3.028 . . . . 0.0 112.842 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.9 16.6 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.332 0.653 . . . . 0.0 112.237 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.8 t0 44.2 56.37 4.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.225 . . . . 0.0 112.405 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.7 p -115.63 32.42 6.08 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.563 0.745 . . . . 0.0 110.943 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.68 114.99 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.572 2.349 . . . . 0.0 107.818 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -128.75 173.8 10.01 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 126.198 1.799 . . . . 0.0 109.72 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -119.89 165.2 14.93 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.009 1.323 . . . . 0.0 113.925 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -128.68 13.67 6.13 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.821 1.677 . . . . 0.0 110.571 167.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 73.9 12.48 4.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.958 2.503 . . . . 0.0 112.774 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -123.54 -48.35 1.94 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 128.789 2.836 . . . . 0.0 109.611 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.83 176.25 10.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.032 2.133 . . . . 0.0 105.371 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.52 166.65 19.11 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.197 0.522 . . . . 0.0 110.269 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -145.39 109.67 4.92 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.767 2.027 . . . . 0.0 107.184 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.89 133.09 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -74.54 111.49 13.21 Favored Pre-proline 0 C--N 1.343 0.301 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 167.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -58.38 -33.53 97.9 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.111 1.207 . . . . 0.0 111.591 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -80.26 -29.83 38.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.705 -0.622 . . . . 0.0 110.599 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.3 -30.68 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.68 125.02 20.4 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.042 0.837 . . . . 0.0 111.308 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 pt -99.05 32.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.258 1.023 . . . . 0.0 111.347 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 26.3 m-20 46.4 41.7 9.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.78 1.632 . . . . 0.0 113.691 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -21.92 59.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.287 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.44 -139.23 25.33 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.847 1.213 . . . . 0.0 110.682 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.48 -60.55 0.5 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.836 2.054 . . . . 0.0 111.409 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -52.31 -40.46 61.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.911 0.884 . . . . 0.0 111.374 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -46.19 80.73 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.768 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.49 76.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.359 0.663 . . . . 0.0 110.292 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.4 -37.76 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.147 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 t -61.21 116.15 18.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.01 1.277 . . . . 0.0 108.103 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.89 -19.83 49.43 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.1 1.867 . . . . 0.0 112.777 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.27 -19.09 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.305 1.442 . . . . 0.0 110.235 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.0 m 51.9 58.36 5.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.359 1.064 . . . . 0.0 111.137 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.17 -13.4 59.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.071 0.948 . . . . 0.0 111.596 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.11 129.81 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.82 179.45 6.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.428 ' CD2' ' H1 ' ' A' ' 1' ' ' ALA . 7.8 t-80 -79.51 145.35 33.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -48.31 -42.47 31.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.02 -39.82 87.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.223 0.535 . . . . 0.0 112.274 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -76.88 -32.41 57.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.517 -168.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.72 128.89 80.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.083 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.79 143.55 47.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.157 2.571 . . . . 0.0 112.4 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -44.05 -44.93 7.75 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.603 2.761 . . . . 0.0 112.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -46.77 -47.73 20.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.086 0.954 . . . . 0.0 110.843 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -93.17 -6.2 48.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.402 1.481 . . . . 0.0 112.301 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -59.85 -16.04 25.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.273 1.397 . . . . 0.0 110.869 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 p -52.73 -47.35 67.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.064 -1.022 . . . . 0.0 108.998 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -65.76 -30.16 70.77 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.355 -0.831 . . . . 0.0 111.621 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.04 -49.85 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -54.32 -41.87 69.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.421 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -49.98 66.75 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.624 0.647 . . . . 0.0 112.351 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.22 -42.18 69.51 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.371 1.468 . . . . 0.0 109.71 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -58.55 7.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.1 -44.38 83.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.887 2.475 . . . . 0.0 112.923 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -38.28 -50.99 1.49 Allowed 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.383 1.073 . . . . 0.0 112.664 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -102.74 -15.08 16.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 111.483 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 73.82 8.64 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 116.429 -1.748 . . . . 0.0 107.601 -169.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -108.27 145.21 34.69 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.317 1.447 . . . . 0.0 110.864 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.09 140.54 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.714 1.206 . . . . 0.0 111.51 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -37.92 71.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 C-N-CA 126.123 1.769 . . . . 0.0 112.133 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p 63.36 -108.08 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.712 2.405 . . . . 0.0 114.24 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.92 -52.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -167.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.75 77.64 2.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.014 1.81 . . . . 0.0 111.077 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -178.03 -41.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.238 2.615 . . . . 0.0 108.026 -170.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.94 143.75 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 124.116 0.966 . . . . 0.0 113.024 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.59 32.98 58.89 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 124.954 1.264 . . . . 0.0 112.146 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -161.47 103.24 1.22 Allowed 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.253 1.421 . . . . 0.0 108.097 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -53.16 -39.11 63.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.091 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.9 t 66.71 -68.14 0.15 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 113.756 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.09 42.2 28.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.767 1.627 . . . . 0.0 112.472 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.4 m -100.51 -50.15 3.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.287 0.635 . . . . 0.0 111.228 171.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.3 p -75.16 68.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.762 0.791 . . . . 0.0 109.766 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.95 151.43 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.903 1.681 . . . . 0.0 109.043 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 59.01 29.74 19.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.701 1.6 . . . . 0.0 111.899 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.35 -38.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.366 1.066 . . . . 0.0 111.498 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.11 131.56 93.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.423 0.689 . . . . 0.0 110.201 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -45.95 -36.63 16.0 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 125.274 3.983 . . . . 0.0 114.229 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.71 19.48 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.051 0.94 . . . . 0.0 111.405 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 40.64 44.25 1.77 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 113.316 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.4 p -90.2 46.73 1.37 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.291 1.037 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.63 125.74 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.063 1.745 . . . . 0.0 106.564 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -133.8 166.57 22.34 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 124.791 1.237 . . . . 0.0 107.882 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -98.48 140.75 32.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 120.206 1.366 . . . . 0.0 112.096 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.79 -50.61 4.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 166.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 175.33 -74.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.516 3.126 . . . . 0.0 105.008 168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.32 10.23 7.41 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.057 1.343 . . . . 0.0 113.023 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.84 153.23 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.08 161.99 22.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.857 0.723 . . . . 0.0 110.233 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -134.53 111.89 10.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.861 2.865 . . . . 0.0 105.325 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.52 138.57 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.421 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 21.0 t0 -78.9 108.16 7.59 Favored Pre-proline 0 N--CA 1.464 0.268 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -76.67 -3.31 13.64 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.319 1.346 . . . . 0.0 112.479 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.89 -38.36 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 109.983 169.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.86 -31.19 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 t -57.19 131.18 49.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.243 0.929 . . . . 0.0 111.211 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.2 pt -103.99 37.19 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.669 1.187 . . . . 0.0 111.53 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 28.0 m-20 52.23 37.06 21.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.393 1.477 . . . . 0.0 114.017 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -20.81 39.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.49 -140.45 24.42 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.03 -57.06 0.57 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 127.359 2.264 . . . . 0.0 111.386 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.2 -37.15 71.76 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.615 0.766 . . . . 0.0 111.188 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -43.28 86.14 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.3 -0.875 . . . . 0.0 110.912 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.17 84.01 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.861 0.464 . . . . 0.0 110.683 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.6 t -67.35 -40.29 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.043 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 t -58.38 115.62 12.13 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.95 61.44 7.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.952 3.101 . . . . 0.0 109.14 -172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 174.93 -36.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.813 2.445 . . . . 0.0 108.593 -167.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m 58.31 53.88 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.086 0.954 . . . . 0.0 110.864 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.285 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.25 121.43 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -118.26 164.13 15.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -71.69 147.28 47.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.79 -36.96 70.48 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.265 1.031 . . . . 0.0 113.183 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.51 -46.21 66.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.307 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -76.48 -36.44 57.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.616 1.167 . . . . 0.0 110.927 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.1 t -52.46 122.14 24.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.5 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.03 147.32 64.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.3 2.667 . . . . 0.0 112.81 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 4.6 mp0 -39.69 -47.06 1.96 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.831 3.252 . . . . 0.0 113.537 174.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.06 -43.42 14.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.769 0.828 . . . . 0.0 111.11 172.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -102.13 -1.68 30.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.617 1.967 . . . . 0.0 112.87 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.5 mmtm -55.52 -28.81 56.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.588 1.54 . . . . 0.0 109.501 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 p -48.78 -45.49 40.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.054 1.342 . . . . 0.0 111.566 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -67.81 -32.68 73.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.549 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.2 mt -63.94 -47.67 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 120.73 1.605 . . . . 0.0 108.283 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -49.99 -53.67 25.02 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.62 93.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.763 0.256 . . . . 0.0 111.204 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.535 0.734 . . . . 0.0 111.111 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -62.85 -57.89 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.934 1.35 . . . . 0.0 109.202 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -59.64 -38.98 82.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.848 2.859 . . . . 0.0 112.25 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -37.33 -57.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 171.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -97.48 -31.58 12.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.806 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -76.56 81.38 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.998 -1.477 . . . . 0.0 108.007 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -101.47 136.71 40.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.934 1.294 . . . . 0.0 108.604 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.7 142.75 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.367 0.667 . . . . 0.0 111.219 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.11 157.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.187 1.795 . . . . 0.0 111.179 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -145.77 160.08 42.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.341 3.6 tt0 1.2 -66.14 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 130.068 3.347 . . . . 0.0 117.445 169.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.04 -25.71 55.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 122.76 2.021 . . . . 0.0 114.633 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 t -57.29 -33.98 68.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 112.177 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.63 83.44 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.646 0.736 . . . . 0.0 111.032 -169.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.88 65.11 0.6 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.148 1.832 . . . . 0.0 108.876 171.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.256 14.2 t 50.13 -156.42 0.1 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.919 1.688 . . . . 0.0 112.435 -175.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -77.4 100.72 6.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.942 0.877 . . . . 0.0 110.56 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.62 177.62 8.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.149 1.78 . . . . 0.0 109.687 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.42 134.33 12.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m 156.42 -68.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.348 2.259 . . . . 0.0 107.412 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.89 40.29 0.24 Allowed 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.564 -0.71 . . . . 0.0 110.876 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.71 -73.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.069 0 O-C-N 120.548 -1.345 . . . . 0.0 107.988 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -80.85 41.5 0.58 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.88 -35.7 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.35 127.91 93.34 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.378 0.99 . . . . 0.0 110.925 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.96 -36.4 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.945 3.763 . . . . 0.0 114.218 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.75 45.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.802 0.841 . . . . 0.0 111.213 -169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 55.62 -115.18 0.91 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.049 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.16 -19.64 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.78 103.26 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.95 1.3 . . . . 0.0 109.824 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.27 142.63 47.29 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.632 1.173 . . . . 0.0 111.823 -169.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -75.8 77.72 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.601 1.091 . . . . 0.0 109.369 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.97 -43.02 96.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.666 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -111.55 -120.72 0.29 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -101.16 -8.79 21.91 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 111.071 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.36 161.87 28.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.425 2.69 . . . . 0.0 108.536 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.49 120.99 25.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.348 0.659 . . . . 0.0 112.255 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 124.14 47.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.441 3.096 . . . . 0.0 106.421 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt -89.34 125.33 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 118.125 -0.94 . . . . 0.0 108.516 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 36.1 t0 -70.24 113.44 17.97 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 120.134 1.334 . . . . 0.0 108.417 169.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -61.9 -31.85 84.86 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 121.277 1.318 . . . . 0.0 110.975 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -79.86 -21.14 44.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.871 -0.518 . . . . 0.0 110.369 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -88.09 -37.55 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.334 0.516 . . . . 0.0 110.706 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.08 148.18 36.73 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.807 0.731 . . . . 0.0 111.207 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 pt -122.62 38.46 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.255 1.422 . . . . 0.0 111.017 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 46.94 39.69 7.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.323 1.849 . . . . 0.0 112.615 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.17 159.0 32.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.829 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.44 63.65 4.38 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.03 174.33 15.38 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 124.373 1.069 . . . . 0.0 108.233 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.283 4.8 p 66.39 -56.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.387 2.275 . . . . 0.0 111.644 -169.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -66.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.992 0.917 . . . . 0.0 111.67 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.83 64.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.261 0.624 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.63 -35.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.555 0.742 . . . . 0.0 109.484 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -60.74 114.07 9.33 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 -2.5 7.72 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.299 2.0 . . . . 0.0 113.026 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -108.8 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.242 1.817 . . . . 0.0 109.894 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.3 m 52.48 55.28 9.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.054 0.942 . . . . 0.0 111.563 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.36 -16.17 50.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 111.058 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.98 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -133.75 167.66 20.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.59 145.15 56.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.58 171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.5 -41.03 65.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.42 -31.42 72.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.806 0.843 . . . . 0.0 110.885 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -81.45 -36.74 29.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.439 0.695 . . . . 0.0 109.945 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -48.92 127.5 14.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.339 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.01 142.51 64.95 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 0.0 112.125 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -41.66 -45.78 3.52 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.755 2.822 . . . . 0.0 112.784 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -47.68 -46.13 28.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.141 0.976 . . . . 0.0 110.882 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -96.19 -6.58 37.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.494 1.518 . . . . 0.0 112.578 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -58.87 -19.9 46.14 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.26 1.391 . . . . 0.0 110.422 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -49.84 -46.71 51.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.705 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -62.7 -35.83 80.97 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.171 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.66 -45.59 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.717 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -65.27 -46.5 80.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.365 0.529 . . . . 0.0 111.654 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -58.24 -42.54 86.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 110.885 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -57.81 -61.64 2.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.719 1.208 . . . . 0.0 108.028 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -52.25 -51.74 56.65 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.801 2.44 . . . . 0.0 113.054 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -50.92 0.29 Allowed 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.175 1.79 . . . . 0.0 113.695 -175.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -110.02 -1.14 17.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.715 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.53 -34.31 41.25 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.165 0.893 . . . . 0.0 111.162 -174.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -109.56 142.62 40.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.027 1.331 . . . . 0.0 109.746 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.07 141.04 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.462 1.105 . . . . 0.0 110.705 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -48.37 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 128.433 2.693 . . . . 0.0 114.316 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p 61.19 -165.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.66 1.584 . . . . 0.0 114.065 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.05 -48.93 59.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 129.446 3.099 . . . . 0.0 115.726 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.09 -22.4 74.16 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 CA-C-N 121.322 1.508 . . . . 0.0 113.327 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -58.33 -34.08 70.23 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.444 0.697 . . . . 0.0 112.026 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -71.14 84.15 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.683 0.754 . . . . 0.0 110.814 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.15 58.28 0.7 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.597 2.046 . . . . 0.0 108.608 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.266 14.5 t 49.23 -150.01 0.2 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.022 1.729 . . . . 0.0 113.025 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 16.2 mmtm -66.56 81.62 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.936 1.695 . . . . 0.0 112.157 -172.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.7 t -66.22 151.37 47.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.995 0.918 . . . . 0.0 109.598 169.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.44 44.19 2.31 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.263 1.025 . . . . 0.0 109.508 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -150.49 144.15 25.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.386 5.7 p 74.01 49.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.657 2.383 . . . . 0.0 108.466 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 -43.28 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.624 1.97 . . . . 0.0 109.246 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.07 27.04 2.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.756 2.822 . . . . 0.0 113.498 -168.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.5 -37.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -168.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 t -59.34 123.66 71.27 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.698 1.135 . . . . 0.0 112.535 -168.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.93 -47.21 19.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 1 C-N-CA 125.318 4.012 . . . . 0.0 113.144 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -133.65 84.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -17.37 112.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.984 2.114 . . . . 0.0 114.544 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m -121.97 1.14 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.135 1.374 . . . . 0.0 109.94 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.14 106.4 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.222 0.919 . . . . 0.0 112.433 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -125.95 144.28 50.75 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.081 0.953 . . . . 0.0 110.191 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' OE1' ' NZ ' ' A' ' 12' ' ' LYS . 56.8 mt-10 -74.39 118.39 17.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 120.157 1.344 . . . . 0.0 111.93 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.66 75.08 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 104.781 -3.327 . . . . 0.0 104.781 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 71.94 -47.83 0.67 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.602 2.761 . . . . 0.0 112.152 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.01 -12.5 1.46 Allowed 'General case' 0 C--N 1.34 0.181 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.04 34.52 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.06 135.83 49.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 109.989 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 128.74 54.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.066 3.346 . . . . 0.0 104.545 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.0 mt -93.48 124.86 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.78 116.04 33.88 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.056 1.298 . . . . 0.0 108.201 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.91 -20.35 17.17 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.959 1.773 . . . . 0.0 111.605 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -88.39 -30.68 19.32 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.58 -38.6 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.41 171.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.43 146.28 51.86 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.528 0.604 . . . . 0.0 111.352 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.1 pt -120.79 37.9 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.264 1.426 . . . . 0.0 111.098 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.88 42.44 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.724 1.61 . . . . 0.0 111.752 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 161.51 28.92 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.889 -0.507 . . . . 0.0 111.483 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.6 61.19 3.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.98 156.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.257 1.5 p 78.35 -55.68 0.48 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.855 2.462 . . . . 0.0 109.953 -169.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -59.26 0.88 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.859 1.664 . . . . 0.0 113.827 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.64 -10.16 57.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.958 . . . . 0.0 112.494 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.08 -37.26 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.64 0.655 . . . . 0.0 109.447 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.95 114.91 9.51 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.21 -7.64 17.96 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.445 2.097 . . . . 0.0 112.616 -174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.33 -20.47 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.536 1.534 . . . . 0.0 109.865 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m 54.35 51.98 13.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 111.318 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.64 34.76 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.8 mt -64.69 120.88 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -130.64 164.25 25.4 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -65.87 150.08 49.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.99 -43.89 60.78 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -66.05 -29.89 70.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.282 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -82.56 -37.09 25.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.282 0.633 . . . . 0.0 109.887 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -50.89 128.96 28.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.371 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.57 148.15 45.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.17 2.58 . . . . 0.0 113.471 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -45.71 -44.61 13.71 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 129.164 2.986 . . . . 0.0 112.881 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -48.43 -44.45 35.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 111.003 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -97.06 -0.27 47.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.104 1.361 . . . . 0.0 112.441 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -55.42 -29.7 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.777 1.171 . . . . 0.0 108.906 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.19 -44.97 11.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.44 1.096 . . . . 0.0 111.557 169.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -66.39 -34.74 78.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.801 -1.095 . . . . 0.0 111.667 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.12 -43.99 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 120.712 1.596 . . . . 0.0 107.133 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -51.43 69.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -59.19 -42.11 90.09 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.128 -0.982 . . . . 0.0 112.231 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -60.45 -44.16 96.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.138 1.775 . . . . 0.0 110.649 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.05 -55.92 27.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.188 0.995 . . . . 0.0 109.178 174.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.11 -42.02 94.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 129.111 2.964 . . . . 0.0 114.043 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.95 -53.81 0.76 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.705 1.202 . . . . 0.0 112.984 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.2 4.3 31.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.008 0.923 . . . . 0.0 111.497 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 79.85 1.25 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 CA-C-O 116.064 -1.922 . . . . 0.0 107.463 -169.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -103.73 143.06 33.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.279 1.032 . . . . 0.0 110.043 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.36 138.15 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.205 1.002 . . . . 0.0 110.814 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.34 151.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.935 1.694 . . . . 0.0 109.833 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.2 p -138.81 160.17 40.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.923 -0.486 . . . . 0.0 110.574 172.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.331 4.9 tt0 -1.28 -64.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 130.192 3.397 . . . . 0.0 117.418 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.63 -25.42 41.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 122.864 2.059 . . . . 0.0 114.844 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 -35.83 68.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.795 0.838 . . . . 0.0 112.261 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.273 3.5 mp -70.31 89.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.747 0.784 . . . . 0.0 112.205 -168.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.4 47.44 0.71 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.621 1.581 . . . . 0.0 110.986 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.363 0.9 OUTLIER 51.56 118.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.472 2.709 . . . . 0.0 118.075 174.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? 68.09 -63.33 0.33 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.476 2.71 . . . . 0.0 112.588 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t 64.11 -66.3 0.12 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.158 1.783 . . . . 0.0 112.966 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.07 47.79 11.52 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 112.406 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.0 m -110.92 -56.37 2.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.303 0.641 . . . . 0.0 110.703 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -72.95 75.33 1.18 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.993 0.901 . . . . 0.0 109.263 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 m -115.56 -140.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 110.116 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -67.73 17.79 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.65 -28.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -62.41 127.98 90.68 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.52 -34.3 71.85 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.482 3.454 . . . . 0.0 114.637 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.56 24.44 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 122.576 0.351 . . . . 0.0 111.449 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 62.94 -176.28 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.192 0.597 . . . . 0.0 109.454 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.2 p 122.18 -5.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.976 3.71 . . . . 0.0 111.923 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.2 110.84 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.37 141.81 50.97 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 109.877 -170.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.98 113.71 9.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 120.175 1.352 . . . . 0.0 109.823 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.34 64.58 3.76 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 170.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 65.5 -59.11 0.29 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 129.811 3.245 . . . . 0.0 111.163 -172.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.48 -54.29 4.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.535 0.734 . . . . 0.0 112.072 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.8 166.49 24.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.588 1.155 . . . . 0.0 110.215 -169.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.82 133.39 50.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.645 0.736 . . . . 0.0 110.695 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 131.19 53.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 131.002 3.721 . . . . 0.0 104.586 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 67.1 mt -99.5 128.41 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.45 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 36.4 t0 -74.66 111.85 14.93 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 120.037 1.29 . . . . 0.0 107.697 168.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.72 -29.61 69.01 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.563 1.509 . . . . 0.0 111.041 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.27 -24.38 40.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.71 -0.619 . . . . 0.0 110.22 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.06 -35.7 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.5 0.591 . . . . 0.0 110.74 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.2 t -54.71 129.88 38.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.03 0.832 . . . . 0.0 110.743 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.02 35.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 111.378 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 2.3 m-20 48.55 37.64 9.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.166 1.787 . . . . 0.0 113.082 175.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -23.79 46.14 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.55 -141.73 21.39 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.357 0.98 . . . . 0.0 111.772 -169.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.48 -65.01 0.36 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.919 2.088 . . . . 0.0 113.026 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -46.87 -42.37 17.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.61 1.164 . . . . 0.0 109.803 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -40.88 -44.62 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.188 2.195 . . . . 0.0 114.426 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 -28.17 16.63 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 110.19 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -63.42 -38.49 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 119.068 -0.492 . . . . 0.0 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.442 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.1 t -61.23 113.0 6.76 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.47 29.68 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.448 2.766 . . . . 0.0 112.74 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.1 m -146.15 -29.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 129.42 3.088 . . . . 0.0 108.056 -173.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m 55.54 57.93 4.95 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.503 1.121 . . . . 0.0 110.759 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.51 57.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.819 1.248 . . . . 0.0 110.745 170.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mt -80.85 124.79 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -128.31 167.57 16.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.39 146.24 54.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.46 -36.47 69.11 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.424 1.107 . . . . 0.0 112.882 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.64 -44.14 76.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.132 171.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -78.32 -34.65 48.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.329 1.452 . . . . 0.0 112.022 -168.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -50.0 124.31 16.8 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.508 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 143.66 67.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.989 2.459 . . . . 0.0 112.114 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -42.77 -46.89 5.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 128.867 2.867 . . . . 0.0 112.462 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -46.38 -45.14 17.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.14 0.976 . . . . 0.0 110.878 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -97.96 0.49 46.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.702 1.601 . . . . 0.0 112.411 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -61.3 -19.21 61.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.23 1.377 . . . . 0.0 110.781 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -54.07 -42.75 69.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.098 0.959 . . . . 0.0 110.167 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -64.83 -36.62 84.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.064 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 mt -60.36 -44.76 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 120.756 1.616 . . . . 0.0 109.047 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -54.13 -48.22 71.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.427 173.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -61.47 -45.06 95.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.465 0.575 . . . . 0.0 112.064 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -58.89 -43.55 91.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.581 1.152 . . . . 0.0 110.904 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -58.13 -60.46 3.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.893 1.277 . . . . 0.0 107.655 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.14 -51.05 63.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.569 2.748 . . . . 0.0 112.942 -171.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -32.68 -49.6 0.23 Allowed 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 126.581 1.952 . . . . 0.0 113.472 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -114.08 -0.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.804 0.69 . . . . 0.0 111.768 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' HZ2' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.11 -34.31 43.56 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.184 0.902 . . . . 0.0 110.873 -174.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.385 0 CA-C-O 115.684 -2.103 . . . . 0.0 106.35 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.429 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -97.46 138.91 34.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.401 0.68 . . . . 0.0 109.177 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.42 140.79 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.751 0.786 . . . . 0.0 111.097 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -75.93 152.56 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.686 3.194 . . . . 0.0 111.054 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -146.47 166.71 25.6 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.713 0.405 . . . . 0.0 111.27 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.272 58.4 tt0 -16.2 -60.05 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 129.002 2.921 . . . . 0.0 116.147 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.07 -18.03 41.3 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 121.691 1.64 . . . . 0.0 115.12 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 t -62.36 -40.62 97.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.771 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.86 118.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.024 0.375 . . . . 0.0 110.354 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.42 76.3 0.06 OUTLIER Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.315 3.1 t 64.39 -49.36 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.286 2.634 . . . . 0.0 116.181 170.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 -60.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.981 1.264 . . . . 0.0 111.102 176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.6 -71.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.522 1.929 . . . . 0.0 114.965 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.18 -123.25 0.49 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 109.337 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m 72.29 -55.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.957 2.103 . . . . 0.0 112.783 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.13 -47.98 82.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.389 1.076 . . . . 0.0 110.634 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.79 -41.61 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 O-C-N 121.434 -0.791 . . . . 0.0 112.418 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -68.19 -7.31 29.13 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.63 -22.95 3.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 120.02 1.282 . . . . 0.0 113.665 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -61.87 128.93 91.24 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.45 1.023 . . . . 0.0 110.973 -172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.29 -41.62 13.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 1 C-N-CA 125.327 4.018 . . . . 0.0 114.312 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.18 57.71 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.905 0.882 . . . . 0.0 109.769 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -4.23 104.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.939 2.096 . . . . 0.0 114.689 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -132.14 29.77 4.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.305 171.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.51 113.79 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 -169.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -136.76 140.59 42.68 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -165.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -68.13 160.69 28.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.522 -1.361 . . . . 0.0 112.767 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.63 -52.99 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -112.92 -63.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.586 1.554 . . . . 0.0 109.712 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.8 -54.49 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 109.007 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 145.25 56.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.516 2.327 . . . . 0.0 111.008 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -86.2 102.69 14.14 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 111.746 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -54.41 110.5 0.63 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.839 2.856 . . . . 0.0 108.505 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -82.97 115.27 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -62.83 117.22 30.08 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.686 1.13 . . . . 0.0 108.544 171.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.88 -24.82 20.66 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 121.493 1.462 . . . . 0.0 112.085 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -36.51 34.18 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.68 -32.02 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.309 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.2 t -59.64 124.22 19.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.215 0.916 . . . . 0.0 110.539 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.91 36.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.998 0.919 . . . . 0.0 111.706 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.429 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 9.1 m-20 39.1 61.9 1.2 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.086 1.755 . . . . 0.0 112.609 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.92 -163.19 1.02 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.862 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 101.87 0.41 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.74 -65.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.06 1.344 . . . . 0.0 110.786 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.1 p -60.37 -52.41 65.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.495 0.718 . . . . 0.0 111.262 -172.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -54.8 24.11 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.757 0.823 . . . . 0.0 111.306 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.98 66.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.02 0.528 . . . . 0.0 112.003 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -41.31 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.349 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.0 t -58.35 111.7 3.93 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.001 0.819 . . . . 0.0 108.877 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.1 22.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.439 2.759 . . . . 0.0 113.038 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -135.09 -28.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 129.871 3.268 . . . . 0.0 107.616 -177.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 54.35 59.53 4.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.623 1.169 . . . . 0.0 110.39 -172.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.14 44.94 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.349 1.06 . . . . 0.0 110.214 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.1 mt -77.67 125.51 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -131.94 171.32 13.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.87 147.18 50.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.141 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -49.11 -41.72 36.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.14 -40.28 89.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.452 0.701 . . . . 0.0 111.461 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -78.79 -34.91 45.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.177 0.991 . . . . 0.0 110.855 -168.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.87 123.99 26.68 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.389 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.76 144.69 53.22 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.066 2.511 . . . . 0.0 112.119 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -41.8 -46.51 3.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.78 2.832 . . . . 0.0 112.497 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -46.89 -46.02 20.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.194 0.997 . . . . 0.0 110.995 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -96.35 -3.02 44.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.713 1.605 . . . . 0.0 112.359 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -61.11 -17.74 54.26 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.478 1.49 . . . . 0.0 110.23 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -51.63 -44.74 63.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.851 0.86 . . . . 0.0 109.189 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -64.79 -32.62 74.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.665 -1.159 . . . . 0.0 111.817 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.72 -47.25 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 121.127 1.785 . . . . 0.0 107.917 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -52.72 -53.99 39.97 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -43.05 99.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.547 0.213 . . . . 0.0 111.082 -171.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.05 -39.17 85.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 111.545 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -51.24 63.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.061 0.934 . . . . 0.0 109.348 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 61.2 t0 -68.86 -47.97 64.63 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.283 2.633 . . . . 0.0 112.54 -169.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -31.11 -56.27 0.23 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.991 1.716 . . . . 0.0 113.053 -175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -98.97 -3.42 35.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.978 0.911 . . . . 0.0 112.543 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -104.02 78.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.063 0.945 . . . . 0.0 109.749 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 127.769 2.427 . . . . 0.0 105.872 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.455 ' H3 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -112.27 156.34 22.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.893 0.77 . . . . 0.0 110.625 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.26 143.43 40.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.846 1.658 . . . . 0.0 109.167 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.19 135.6 25.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.561 1.144 . . . . 0.0 108.666 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 p -127.88 170.78 12.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.222 1.009 . . . . 0.0 111.08 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -14.09 -56.85 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 129.628 3.171 . . . . 0.0 116.553 172.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.49 -21.33 61.18 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 122.25 1.839 . . . . 0.0 114.147 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.53 -27.04 68.69 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.84 0.745 . . . . 0.0 112.094 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.02 79.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.811 0.844 . . . . 0.0 110.969 -170.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.67 0.79 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.236 1.874 . . . . 0.0 108.571 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.331 14.6 t 46.83 88.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.326 2.251 . . . . 0.0 114.603 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 73.8 -61.2 0.5 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.703 2.001 . . . . 0.0 114.347 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 t 61.61 -68.6 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 0.0 113.217 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.01 35.01 8.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.399 1.879 . . . . 0.0 114.455 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -106.06 14.69 27.46 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -121.92 54.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.3 -45.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.407 -0.808 . . . . 0.0 111.104 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.84 10.5 1.4 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.183 2.193 . . . . 0.0 114.001 -169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.64 -24.79 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -70.6 124.53 91.06 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 119.595 1.089 . . . . 0.0 111.198 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.24 -26.76 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.804 3.003 . . . . 0.0 113.161 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.98 38.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.396 0.679 . . . . 0.0 110.004 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 29.97 42.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.079 2.551 . . . . 0.0 116.361 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.1 p -92.18 36.02 0.99 Allowed 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.092 -1.005 . . . . 0.0 110.746 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 120.32 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 126.313 1.845 . . . . 0.0 108.062 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -137.12 171.06 15.06 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.039 1.335 . . . . 0.0 109.607 -169.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.18 172.01 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 119.387 0.994 . . . . 0.0 110.217 168.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.49 -53.9 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.259 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -139.64 58.38 1.61 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.355 0.662 . . . . 0.0 109.27 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 45.76 37.36 3.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.172 1.789 . . . . 0.0 112.578 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 154.25 38.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 172.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -76.41 163.21 27.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.669 0.606 . . . . 0.0 110.707 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.45 110.37 5.63 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 106.057 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.11 132.23 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 76' ' ' LYS . 17.8 t0 -75.81 112.95 22.62 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 167.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.06 -28.97 48.82 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.826 1.684 . . . . 0.0 110.672 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.03 -27.93 29.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.784 0.834 . . . . 0.0 109.804 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.2 t -85.5 -32.27 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.836 0.743 . . . . 0.0 111.122 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.4 t -56.13 130.43 44.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.09 0.859 . . . . 0.0 111.152 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 pt -102.44 35.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.3 1.04 . . . . 0.0 111.184 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 7.1 m-20 50.65 32.19 6.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.24 1.816 . . . . 0.0 114.636 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -23.08 62.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.13 -132.53 11.27 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -168.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.83 -68.25 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.749 1.62 . . . . 0.0 113.098 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -48.84 -49.99 36.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.324 1.05 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -48.47 -56.2 8.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.255 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.0 68.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.16 0.584 . . . . 0.0 112.465 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.98 -7.73 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.982 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -82.79 111.29 28.38 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.51 41.64 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.237 2.624 . . . . 0.0 111.727 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.7 -27.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 128.346 2.658 . . . . 0.0 109.2 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 55.65 60.18 3.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.847 0.859 . . . . 0.0 110.025 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.55 -25.07 41.75 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.25 1.02 . . . . 0.0 110.169 170.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.9 mt -72.7 117.47 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -127.81 165.16 20.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.29 150.19 40.33 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -54.67 -40.44 69.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.677 -0.64 . . . . 0.0 112.69 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.98 -24.17 63.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.426 -0.796 . . . . 0.0 111.032 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.88 -45.32 43.66 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.915 0.325 . . . . 0.0 110.167 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.0 t -52.69 123.75 32.14 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.792 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.85 149.32 61.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.924 2.416 . . . . 0.0 112.606 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -42.66 -46.25 4.97 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 129.698 3.199 . . . . 0.0 112.258 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.54 -40.44 12.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.11 0.964 . . . . 0.0 111.767 172.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -106.08 7.77 31.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.857 1.663 . . . . 0.0 112.482 -176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -57.89 -27.37 63.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.403 1.001 . . . . 0.0 110.038 170.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -49.28 -44.53 44.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.165 1.386 . . . . 0.0 111.051 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -67.98 -33.02 73.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.68 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.99 -48.18 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 120.803 1.638 . . . . 0.0 108.124 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -53.29 -50.52 64.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -62.8 -43.27 99.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 0.541 . . . . 0.0 111.968 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -58.69 -44.18 90.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.039 1.335 . . . . 0.0 110.763 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -55.55 33.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.163 0.985 . . . . 0.0 109.041 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.68 -45.7 93.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.982 2.513 . . . . 0.0 112.402 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.05 -50.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 113.463 -171.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.2 4.66 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.282 1.033 . . . . 0.0 111.983 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -108.22 73.41 0.88 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.685 1.194 . . . . 0.0 109.135 -175.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.142 0 C-N-CA 127.63 2.372 . . . . 0.0 105.916 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 118.351 -0.833 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -105.23 153.86 21.01 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.641 0.655 . . . . 0.0 110.17 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 t -138.13 145.83 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.746 0.818 . . . . 0.0 110.764 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 4' ' ' ILE . 2.4 pp -60.81 165.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.237 1.815 . . . . 0.0 111.536 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 p -151.93 168.67 24.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.994 0.918 . . . . 0.0 109.094 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -8.52 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 128.506 2.722 . . . . 0.0 116.336 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 -21.39 71.91 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 121.487 1.567 . . . . 0.0 113.541 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.18 -30.34 71.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.756 0.822 . . . . 0.0 112.177 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.21 90.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.598 0.713 . . . . 0.0 110.385 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.11 60.8 0.67 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.941 1.734 . . . . 0.0 109.92 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t 39.56 73.03 0.12 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.158 1.783 . . . . 0.0 114.307 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 68.94 48.5 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.57 1.148 . . . . 0.0 113.053 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.19 152.42 40.8 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.75 40.12 0.89 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.795 0.725 . . . . 0.0 112.125 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 m -83.89 -37.35 22.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 112.205 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 p -70.04 -13.73 62.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.272 1.429 . . . . 0.0 113.215 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.26 153.85 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 112.431 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 75.86 -40.29 0.4 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.834 2.053 . . . . 0.0 113.038 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.65 -29.11 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.705 -0.622 . . . . 0.0 110.156 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.0 t -65.63 126.58 91.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.949 0.5 . . . . 0.0 110.103 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -39.72 -37.44 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 126.377 4.718 . . . . 0.0 115.407 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.0 m -126.54 21.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.822 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t70 33.2 51.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.702 2.001 . . . . 0.0 113.668 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.5 p -94.57 42.34 1.09 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.298 1.039 . . . . 0.0 110.922 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 132.32 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -133.51 142.13 48.08 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -167.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -83.52 125.15 31.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.309 -0.87 . . . . 0.0 111.627 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.82 -55.07 2.48 Favored Glycine 0 CA--C 1.525 0.69 1 N-CA-C 103.047 -4.021 . . . . 0.0 103.047 166.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -60.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.195 2.198 . . . . 0.0 106.614 168.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.4 -29.17 69.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.266 1.826 . . . . 0.0 114.787 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.18 177.5 11.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.343 0.657 . . . . 0.0 109.476 -168.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.87 116.03 28.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.233 1.013 . . . . 0.0 108.699 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -94.88 119.62 33.74 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 130.441 3.497 . . . . 0.0 109.388 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 54' ' ' ILE . 76.7 mt -81.33 130.13 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 118.878 0.763 . . . . 0.0 109.839 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.39 111.64 18.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.01 -30.98 92.86 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-N 120.98 1.386 . . . . 0.0 111.273 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -79.1 -23.63 43.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -92.1 -32.84 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.276 0.489 . . . . 0.0 110.978 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.56 123.56 16.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.979 0.809 . . . . 0.0 111.45 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.8 pt -89.46 21.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 50.75 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.37 2.268 . . . . 0.0 113.089 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.0 148.41 31.67 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.944 -0.472 . . . . 0.0 110.951 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.72 51.75 4.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.191 -0.943 . . . . 0.0 113.08 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.67 -76.99 0.59 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.363 1.082 . . . . 0.0 111.633 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -47.96 -48.8 31.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.598 1.159 . . . . 0.0 112.497 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.5 -46.55 83.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.171 0.896 . . . . 0.0 111.562 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.14 74.86 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.486 -0.759 . . . . 0.0 110.538 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -74.81 -38.26 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.094 0.557 . . . . 0.0 111.45 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.4 t -64.27 112.41 7.59 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.227 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.48 20.88 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.207 2.604 . . . . 0.0 113.087 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.39 -30.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.103 1.761 . . . . 0.0 109.354 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 t 62.27 81.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 0.0 109.894 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.32 -9.92 0.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' ILE . 77.7 mt -79.82 92.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -109.36 164.57 12.36 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.1 0.96 . . . . 0.0 108.894 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -62.5 146.94 50.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.855 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -40.96 64.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.113 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -73.35 -38.91 65.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -53.76 124.53 43.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.667 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 144.95 52.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.103 2.535 . . . . 0.0 112.191 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -41.49 -47.36 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 128.933 2.893 . . . . 0.0 112.676 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.59 -44.41 26.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.049 0.94 . . . . 0.0 111.063 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -96.71 -6.73 35.73 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.173 1.389 . . . . 0.0 112.424 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -57.99 -22.38 49.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.562 1.528 . . . . 0.0 110.231 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.01 -43.08 40.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.701 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -64.35 -35.06 79.63 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.6 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.35 -46.12 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -56.91 -46.58 81.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.115 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -46.42 90.62 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.427 -0.796 . . . . 0.0 111.631 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -61.59 -40.0 93.22 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.051 0.94 . . . . 0.0 111.357 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -57.22 -61.86 2.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.43 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 4.0 t70 -52.96 -50.42 64.13 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 128.122 2.569 . . . . 0.0 112.529 -170.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -37.46 -46.35 0.8 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 125.57 1.548 . . . . 0.0 113.432 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -111.39 -3.21 15.33 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.789 0.681 . . . . 0.0 111.447 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -36.67 25.05 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.939 0.791 . . . . 0.0 110.31 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -100.8 147.58 25.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.413 0.685 . . . . 0.0 111.128 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.64 142.29 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.845 1.258 . . . . 0.0 110.708 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.88 168.57 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 125.772 1.629 . . . . 0.0 110.904 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 p -145.02 171.65 14.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -9.82 -61.22 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 128.661 2.785 . . . . 0.0 116.164 169.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.5 Cg_exo -62.59 -15.42 45.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 121.991 1.747 . . . . 0.0 113.635 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.37 -26.09 63.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.851 0.86 . . . . 0.0 112.742 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.15 115.95 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.95 130.31 1.34 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -169.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -60.06 119.57 8.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.957 0.503 . . . . 0.0 112.026 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 36.22 50.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.492 1.917 . . . . 0.0 113.376 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.24 -50.85 72.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.673 0.789 . . . . 0.0 112.616 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.95 -136.01 0.86 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.918 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m 62.7 45.34 5.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.856 1.263 . . . . 0.0 111.878 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 p -176.51 -28.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.162 2.985 . . . . 0.0 109.138 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.75 -44.87 51.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.22 1.008 . . . . 0.0 110.469 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.6 pm0 -67.34 0.3 3.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.399 1.88 . . . . 0.0 114.175 -169.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.03 -16.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.277 1.031 . . . . 0.0 113.136 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -75.36 126.15 88.05 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 119.751 1.16 . . . . 0.0 111.624 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -62.11 141.24 87.88 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.565 2.177 . . . . 0.0 109.227 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.287 11.6 m 45.17 37.09 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 114.217 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 35.92 49.1 0.56 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.335 2.654 . . . . 0.0 114.17 168.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -85.89 30.14 0.68 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.058 -1.027 . . . . 0.0 112.643 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.44 142.13 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -141.55 156.8 45.69 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.086 1.354 . . . . 0.0 107.849 -170.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -91.53 134.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 118.888 0.767 . . . . 0.0 111.254 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.54 -46.96 7.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 104.987 -3.245 . . . . 0.0 104.987 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -175.56 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.245 2.618 . . . . 0.0 104.284 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -98.21 54.1 1.09 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.901 1.81 . . . . 0.0 108.94 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -177.71 137.37 0.2 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 -169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -102.37 168.41 9.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.889 0.743 . . . . 0.0 109.663 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -146.44 119.82 9.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.192 1.797 . . . . 0.0 107.797 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 57.3 mt -90.38 130.76 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -73.33 114.64 33.38 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -30.85 52.42 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.619 0.879 . . . . 0.0 111.1 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -83.07 -28.43 29.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.279 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.52 -27.63 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.397 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -59.45 120.99 10.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.497 1.044 . . . . 0.0 110.945 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 pt -96.14 34.03 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 46.17 42.31 9.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.574 1.549 . . . . 0.0 113.282 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -23.21 60.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.244 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.75 -138.94 20.9 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.531 1.062 . . . . 0.0 110.934 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.17 -67.51 0.25 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.689 1.596 . . . . 0.0 111.95 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 p -47.98 -50.64 26.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.888 1.275 . . . . 0.0 110.412 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -43.92 -41.25 5.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.714 2.005 . . . . 0.0 113.815 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.47 -34.87 21.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.162 0.985 . . . . 0.0 110.064 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -79.18 -25.57 12.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.94 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -59.84 111.97 4.67 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.413 1.006 . . . . 0.0 108.49 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.12 49.53 3.26 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.857 3.038 . . . . 0.0 110.117 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -169.35 -35.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 128.232 2.613 . . . . 0.0 107.74 -168.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 58.0 58.14 3.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 110.045 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.75 -17.57 50.54 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.665 1.186 . . . . 0.0 110.873 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -77.66 125.42 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.48 170.47 15.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 6.7 t-80 -65.62 146.35 54.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -48.69 -44.12 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.174 0.512 . . . . 0.0 112.058 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.32 -40.22 77.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.177 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -78.96 -34.13 44.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 111.56 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.96 126.55 59.89 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.95 145.5 62.45 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.118 2.545 . . . . 0.0 112.469 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.416 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.6 mp0 -40.91 -45.69 2.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.62 3.168 . . . . 0.0 113.811 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.45 -44.68 12.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.914 0.864 . . . . 0.0 111.093 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -101.26 0.06 36.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.475 1.91 . . . . 0.0 112.945 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 28.3 mmtm -59.27 -21.42 59.61 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.593 1.542 . . . . 0.0 109.456 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 p -50.46 -49.03 56.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.713 1.205 . . . . 0.0 109.896 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -61.91 -35.91 79.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.053 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.45 -50.65 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -54.29 -41.69 69.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.623 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -66.84 -45.58 77.77 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.2 -42.16 94.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.276 1.43 . . . . 0.0 110.587 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -55.76 29.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.84 -48.97 69.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.738 2.815 . . . . 0.0 113.987 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -31.66 -48.92 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.09 1.756 . . . . 0.0 114.942 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -117.12 1.72 12.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.746 0.818 . . . . 0.0 111.985 -170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -40.21 13.24 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.822 0.737 . . . . 0.0 110.814 -169.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.567 2.347 . . . . 0.0 104.682 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.57 150.21 31.67 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.477 0.581 . . . . 0.0 110.612 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.2 140.01 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.287 0.635 . . . . 0.0 111.661 -174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.04 144.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 125.331 1.452 . . . . 0.0 109.93 172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 p -133.65 168.4 18.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 110.332 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -15.49 -57.65 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 129.107 2.963 . . . . 0.0 116.484 173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.26 -21.32 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 CA-C-N 121.774 1.669 . . . . 0.0 114.325 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.7 -32.65 72.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.733 0.697 . . . . 0.0 112.246 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -65.34 86.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.982 0.896 . . . . 0.0 109.943 -172.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 53.11 0.57 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 127.191 2.329 . . . . 0.0 108.256 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.298 12.2 t 53.28 -153.61 0.25 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.624 1.97 . . . . 0.0 113.939 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -73.77 66.96 1.14 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.324 1.45 . . . . 0.0 112.276 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.27 -57.54 8.57 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.722 1.609 . . . . 0.0 111.083 170.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.55 43.93 16.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.476 1.51 . . . . 0.0 112.924 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -98.54 -42.11 7.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.355 0.662 . . . . 0.0 111.564 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -74.28 67.96 1.45 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.006 0.908 . . . . 0.0 108.696 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.43 163.6 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.938 2.095 . . . . 0.0 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 40.93 39.24 0.79 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.627 1.971 . . . . 0.0 114.403 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.61 -39.74 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.423 1.089 . . . . 0.0 111.217 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -65.58 124.98 88.8 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 121.922 -0.486 . . . . 0.0 110.934 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.73 -42.78 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.624 1 C-N-CA 126.012 4.475 . . . . 0.0 115.533 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.5 27.77 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.415 0.686 . . . . 0.0 111.411 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 58.99 -173.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p 124.28 -2.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 130.702 3.601 . . . . 0.0 111.985 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -89.22 115.57 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.708 0.803 . . . . 0.0 109.149 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -134.52 172.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.528 1.531 . . . . 0.0 108.815 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -114.72 177.52 4.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.689 0.757 . . . . 0.0 109.673 168.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.8 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 124.608 1.099 . . . . 0.0 110.692 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -128.94 -94.78 0.42 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.3 58.25 1.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.411 1.101 . . . . 0.0 108.95 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -175.22 2.78 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 128.685 2.794 . . . . 0.0 105.786 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -111.56 159.09 18.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.286 0.494 . . . . 0.0 110.947 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.12 130.86 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.724 2.81 . . . . 0.0 104.444 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -106.06 126.39 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -66.95 114.6 18.73 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 118.022 -1.471 . . . . 0.0 107.516 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.32 -28.46 22.54 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.854 1.703 . . . . 0.0 110.0 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -81.26 -28.77 34.61 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.08 -38.45 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.875 0.761 . . . . 0.0 111.27 169.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.8 t -55.13 124.94 18.52 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 111.838 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 pt -95.23 37.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.111 0.964 . . . . 0.0 111.617 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 38.57 60.33 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.182 2.193 . . . . 0.0 113.691 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 -20.98 16.32 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.1 -132.34 11.4 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.89 -70.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.458 1.503 . . . . 0.0 112.042 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.6 p -48.73 -47.3 41.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.711 1.205 . . . . 0.0 111.197 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.66 -42.64 79.33 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.653 -0.654 . . . . 0.0 111.755 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.74 75.83 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.499 -0.751 . . . . 0.0 110.337 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.72 -40.84 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.596 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -59.55 112.15 4.84 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 119.072 0.851 . . . . 0.0 109.464 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.67 11.66 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.909 2.406 . . . . 0.0 112.862 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -117.14 -26.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 127.679 2.392 . . . . 0.0 108.843 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m 54.39 76.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.483 1.513 . . . . 0.0 111.18 -169.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 6.58 5.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.154 1.382 . . . . 0.0 112.719 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.43 80.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -95.99 162.84 13.39 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -59.35 149.14 29.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.947 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -50.39 -42.42 53.46 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -80.82 -21.59 40.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 119.279 -0.969 . . . . 0.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -71.48 -33.3 69.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -58.36 126.75 79.66 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 119.252 -0.404 . . . . 0.0 109.911 171.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.73 153.17 57.94 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.656 2.904 . . . . 0.0 113.156 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -45.61 -45.12 13.63 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 129.968 3.307 . . . . 0.0 112.747 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -48.79 -46.2 41.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.894 0.878 . . . . 0.0 110.889 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -97.06 -1.19 45.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 0.0 112.525 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -54.46 -27.98 41.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.565 1.075 . . . . 0.0 109.324 169.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -45.86 -46.95 16.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.626 1.17 . . . . 0.0 110.8 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -64.25 -34.36 77.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.766 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.35 -47.55 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 120.698 1.59 . . . . 0.0 107.183 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -57.63 -44.07 85.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -60.56 -51.15 70.63 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 118.682 0.674 . . . . 0.0 111.211 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -56.36 -38.93 72.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.382 1.073 . . . . 0.0 110.733 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -63.28 -58.68 6.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.53 1.132 . . . . 0.0 109.859 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.85 -47.15 87.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.658 2.383 . . . . 0.0 112.936 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.65 -46.32 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.093 1.357 . . . . 0.0 113.954 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.77 3.24 24.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.666 0.786 . . . . 0.0 112.193 -171.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 -60.08 1.93 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.507 1.523 . . . . 0.0 107.913 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.643 3.177 . . . . 0.0 112.738 -174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.209 0.052 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -92.24 136.04 33.52 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.63 142.05 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.473 0.709 . . . . 0.0 110.776 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -65.64 158.26 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 126.728 2.011 . . . . 0.0 110.656 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.7 p -144.9 156.26 43.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.33 0.514 . . . . 0.0 111.687 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.351 3.7 tt0 6.87 -72.05 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 130.108 3.363 . . . . 0.0 117.58 169.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 34.3 Cg_exo -52.95 -26.17 30.62 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.693 1.998 . . . . 0.0 114.905 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -58.46 -36.39 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.699 0.8 . . . . 0.0 112.058 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.07 144.23 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.069 0.462 . . . . 0.0 111.06 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.38 37.87 2.75 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 125.465 1.507 . . . . 0.0 111.315 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -166.87 129.11 1.74 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -70.89 88.01 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.87 167.9 20.52 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.841 0.856 . . . . 0.0 110.939 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.03 71.69 0.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.843 1.657 . . . . 0.0 107.12 173.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.3 m -141.99 -59.0 0.47 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.743 -0.598 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.43 72.63 0.98 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.076 0.941 . . . . 0.0 108.962 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.3 152.56 15.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 108.72 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 62.97 -12.77 0.08 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.28 -24.45 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 120.822 -1.174 . . . . 0.0 110.884 -170.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.71 126.48 92.65 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 122.775 0.43 . . . . 0.0 110.619 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.32 -43.89 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 126.485 4.79 . . . . 0.0 115.975 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.34 7.1 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.868 0.867 . . . . 0.0 112.146 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.2 t0 65.87 149.87 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 111.539 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.9 m -163.06 -102.09 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.509 1.923 . . . . 0.0 106.209 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.255 2.2 pp 13.78 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.785 3.234 . . . . 0.0 116.474 169.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -103.4 138.7 39.79 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.487 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 32.6 mt-10 -76.57 131.84 39.16 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 120.775 -1.203 . . . . 0.0 112.661 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.84 8.63 Favored Glycine 0 CA--C 1.532 1.099 1 N-CA-C 102.886 -4.085 . . . . 0.0 102.886 165.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.44 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.236 3.014 . . . . 0.0 104.286 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.15 -35.88 74.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.661 -0.649 . . . . 0.0 111.584 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.68 146.87 46.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.227 1.411 . . . . 0.0 110.411 -169.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 27' ' ' GLU . 96.9 m-85 -80.44 150.95 29.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.94 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -119.68 114.55 22.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 129.808 3.243 . . . . 0.0 105.554 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -83.95 116.88 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.9 109.07 1.27 Allowed Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 126.868 2.067 . . . . 0.0 111.659 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -67.78 -26.98 38.2 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.039 1.16 . . . . 0.0 111.685 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.15 -41.87 85.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.798 0.839 . . . . 0.0 109.852 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -92.94 -38.31 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.663 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.12 120.01 7.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.107 0.867 . . . . 0.0 111.278 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 pt -89.87 35.58 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.155 0.982 . . . . 0.0 111.572 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.52 60.05 3.04 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.36 1.464 . . . . 0.0 112.905 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.13 -164.75 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.065 0.946 . . . . 0.0 109.03 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.42 -112.15 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 168.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.72 -67.29 0.14 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 126.292 1.837 . . . . 0.0 112.665 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.5 p -62.17 -49.06 77.34 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 137.21 58.22 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 168.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 84.47 -22.24 0.22 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.015 2.526 . . . . 0.0 111.873 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.7 -34.22 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.89 116.76 26.53 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.15 26.78 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.41 2.74 . . . . 0.0 113.03 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.5 -27.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 128.393 2.677 . . . . 0.0 108.331 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.9 m 54.14 62.93 2.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.693 1.197 . . . . 0.0 111.288 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.1 -7.36 45.77 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.276 1.031 . . . . 0.0 111.128 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.4 mt -83.05 124.67 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -134.58 168.51 18.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -64.08 143.51 57.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.517 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.41 -40.82 51.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.33 -38.49 89.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.372 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -77.28 -31.54 54.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.043 -169.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.47 125.38 52.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.635 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.79 144.34 55.0 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.045 2.497 . . . . 0.0 112.043 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -41.91 -47.13 4.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 128.995 2.918 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -46.99 -45.36 20.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.138 0.975 . . . . 0.0 110.863 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -96.72 -4.51 40.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.752 1.621 . . . . 0.0 112.528 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -60.89 -17.2 49.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.156 1.344 . . . . 0.0 109.841 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -51.52 -42.6 61.87 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.628 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -67.82 -31.2 70.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.29 -0.881 . . . . 0.0 111.752 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.77 -45.67 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -55.85 -48.98 74.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.71 0.404 . . . . 0.0 110.032 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.59 73.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.248 0.476 . . . . 0.0 110.497 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.61 -39.61 68.06 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 124.021 0.826 . . . . 0.0 110.568 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -56.15 19.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -50.97 -43.18 60.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.868 2.067 . . . . 0.0 112.526 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -43.84 -44.71 7.03 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.756 0.66 . . . . 0.0 112.151 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -107.95 21.47 17.35 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 111.139 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -132.67 74.51 1.58 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 169.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -169.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.28 144.98 26.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.103 0.961 . . . . 0.0 110.248 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 68' ' ' ILE . 71.3 t -139.85 144.05 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.273 1.029 . . . . 0.0 111.296 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.73 142.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.489 1.515 . . . . 0.0 109.553 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 p -131.42 165.47 23.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.038 0.535 . . . . 0.0 110.237 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -12.21 -58.33 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 129.587 3.155 . . . . 0.0 116.568 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.72 -20.65 69.82 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 CA-C-N 122.115 1.791 . . . . 0.0 114.06 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -62.73 -33.3 74.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.64 0.655 . . . . 0.0 111.532 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.31 3.9 mp -70.58 95.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.965 0.888 . . . . 0.0 112.168 -168.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 151.6 23.34 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 103.784 -3.726 . . . . 0.0 103.784 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -48.07 125.14 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.393 1.877 . . . . 0.0 112.789 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 18.31 72.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.41 2.684 . . . . 0.0 116.037 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -51.01 -58.63 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.577 1.951 . . . . 0.0 112.342 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.0 42.45 32.25 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.265 1.426 . . . . 0.0 113.318 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -103.06 -51.13 3.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.257 0.623 . . . . 0.0 111.583 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 p -75.27 69.66 2.12 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.96 0.886 . . . . 0.0 109.416 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.9 156.44 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.972 1.709 . . . . 0.0 109.324 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 40.76 58.47 2.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.857 . . . . 0.0 112.79 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 p -160.39 -37.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -72.62 141.34 82.46 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -37.29 -36.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.623 4.215 . . . . 0.0 115.575 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.02 29.82 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.297 31.1 m-20 21.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.576 2.351 . . . . 0.0 114.751 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.3 p -86.17 41.58 0.94 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.235 1.014 . . . . 0.0 110.415 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 pp -109.41 126.88 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.864 1.666 . . . . 0.0 108.422 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -141.56 145.46 35.13 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 124.226 1.011 . . . . 0.0 109.991 -169.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.6 115.96 7.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.786 169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.87 -59.32 4.07 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.04 -2.424 . . . . 0.0 107.04 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -124.12 -69.24 0.82 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -128.08 -37.58 1.87 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.538 1.135 . . . . 0.0 113.18 172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.538 ' H ' ' CD ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -87.02 160.2 18.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.986 2.914 . . . . 0.0 110.551 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -76.38 124.9 28.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.613 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 159.07 16.47 Favored 'General case' 0 N--CA 1.444 -0.729 1 C-N-CA 131.835 4.054 . . . . 0.0 104.962 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -116.29 137.19 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.203 1.001 . . . . 0.0 108.369 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.24 112.4 25.54 Favored Pre-proline 0 C--N 1.341 0.222 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 167.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.94 -30.9 67.35 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.052 1.168 . . . . 0.0 110.585 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -80.44 -22.94 40.66 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.477 -0.764 . . . . 0.0 110.223 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -90.03 -29.28 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.47 0.577 . . . . 0.0 111.009 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.6 t -58.52 128.92 39.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.477 1.035 . . . . 0.0 110.568 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 pt -98.31 36.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.342 1.057 . . . . 0.0 111.473 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.6 m-20 42.8 57.32 3.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.96 1.704 . . . . 0.0 112.11 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -176.73 4.3 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.042 0.537 . . . . 0.0 111.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.13 69.16 0.23 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.96 162.39 28.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.019 1.727 . . . . 0.0 106.634 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.27 1.9 p 77.75 -54.76 0.52 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.854 2.862 . . . . 0.0 111.264 -170.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -52.89 15.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.866 0.866 . . . . 0.0 111.998 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.16 62.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.461 1.105 . . . . 0.0 112.025 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.11 -38.2 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.826 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.5 t -61.55 110.37 3.06 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.763 0.71 . . . . 0.0 109.371 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.02 -0.04 6.55 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.999 1.799 . . . . 0.0 112.653 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.19 -23.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.82 1.648 . . . . 0.0 109.837 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 t 60.46 56.97 2.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 110.888 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.95 -22.47 21.94 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.915 0.886 . . . . 0.0 111.062 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -78.68 119.11 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -128.43 167.13 17.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -68.93 144.45 54.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -51.74 -40.99 61.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.18 60.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -82.49 -34.2 28.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.922 0.783 . . . . 0.0 109.814 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.44 127.81 90.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.13 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.98 148.64 37.81 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.546 2.831 . . . . 0.0 112.571 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -51.4 -43.78 62.03 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.865 1.266 . . . . 0.0 111.492 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -41.47 -44.76 2.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.996 1.319 . . . . 0.0 111.267 172.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.41 -1.31 31.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.447 1.499 . . . . 0.0 112.586 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -61.37 -19.45 61.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.473 1.488 . . . . 0.0 110.317 169.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -51.44 -45.02 62.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.339 1.055 . . . . 0.0 109.268 167.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.57 -33.99 77.19 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.678 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.43 HD12 HG11 ' A' ' 3' ' ' VAL . 1.5 mp -63.09 -47.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 120.616 1.553 . . . . 0.0 107.691 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -52.9 -49.85 65.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.925 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -46.46 88.76 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.707 -0.62 . . . . 0.0 111.872 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -57.8 -43.06 85.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.095 1.358 . . . . 0.0 110.589 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -58.68 -60.92 3.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.11 -51.15 62.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.435 2.694 . . . . 0.0 112.001 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -48.46 0.21 Allowed 'General case' 0 C--N 1.337 0.055 0 C-N-CA 126.152 1.781 . . . . 0.0 114.139 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.57 -4.17 14.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.56 0.744 . . . . 0.0 111.296 -170.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -37.24 14.66 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.487 -1.244 . . . . 0.0 107.904 -172.074 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.542 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 119.886 -0.102 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -92.18 146.19 23.91 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.019 0.528 . . . . 0.0 110.245 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.01 143.02 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.013 . . . . 0.0 111.169 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.87 142.26 14.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 126.869 2.068 . . . . 0.0 109.052 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.3 p -133.96 166.43 22.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.059 0.544 . . . . 0.0 111.628 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.282 3.0 tt0 -8.77 -61.4 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 129.776 3.23 . . . . 0.0 116.642 172.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -58.17 -20.03 44.61 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 122.56 1.95 . . . . 0.0 114.619 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 t -61.04 -36.44 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.595 0.634 . . . . 0.0 112.523 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.267 8.6 mt -40.04 113.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.129 0.972 . . . . 0.0 112.066 -169.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.37 130.41 1.41 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -53.82 99.65 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.627 1.571 . . . . 0.0 115.107 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 46.66 56.03 7.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.381 1.873 . . . . 0.0 112.332 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -62.17 95.67 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.451 1.1 . . . . 0.0 110.463 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.41 78.21 9.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 m -128.89 -59.48 1.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.169 0.588 . . . . 0.0 110.876 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 p -74.22 66.71 1.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.79 0.805 . . . . 0.0 109.162 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -120.49 -124.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 109.936 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.6 pm0 -68.52 21.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.68 -27.2 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.158 1.383 . . . . 0.0 109.332 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -67.68 124.05 88.37 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.944 -0.473 . . . . 0.0 110.168 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.99 -45.1 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 125.285 3.99 . . . . 0.0 114.67 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.22 13.61 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.367 -170.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 65.2 t0 59.88 111.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.645 1.578 . . . . 0.0 112.241 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 78.7 m -135.57 4.1 3.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.939 172.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.53 113.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 111.409 -167.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.13 167.08 19.72 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.755 1.222 . . . . 0.0 109.325 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -106.99 177.2 4.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 168.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.38 -43.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -129.77 -97.28 0.36 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -144.08 53.8 1.29 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 123.42 1.581 . . . . 0.0 110.564 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -178.85 6.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.999 2.92 . . . . 0.0 105.022 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.39 164.16 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.56 118.48 16.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.489 2.316 . . . . 0.0 106.177 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.3 mt -90.09 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 113.76 14.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.232 1.378 . . . . 0.0 107.807 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.82 -30.83 40.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.789 1.66 . . . . 0.0 110.582 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -82.82 -28.06 30.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.772 0.829 . . . . 0.0 109.272 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 t -85.38 -31.46 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.752 0.706 . . . . 0.0 111.163 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -58.02 129.89 44.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.387 0.994 . . . . 0.0 111.327 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.7 pt -103.52 33.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.564 1.146 . . . . 0.0 111.391 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 31.2 m-20 46.0 42.68 9.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.967 1.707 . . . . 0.0 113.478 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -23.57 60.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.276 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.69 -141.26 23.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.59 1.09 . . . . 0.0 111.15 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.52 -66.72 0.25 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.132 1.373 . . . . 0.0 111.117 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -49.93 -49.75 48.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.636 1.174 . . . . 0.0 110.352 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -53.97 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.775 2.03 . . . . 0.0 113.096 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.86 65.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.014 0.526 . . . . 0.0 110.568 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.06 -37.81 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.917 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -68.46 108.51 2.93 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 119.934 1.243 . . . . 0.0 108.834 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.64 11.35 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.633 2.222 . . . . 0.0 113.129 -172.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.07 -26.0 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.588 2.355 . . . . 0.0 108.535 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.35 58.92 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.592 0.757 . . . . 0.0 110.51 -170.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.29 -11.69 58.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.744 0.817 . . . . 0.0 111.186 171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.03 127.37 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.6 1.56 . . . . 0.0 107.276 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -134.83 168.71 18.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -65.78 144.33 56.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -52.93 -39.02 62.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.41 -40.86 79.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.814 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -77.48 -31.32 53.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.518 0.727 . . . . 0.0 110.523 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.22 127.05 69.81 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.695 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 144.84 50.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.163 2.576 . . . . 0.0 112.35 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -43.64 -45.57 6.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 128.734 2.814 . . . . 0.0 112.662 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.21 -48.84 23.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 0.0 110.506 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -90.9 -7.92 50.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.905 1.282 . . . . 0.0 112.456 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -58.05 -21.99 47.99 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 120.629 1.559 . . . . 0.0 110.028 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -49.3 -43.9 43.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.519 -0.738 . . . . 0.0 110.466 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -65.73 -33.57 76.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.504 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.89 -46.04 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 120.906 1.684 . . . . 0.0 107.247 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -56.89 -44.18 82.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.723 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.62 -50.7 72.47 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.352 0.524 . . . . 0.0 111.227 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -57.69 -39.77 77.91 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -60.67 -58.31 9.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.236 1.014 . . . . 0.0 109.003 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.79 -42.2 95.23 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 127.625 2.37 . . . . 0.0 112.957 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.96 -46.26 2.03 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.776 1.23 . . . . 0.0 113.367 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.61 5.47 31.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.649 0.779 . . . . 0.0 111.794 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -170.2 2.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.419 1.887 . . . . 0.0 106.218 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 C-N-CA 128.891 2.877 . . . . 0.0 103.877 168.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 111.331 0.122 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -100.1 143.37 30.39 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.444 1.098 . . . . 0.0 109.132 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.06 145.69 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.38 129.94 44.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 127.601 2.36 . . . . 0.0 107.391 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -110.0 -84.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.961 0.904 . . . . 0.0 112.322 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.95 -63.48 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.394 1.878 . . . . 0.0 113.728 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.79 86.0 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.883 1.722 . . . . 0.0 109.9 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 177.68 -44.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.197 2.599 . . . . 0.0 107.489 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.65 131.35 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.653 0.781 . . . . 0.0 110.944 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.65 72.49 0.02 OUTLIER Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.492 0.568 . . . . 0.0 113.016 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 61.44 -59.4 0.1 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.575 2.75 . . . . 0.0 116.346 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -166.45 148.39 6.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.218 0.917 . . . . 0.0 109.095 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 t -149.94 166.74 28.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.684 1.594 . . . . 0.0 106.953 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -145.83 176.79 9.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.153 2.581 . . . . 0.0 104.038 168.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 49.0 m 117.26 -66.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.334 2.254 . . . . 0.0 109.144 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -74.16 33.19 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.498 -0.751 . . . . 0.0 111.057 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.9 -75.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 O-C-N 120.723 -1.236 . . . . 0.0 108.42 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.09 28.28 0.06 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.22 1.808 . . . . 0.0 115.144 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -130.58 -27.38 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.701 1.2 . . . . 0.0 112.186 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.55 125.73 91.15 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 119.344 0.975 . . . . 0.0 112.267 -169.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.9 121.7 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.911 2.407 . . . . 0.0 108.835 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t 76.25 24.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 111.314 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 36.87 40.69 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.486 2.314 . . . . 0.0 115.067 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.02 44.48 1.18 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 120.672 -1.267 . . . . 0.0 111.176 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.57 122.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.76 2.024 . . . . 0.0 106.14 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.63 143.02 50.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.238 1.415 . . . . 0.0 111.551 -167.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -76.06 135.31 39.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.63 38.23 3.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 105.977 -2.849 . . . . 0.0 105.977 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 65.72 -64.23 0.2 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.756 3.222 . . . . 0.0 110.189 -169.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.41 -27.29 66.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 112.6 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 172.19 18.66 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -91.85 151.35 20.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 125.39 15.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.624 2.77 . . . . 0.0 108.736 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -76.79 142.22 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.763 0.825 . . . . 0.0 109.288 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -80.72 108.92 11.21 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -74.9 -3.14 13.46 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.797 1.665 . . . . 0.0 113.263 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.44 -38.19 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.0 -33.07 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.762 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 t -55.53 123.39 13.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.227 0.921 . . . . 0.0 111.149 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 pt -88.75 35.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.176 0.99 . . . . 0.0 111.672 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.2 m-20 44.83 48.21 9.09 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.325 1.45 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.48 178.22 7.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.08 103.25 0.76 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.45 -56.67 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.08 0.94 . . . . 0.0 111.675 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.3 p -63.51 -43.02 98.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.699 0.8 . . . . 0.0 109.819 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.11 137.14 40.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.59 -0.694 . . . . 0.0 110.023 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.59 -18.33 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.199 1.4 . . . . 0.0 113.052 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.69 -36.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 t -62.76 118.1 38.44 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.33 -23.69 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.101 1.868 . . . . 0.0 112.025 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.39 -22.73 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.139 0.975 . . . . 0.0 110.569 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.6 m 54.05 51.52 14.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.661 1.184 . . . . 0.0 111.87 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.46 -19.64 30.96 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.961 0.904 . . . . 0.0 111.624 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.02 117.72 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -128.87 164.89 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.047 0.939 . . . . 0.0 108.793 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.54 144.89 55.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.07 -40.36 61.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.373 0.606 . . . . 0.0 112.456 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.91 -40.92 77.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.996 1.318 . . . . 0.0 111.854 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -80.09 -36.71 35.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.791 1.237 . . . . 0.0 110.234 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.27 126.41 36.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.493 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.18 144.56 37.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.228 2.618 . . . . 0.0 112.39 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -43.38 -45.87 6.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.407 2.683 . . . . 0.0 112.188 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -46.11 -43.98 15.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.271 1.029 . . . . 0.0 111.245 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -98.6 -6.39 30.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.37 1.868 . . . . 0.0 112.711 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -58.83 -22.32 58.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.437 1.472 . . . . 0.0 110.532 170.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 p -50.41 -44.75 55.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.618 167.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.06 -30.5 70.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.94 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.14 -48.26 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 120.89 1.677 . . . . 0.0 106.81 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -55.87 -47.76 76.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.125 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.37 -46.63 87.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.283 0.492 . . . . 0.0 111.713 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -56.55 -43.08 79.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.056 1.342 . . . . 0.0 109.794 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -61.38 -58.01 9.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 123.109 1.433 . . . . 0.0 108.335 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.36 -39.79 73.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.955 2.102 . . . . 0.0 112.933 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -38.88 -53.73 1.69 Allowed 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.684 1.194 . . . . 0.0 111.61 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.39 -29.55 11.97 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.43 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.7 78.34 4.2 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.431 -1.747 . . . . 0.0 108.02 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -95.96 135.56 37.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.4 t -134.66 139.3 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.035 0.534 . . . . 0.0 110.844 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.49 170.0 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.497 1.919 . . . . 0.0 110.54 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 p -140.74 -107.96 0.15 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -120.86 -54.39 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.4 -23.22 54.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.771 1.647 . . . . 0.0 111.935 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -53.32 -39.61 64.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 112.973 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.13 125.25 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.82 -147.0 4.63 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-O 123.203 1.446 . . . . 0.0 110.931 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 p -89.04 64.35 7.06 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 126.135 1.774 . . . . 0.0 109.429 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.87 0.48 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.919 0.888 . . . . 0.0 110.246 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.16 146.99 52.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.565 0.346 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.03 90.01 1.79 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.491 1.516 . . . . 0.0 107.507 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.4 m -144.14 -55.12 0.36 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.562 -0.711 . . . . 0.0 111.062 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.19 70.54 0.83 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.924 0.868 . . . . 0.0 109.523 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.1 -117.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.545 1.538 . . . . 0.0 108.613 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.02 7.48 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.361 1.864 . . . . 0.0 115.291 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.39 -25.4 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 110.102 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.2 t -69.34 126.09 92.43 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.04 0.382 . . . . 0.0 110.31 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -42.42 -38.21 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.738 4.292 . . . . 0.0 114.543 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -124.47 24.73 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 111.193 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t0 39.29 62.54 1.12 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.559 1.544 . . . . 0.0 113.152 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.1 p -125.17 51.82 1.65 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.523 0.729 . . . . 0.0 110.994 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.56 127.37 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.925 2.09 . . . . 0.0 106.462 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.93 133.45 30.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 119.796 1.18 . . . . 0.0 113.987 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.42 146.86 32.56 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.788 -1.195 . . . . 0.0 112.336 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.18 -50.1 0.43 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -54.67 0.82 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.513 1.525 . . . . 0.0 110.212 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -141.16 -49.66 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.908 2.483 . . . . 0.0 110.813 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.1 137.49 37.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.785 -0.572 . . . . 0.0 111.394 -168.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -75.21 102.14 4.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.838 0.828 . . . . 0.0 109.15 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.65 113.31 3.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.925 2.49 . . . . 0.0 106.911 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mt -78.59 130.96 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.12 119.68 71.63 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.754 0.706 . . . . 0.0 109.254 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.29 -27.05 16.84 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 121.706 1.604 . . . . 0.0 112.56 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -42.6 60.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.14 -33.34 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.795 -0.622 . . . . 0.0 112.243 -172.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -61.55 116.86 5.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.133 1.333 . . . . 0.0 110.998 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -83.23 35.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.974 0.91 . . . . 0.0 111.853 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.39 49.69 6.07 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.654 1.982 . . . . 0.0 113.259 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -161.81 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.609 0.764 . . . . 0.0 109.508 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.6 -125.49 4.46 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.88 -67.51 0.26 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 127.662 2.385 . . . . 0.0 110.408 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.3 p -56.61 -46.56 80.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.103 0.561 . . . . 0.0 110.242 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -44.92 78.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.144 0.978 . . . . 0.0 112.878 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.13 72.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.05 0.54 . . . . 0.0 110.655 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.7 -38.17 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.882 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' VAL . 13.9 t -59.86 114.7 10.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.4 18.91 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.242 2.628 . . . . 0.0 113.139 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.9 m -133.08 -25.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.85 2.86 . . . . 0.0 108.295 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 m 53.2 58.39 5.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.623 1.169 . . . . 0.0 111.242 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.71 -12.6 55.62 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.719 1.208 . . . . 0.0 111.322 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.81 128.5 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.02 170.5 15.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -58.49 143.31 46.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.22 -40.49 58.9 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -74.69 -26.5 59.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.376 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -71.04 -28.9 64.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.65 124.6 73.3 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.12 -0.467 . . . . 0.0 109.753 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.9 149.15 71.79 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.039 3.159 . . . . 0.0 112.573 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.8 mp0 -44.26 -44.91 8.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.578 3.151 . . . . 0.0 113.772 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -48.05 -39.83 21.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.466 0.706 . . . . 0.0 111.472 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -105.79 -1.42 24.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.533 1.933 . . . . 0.0 112.66 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 22.3 mmtm -57.83 -22.51 48.06 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.035 1.288 . . . . 0.0 109.336 169.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.93 -46.37 31.92 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.303 1.441 . . . . 0.0 110.221 168.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.32 -35.18 80.04 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.506 -0.746 . . . . 0.0 110.788 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.63 -37.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.781 1.173 . . . . 0.0 108.39 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -62.71 -46.89 86.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.171 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.5 -49.33 78.19 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.575 -0.703 . . . . 0.0 110.238 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -45.84 -44.7 14.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 127.612 2.365 . . . . 0.0 111.552 169.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -59.51 4.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.56 -44.48 62.73 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.522 1.929 . . . . 0.0 111.524 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -43.2 -42.81 4.39 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -115.51 19.73 15.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.153 0.581 . . . . 0.0 110.855 -174.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 77.99 1.5 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -113.43 142.04 46.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.51 144.38 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.321 1.048 . . . . 0.0 111.815 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.51 161.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.961 2.105 . . . . 0.0 110.916 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 p -148.96 163.73 36.62 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.623 0.725 . . . . 0.0 111.899 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.255 2.8 tt0 -15.1 -62.21 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.805 3.242 . . . . 0.0 116.838 175.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 22.5 Cg_exo -61.53 -25.71 79.87 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 CA-C-N 122.008 1.753 . . . . 0.0 113.451 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -12.3 60.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.352 0.661 . . . . 0.0 111.612 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.09 85.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.268 -0.895 . . . . 0.0 109.204 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.04 58.42 0.57 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.22 1.39 . . . . 0.0 110.131 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.311 14.5 t 38.1 115.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.503 3.121 . . . . 0.0 116.728 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 61.97 -62.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.751 2.021 . . . . 0.0 114.075 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.6 t 66.01 -63.92 0.22 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.859 2.064 . . . . 0.0 112.396 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.94 24.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.004 1.722 . . . . 0.0 113.42 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.0 m -97.31 -48.68 5.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.675 0.39 . . . . 0.0 110.998 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -73.51 71.82 1.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.807 0.813 . . . . 0.0 109.137 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 152.78 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.763 1.625 . . . . 0.0 109.745 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 48.46 21.29 0.37 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.85 -16.92 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.456 0.703 . . . . 0.0 111.718 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -71.98 131.73 85.32 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -172.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -45.44 -37.23 14.37 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.026 3.817 . . . . 0.0 115.084 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 -15.06 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.959 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 t0 99.2 162.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.341 2.657 . . . . 0.0 108.951 -171.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.8 p 154.96 -9.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.608 2.763 . . . . 0.0 112.708 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.91 100.16 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.625 1.102 . . . . 0.0 110.253 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -112.96 142.52 45.56 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.128 0.971 . . . . 0.0 111.749 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.95 98.59 3.07 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.663 -1.273 . . . . 0.0 111.806 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.43 68.51 2.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 69.91 -59.9 0.49 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 130.066 3.346 . . . . 0.0 111.509 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -141.71 33.52 1.61 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.968 0.89 . . . . 0.0 112.235 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -166.05 140.27 4.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -80.13 114.99 19.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.07 117.93 35.67 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.953 2.501 . . . . 0.0 106.004 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.91 123.19 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.47 113.92 16.6 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.309 0.959 . . . . 0.0 108.589 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 46.9 Cg_endo -61.24 -32.47 90.44 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.801 1.667 . . . . 0.0 110.699 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -77.12 -28.18 54.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -172.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.06 -32.97 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.171 0.441 . . . . 0.0 110.836 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 t -59.54 104.42 0.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.051 0.842 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.7 pt -78.82 46.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.936 -1.103 . . . . 0.0 111.262 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.37 -110.67 0.53 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.265 1.426 . . . . 0.0 109.401 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.83 -45.74 0.49 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.68 1.592 . . . . 0.0 114.386 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.42 -122.82 6.09 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.84 -75.09 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.9 1.28 . . . . 0.0 112.179 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -51.18 -43.46 61.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.201 1.0 . . . . 0.0 110.417 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -48.27 -59.92 3.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.224 1.41 . . . . 0.0 110.511 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.89 74.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.995 0.518 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 t -64.81 -36.54 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.894 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.7 t -63.83 114.3 13.03 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.15 46.09 2.14 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.352 2.702 . . . . 0.0 110.97 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -164.19 -29.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.739 2.415 . . . . 0.0 109.536 -169.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 m 57.59 58.55 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 110.315 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.59 -20.87 38.91 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.221 1.008 . . . . 0.0 110.673 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.87 116.39 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.1 166.85 12.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -54.26 -39.65 67.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -52.49 -43.63 65.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.073 0.949 . . . . 0.0 112.222 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.57 -34.33 53.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.406 1.082 . . . . 0.0 110.38 -169.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.26 124.17 59.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 118.213 -0.899 . . . . 0.0 109.57 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.67 146.12 56.09 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.01 2.474 . . . . 0.0 112.399 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.5 mp0 -41.75 -44.67 3.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -46.73 -44.01 18.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.592 0.757 . . . . 0.0 110.931 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -101.55 -1.65 32.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.375 1.87 . . . . 0.0 113.246 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.5 mmtm -57.91 -23.96 55.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.454 1.479 . . . . 0.0 108.92 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 p -48.18 -45.36 33.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.717 1.207 . . . . 0.0 110.623 168.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.33 -35.83 82.15 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 121.395 -0.815 . . . . 0.0 111.305 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -46.26 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.76 -44.81 73.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.384 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.39 -45.85 78.62 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.359 0.527 . . . . 0.0 112.047 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 15.0 m-80 -59.61 -41.34 90.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.565 1.146 . . . . 0.0 111.135 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -58.42 -61.21 2.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -52.69 -52.47 55.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.864 2.466 . . . . 0.0 113.359 -170.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -34.99 -47.99 0.39 Allowed 'General case' 0 C--O 1.228 -0.07 0 O-C-N 125.427 1.705 . . . . 0.0 113.466 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.97 -2.84 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.705 0.628 . . . . 0.0 111.894 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -34.1 40.94 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.035 0.834 . . . . 0.0 111.038 -173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -110.35 149.08 30.73 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 117.964 0.347 . . . . 0.0 110.374 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -128.34 139.05 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.179 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.62 140.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 126.553 1.941 . . . . 0.0 107.833 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -129.79 172.44 11.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.163 0.585 . . . . 0.0 111.102 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.641 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.8 tt0 -12.71 -59.59 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 129.408 3.083 . . . . 0.0 115.946 171.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.4 -17.74 59.25 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.894 1.712 . . . . 0.0 114.206 -173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.69 -31.82 73.22 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.139 0.882 . . . . 0.0 111.659 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 6' ' ' GLU . 6.9 mt -54.14 101.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.988 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.71 54.42 0.08 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.286 7.1 t 54.99 -160.09 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.134 1.774 . . . . 0.0 113.763 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -77.24 67.02 3.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.347 1.459 . . . . 0.0 111.189 -171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.32 -49.42 77.08 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.27 1.428 . . . . 0.0 110.989 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.86 -127.44 0.75 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.057 0.943 . . . . 0.0 109.329 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 m 75.98 -57.17 0.57 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.209 2.203 . . . . 0.0 110.853 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -57.21 -37.16 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.0 t -54.64 -62.21 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.062 0.945 . . . . 0.0 111.491 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -64.28 6.84 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -168.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.21 -12.06 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.975 1.261 . . . . 0.0 113.418 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.4 t -69.63 130.02 90.84 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.795 1.18 . . . . 0.0 110.7 -171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -57.12 -29.5 83.49 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.947 3.098 . . . . 0.0 113.749 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.4 67.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.214 0.606 . . . . 0.0 109.43 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 6.96 64.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 130.752 3.621 . . . . 0.0 115.354 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 p -116.33 37.51 3.69 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.561 0.744 . . . . 0.0 110.394 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.16 123.51 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 128.056 2.542 . . . . 0.0 105.485 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.32 165.12 25.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.367 1.867 . . . . 0.0 108.643 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -90.41 160.83 15.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.649 0.659 . . . . 0.0 110.351 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 68.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.3 84.01 0.16 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.853 2.061 . . . . 0.0 109.318 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.274 1.1 m-20 47.33 41.43 12.3 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.929 2.092 . . . . 0.0 114.875 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 160.18 28.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.768 2.827 . . . . 0.0 104.195 168.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -102.1 164.07 11.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 123.158 0.287 . . . . 0.0 110.637 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.31 148.62 41.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 106.958 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.2 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.82 123.42 89.2 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 119.621 1.101 . . . . 0.0 109.553 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.87 -28.25 16.78 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.348 1.365 . . . . 0.0 112.961 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -27.46 18.27 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.857 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -81.84 -29.58 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.816 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.32 118.61 9.58 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.428 1.013 . . . . 0.0 110.4 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 pt -88.74 32.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 123.673 0.789 . . . . 0.0 111.336 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 1.6 t70 42.3 52.52 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.953 2.101 . . . . 0.0 111.103 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.5 p -74.35 -44.73 51.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -168.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.85 86.09 1.25 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.64 -59.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.715 0.806 . . . . 0.0 110.65 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -54.97 -48.17 73.6 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.057 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -48.96 70.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.207 1.003 . . . . 0.0 111.422 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.63 77.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.272 0.629 . . . . 0.0 111.768 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.74 2.4 6.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 117.809 -1.091 . . . . 0.0 113.482 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -87.44 102.33 3.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.05 15.59 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.694 2.929 . . . . 0.0 113.112 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.07 -27.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 129.624 3.17 . . . . 0.0 107.343 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 56.83 58.15 4.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.85 1.26 . . . . 0.0 110.15 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -20.1 33.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.187 0.995 . . . . 0.0 110.466 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.75 121.83 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -135.82 168.83 18.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -64.89 142.79 58.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -47.3 -43.91 22.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.09 -39.88 79.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.72 0.808 . . . . 0.0 111.538 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -77.06 -38.9 51.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.56 1.144 . . . . 0.0 110.681 -168.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.88 122.68 14.29 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.191 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.97 146.61 46.46 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.299 2.666 . . . . 0.0 112.668 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.4 mp0 -41.47 -45.5 3.21 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.512 3.125 . . . . 0.0 113.735 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -46.31 -44.73 16.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.851 0.834 . . . . 0.0 110.894 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.93 -0.43 39.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.315 1.846 . . . . 0.0 112.83 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.0 mmtm -59.21 -22.44 61.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.621 1.555 . . . . 0.0 109.341 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 p -48.46 -46.1 37.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.441 1.096 . . . . 0.0 109.764 168.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -62.55 -34.45 76.97 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.322 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.4 -35.53 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 120.849 1.659 . . . . 0.0 109.403 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -62.69 -50.14 72.3 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -48.05 83.51 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.192 0.597 . . . . 0.0 111.384 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -42.25 -47.93 4.84 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 129.591 3.156 . . . . 0.0 112.368 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -61.36 1.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.33 -31.0 65.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.301 1.84 . . . . 0.0 113.616 -170.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.36 17.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.202 0.601 . . . . 0.0 111.828 174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -113.31 -33.25 6.01 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.251 0.621 . . . . 0.0 110.747 -170.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.75 140.9 33.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.67 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -103.92 145.92 29.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.586 0.754 . . . . 0.0 108.981 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG11 HD12 ' A' ' 68' ' ' ILE . 37.4 t -132.36 141.93 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.276 1.031 . . . . 0.0 111.37 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.72 139.8 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.341 1.856 . . . . 0.0 109.177 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.2 p -126.95 174.36 8.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.736 0.815 . . . . 0.0 111.289 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -12.91 -59.62 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.957 2.903 . . . . 0.0 115.577 169.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.09 -12.48 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 121.181 1.458 . . . . 0.0 114.23 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -70.23 -33.86 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.075 0.852 . . . . 0.0 111.951 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.41 127.65 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.527 0.603 . . . . 0.0 109.753 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.6 48.7 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.411 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 19.7 m 52.15 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 116.241 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm 73.9 -64.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.742 2.817 . . . . 0.0 113.247 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 t 60.71 -67.36 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.237 1.415 . . . . 0.0 112.165 -170.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.51 34.32 6.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.364 1.866 . . . . 0.0 113.339 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 m -89.9 -47.72 7.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 111.227 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 p -72.92 69.99 0.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.724 0.773 . . . . 0.0 109.36 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.71 -96.48 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.553 1.141 . . . . 0.0 109.594 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.51 24.71 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.699 1.599 . . . . 0.0 115.133 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.01 -25.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.479 1.512 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.11 121.79 86.03 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.254 0.933 . . . . 0.0 110.765 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.2 -38.17 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 125.261 3.974 . . . . 0.0 114.148 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -116.16 18.77 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.953 0.901 . . . . 0.0 111.804 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t0 42.9 52.25 5.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.699 1.2 . . . . 0.0 112.658 172.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.9 p -107.42 26.95 9.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.765 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.29 126.7 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.364 1.466 . . . . 0.0 109.09 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -136.77 170.28 16.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.892 1.677 . . . . 0.0 107.868 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -100.52 156.74 17.12 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 122.146 0.974 . . . . 0.0 113.209 169.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.87 73.54 0.45 Allowed Glycine 0 N--CA 1.444 -0.77 1 N-CA-C 102.848 -4.101 . . . . 0.0 102.848 167.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 61.98 -66.58 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 131.206 3.803 . . . . 0.0 112.59 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 11' ' ' THR . 22.0 t70 -102.56 -21.14 14.23 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.295 1.438 . . . . 0.0 112.452 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.75 163.68 31.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.221 -169.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -81.41 164.36 22.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 123.574 0.546 . . . . 0.0 110.27 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -143.77 120.6 11.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.516 2.326 . . . . 0.0 106.114 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.09 134.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -77.47 112.33 23.22 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.11 -28.33 41.1 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.74 1.626 . . . . 0.0 110.768 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -78.61 -25.42 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.4 t -89.61 -36.44 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 118.694 0.679 . . . . 0.0 111.868 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.3 t -55.08 136.52 48.04 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.62 1.1 . . . . 0.0 110.722 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.64 38.4 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.476 1.111 . . . . 0.0 111.408 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 44.53 55.47 5.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.438 1.495 . . . . 0.0 112.198 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -159.66 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.705 0.402 . . . . 0.0 111.358 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.47 109.42 0.59 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 169.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -168.63 -66.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.706 1.202 . . . . 0.0 110.094 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.0 p -54.74 -44.44 73.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.99 0.916 . . . . 0.0 111.159 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -50.94 70.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.158 0.583 . . . . 0.0 111.972 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.66 78.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.031 0.532 . . . . 0.0 110.889 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.07 -37.09 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.836 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 t -73.5 106.97 2.77 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 108.706 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.17 -14.0 41.65 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.615 1.544 . . . . 0.0 111.805 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.26 -21.53 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.283 1.433 . . . . 0.0 109.974 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 53.48 58.85 4.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.254 1.022 . . . . 0.0 110.987 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.98 46.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.854 0.862 . . . . 0.0 110.551 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.82 125.08 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.82 167.59 20.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.13 145.4 55.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -48.84 -46.41 42.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.508 0.671 . . . . 0.0 111.048 174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.8 -38.11 60.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.012 1.725 . . . . 0.0 111.109 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -82.77 -41.25 19.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.284 1.034 . . . . 0.0 110.437 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.26 121.81 27.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.752 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.31 147.69 54.73 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.403 2.735 . . . . 0.0 112.531 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.0 mp0 -39.98 -46.6 2.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.517 3.127 . . . . 0.0 113.399 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -45.53 -43.72 12.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.699 0.8 . . . . 0.0 111.148 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -102.11 -0.49 33.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.524 1.93 . . . . 0.0 113.08 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.6 mmtm -57.9 -25.76 61.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.86 1.663 . . . . 0.0 109.23 169.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -46.87 -46.41 21.01 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.029 1.332 . . . . 0.0 110.272 168.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -64.31 -34.89 79.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.656 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.421 HD12 HG11 ' A' ' 3' ' ' VAL . 1.6 mp -62.66 -47.11 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 120.869 1.668 . . . . 0.0 106.952 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -58.75 -43.69 90.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.956 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -64.1 -44.39 92.46 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.367 0.531 . . . . 0.0 111.766 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -59.11 -43.0 91.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.675 1.59 . . . . 0.0 110.497 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -56.7 -60.13 4.01 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.86 -42.06 88.51 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.132 2.573 . . . . 0.0 112.651 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -37.41 -50.41 1.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 112.276 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.18 -21.58 13.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 -170.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 81.62 5.17 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.964 -1.493 . . . . 0.0 108.376 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.79 141.05 33.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.947 0.499 . . . . 0.0 109.998 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.39 143.26 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.836 0.855 . . . . 0.0 110.264 -173.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.08 161.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 110.552 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 p -148.49 174.55 11.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.015 0.926 . . . . 0.0 109.198 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -10.2 -61.71 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 128.661 2.785 . . . . 0.0 116.071 170.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.9 Cg_exo -62.85 -17.16 58.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 CA-C-N 121.494 1.569 . . . . 0.0 113.694 -172.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.67 -31.24 72.15 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.741 0.701 . . . . 0.0 112.03 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.17 91.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.806 0.812 . . . . 0.0 110.14 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.89 85.43 0.16 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.092 2.282 . . . . 0.0 107.639 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.287 6.5 t -6.85 99.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.466 2.706 . . . . 0.0 117.096 -172.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp 56.09 41.62 29.35 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.486 2.314 . . . . 0.0 113.108 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -46.36 -52.11 13.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.741 1.617 . . . . 0.0 112.472 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.04 -121.58 0.72 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.81 0.844 . . . . 0.0 109.229 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m 68.86 -57.38 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.056 1.743 . . . . 0.0 111.634 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.3 p -70.21 64.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 0.0 108.671 169.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.36 152.36 21.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 126.053 1.741 . . . . 0.0 108.0 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 61.12 -10.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.982 2.215 . . . . 0.0 116.982 173.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m -90.55 -24.62 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.812 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -72.76 125.52 91.15 Favored Pre-proline 0 CA--C 1.538 0.512 0 O-C-N 122.211 -0.306 . . . . 0.0 110.19 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.15 -31.54 55.44 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.278 3.318 . . . . 0.0 113.531 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.17 19.92 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.89 0.876 . . . . 0.0 111.853 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.6 t70 41.23 56.39 3.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.065 1.346 . . . . 0.0 113.202 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -110.85 36.19 3.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.681 0.793 . . . . 0.0 111.006 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.41 131.96 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 106.713 176.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -142.1 174.65 10.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.815 1.646 . . . . 0.0 107.749 -169.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -107.94 160.39 15.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.117 0.96 . . . . 0.0 113.095 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.36 67.65 0.56 Allowed Glycine 0 N--CA 1.445 -0.716 1 N-CA-C 102.732 -4.147 . . . . 0.0 102.732 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 64.41 -63.22 0.17 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 131.096 3.758 . . . . 0.0 112.631 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -101.74 -20.5 14.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 112.57 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.45 162.81 38.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.12 -0.987 . . . . 0.0 108.62 -169.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -85.05 162.72 19.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.75 0.656 . . . . 0.0 110.911 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -145.19 131.45 19.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.789 2.436 . . . . 0.0 106.495 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 25' ' ' ILE . 67.6 mt -108.82 129.31 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 13.3 t0 -69.13 113.95 20.06 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.327 0.967 . . . . 0.0 109.192 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -28.94 71.1 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.385 1.39 . . . . 0.0 112.304 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -31.48 23.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.092 -0.48 . . . . 0.0 109.763 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.74 -28.29 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.247 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -58.94 119.53 7.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.946 1.248 . . . . 0.0 111.09 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 pt -91.65 33.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.103 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 43.92 58.98 3.35 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.015 1.326 . . . . 0.0 112.592 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.94 -173.86 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.98 172.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.58 104.4 0.8 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -163.03 -75.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.243 1.017 . . . . 0.0 110.025 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.4 p -50.83 -44.39 59.3 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.601 1.161 . . . . 0.0 112.365 -172.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -39.14 90.54 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.544 -0.722 . . . . 0.0 111.658 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.01 -36.92 67.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.812 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.0 t -65.86 -43.23 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.948 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 t -58.65 112.95 5.67 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 119.272 0.942 . . . . 0.0 108.665 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.28 42.35 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.621 2.881 . . . . 0.0 111.08 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.1 -34.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 128.979 2.911 . . . . 0.0 107.8 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m 57.13 59.85 3.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.276 1.031 . . . . 0.0 110.085 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.65 -23.99 56.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.476 1.51 . . . . 0.0 109.873 169.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.94 116.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.402 1.481 . . . . 0.0 107.008 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -122.87 166.45 15.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.82 145.39 52.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -44.05 62.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.615 -0.678 . . . . 0.0 111.995 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.49 -16.7 63.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.246 1.019 . . . . 0.0 112.597 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -80.8 -38.51 28.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.83 121.07 62.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.822 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -54.03 148.6 38.44 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.717 2.945 . . . . 0.0 112.119 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -52.88 -41.43 64.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.679 1.191 . . . . 0.0 110.728 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -44.34 -47.92 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.067 1.347 . . . . 0.0 111.292 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -95.9 -8.56 33.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.694 1.198 . . . . 0.0 112.08 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -59.95 -16.79 32.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 119.524 1.056 . . . . 0.0 110.869 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -50.56 -47.57 57.73 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.624 -0.673 . . . . 0.0 109.427 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -63.63 -37.34 86.95 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 121.651 -0.656 . . . . 0.0 111.18 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -45.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -55.89 -45.03 78.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -64.07 -45.89 86.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.605 0.639 . . . . 0.0 112.202 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -55.69 -41.58 73.96 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.417 1.487 . . . . 0.0 110.876 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -63.78 -58.44 6.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.1 -46.04 75.5 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.058 1.743 . . . . 0.0 112.833 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -34.76 -53.5 0.55 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.729 1.212 . . . . 0.0 112.298 -173.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -106.71 1.7 25.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 124.438 1.087 . . . . 0.0 112.315 -170.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 11.8 mptt -102.72 -8.65 20.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.778 0.717 . . . . 0.0 112.667 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.563 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -119.7 152.42 37.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.42 0.555 . . . . 0.0 109.704 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 68' ' ' ILE . 46.7 t -131.9 140.6 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.976 0.911 . . . . 0.0 110.613 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 127.344 2.257 . . . . 0.0 107.968 169.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -113.75 -89.97 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -134.46 -52.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -167.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.67 -25.16 74.19 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.935 1.757 . . . . 0.0 113.529 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.12 -37.32 66.74 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.832 0.853 . . . . 0.0 112.294 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.292 3.6 mp -69.01 96.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 122.181 0.991 . . . . 0.0 112.574 -168.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.3 -171.89 14.58 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 103.471 -3.852 . . . . 0.0 103.471 169.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.95 105.33 1.97 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.561 1.944 . . . . 0.0 111.789 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm 62.58 -63.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.638 2.375 . . . . 0.0 115.528 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t 66.03 -89.42 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.827 2.051 . . . . 0.0 112.093 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 96.54 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.341 2.657 . . . . 0.0 108.68 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m 73.92 -57.66 0.61 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.406 2.282 . . . . 0.0 111.584 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.52 -24.47 61.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.34 1.056 . . . . 0.0 111.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.26 7.9 p -72.55 -52.19 24.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 O-C-N 121.345 -0.847 . . . . 0.0 112.27 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -74.13 17.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.46 -20.51 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.68 129.25 94.29 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 120.476 1.489 . . . . 0.0 109.711 -172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.01 -42.32 25.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.801 3.667 . . . . 0.0 113.3 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.72 110.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 25' ' ' ILE . 33.4 t0 -31.01 120.25 0.21 Allowed 'General case' 0 C--O 1.23 0.077 0 C-N-CA 126.101 1.76 . . . . 0.0 114.686 -176.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.7 m -133.7 16.93 3.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 108.036 168.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.62 110.99 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -115.92 145.75 42.64 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -166.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.82 78.08 3.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 122.483 1.135 . . . . 0.0 108.861 169.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.66 97.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.26 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -125.0 -74.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.751 1.221 . . . . 0.0 107.803 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -135.71 -39.25 0.72 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.144 0.978 . . . . 0.0 113.12 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 170.88 8.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.488 1.915 . . . . 0.0 108.954 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.02 127.19 32.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.86 -172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -109.19 117.18 33.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.849 3.26 . . . . 0.0 106.976 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 44.1 mt -82.08 129.09 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.88 0.764 . . . . 0.0 109.487 -175.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.14 112.91 26.23 Favored Pre-proline 0 C--O 1.232 0.181 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.8 -29.74 50.32 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.41 1.407 . . . . 0.0 111.203 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -82.63 -29.64 29.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.293 0.637 . . . . 0.0 109.608 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.94 -33.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.562 0.619 . . . . 0.0 110.932 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.9 t -52.07 120.66 5.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.323 0.965 . . . . 0.0 111.436 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.58 35.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.738 0.815 . . . . 0.0 112.112 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 45.04 50.08 9.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 0.0 113.496 176.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.31 -167.51 1.8 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.55 101.02 0.44 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 169.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.7 -76.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.094 0.947 . . . . 0.0 110.042 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.2 p -48.16 -46.06 34.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.759 1.224 . . . . 0.0 111.844 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -50.9 71.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.956 0.902 . . . . 0.0 112.18 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.34 70.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.15 0.58 . . . . 0.0 110.828 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 t -69.65 -38.81 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.236 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.4 t -57.73 111.67 3.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.753 1.16 . . . . 0.0 109.67 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 -14.26 41.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.501 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.91 -22.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.265 1.426 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m 53.16 57.25 6.47 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 111.258 -171.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.97 -19.85 29.8 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 111.444 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.99 127.99 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 124.989 1.316 . . . . 0.0 107.649 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -139.65 168.45 19.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.21 148.21 52.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -53.28 -42.8 66.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.76 -23.22 60.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.819 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.58 -35.87 52.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.19 125.26 70.12 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.631 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.82 141.91 64.46 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.442 2.761 . . . . 0.0 112.148 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -35.37 -51.3 0.59 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.403 2.681 . . . . 0.0 113.461 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.48 -46.89 14.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.953 0.882 . . . . 0.0 110.617 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -95.18 -3.13 48.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.464 1.506 . . . . 0.0 112.629 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -60.34 -22.53 63.34 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.531 1.514 . . . . 0.0 110.119 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -48.58 -41.75 31.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.317 0.647 . . . . 0.0 110.294 167.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -68.44 -32.49 72.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.245 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.497 HD12 HG11 ' A' ' 3' ' ' VAL . 1.4 mp -61.84 -46.84 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 121.135 1.789 . . . . 0.0 107.365 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -49.12 72.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.017 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -63.71 -43.25 97.15 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -61.32 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.489 1.515 . . . . 0.0 110.297 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -57.23 13.41 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.32 -42.38 99.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 128.375 2.67 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -37.15 -51.84 1.01 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.414 1.086 . . . . 0.0 112.836 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.34 4.14 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.795 0.838 . . . . 0.0 111.503 -170.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 80.63 1.33 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.032 -1.937 . . . . 0.0 107.365 -169.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -90.18 161.59 15.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.195 0.521 . . . . 0.0 111.294 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.19 149.58 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.339 1.055 . . . . 0.0 110.794 -172.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.45 138.71 25.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.979 1.312 . . . . 0.0 109.196 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -128.79 170.84 12.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 111.939 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.25 7.8 tt0 -12.25 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 129.756 3.222 . . . . 0.0 116.657 171.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.66 -19.74 54.66 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 122.559 1.95 . . . . 0.0 114.572 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -68.07 -29.1 67.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.071 0.851 . . . . 0.0 111.895 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.7 mt -44.18 110.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.3 0 C-N-CA 124.576 1.15 . . . . 0.0 113.188 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 38.47 0.07 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.9 m 57.51 -83.63 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.954 2.101 . . . . 0.0 113.258 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -124.86 110.46 14.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.601 0.761 . . . . 0.0 109.556 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -129.76 163.82 25.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.446 2.299 . . . . 0.0 105.242 170.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.71 -130.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.6 m 73.6 -68.17 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.601 2.36 . . . . 0.0 110.569 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 p -59.57 -28.44 67.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.826 0.451 . . . . 0.0 110.392 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.58 -66.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.39 1.076 . . . . 0.0 111.846 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -76.95 38.68 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.782 1.233 . . . . 0.0 113.839 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.45 -33.48 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.17 0.988 . . . . 0.0 113.195 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.03 122.6 73.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 120.064 1.302 . . . . 0.0 112.305 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.73 -31.06 91.5 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.841 3.028 . . . . 0.0 112.842 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.9 16.6 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.332 0.653 . . . . 0.0 112.237 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.8 t0 44.2 56.37 4.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.225 . . . . 0.0 112.405 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.7 p -115.63 32.42 6.08 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.563 0.745 . . . . 0.0 110.943 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.68 114.99 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.572 2.349 . . . . 0.0 107.818 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -128.75 173.8 10.01 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 126.198 1.799 . . . . 0.0 109.72 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -119.89 165.2 14.93 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.009 1.323 . . . . 0.0 113.925 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -128.68 13.67 6.13 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.821 1.677 . . . . 0.0 110.571 167.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 73.9 12.48 4.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.958 2.503 . . . . 0.0 112.774 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -123.54 -48.35 1.94 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 128.789 2.836 . . . . 0.0 109.611 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.83 176.25 10.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.032 2.133 . . . . 0.0 105.371 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.52 166.65 19.11 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.197 0.522 . . . . 0.0 110.269 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -145.39 109.67 4.92 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.767 2.027 . . . . 0.0 107.184 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.89 133.09 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -74.54 111.49 13.21 Favored Pre-proline 0 C--N 1.343 0.301 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 167.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -58.38 -33.53 97.9 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.111 1.207 . . . . 0.0 111.591 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -80.26 -29.83 38.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.705 -0.622 . . . . 0.0 110.599 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.3 -30.68 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.68 125.02 20.4 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.042 0.837 . . . . 0.0 111.308 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 pt -99.05 32.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.258 1.023 . . . . 0.0 111.347 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 46.4 41.7 9.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.78 1.632 . . . . 0.0 113.691 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -21.92 59.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.287 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.44 -139.23 25.33 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.847 1.213 . . . . 0.0 110.682 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.48 -60.55 0.5 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.836 2.054 . . . . 0.0 111.409 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -52.31 -40.46 61.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.911 0.884 . . . . 0.0 111.374 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -46.19 80.73 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.768 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.49 76.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.359 0.663 . . . . 0.0 110.292 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.4 -37.76 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.147 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 t -61.21 116.15 18.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.01 1.277 . . . . 0.0 108.103 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.89 -19.83 49.43 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.1 1.867 . . . . 0.0 112.777 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.27 -19.09 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.305 1.442 . . . . 0.0 110.235 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.0 m 51.9 58.36 5.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.359 1.064 . . . . 0.0 111.137 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.17 -13.4 59.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.071 0.948 . . . . 0.0 111.596 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.11 129.81 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.82 179.45 6.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.431 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 7.8 t-80 -79.51 145.35 33.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -48.31 -42.47 31.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.02 -39.82 87.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.223 0.535 . . . . 0.0 112.274 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -76.88 -32.41 57.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.517 -168.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.72 128.89 80.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.083 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.79 143.55 47.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.157 2.571 . . . . 0.0 112.4 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -44.05 -44.93 7.75 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.603 2.761 . . . . 0.0 112.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -46.77 -47.73 20.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.086 0.954 . . . . 0.0 110.843 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -93.17 -6.2 48.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.402 1.481 . . . . 0.0 112.301 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -59.85 -16.04 25.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.273 1.397 . . . . 0.0 110.869 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 p -52.73 -47.35 67.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.064 -1.022 . . . . 0.0 108.998 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -65.76 -30.16 70.77 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.355 -0.831 . . . . 0.0 111.621 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.04 -49.85 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -54.32 -41.87 69.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.421 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -49.98 66.75 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.624 0.647 . . . . 0.0 112.351 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.22 -42.18 69.51 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.371 1.468 . . . . 0.0 109.71 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -58.55 7.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.1 -44.38 83.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.887 2.475 . . . . 0.0 112.923 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -38.28 -50.99 1.49 Allowed 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.383 1.073 . . . . 0.0 112.664 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -102.74 -15.08 16.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 111.483 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 73.82 8.64 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 116.429 -1.748 . . . . 0.0 107.601 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -108.27 145.21 34.69 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.317 1.447 . . . . 0.0 110.864 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.09 140.54 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.714 1.206 . . . . 0.0 111.51 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -37.92 71.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 C-N-CA 126.123 1.769 . . . . 0.0 112.133 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p 63.36 -108.08 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.712 2.405 . . . . 0.0 114.24 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.92 -52.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -167.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.75 77.64 2.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.014 1.81 . . . . 0.0 111.077 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -178.03 -41.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.238 2.615 . . . . 0.0 108.026 -170.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.94 143.75 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 124.116 0.966 . . . . 0.0 113.024 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.59 32.98 58.89 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 124.954 1.264 . . . . 0.0 112.146 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -161.47 103.24 1.22 Allowed 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.253 1.421 . . . . 0.0 108.097 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -53.16 -39.11 63.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.091 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.9 t 66.71 -68.14 0.15 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 113.756 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.09 42.2 28.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.767 1.627 . . . . 0.0 112.472 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.4 m -100.51 -50.15 3.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.287 0.635 . . . . 0.0 111.228 171.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.3 p -75.16 68.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.762 0.791 . . . . 0.0 109.766 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.95 151.43 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.903 1.681 . . . . 0.0 109.043 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 59.01 29.74 19.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.701 1.6 . . . . 0.0 111.899 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.35 -38.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.366 1.066 . . . . 0.0 111.498 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.11 131.56 93.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.423 0.689 . . . . 0.0 110.201 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -45.95 -36.63 16.0 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 125.274 3.983 . . . . 0.0 114.229 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.71 19.48 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.051 0.94 . . . . 0.0 111.405 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 40.64 44.25 1.77 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 113.316 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.4 p -90.2 46.73 1.37 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.291 1.037 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.63 125.74 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.063 1.745 . . . . 0.0 106.564 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -133.8 166.57 22.34 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 124.791 1.237 . . . . 0.0 107.882 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -98.48 140.75 32.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 120.206 1.366 . . . . 0.0 112.096 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.79 -50.61 4.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 166.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 175.33 -74.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.516 3.126 . . . . 0.0 105.008 168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.32 10.23 7.41 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.057 1.343 . . . . 0.0 113.023 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.84 153.23 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.08 161.99 22.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.857 0.723 . . . . 0.0 110.233 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -134.53 111.89 10.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.861 2.865 . . . . 0.0 105.325 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.52 138.57 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 21.0 t0 -78.9 108.16 7.59 Favored Pre-proline 0 N--CA 1.464 0.268 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -76.67 -3.31 13.64 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.319 1.346 . . . . 0.0 112.479 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' ' HZ2' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -92.89 -38.36 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 109.983 169.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.86 -31.19 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 t -57.19 131.18 49.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.243 0.929 . . . . 0.0 111.211 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.2 pt -103.99 37.19 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.669 1.187 . . . . 0.0 111.53 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 28.0 m-20 52.23 37.06 21.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.393 1.477 . . . . 0.0 114.017 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -20.81 39.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.49 -140.45 24.42 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.03 -57.06 0.57 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 127.359 2.264 . . . . 0.0 111.386 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.2 -37.15 71.76 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.615 0.766 . . . . 0.0 111.188 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -43.28 86.14 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.3 -0.875 . . . . 0.0 110.912 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.17 84.01 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.861 0.464 . . . . 0.0 110.683 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.6 t -67.35 -40.29 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.043 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' HG13 ' A' ' 51' ' ' VAL . 5.6 t -58.38 115.62 12.13 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.95 61.44 7.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.952 3.101 . . . . 0.0 109.14 -172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG13 ' SG ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER 174.93 -36.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.813 2.445 . . . . 0.0 108.593 -167.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m 58.31 53.88 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.086 0.954 . . . . 0.0 110.864 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.285 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.25 121.43 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -118.26 164.13 15.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -71.69 147.28 47.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.79 -36.96 70.48 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.265 1.031 . . . . 0.0 113.183 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.51 -46.21 66.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.307 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -76.48 -36.44 57.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.616 1.167 . . . . 0.0 110.927 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HD11 ' A' ' 68' ' ' ILE . 49.1 t -52.46 122.14 24.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.5 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.03 147.32 64.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.3 2.667 . . . . 0.0 112.81 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 4.6 mp0 -39.69 -47.06 1.96 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.831 3.252 . . . . 0.0 113.537 174.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.06 -43.42 14.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.769 0.828 . . . . 0.0 111.11 172.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -102.13 -1.68 30.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.617 1.967 . . . . 0.0 112.87 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 68' ' ' ILE . 30.5 mmtm -55.52 -28.81 56.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.588 1.54 . . . . 0.0 109.501 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 p -48.78 -45.49 40.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.054 1.342 . . . . 0.0 111.566 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -67.81 -32.68 73.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.549 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 65' ' ' LYS . 10.2 mt -63.94 -47.67 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 120.73 1.605 . . . . 0.0 108.283 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -49.99 -53.67 25.02 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.62 93.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.763 0.256 . . . . 0.0 111.204 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.535 0.734 . . . . 0.0 111.111 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -62.85 -57.89 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.934 1.35 . . . . 0.0 109.202 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.413 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 47.9 t0 -59.64 -38.98 82.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.848 2.859 . . . . 0.0 112.25 -169.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -37.33 -57.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 171.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -97.48 -31.58 12.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.806 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -76.56 81.38 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.998 -1.477 . . . . 0.0 108.007 -169.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -101.47 136.71 40.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.934 1.294 . . . . 0.0 108.604 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.7 142.75 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.367 0.667 . . . . 0.0 111.219 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.11 157.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.187 1.795 . . . . 0.0 111.179 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -145.77 160.08 42.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.341 3.6 tt0 1.2 -66.14 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 130.068 3.347 . . . . 0.0 117.445 169.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.6 Cg_exo -56.04 -25.71 55.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 122.76 2.021 . . . . 0.0 114.633 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 t -57.29 -33.98 68.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 112.177 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.63 83.44 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.646 0.736 . . . . 0.0 111.032 -169.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.88 65.11 0.6 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.148 1.832 . . . . 0.0 108.876 171.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.256 14.2 t 50.13 -156.42 0.1 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.919 1.688 . . . . 0.0 112.435 -175.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -77.4 100.72 6.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.942 0.877 . . . . 0.0 110.56 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.62 177.62 8.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.149 1.78 . . . . 0.0 109.687 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.42 134.33 12.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m 156.42 -68.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.348 2.259 . . . . 0.0 107.412 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.89 40.29 0.24 Allowed 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.564 -0.71 . . . . 0.0 110.876 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.71 -73.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.069 0 O-C-N 120.548 -1.345 . . . . 0.0 107.988 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -80.85 41.5 0.58 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.88 -35.7 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.35 127.91 93.34 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.378 0.99 . . . . 0.0 110.925 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.96 -36.4 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.945 3.763 . . . . 0.0 114.218 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.75 45.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.802 0.841 . . . . 0.0 111.213 -169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 55.62 -115.18 0.91 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.049 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.16 -19.64 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.78 103.26 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.95 1.3 . . . . 0.0 109.824 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.27 142.63 47.29 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.632 1.173 . . . . 0.0 111.823 -169.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -75.8 77.72 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.601 1.091 . . . . 0.0 109.369 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.97 -43.02 96.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.666 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -111.55 -120.72 0.29 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -101.16 -8.79 21.91 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 111.071 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.36 161.87 28.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.425 2.69 . . . . 0.0 108.536 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.49 120.99 25.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.348 0.659 . . . . 0.0 112.255 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 124.14 47.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.441 3.096 . . . . 0.0 106.421 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt -89.34 125.33 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 118.125 -0.94 . . . . 0.0 108.516 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.1 t0 -70.24 113.44 17.97 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 120.134 1.334 . . . . 0.0 108.417 169.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 57.2 Cg_endo -61.9 -31.85 84.86 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 121.277 1.318 . . . . 0.0 110.975 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -79.86 -21.14 44.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.871 -0.518 . . . . 0.0 110.369 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -88.09 -37.55 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.334 0.516 . . . . 0.0 110.706 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.08 148.18 36.73 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.807 0.731 . . . . 0.0 111.207 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 pt -122.62 38.46 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.255 1.422 . . . . 0.0 111.017 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 46.94 39.69 7.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.323 1.849 . . . . 0.0 112.615 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.17 159.0 32.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.829 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.44 63.65 4.38 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.03 174.33 15.38 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 124.373 1.069 . . . . 0.0 108.233 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.283 4.8 p 66.39 -56.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.387 2.275 . . . . 0.0 111.644 -169.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -66.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.992 0.917 . . . . 0.0 111.67 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.83 64.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.261 0.624 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.63 -35.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.555 0.742 . . . . 0.0 109.484 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -60.74 114.07 9.33 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 -2.5 7.72 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.299 2.0 . . . . 0.0 113.026 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -108.8 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.242 1.817 . . . . 0.0 109.894 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.3 m 52.48 55.28 9.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.054 0.942 . . . . 0.0 111.563 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.36 -16.17 50.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 111.058 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.98 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -133.75 167.66 20.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.59 145.15 56.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.58 171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.5 -41.03 65.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.42 -31.42 72.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.806 0.843 . . . . 0.0 110.885 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -81.45 -36.74 29.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.439 0.695 . . . . 0.0 109.945 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -48.92 127.5 14.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.339 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.01 142.51 64.95 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 0.0 112.125 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -41.66 -45.78 3.52 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.755 2.822 . . . . 0.0 112.784 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -47.68 -46.13 28.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.141 0.976 . . . . 0.0 110.882 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -96.19 -6.58 37.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.494 1.518 . . . . 0.0 112.578 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -58.87 -19.9 46.14 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.26 1.391 . . . . 0.0 110.422 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -49.84 -46.71 51.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.705 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -62.7 -35.83 80.97 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.171 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.66 -45.59 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.717 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -65.27 -46.5 80.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.365 0.529 . . . . 0.0 111.654 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 12.3 m-80 -58.24 -42.54 86.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 110.885 175.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -57.81 -61.64 2.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.719 1.208 . . . . 0.0 108.028 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -52.25 -51.74 56.65 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.801 2.44 . . . . 0.0 113.054 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -50.92 0.29 Allowed 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.175 1.79 . . . . 0.0 113.695 -175.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -110.02 -1.14 17.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.715 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.53 -34.31 41.25 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.165 0.893 . . . . 0.0 111.162 -174.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -109.56 142.62 40.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.027 1.331 . . . . 0.0 109.746 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.07 141.04 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.462 1.105 . . . . 0.0 110.705 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -48.37 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 128.433 2.693 . . . . 0.0 114.316 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p 61.19 -165.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.66 1.584 . . . . 0.0 114.065 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.05 -48.93 59.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 129.446 3.099 . . . . 0.0 115.726 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.09 -22.4 74.16 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 CA-C-N 121.322 1.508 . . . . 0.0 113.327 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -58.33 -34.08 70.23 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.444 0.697 . . . . 0.0 112.026 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -71.14 84.15 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.683 0.754 . . . . 0.0 110.814 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.15 58.28 0.7 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.597 2.046 . . . . 0.0 108.608 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.266 14.5 t 49.23 -150.01 0.2 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.022 1.729 . . . . 0.0 113.025 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -66.56 81.62 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.936 1.695 . . . . 0.0 112.157 -172.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.7 t -66.22 151.37 47.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.995 0.918 . . . . 0.0 109.598 169.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.44 44.19 2.31 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.263 1.025 . . . . 0.0 109.508 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -150.49 144.15 25.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.386 5.7 p 74.01 49.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.657 2.383 . . . . 0.0 108.466 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 -43.28 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.624 1.97 . . . . 0.0 109.246 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.07 27.04 2.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.756 2.822 . . . . 0.0 113.498 -168.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.5 -37.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -168.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 t -59.34 123.66 71.27 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.698 1.135 . . . . 0.0 112.535 -168.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.93 -47.21 19.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 1 C-N-CA 125.318 4.012 . . . . 0.0 113.144 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -133.65 84.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -17.37 112.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.984 2.114 . . . . 0.0 114.544 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m -121.97 1.14 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.135 1.374 . . . . 0.0 109.94 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.14 106.4 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.222 0.919 . . . . 0.0 112.433 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -125.95 144.28 50.75 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.081 0.953 . . . . 0.0 110.191 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.39 118.39 17.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 120.157 1.344 . . . . 0.0 111.93 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.66 75.08 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 104.781 -3.327 . . . . 0.0 104.781 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 71.94 -47.83 0.67 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.602 2.761 . . . . 0.0 112.152 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.01 -12.5 1.46 Allowed 'General case' 0 C--N 1.34 0.181 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.97 147.04 34.52 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.06 135.83 49.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 109.989 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 128.74 54.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.066 3.346 . . . . 0.0 104.545 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.0 mt -93.48 124.86 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.78 116.04 33.88 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.056 1.298 . . . . 0.0 108.201 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.91 -20.35 17.17 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.959 1.773 . . . . 0.0 111.605 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -88.39 -30.68 19.32 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.58 -38.6 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.41 171.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.43 146.28 51.86 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.528 0.604 . . . . 0.0 111.352 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.1 pt -120.79 37.9 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.264 1.426 . . . . 0.0 111.098 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.88 42.44 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.724 1.61 . . . . 0.0 111.752 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 161.51 28.92 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.889 -0.507 . . . . 0.0 111.483 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.6 61.19 3.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.98 156.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.257 1.5 p 78.35 -55.68 0.48 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.855 2.462 . . . . 0.0 109.953 -169.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -59.26 0.88 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.859 1.664 . . . . 0.0 113.827 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.64 -10.16 57.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.958 . . . . 0.0 112.494 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.08 -37.26 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.64 0.655 . . . . 0.0 109.447 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.95 114.91 9.51 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.21 -7.64 17.96 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.445 2.097 . . . . 0.0 112.616 -174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.33 -20.47 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.536 1.534 . . . . 0.0 109.865 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m 54.35 51.98 13.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 111.318 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.64 34.76 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.8 mt -64.69 120.88 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -130.64 164.25 25.4 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -65.87 150.08 49.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.99 -43.89 60.78 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -66.05 -29.89 70.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.282 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -82.56 -37.09 25.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.282 0.633 . . . . 0.0 109.887 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -50.89 128.96 28.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.371 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.57 148.15 45.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.17 2.58 . . . . 0.0 113.471 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -45.71 -44.61 13.71 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 129.164 2.986 . . . . 0.0 112.881 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -48.43 -44.45 35.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 111.003 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -97.06 -0.27 47.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.104 1.361 . . . . 0.0 112.441 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -55.42 -29.7 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.777 1.171 . . . . 0.0 108.906 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.19 -44.97 11.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.44 1.096 . . . . 0.0 111.557 169.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -66.39 -34.74 78.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.801 -1.095 . . . . 0.0 111.667 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.12 -43.99 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 120.712 1.596 . . . . 0.0 107.133 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -51.43 69.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -59.19 -42.11 90.09 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.128 -0.982 . . . . 0.0 112.231 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -60.45 -44.16 96.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.138 1.775 . . . . 0.0 110.649 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.05 -55.92 27.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.188 0.995 . . . . 0.0 109.178 174.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.11 -42.02 94.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 129.111 2.964 . . . . 0.0 114.043 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.95 -53.81 0.76 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.705 1.202 . . . . 0.0 112.984 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.2 4.3 31.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.008 0.923 . . . . 0.0 111.497 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 79.85 1.25 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 CA-C-O 116.064 -1.922 . . . . 0.0 107.463 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -103.73 143.06 33.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.279 1.032 . . . . 0.0 110.043 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.36 138.15 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.205 1.002 . . . . 0.0 110.814 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.34 151.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.935 1.694 . . . . 0.0 109.833 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.2 p -138.81 160.17 40.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.923 -0.486 . . . . 0.0 110.574 172.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.331 4.9 tt0 -1.28 -64.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 130.192 3.397 . . . . 0.0 117.418 172.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 52.3 Cg_exo -54.63 -25.42 41.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 122.864 2.059 . . . . 0.0 114.844 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 -35.83 68.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.795 0.838 . . . . 0.0 112.261 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.434 HG13 ' HG2' ' A' ' 31' ' ' GLN 0.273 3.5 mp -70.31 89.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.747 0.784 . . . . 0.0 112.205 -168.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.4 47.44 0.71 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.621 1.581 . . . . 0.0 110.986 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.363 0.9 OUTLIER 51.56 118.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.472 2.709 . . . . 0.0 118.075 174.082 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? 68.09 -63.33 0.33 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.476 2.71 . . . . 0.0 112.588 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t 64.11 -66.3 0.12 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.158 1.783 . . . . 0.0 112.966 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.07 47.79 11.52 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 112.406 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.0 m -110.92 -56.37 2.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.303 0.641 . . . . 0.0 110.703 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -72.95 75.33 1.18 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.993 0.901 . . . . 0.0 109.263 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 m -115.56 -140.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 110.116 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -67.73 17.79 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.65 -28.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -62.41 127.98 90.68 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.52 -34.3 71.85 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.482 3.454 . . . . 0.0 114.637 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.56 24.44 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 122.576 0.351 . . . . 0.0 111.449 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 62.94 -176.28 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.192 0.597 . . . . 0.0 109.454 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.2 p 122.18 -5.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.976 3.71 . . . . 0.0 111.923 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -91.2 110.84 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.556 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.37 141.81 50.97 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 109.877 -170.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.98 113.71 9.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 120.175 1.352 . . . . 0.0 109.823 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.34 64.58 3.76 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 170.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 65.5 -59.11 0.29 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 129.811 3.245 . . . . 0.0 111.163 -172.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.48 -54.29 4.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.535 0.734 . . . . 0.0 112.072 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.434 ' HG2' HG13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -141.8 166.49 24.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.588 1.155 . . . . 0.0 110.215 -169.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.82 133.39 50.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.645 0.736 . . . . 0.0 110.695 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 131.19 53.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 131.002 3.721 . . . . 0.0 104.586 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 25' ' ' ILE . 67.1 mt -99.5 128.41 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.445 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.4 t0 -74.66 111.85 14.93 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 120.037 1.29 . . . . 0.0 107.697 168.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.72 -29.61 69.01 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.563 1.509 . . . . 0.0 111.041 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.27 -24.38 40.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.71 -0.619 . . . . 0.0 110.22 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.06 -35.7 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.5 0.591 . . . . 0.0 110.74 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.2 t -54.71 129.88 38.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.03 0.832 . . . . 0.0 110.743 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.02 35.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 111.378 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.55 37.64 9.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.166 1.787 . . . . 0.0 113.082 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -23.79 46.14 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.55 -141.73 21.39 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.357 0.98 . . . . 0.0 111.772 -169.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.48 -65.01 0.36 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.919 2.088 . . . . 0.0 113.026 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -46.87 -42.37 17.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.61 1.164 . . . . 0.0 109.803 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -40.88 -44.62 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.188 2.195 . . . . 0.0 114.426 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 -28.17 16.63 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 110.19 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -63.42 -38.49 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 119.068 -0.492 . . . . 0.0 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -61.23 113.0 6.76 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.47 29.68 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.448 2.766 . . . . 0.0 112.74 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.15 -29.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 129.42 3.088 . . . . 0.0 108.056 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m 55.54 57.93 4.95 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.503 1.121 . . . . 0.0 110.759 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.51 57.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.819 1.248 . . . . 0.0 110.745 170.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mt -80.85 124.79 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -128.31 167.57 16.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.39 146.24 54.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.46 -36.47 69.11 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.424 1.107 . . . . 0.0 112.882 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.64 -44.14 76.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.132 171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -78.32 -34.65 48.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.329 1.452 . . . . 0.0 112.022 -168.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 68' ' ' ILE . 40.3 t -50.0 124.31 16.8 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.508 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 143.66 67.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.989 2.459 . . . . 0.0 112.114 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -42.77 -46.89 5.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 128.867 2.867 . . . . 0.0 112.462 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -46.38 -45.14 17.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.14 0.976 . . . . 0.0 110.878 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -97.96 0.49 46.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.702 1.601 . . . . 0.0 112.411 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 68' ' ' ILE . 40.9 mttp -61.3 -19.21 61.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.23 1.377 . . . . 0.0 110.781 170.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -54.07 -42.75 69.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.098 0.959 . . . . 0.0 110.167 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -64.83 -36.62 84.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.064 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 60' ' ' VAL . 11.0 mt -60.36 -44.76 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 120.756 1.616 . . . . 0.0 109.047 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -54.13 -48.22 71.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.427 173.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -61.47 -45.06 95.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.465 0.575 . . . . 0.0 112.064 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -58.89 -43.55 91.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.581 1.152 . . . . 0.0 110.904 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -58.13 -60.46 3.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.893 1.277 . . . . 0.0 107.655 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.14 -51.05 63.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.569 2.748 . . . . 0.0 112.942 -171.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -32.68 -49.6 0.23 Allowed 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 126.581 1.952 . . . . 0.0 113.472 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -114.08 -0.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.804 0.69 . . . . 0.0 111.768 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.11 -34.31 43.56 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.184 0.902 . . . . 0.0 110.873 -174.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.385 0 CA-C-O 115.684 -2.103 . . . . 0.0 106.35 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -97.46 138.91 34.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.401 0.68 . . . . 0.0 109.177 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.42 140.79 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.751 0.786 . . . . 0.0 111.097 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -75.93 152.56 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.686 3.194 . . . . 0.0 111.054 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -146.47 166.71 25.6 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.713 0.405 . . . . 0.0 111.27 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.272 58.4 tt0 -16.2 -60.05 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 129.002 2.921 . . . . 0.0 116.147 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.07 -18.03 41.3 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 121.691 1.64 . . . . 0.0 115.12 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 t -62.36 -40.62 97.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.771 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.86 118.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.024 0.375 . . . . 0.0 110.354 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.42 76.3 0.06 OUTLIER Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.315 3.1 t 64.39 -49.36 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.286 2.634 . . . . 0.0 116.181 170.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 -60.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.981 1.264 . . . . 0.0 111.102 176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.6 -71.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.522 1.929 . . . . 0.0 114.965 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.18 -123.25 0.49 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 109.337 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m 72.29 -55.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.957 2.103 . . . . 0.0 112.783 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.13 -47.98 82.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.389 1.076 . . . . 0.0 110.634 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.79 -41.61 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 O-C-N 121.434 -0.791 . . . . 0.0 112.418 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -68.19 -7.31 29.13 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.63 -22.95 3.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 120.02 1.282 . . . . 0.0 113.665 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -61.87 128.93 91.24 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.45 1.023 . . . . 0.0 110.973 -172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.29 -41.62 13.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 1 C-N-CA 125.327 4.018 . . . . 0.0 114.312 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.18 57.71 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.905 0.882 . . . . 0.0 109.769 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -4.23 104.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.939 2.096 . . . . 0.0 114.689 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -132.14 29.77 4.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.305 171.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.552 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -110.51 113.79 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 -169.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -136.76 140.59 42.68 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -165.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -68.13 160.69 28.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.522 -1.361 . . . . 0.0 112.767 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.63 -52.99 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -112.92 -63.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.586 1.554 . . . . 0.0 109.712 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.8 -54.49 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 109.007 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 145.25 56.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.516 2.327 . . . . 0.0 111.008 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HB3' HG22 ' A' ' 25' ' ' ILE . 69.4 m-85 -86.2 102.69 14.14 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 111.746 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -54.41 110.5 0.63 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.839 2.856 . . . . 0.0 108.505 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -82.97 115.27 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.417 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 9.6 t0 -62.83 117.22 30.08 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.686 1.13 . . . . 0.0 108.544 171.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.88 -24.82 20.66 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 121.493 1.462 . . . . 0.0 112.085 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -36.51 34.18 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.68 -32.02 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.309 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.2 t -59.64 124.22 19.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.215 0.916 . . . . 0.0 110.539 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.91 36.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.998 0.919 . . . . 0.0 111.706 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 39.1 61.9 1.2 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.086 1.755 . . . . 0.0 112.609 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.92 -163.19 1.02 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.862 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 101.87 0.41 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.74 -65.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.06 1.344 . . . . 0.0 110.786 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.1 p -60.37 -52.41 65.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.495 0.718 . . . . 0.0 111.262 -172.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -54.8 24.11 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.757 0.823 . . . . 0.0 111.306 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.98 66.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.02 0.528 . . . . 0.0 112.003 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -41.31 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.349 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.0 t -58.35 111.7 3.93 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.001 0.819 . . . . 0.0 108.877 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.1 22.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.439 2.759 . . . . 0.0 113.038 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -135.09 -28.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 129.871 3.268 . . . . 0.0 107.616 -177.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 54.35 59.53 4.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.623 1.169 . . . . 0.0 110.39 -172.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.14 44.94 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.349 1.06 . . . . 0.0 110.214 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.1 mt -77.67 125.51 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -131.94 171.32 13.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.87 147.18 50.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.141 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -49.11 -41.72 36.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.14 -40.28 89.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.452 0.701 . . . . 0.0 111.461 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -78.79 -34.91 45.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.177 0.991 . . . . 0.0 110.855 -168.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.87 123.99 26.68 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.389 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.76 144.69 53.22 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.066 2.511 . . . . 0.0 112.119 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -41.8 -46.51 3.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.78 2.832 . . . . 0.0 112.497 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -46.89 -46.02 20.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.194 0.997 . . . . 0.0 110.995 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -96.35 -3.02 44.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.713 1.605 . . . . 0.0 112.359 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -61.11 -17.74 54.26 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.478 1.49 . . . . 0.0 110.23 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -51.63 -44.74 63.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.851 0.86 . . . . 0.0 109.189 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -64.79 -32.62 74.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.665 -1.159 . . . . 0.0 111.817 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.72 -47.25 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 121.127 1.785 . . . . 0.0 107.917 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -52.72 -53.99 39.97 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -43.05 99.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.547 0.213 . . . . 0.0 111.082 -171.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.05 -39.17 85.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 111.545 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -51.24 63.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.061 0.934 . . . . 0.0 109.348 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 61.2 t0 -68.86 -47.97 64.63 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.283 2.633 . . . . 0.0 112.54 -169.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -31.11 -56.27 0.23 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.991 1.716 . . . . 0.0 113.053 -175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -98.97 -3.42 35.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.978 0.911 . . . . 0.0 112.543 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 10.8 mptt -104.02 78.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.063 0.945 . . . . 0.0 109.749 -172.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 127.769 2.427 . . . . 0.0 105.872 168.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -112.27 156.34 22.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.893 0.77 . . . . 0.0 110.625 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 68' ' ' ILE . 11.1 t -132.26 143.43 40.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.846 1.658 . . . . 0.0 109.167 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.19 135.6 25.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.561 1.144 . . . . 0.0 108.666 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 p -127.88 170.78 12.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.222 1.009 . . . . 0.0 111.08 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -14.09 -56.85 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 129.628 3.171 . . . . 0.0 116.553 172.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.49 -21.33 61.18 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 122.25 1.839 . . . . 0.0 114.147 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.53 -27.04 68.69 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.84 0.745 . . . . 0.0 112.094 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 9' ' ' ILE . 81.5 mt -67.02 79.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.811 0.844 . . . . 0.0 110.969 -170.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.67 0.79 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.236 1.874 . . . . 0.0 108.571 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.331 14.6 t 46.83 88.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.326 2.251 . . . . 0.0 114.603 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 73.8 -61.2 0.5 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.703 2.001 . . . . 0.0 114.347 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 t 61.61 -68.6 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 0.0 113.217 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.01 35.01 8.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.399 1.879 . . . . 0.0 114.455 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -106.06 14.69 27.46 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -121.92 54.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.3 -45.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.407 -0.808 . . . . 0.0 111.104 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.5 pm0 -74.84 10.5 1.4 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.183 2.193 . . . . 0.0 114.001 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.64 -24.79 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -70.6 124.53 91.06 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 119.595 1.089 . . . . 0.0 111.198 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.24 -26.76 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.804 3.003 . . . . 0.0 113.161 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.98 38.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.396 0.679 . . . . 0.0 110.004 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 29.97 42.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.079 2.551 . . . . 0.0 116.361 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.1 p -92.18 36.02 0.99 Allowed 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.092 -1.005 . . . . 0.0 110.746 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 120.32 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 126.313 1.845 . . . . 0.0 108.062 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -137.12 171.06 15.06 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.039 1.335 . . . . 0.0 109.607 -169.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.18 172.01 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 119.387 0.994 . . . . 0.0 110.217 168.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.49 -53.9 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.259 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -139.64 58.38 1.61 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.355 0.662 . . . . 0.0 109.27 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 45.76 37.36 3.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.172 1.789 . . . . 0.0 112.578 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 154.25 38.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 172.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -76.41 163.21 27.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.669 0.606 . . . . 0.0 110.707 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.45 110.37 5.63 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 106.057 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.11 132.23 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.81 112.95 22.62 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 167.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.06 -28.97 48.82 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.826 1.684 . . . . 0.0 110.672 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.03 -27.93 29.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.784 0.834 . . . . 0.0 109.804 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.2 t -85.5 -32.27 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.836 0.743 . . . . 0.0 111.122 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.4 t -56.13 130.43 44.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.09 0.859 . . . . 0.0 111.152 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 pt -102.44 35.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.3 1.04 . . . . 0.0 111.184 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 50.65 32.19 6.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.24 1.816 . . . . 0.0 114.636 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -23.08 62.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.13 -132.53 11.27 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -168.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.83 -68.25 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.749 1.62 . . . . 0.0 113.098 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -48.84 -49.99 36.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.324 1.05 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -48.47 -56.2 8.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.255 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.0 68.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.16 0.584 . . . . 0.0 112.465 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.98 -7.73 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.982 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -82.79 111.29 28.38 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.51 41.64 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.237 2.624 . . . . 0.0 111.727 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.7 -27.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 128.346 2.658 . . . . 0.0 109.2 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 55.65 60.18 3.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.847 0.859 . . . . 0.0 110.025 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.55 -25.07 41.75 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.25 1.02 . . . . 0.0 110.169 170.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.9 mt -72.7 117.47 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -127.81 165.16 20.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.29 150.19 40.33 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -54.67 -40.44 69.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.677 -0.64 . . . . 0.0 112.69 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.98 -24.17 63.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.426 -0.796 . . . . 0.0 111.032 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.88 -45.32 43.66 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.915 0.325 . . . . 0.0 110.167 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' HD11 ' A' ' 68' ' ' ILE . 68.0 t -52.69 123.75 32.14 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.792 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.85 149.32 61.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.924 2.416 . . . . 0.0 112.606 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -42.66 -46.25 4.97 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 129.698 3.199 . . . . 0.0 112.258 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.54 -40.44 12.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.11 0.964 . . . . 0.0 111.767 172.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -106.08 7.77 31.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.857 1.663 . . . . 0.0 112.482 -176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.7 mptt -57.89 -27.37 63.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.403 1.001 . . . . 0.0 110.038 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -49.28 -44.53 44.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.165 1.386 . . . . 0.0 111.051 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -67.98 -33.02 73.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.68 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.624 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.6 mt -60.99 -48.18 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 120.803 1.638 . . . . 0.0 108.124 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -53.29 -50.52 64.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -62.8 -43.27 99.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 0.541 . . . . 0.0 111.968 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -58.69 -44.18 90.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.039 1.335 . . . . 0.0 110.763 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -55.55 33.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.163 0.985 . . . . 0.0 109.041 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.68 -45.7 93.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.982 2.513 . . . . 0.0 112.402 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.05 -50.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 113.463 -171.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.2 4.66 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.282 1.033 . . . . 0.0 111.983 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 73.41 0.88 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.685 1.194 . . . . 0.0 109.135 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.142 0 C-N-CA 127.63 2.372 . . . . 0.0 105.916 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 118.351 -0.833 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -105.23 153.86 21.01 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.641 0.655 . . . . 0.0 110.17 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 t -138.13 145.83 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.746 0.818 . . . . 0.0 110.764 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 4' ' ' ILE . 2.4 pp -60.81 165.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.237 1.815 . . . . 0.0 111.536 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 p -151.93 168.67 24.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.994 0.918 . . . . 0.0 109.094 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -8.52 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 128.506 2.722 . . . . 0.0 116.336 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 -21.39 71.91 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 121.487 1.567 . . . . 0.0 113.541 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.18 -30.34 71.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.756 0.822 . . . . 0.0 112.177 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.21 90.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.598 0.713 . . . . 0.0 110.385 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.11 60.8 0.67 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.941 1.734 . . . . 0.0 109.92 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t 39.56 73.03 0.12 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.158 1.783 . . . . 0.0 114.307 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 68.94 48.5 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.57 1.148 . . . . 0.0 113.053 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.19 152.42 40.8 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.75 40.12 0.89 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.795 0.725 . . . . 0.0 112.125 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 m -83.89 -37.35 22.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 112.205 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 p -70.04 -13.73 62.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.272 1.429 . . . . 0.0 113.215 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.26 153.85 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 112.431 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 75.86 -40.29 0.4 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.834 2.053 . . . . 0.0 113.038 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.65 -29.11 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.705 -0.622 . . . . 0.0 110.156 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.0 t -65.63 126.58 91.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.949 0.5 . . . . 0.0 110.103 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -39.72 -37.44 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 126.377 4.718 . . . . 0.0 115.407 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.0 m -126.54 21.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.822 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t70 33.2 51.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.702 2.001 . . . . 0.0 113.668 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.5 p -94.57 42.34 1.09 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.298 1.039 . . . . 0.0 110.922 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 132.32 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -133.51 142.13 48.08 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -167.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -83.52 125.15 31.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.309 -0.87 . . . . 0.0 111.627 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.82 -55.07 2.48 Favored Glycine 0 CA--C 1.525 0.69 1 N-CA-C 103.047 -4.021 . . . . 0.0 103.047 166.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -60.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.195 2.198 . . . . 0.0 106.614 168.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.4 -29.17 69.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.266 1.826 . . . . 0.0 114.787 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.18 177.5 11.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.343 0.657 . . . . 0.0 109.476 -168.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.87 116.03 28.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.233 1.013 . . . . 0.0 108.699 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -94.88 119.62 33.74 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 130.441 3.497 . . . . 0.0 109.388 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 54' ' ' ILE . 76.7 mt -81.33 130.13 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 118.878 0.763 . . . . 0.0 109.839 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.39 111.64 18.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.01 -30.98 92.86 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-N 120.98 1.386 . . . . 0.0 111.273 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -79.1 -23.63 43.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -92.1 -32.84 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.276 0.489 . . . . 0.0 110.978 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.56 123.56 16.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.979 0.809 . . . . 0.0 111.45 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.8 pt -89.46 21.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 50.75 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.37 2.268 . . . . 0.0 113.089 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.0 148.41 31.67 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.944 -0.472 . . . . 0.0 110.951 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.72 51.75 4.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.191 -0.943 . . . . 0.0 113.08 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.67 -76.99 0.59 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.363 1.082 . . . . 0.0 111.633 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -47.96 -48.8 31.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.598 1.159 . . . . 0.0 112.497 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.5 -46.55 83.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.171 0.896 . . . . 0.0 111.562 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.14 74.86 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.486 -0.759 . . . . 0.0 110.538 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -74.81 -38.26 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.094 0.557 . . . . 0.0 111.45 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.4 t -64.27 112.41 7.59 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.227 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.48 20.88 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.207 2.604 . . . . 0.0 113.087 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.39 -30.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.103 1.761 . . . . 0.0 109.354 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 t 62.27 81.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 0.0 109.894 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.32 -9.92 0.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' ILE . 77.7 mt -79.82 92.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -109.36 164.57 12.36 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.1 0.96 . . . . 0.0 108.894 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -62.5 146.94 50.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.855 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -40.96 64.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.113 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -73.35 -38.91 65.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -53.76 124.53 43.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.667 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 144.95 52.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.103 2.535 . . . . 0.0 112.191 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -41.49 -47.36 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 128.933 2.893 . . . . 0.0 112.676 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.59 -44.41 26.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.049 0.94 . . . . 0.0 111.063 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -96.71 -6.73 35.73 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.173 1.389 . . . . 0.0 112.424 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -57.99 -22.38 49.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.562 1.528 . . . . 0.0 110.231 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.01 -43.08 40.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.701 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -64.35 -35.06 79.63 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.6 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.35 -46.12 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -56.91 -46.58 81.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.115 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -46.42 90.62 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.427 -0.796 . . . . 0.0 111.631 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -61.59 -40.0 93.22 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.051 0.94 . . . . 0.0 111.357 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -57.22 -61.86 2.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 4.0 t70 -52.96 -50.42 64.13 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 128.122 2.569 . . . . 0.0 112.529 -170.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -37.46 -46.35 0.8 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 125.57 1.548 . . . . 0.0 113.432 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -111.39 -3.21 15.33 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.789 0.681 . . . . 0.0 111.447 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -36.67 25.05 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.939 0.791 . . . . 0.0 110.31 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -100.8 147.58 25.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.413 0.685 . . . . 0.0 111.128 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.64 142.29 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.845 1.258 . . . . 0.0 110.708 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.88 168.57 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 125.772 1.629 . . . . 0.0 110.904 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 p -145.02 171.65 14.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -9.82 -61.22 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 128.661 2.785 . . . . 0.0 116.164 169.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.5 Cg_exo -62.59 -15.42 45.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 121.991 1.747 . . . . 0.0 113.635 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HA ' ' S1 ' ' A' ' 78' ' ' SF4 . 15.2 t -70.37 -26.09 63.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.851 0.86 . . . . 0.0 112.742 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.15 115.95 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.95 130.31 1.34 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -169.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -60.06 119.57 8.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.957 0.503 . . . . 0.0 112.026 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 36.22 50.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.492 1.917 . . . . 0.0 113.376 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.24 -50.85 72.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.673 0.789 . . . . 0.0 112.616 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.95 -136.01 0.86 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.918 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m 62.7 45.34 5.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.856 1.263 . . . . 0.0 111.878 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 p -176.51 -28.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.162 2.985 . . . . 0.0 109.138 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.75 -44.87 51.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.22 1.008 . . . . 0.0 110.469 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.6 pm0 -67.34 0.3 3.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.399 1.88 . . . . 0.0 114.175 -169.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.03 -16.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.277 1.031 . . . . 0.0 113.136 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -75.36 126.15 88.05 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 119.751 1.16 . . . . 0.0 111.624 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -62.11 141.24 87.88 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.565 2.177 . . . . 0.0 109.227 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.287 11.6 m 45.17 37.09 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 114.217 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 35.92 49.1 0.56 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.335 2.654 . . . . 0.0 114.17 168.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -85.89 30.14 0.68 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.058 -1.027 . . . . 0.0 112.643 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.44 142.13 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -141.55 156.8 45.69 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.086 1.354 . . . . 0.0 107.849 -170.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -91.53 134.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 118.888 0.767 . . . . 0.0 111.254 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.54 -46.96 7.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 104.987 -3.245 . . . . 0.0 104.987 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -175.56 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.245 2.618 . . . . 0.0 104.284 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -98.21 54.1 1.09 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.901 1.81 . . . . 0.0 108.94 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -177.71 137.37 0.2 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 -169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -102.37 168.41 9.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.889 0.743 . . . . 0.0 109.663 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -146.44 119.82 9.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.192 1.797 . . . . 0.0 107.797 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 57.3 mt -90.38 130.76 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -73.33 114.64 33.38 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -30.85 52.42 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.619 0.879 . . . . 0.0 111.1 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -83.07 -28.43 29.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.279 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.52 -27.63 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.397 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -59.45 120.99 10.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.497 1.044 . . . . 0.0 110.945 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 pt -96.14 34.03 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 46.17 42.31 9.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.574 1.549 . . . . 0.0 113.282 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -23.21 60.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.244 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.75 -138.94 20.9 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.531 1.062 . . . . 0.0 110.934 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.17 -67.51 0.25 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.689 1.596 . . . . 0.0 111.95 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 p -47.98 -50.64 26.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.888 1.275 . . . . 0.0 110.412 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -43.92 -41.25 5.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.714 2.005 . . . . 0.0 113.815 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.47 -34.87 21.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.162 0.985 . . . . 0.0 110.064 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -79.18 -25.57 12.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.94 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' S4 ' ' A' ' 78' ' ' SF4 . 12.2 t -59.84 111.97 4.67 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.413 1.006 . . . . 0.0 108.49 171.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.12 49.53 3.26 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.857 3.038 . . . . 0.0 110.117 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -169.35 -35.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 128.232 2.613 . . . . 0.0 107.74 -168.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 58.0 58.14 3.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 110.045 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.75 -17.57 50.54 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.665 1.186 . . . . 0.0 110.873 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -77.66 125.42 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.48 170.47 15.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 6.7 t-80 -65.62 146.35 54.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -48.69 -44.12 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.174 0.512 . . . . 0.0 112.058 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.32 -40.22 77.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.177 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -78.96 -34.13 44.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 111.56 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.96 126.55 59.89 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.95 145.5 62.45 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.118 2.545 . . . . 0.0 112.469 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.416 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.6 mp0 -40.91 -45.69 2.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.62 3.168 . . . . 0.0 113.811 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.45 -44.68 12.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.914 0.864 . . . . 0.0 111.093 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -101.26 0.06 36.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.475 1.91 . . . . 0.0 112.945 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 28.3 mmtm -59.27 -21.42 59.61 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.593 1.542 . . . . 0.0 109.456 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 p -50.46 -49.03 56.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.713 1.205 . . . . 0.0 109.896 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -61.91 -35.91 79.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.053 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.45 -50.65 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -54.29 -41.69 69.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.623 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -66.84 -45.58 77.77 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.2 -42.16 94.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.276 1.43 . . . . 0.0 110.587 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -55.76 29.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.84 -48.97 69.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.738 2.815 . . . . 0.0 113.987 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -31.66 -48.92 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.09 1.756 . . . . 0.0 114.942 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -117.12 1.72 12.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.746 0.818 . . . . 0.0 111.985 -170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -40.21 13.24 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.822 0.737 . . . . 0.0 110.814 -169.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.567 2.347 . . . . 0.0 104.682 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . 0.448 ' S1 ' ' HA ' ' A' ' 8' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.57 150.21 31.67 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.477 0.581 . . . . 0.0 110.612 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.2 140.01 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.287 0.635 . . . . 0.0 111.661 -174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.04 144.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 125.331 1.452 . . . . 0.0 109.93 172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 p -133.65 168.4 18.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 110.332 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -15.49 -57.65 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 129.107 2.963 . . . . 0.0 116.484 173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.26 -21.32 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 CA-C-N 121.774 1.669 . . . . 0.0 114.325 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.7 -32.65 72.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.733 0.697 . . . . 0.0 112.246 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -65.34 86.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.982 0.896 . . . . 0.0 109.943 -172.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 53.11 0.57 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 127.191 2.329 . . . . 0.0 108.256 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.298 12.2 t 53.28 -153.61 0.25 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.624 1.97 . . . . 0.0 113.939 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -73.77 66.96 1.14 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.324 1.45 . . . . 0.0 112.276 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.27 -57.54 8.57 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.722 1.609 . . . . 0.0 111.083 170.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.55 43.93 16.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.476 1.51 . . . . 0.0 112.924 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -98.54 -42.11 7.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.355 0.662 . . . . 0.0 111.564 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -74.28 67.96 1.45 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.006 0.908 . . . . 0.0 108.696 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.43 163.6 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.938 2.095 . . . . 0.0 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 40.93 39.24 0.79 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.627 1.971 . . . . 0.0 114.403 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.61 -39.74 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.423 1.089 . . . . 0.0 111.217 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -65.58 124.98 88.8 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 121.922 -0.486 . . . . 0.0 110.934 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.73 -42.78 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.624 1 C-N-CA 126.012 4.475 . . . . 0.0 115.533 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.5 27.77 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.415 0.686 . . . . 0.0 111.411 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 58.99 -173.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p 124.28 -2.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 130.702 3.601 . . . . 0.0 111.985 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -89.22 115.57 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.708 0.803 . . . . 0.0 109.149 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -134.52 172.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.528 1.531 . . . . 0.0 108.815 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -114.72 177.52 4.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.689 0.757 . . . . 0.0 109.673 168.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.8 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 124.608 1.099 . . . . 0.0 110.692 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -128.94 -94.78 0.42 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.3 58.25 1.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.411 1.101 . . . . 0.0 108.95 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -175.22 2.78 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 128.685 2.794 . . . . 0.0 105.786 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -111.56 159.09 18.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.286 0.494 . . . . 0.0 110.947 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.12 130.86 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.724 2.81 . . . . 0.0 104.444 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -106.06 126.39 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -66.95 114.6 18.73 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 118.022 -1.471 . . . . 0.0 107.516 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.32 -28.46 22.54 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.854 1.703 . . . . 0.0 110.0 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -81.26 -28.77 34.61 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.08 -38.45 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.875 0.761 . . . . 0.0 111.27 169.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.8 t -55.13 124.94 18.52 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 111.838 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 pt -95.23 37.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.111 0.964 . . . . 0.0 111.617 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 38.57 60.33 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.182 2.193 . . . . 0.0 113.691 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 -20.98 16.32 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.1 -132.34 11.4 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.89 -70.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.458 1.503 . . . . 0.0 112.042 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.6 p -48.73 -47.3 41.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.711 1.205 . . . . 0.0 111.197 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.66 -42.64 79.33 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.653 -0.654 . . . . 0.0 111.755 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.74 75.83 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.499 -0.751 . . . . 0.0 110.337 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.72 -40.84 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.596 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -59.55 112.15 4.84 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 119.072 0.851 . . . . 0.0 109.464 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.67 11.66 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.909 2.406 . . . . 0.0 112.862 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -117.14 -26.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 127.679 2.392 . . . . 0.0 108.843 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m 54.39 76.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.483 1.513 . . . . 0.0 111.18 -169.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 6.58 5.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.154 1.382 . . . . 0.0 112.719 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.43 80.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -95.99 162.84 13.39 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -59.35 149.14 29.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.947 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -50.39 -42.42 53.46 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -80.82 -21.59 40.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 119.279 -0.969 . . . . 0.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -71.48 -33.3 69.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -58.36 126.75 79.66 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 119.252 -0.404 . . . . 0.0 109.911 171.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.73 153.17 57.94 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.656 2.904 . . . . 0.0 113.156 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -45.61 -45.12 13.63 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 129.968 3.307 . . . . 0.0 112.747 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -48.79 -46.2 41.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.894 0.878 . . . . 0.0 110.889 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -97.06 -1.19 45.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 0.0 112.525 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -54.46 -27.98 41.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.565 1.075 . . . . 0.0 109.324 169.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -45.86 -46.95 16.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.626 1.17 . . . . 0.0 110.8 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -64.25 -34.36 77.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.766 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.35 -47.55 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 120.698 1.59 . . . . 0.0 107.183 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -57.63 -44.07 85.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -60.56 -51.15 70.63 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 118.682 0.674 . . . . 0.0 111.211 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -56.36 -38.93 72.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.382 1.073 . . . . 0.0 110.733 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -63.28 -58.68 6.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.53 1.132 . . . . 0.0 109.859 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.85 -47.15 87.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.658 2.383 . . . . 0.0 112.936 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.65 -46.32 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.093 1.357 . . . . 0.0 113.954 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.77 3.24 24.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.666 0.786 . . . . 0.0 112.193 -171.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 -60.08 1.93 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.507 1.523 . . . . 0.0 107.913 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.643 3.177 . . . . 0.0 112.738 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.209 0.052 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -92.24 136.04 33.52 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.63 142.05 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.473 0.709 . . . . 0.0 110.776 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -65.64 158.26 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 126.728 2.011 . . . . 0.0 110.656 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.7 p -144.9 156.26 43.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.33 0.514 . . . . 0.0 111.687 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.351 3.7 tt0 6.87 -72.05 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 130.108 3.363 . . . . 0.0 117.58 169.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 34.3 Cg_exo -52.95 -26.17 30.62 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.693 1.998 . . . . 0.0 114.905 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -58.46 -36.39 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.699 0.8 . . . . 0.0 112.058 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.07 144.23 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.069 0.462 . . . . 0.0 111.06 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.38 37.87 2.75 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 125.465 1.507 . . . . 0.0 111.315 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -166.87 129.11 1.74 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -70.89 88.01 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.87 167.9 20.52 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.841 0.856 . . . . 0.0 110.939 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.03 71.69 0.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.843 1.657 . . . . 0.0 107.12 173.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.3 m -141.99 -59.0 0.47 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.743 -0.598 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.43 72.63 0.98 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.076 0.941 . . . . 0.0 108.962 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.3 152.56 15.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 108.72 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 62.97 -12.77 0.08 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.28 -24.45 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 120.822 -1.174 . . . . 0.0 110.884 -170.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.71 126.48 92.65 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 122.775 0.43 . . . . 0.0 110.619 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.32 -43.89 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 126.485 4.79 . . . . 0.0 115.975 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.34 7.1 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.868 0.867 . . . . 0.0 112.146 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.2 t0 65.87 149.87 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 111.539 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.9 m -163.06 -102.09 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.509 1.923 . . . . 0.0 106.209 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.255 2.2 pp 13.78 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.785 3.234 . . . . 0.0 116.474 169.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -103.4 138.7 39.79 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.487 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 32.6 mt-10 -76.57 131.84 39.16 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 120.775 -1.203 . . . . 0.0 112.661 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.84 8.63 Favored Glycine 0 CA--C 1.532 1.099 1 N-CA-C 102.886 -4.085 . . . . 0.0 102.886 165.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.44 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.236 3.014 . . . . 0.0 104.286 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.15 -35.88 74.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.661 -0.649 . . . . 0.0 111.584 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.68 146.87 46.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.227 1.411 . . . . 0.0 110.411 -169.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 27' ' ' GLU . 96.9 m-85 -80.44 150.95 29.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.94 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -119.68 114.55 22.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 129.808 3.243 . . . . 0.0 105.554 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -83.95 116.88 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.9 109.07 1.27 Allowed Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 126.868 2.067 . . . . 0.0 111.659 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -67.78 -26.98 38.2 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.039 1.16 . . . . 0.0 111.685 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.15 -41.87 85.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.798 0.839 . . . . 0.0 109.852 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -92.94 -38.31 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.663 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.12 120.01 7.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.107 0.867 . . . . 0.0 111.278 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 pt -89.87 35.58 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.155 0.982 . . . . 0.0 111.572 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.52 60.05 3.04 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.36 1.464 . . . . 0.0 112.905 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.13 -164.75 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.065 0.946 . . . . 0.0 109.03 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.42 -112.15 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 168.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.72 -67.29 0.14 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 126.292 1.837 . . . . 0.0 112.665 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.5 p -62.17 -49.06 77.34 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 137.21 58.22 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 168.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 84.47 -22.24 0.22 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.015 2.526 . . . . 0.0 111.873 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.7 -34.22 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.89 116.76 26.53 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.15 26.78 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.41 2.74 . . . . 0.0 113.03 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.5 -27.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 128.393 2.677 . . . . 0.0 108.331 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.9 m 54.14 62.93 2.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.693 1.197 . . . . 0.0 111.288 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.1 -7.36 45.77 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.276 1.031 . . . . 0.0 111.128 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.4 mt -83.05 124.67 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -134.58 168.51 18.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -64.08 143.51 57.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.517 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.41 -40.82 51.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.33 -38.49 89.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.372 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -77.28 -31.54 54.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.043 -169.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.47 125.38 52.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.635 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.79 144.34 55.0 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.045 2.497 . . . . 0.0 112.043 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -41.91 -47.13 4.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 128.995 2.918 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -46.99 -45.36 20.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.138 0.975 . . . . 0.0 110.863 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -96.72 -4.51 40.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.752 1.621 . . . . 0.0 112.528 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -60.89 -17.2 49.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.156 1.344 . . . . 0.0 109.841 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -51.52 -42.6 61.87 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.628 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -67.82 -31.2 70.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.29 -0.881 . . . . 0.0 111.752 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.77 -45.67 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -55.85 -48.98 74.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.71 0.404 . . . . 0.0 110.032 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.59 73.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.248 0.476 . . . . 0.0 110.497 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.61 -39.61 68.06 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 124.021 0.826 . . . . 0.0 110.568 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -56.15 19.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -50.97 -43.18 60.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.868 2.067 . . . . 0.0 112.526 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -43.84 -44.71 7.03 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.756 0.66 . . . . 0.0 112.151 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -107.95 21.47 17.35 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 111.139 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -132.67 74.51 1.58 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 169.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -169.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.28 144.98 26.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.103 0.961 . . . . 0.0 110.248 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 68' ' ' ILE . 71.3 t -139.85 144.05 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.273 1.029 . . . . 0.0 111.296 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.73 142.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.489 1.515 . . . . 0.0 109.553 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 p -131.42 165.47 23.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.038 0.535 . . . . 0.0 110.237 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -12.21 -58.33 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 129.587 3.155 . . . . 0.0 116.568 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.72 -20.65 69.82 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 CA-C-N 122.115 1.791 . . . . 0.0 114.06 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -62.73 -33.3 74.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.64 0.655 . . . . 0.0 111.532 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.31 3.9 mp -70.58 95.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.965 0.888 . . . . 0.0 112.168 -168.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 151.6 23.34 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 103.784 -3.726 . . . . 0.0 103.784 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -48.07 125.14 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.393 1.877 . . . . 0.0 112.789 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 18.31 72.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.41 2.684 . . . . 0.0 116.037 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -51.01 -58.63 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.577 1.951 . . . . 0.0 112.342 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.0 42.45 32.25 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.265 1.426 . . . . 0.0 113.318 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -103.06 -51.13 3.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.257 0.623 . . . . 0.0 111.583 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 p -75.27 69.66 2.12 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.96 0.886 . . . . 0.0 109.416 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.9 156.44 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.972 1.709 . . . . 0.0 109.324 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 40.76 58.47 2.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.857 . . . . 0.0 112.79 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 p -160.39 -37.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -72.62 141.34 82.46 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -37.29 -36.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.623 4.215 . . . . 0.0 115.575 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.02 29.82 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.297 31.1 m-20 21.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.576 2.351 . . . . 0.0 114.751 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.3 p -86.17 41.58 0.94 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.235 1.014 . . . . 0.0 110.415 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 pp -109.41 126.88 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.864 1.666 . . . . 0.0 108.422 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -141.56 145.46 35.13 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 124.226 1.011 . . . . 0.0 109.991 -169.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.6 115.96 7.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.786 169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.87 -59.32 4.07 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.04 -2.424 . . . . 0.0 107.04 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -124.12 -69.24 0.82 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -128.08 -37.58 1.87 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.538 1.135 . . . . 0.0 113.18 172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.538 ' H ' ' CD ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -87.02 160.2 18.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.986 2.914 . . . . 0.0 110.551 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -76.38 124.9 28.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.613 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 159.07 16.47 Favored 'General case' 0 N--CA 1.444 -0.729 1 C-N-CA 131.835 4.054 . . . . 0.0 104.962 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -116.29 137.19 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.203 1.001 . . . . 0.0 108.369 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.24 112.4 25.54 Favored Pre-proline 0 C--N 1.341 0.222 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 167.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.94 -30.9 67.35 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.052 1.168 . . . . 0.0 110.585 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -80.44 -22.94 40.66 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.477 -0.764 . . . . 0.0 110.223 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -90.03 -29.28 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.47 0.577 . . . . 0.0 111.009 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.6 t -58.52 128.92 39.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.477 1.035 . . . . 0.0 110.568 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 pt -98.31 36.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.342 1.057 . . . . 0.0 111.473 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.6 m-20 42.8 57.32 3.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.96 1.704 . . . . 0.0 112.11 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -176.73 4.3 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.042 0.537 . . . . 0.0 111.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.13 69.16 0.23 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.96 162.39 28.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.019 1.727 . . . . 0.0 106.634 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.27 1.9 p 77.75 -54.76 0.52 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.854 2.862 . . . . 0.0 111.264 -170.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -52.89 15.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.866 0.866 . . . . 0.0 111.998 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.16 62.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.461 1.105 . . . . 0.0 112.025 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.11 -38.2 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.826 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.5 t -61.55 110.37 3.06 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.763 0.71 . . . . 0.0 109.371 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.02 -0.04 6.55 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.999 1.799 . . . . 0.0 112.653 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.19 -23.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.82 1.648 . . . . 0.0 109.837 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 t 60.46 56.97 2.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 110.888 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.95 -22.47 21.94 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.915 0.886 . . . . 0.0 111.062 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -78.68 119.11 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -128.43 167.13 17.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -68.93 144.45 54.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -51.74 -40.99 61.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.18 60.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -82.49 -34.2 28.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.922 0.783 . . . . 0.0 109.814 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.44 127.81 90.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.13 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.98 148.64 37.81 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.546 2.831 . . . . 0.0 112.571 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -51.4 -43.78 62.03 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.865 1.266 . . . . 0.0 111.492 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -41.47 -44.76 2.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.996 1.319 . . . . 0.0 111.267 172.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.41 -1.31 31.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.447 1.499 . . . . 0.0 112.586 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -61.37 -19.45 61.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.473 1.488 . . . . 0.0 110.317 169.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -51.44 -45.02 62.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.339 1.055 . . . . 0.0 109.268 167.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.57 -33.99 77.19 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.678 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.43 HD12 HG11 ' A' ' 3' ' ' VAL . 1.5 mp -63.09 -47.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 120.616 1.553 . . . . 0.0 107.691 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -52.9 -49.85 65.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.925 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -46.46 88.76 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.707 -0.62 . . . . 0.0 111.872 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -57.8 -43.06 85.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.095 1.358 . . . . 0.0 110.589 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -58.68 -60.92 3.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.11 -51.15 62.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.435 2.694 . . . . 0.0 112.001 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -48.46 0.21 Allowed 'General case' 0 C--N 1.337 0.055 0 C-N-CA 126.152 1.781 . . . . 0.0 114.139 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.57 -4.17 14.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.56 0.744 . . . . 0.0 111.296 -170.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -37.24 14.66 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.487 -1.244 . . . . 0.0 107.904 -172.074 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.542 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 119.886 -0.102 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -92.18 146.19 23.91 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.019 0.528 . . . . 0.0 110.245 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.01 143.02 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.013 . . . . 0.0 111.169 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.87 142.26 14.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 126.869 2.068 . . . . 0.0 109.052 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.3 p -133.96 166.43 22.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.059 0.544 . . . . 0.0 111.628 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.282 3.0 tt0 -8.77 -61.4 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 129.776 3.23 . . . . 0.0 116.642 172.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -58.17 -20.03 44.61 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 122.56 1.95 . . . . 0.0 114.619 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 t -61.04 -36.44 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.595 0.634 . . . . 0.0 112.523 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.267 8.6 mt -40.04 113.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.129 0.972 . . . . 0.0 112.066 -169.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.37 130.41 1.41 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -53.82 99.65 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.627 1.571 . . . . 0.0 115.107 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 46.66 56.03 7.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.381 1.873 . . . . 0.0 112.332 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -62.17 95.67 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.451 1.1 . . . . 0.0 110.463 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.41 78.21 9.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 m -128.89 -59.48 1.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.169 0.588 . . . . 0.0 110.876 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 p -74.22 66.71 1.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.79 0.805 . . . . 0.0 109.162 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -120.49 -124.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 109.936 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.6 pm0 -68.52 21.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.68 -27.2 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.158 1.383 . . . . 0.0 109.332 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -67.68 124.05 88.37 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.944 -0.473 . . . . 0.0 110.168 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.99 -45.1 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 125.285 3.99 . . . . 0.0 114.67 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.22 13.61 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.367 -170.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 65.2 t0 59.88 111.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.645 1.578 . . . . 0.0 112.241 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 78.7 m -135.57 4.1 3.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.939 172.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.53 113.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 111.409 -167.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.13 167.08 19.72 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.755 1.222 . . . . 0.0 109.325 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -106.99 177.2 4.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 168.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.38 -43.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -129.77 -97.28 0.36 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -144.08 53.8 1.29 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 123.42 1.581 . . . . 0.0 110.564 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -178.85 6.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.999 2.92 . . . . 0.0 105.022 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.39 164.16 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.56 118.48 16.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.489 2.316 . . . . 0.0 106.177 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.3 mt -90.09 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 113.76 14.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.232 1.378 . . . . 0.0 107.807 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.82 -30.83 40.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.789 1.66 . . . . 0.0 110.582 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -82.82 -28.06 30.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.772 0.829 . . . . 0.0 109.272 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 t -85.38 -31.46 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.752 0.706 . . . . 0.0 111.163 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -58.02 129.89 44.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.387 0.994 . . . . 0.0 111.327 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.7 pt -103.52 33.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.564 1.146 . . . . 0.0 111.391 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 31.2 m-20 46.0 42.68 9.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.967 1.707 . . . . 0.0 113.478 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -23.57 60.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.276 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.69 -141.26 23.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.59 1.09 . . . . 0.0 111.15 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.52 -66.72 0.25 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.132 1.373 . . . . 0.0 111.117 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -49.93 -49.75 48.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.636 1.174 . . . . 0.0 110.352 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -53.97 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.775 2.03 . . . . 0.0 113.096 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.86 65.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.014 0.526 . . . . 0.0 110.568 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.06 -37.81 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.917 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -68.46 108.51 2.93 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 119.934 1.243 . . . . 0.0 108.834 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.64 11.35 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.633 2.222 . . . . 0.0 113.129 -172.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.07 -26.0 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.588 2.355 . . . . 0.0 108.535 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.35 58.92 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.592 0.757 . . . . 0.0 110.51 -170.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.29 -11.69 58.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.744 0.817 . . . . 0.0 111.186 171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.03 127.37 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.6 1.56 . . . . 0.0 107.276 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -134.83 168.71 18.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -65.78 144.33 56.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -52.93 -39.02 62.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.41 -40.86 79.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.814 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -77.48 -31.32 53.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.518 0.727 . . . . 0.0 110.523 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.22 127.05 69.81 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.695 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 144.84 50.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.163 2.576 . . . . 0.0 112.35 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -43.64 -45.57 6.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 128.734 2.814 . . . . 0.0 112.662 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.21 -48.84 23.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 0.0 110.506 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -90.9 -7.92 50.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.905 1.282 . . . . 0.0 112.456 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -58.05 -21.99 47.99 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 120.629 1.559 . . . . 0.0 110.028 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -49.3 -43.9 43.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.519 -0.738 . . . . 0.0 110.466 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -65.73 -33.57 76.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.504 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.89 -46.04 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 120.906 1.684 . . . . 0.0 107.247 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -56.89 -44.18 82.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.723 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.62 -50.7 72.47 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.352 0.524 . . . . 0.0 111.227 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -57.69 -39.77 77.91 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -60.67 -58.31 9.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.236 1.014 . . . . 0.0 109.003 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.79 -42.2 95.23 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 127.625 2.37 . . . . 0.0 112.957 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.96 -46.26 2.03 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.776 1.23 . . . . 0.0 113.367 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.61 5.47 31.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.649 0.779 . . . . 0.0 111.794 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -170.2 2.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.419 1.887 . . . . 0.0 106.218 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 C-N-CA 128.891 2.877 . . . . 0.0 103.877 168.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 111.331 0.122 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -100.1 143.37 30.39 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.444 1.098 . . . . 0.0 109.132 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.06 145.69 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.38 129.94 44.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 127.601 2.36 . . . . 0.0 107.391 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -110.0 -84.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.961 0.904 . . . . 0.0 112.322 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.95 -63.48 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.394 1.878 . . . . 0.0 113.728 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.79 86.0 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.883 1.722 . . . . 0.0 109.9 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 177.68 -44.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.197 2.599 . . . . 0.0 107.489 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.65 131.35 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.653 0.781 . . . . 0.0 110.944 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.65 72.49 0.02 OUTLIER Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.492 0.568 . . . . 0.0 113.016 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 61.44 -59.4 0.1 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.575 2.75 . . . . 0.0 116.346 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -166.45 148.39 6.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.218 0.917 . . . . 0.0 109.095 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 t -149.94 166.74 28.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.684 1.594 . . . . 0.0 106.953 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -145.83 176.79 9.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.153 2.581 . . . . 0.0 104.038 168.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 49.0 m 117.26 -66.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.334 2.254 . . . . 0.0 109.144 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -74.16 33.19 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.498 -0.751 . . . . 0.0 111.057 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.9 -75.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 O-C-N 120.723 -1.236 . . . . 0.0 108.42 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.09 28.28 0.06 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.22 1.808 . . . . 0.0 115.144 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -130.58 -27.38 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.701 1.2 . . . . 0.0 112.186 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.55 125.73 91.15 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 119.344 0.975 . . . . 0.0 112.267 -169.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.9 121.7 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.911 2.407 . . . . 0.0 108.835 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t 76.25 24.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 111.314 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 36.87 40.69 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.486 2.314 . . . . 0.0 115.067 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.02 44.48 1.18 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 120.672 -1.267 . . . . 0.0 111.176 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.57 122.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.76 2.024 . . . . 0.0 106.14 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.63 143.02 50.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.238 1.415 . . . . 0.0 111.551 -167.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -76.06 135.31 39.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.63 38.23 3.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 105.977 -2.849 . . . . 0.0 105.977 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 65.72 -64.23 0.2 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.756 3.222 . . . . 0.0 110.189 -169.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.41 -27.29 66.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 112.6 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 172.19 18.66 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -91.85 151.35 20.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 125.39 15.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.624 2.77 . . . . 0.0 108.736 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -76.79 142.22 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.763 0.825 . . . . 0.0 109.288 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -80.72 108.92 11.21 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -74.9 -3.14 13.46 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.797 1.665 . . . . 0.0 113.263 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.44 -38.19 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.0 -33.07 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.762 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 t -55.53 123.39 13.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.227 0.921 . . . . 0.0 111.149 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 pt -88.75 35.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.176 0.99 . . . . 0.0 111.672 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.2 m-20 44.83 48.21 9.09 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.325 1.45 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.48 178.22 7.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.08 103.25 0.76 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.45 -56.67 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.08 0.94 . . . . 0.0 111.675 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.3 p -63.51 -43.02 98.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.699 0.8 . . . . 0.0 109.819 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.11 137.14 40.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.59 -0.694 . . . . 0.0 110.023 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.59 -18.33 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.199 1.4 . . . . 0.0 113.052 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.69 -36.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 t -62.76 118.1 38.44 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.33 -23.69 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.101 1.868 . . . . 0.0 112.025 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.39 -22.73 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.139 0.975 . . . . 0.0 110.569 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.6 m 54.05 51.52 14.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.661 1.184 . . . . 0.0 111.87 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.46 -19.64 30.96 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.961 0.904 . . . . 0.0 111.624 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.02 117.72 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -128.87 164.89 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.047 0.939 . . . . 0.0 108.793 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.54 144.89 55.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.07 -40.36 61.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.373 0.606 . . . . 0.0 112.456 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.91 -40.92 77.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.996 1.318 . . . . 0.0 111.854 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -80.09 -36.71 35.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.791 1.237 . . . . 0.0 110.234 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.27 126.41 36.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.493 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.18 144.56 37.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.228 2.618 . . . . 0.0 112.39 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -43.38 -45.87 6.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.407 2.683 . . . . 0.0 112.188 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -46.11 -43.98 15.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.271 1.029 . . . . 0.0 111.245 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -98.6 -6.39 30.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.37 1.868 . . . . 0.0 112.711 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -58.83 -22.32 58.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.437 1.472 . . . . 0.0 110.532 170.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 p -50.41 -44.75 55.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.618 167.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.06 -30.5 70.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.94 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.14 -48.26 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 120.89 1.677 . . . . 0.0 106.81 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -55.87 -47.76 76.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.125 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.37 -46.63 87.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.283 0.492 . . . . 0.0 111.713 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -56.55 -43.08 79.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.056 1.342 . . . . 0.0 109.794 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -61.38 -58.01 9.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 123.109 1.433 . . . . 0.0 108.335 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.36 -39.79 73.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.955 2.102 . . . . 0.0 112.933 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -38.88 -53.73 1.69 Allowed 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.684 1.194 . . . . 0.0 111.61 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.39 -29.55 11.97 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.43 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.7 78.34 4.2 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.431 -1.747 . . . . 0.0 108.02 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -95.96 135.56 37.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.4 t -134.66 139.3 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.035 0.534 . . . . 0.0 110.844 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.49 170.0 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.497 1.919 . . . . 0.0 110.54 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 p -140.74 -107.96 0.15 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -120.86 -54.39 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.4 -23.22 54.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.771 1.647 . . . . 0.0 111.935 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -53.32 -39.61 64.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 112.973 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.13 125.25 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.82 -147.0 4.63 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-O 123.203 1.446 . . . . 0.0 110.931 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 p -89.04 64.35 7.06 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 126.135 1.774 . . . . 0.0 109.429 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.87 0.48 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.919 0.888 . . . . 0.0 110.246 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.16 146.99 52.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.565 0.346 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.03 90.01 1.79 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.491 1.516 . . . . 0.0 107.507 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.4 m -144.14 -55.12 0.36 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.562 -0.711 . . . . 0.0 111.062 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.19 70.54 0.83 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.924 0.868 . . . . 0.0 109.523 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.1 -117.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.545 1.538 . . . . 0.0 108.613 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.02 7.48 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.361 1.864 . . . . 0.0 115.291 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.39 -25.4 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 110.102 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.2 t -69.34 126.09 92.43 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.04 0.382 . . . . 0.0 110.31 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -42.42 -38.21 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.738 4.292 . . . . 0.0 114.543 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -124.47 24.73 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 111.193 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t0 39.29 62.54 1.12 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.559 1.544 . . . . 0.0 113.152 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.1 p -125.17 51.82 1.65 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.523 0.729 . . . . 0.0 110.994 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.56 127.37 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.925 2.09 . . . . 0.0 106.462 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.93 133.45 30.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 119.796 1.18 . . . . 0.0 113.987 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.42 146.86 32.56 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.788 -1.195 . . . . 0.0 112.336 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.18 -50.1 0.43 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -54.67 0.82 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.513 1.525 . . . . 0.0 110.212 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -141.16 -49.66 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.908 2.483 . . . . 0.0 110.813 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -79.1 137.49 37.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.785 -0.572 . . . . 0.0 111.394 -168.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -75.21 102.14 4.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.838 0.828 . . . . 0.0 109.15 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.65 113.31 3.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.925 2.49 . . . . 0.0 106.911 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mt -78.59 130.96 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.12 119.68 71.63 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.754 0.706 . . . . 0.0 109.254 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.29 -27.05 16.84 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 121.706 1.604 . . . . 0.0 112.56 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -42.6 60.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.14 -33.34 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.795 -0.622 . . . . 0.0 112.243 -172.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -61.55 116.86 5.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.133 1.333 . . . . 0.0 110.998 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -83.23 35.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.974 0.91 . . . . 0.0 111.853 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.39 49.69 6.07 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.654 1.982 . . . . 0.0 113.259 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -161.81 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.609 0.764 . . . . 0.0 109.508 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.6 -125.49 4.46 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.88 -67.51 0.26 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 127.662 2.385 . . . . 0.0 110.408 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.3 p -56.61 -46.56 80.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.103 0.561 . . . . 0.0 110.242 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -44.92 78.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.144 0.978 . . . . 0.0 112.878 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.13 72.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.05 0.54 . . . . 0.0 110.655 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.7 -38.17 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.882 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' VAL . 13.9 t -59.86 114.7 10.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.4 18.91 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.242 2.628 . . . . 0.0 113.139 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.9 m -133.08 -25.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.85 2.86 . . . . 0.0 108.295 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 m 53.2 58.39 5.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.623 1.169 . . . . 0.0 111.242 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.71 -12.6 55.62 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.719 1.208 . . . . 0.0 111.322 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.81 128.5 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.02 170.5 15.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -58.49 143.31 46.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.22 -40.49 58.9 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -74.69 -26.5 59.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.376 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -71.04 -28.9 64.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.65 124.6 73.3 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.12 -0.467 . . . . 0.0 109.753 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.9 149.15 71.79 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.039 3.159 . . . . 0.0 112.573 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.8 mp0 -44.26 -44.91 8.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.578 3.151 . . . . 0.0 113.772 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -48.05 -39.83 21.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.466 0.706 . . . . 0.0 111.472 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -105.79 -1.42 24.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.533 1.933 . . . . 0.0 112.66 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 22.3 mmtm -57.83 -22.51 48.06 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.035 1.288 . . . . 0.0 109.336 169.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.93 -46.37 31.92 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.303 1.441 . . . . 0.0 110.221 168.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.32 -35.18 80.04 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.506 -0.746 . . . . 0.0 110.788 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.63 -37.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.781 1.173 . . . . 0.0 108.39 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -62.71 -46.89 86.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.171 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.5 -49.33 78.19 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.575 -0.703 . . . . 0.0 110.238 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -45.84 -44.7 14.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 127.612 2.365 . . . . 0.0 111.552 169.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -59.51 4.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.56 -44.48 62.73 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.522 1.929 . . . . 0.0 111.524 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -43.2 -42.81 4.39 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -115.51 19.73 15.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.153 0.581 . . . . 0.0 110.855 -174.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 77.99 1.5 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -113.43 142.04 46.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.51 144.38 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.321 1.048 . . . . 0.0 111.815 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.51 161.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.961 2.105 . . . . 0.0 110.916 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 p -148.96 163.73 36.62 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.623 0.725 . . . . 0.0 111.899 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.255 2.8 tt0 -15.1 -62.21 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.805 3.242 . . . . 0.0 116.838 175.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 22.5 Cg_exo -61.53 -25.71 79.87 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 CA-C-N 122.008 1.753 . . . . 0.0 113.451 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.442 ' SG ' ' NE2' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -78.77 -12.3 60.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.352 0.661 . . . . 0.0 111.612 -176.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.09 85.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.268 -0.895 . . . . 0.0 109.204 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.04 58.42 0.57 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.22 1.39 . . . . 0.0 110.131 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.311 14.5 t 38.1 115.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.503 3.121 . . . . 0.0 116.728 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 61.97 -62.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.751 2.021 . . . . 0.0 114.075 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.6 t 66.01 -63.92 0.22 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.859 2.064 . . . . 0.0 112.396 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.94 24.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.004 1.722 . . . . 0.0 113.42 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.0 m -97.31 -48.68 5.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.675 0.39 . . . . 0.0 110.998 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -73.51 71.82 1.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.807 0.813 . . . . 0.0 109.137 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 152.78 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.763 1.625 . . . . 0.0 109.745 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 48.46 21.29 0.37 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.85 -16.92 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.456 0.703 . . . . 0.0 111.718 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -71.98 131.73 85.32 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -172.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -45.44 -37.23 14.37 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.026 3.817 . . . . 0.0 115.084 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 -15.06 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.959 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 t0 99.2 162.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.341 2.657 . . . . 0.0 108.951 -171.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.8 p 154.96 -9.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.608 2.763 . . . . 0.0 112.708 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.91 100.16 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.625 1.102 . . . . 0.0 110.253 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -112.96 142.52 45.56 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.128 0.971 . . . . 0.0 111.749 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.95 98.59 3.07 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.663 -1.273 . . . . 0.0 111.806 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.43 68.51 2.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 69.91 -59.9 0.49 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 130.066 3.346 . . . . 0.0 111.509 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -141.71 33.52 1.61 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.968 0.89 . . . . 0.0 112.235 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.442 ' NE2' ' SG ' ' A' ' 8' ' ' CYS . 40.8 tp60 -166.05 140.27 4.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -80.13 114.99 19.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.07 117.93 35.67 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.953 2.501 . . . . 0.0 106.004 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.91 123.19 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.47 113.92 16.6 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.309 0.959 . . . . 0.0 108.589 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 46.9 Cg_endo -61.24 -32.47 90.44 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.801 1.667 . . . . 0.0 110.699 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -77.12 -28.18 54.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -172.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.06 -32.97 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.171 0.441 . . . . 0.0 110.836 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 t -59.54 104.42 0.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.051 0.842 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.7 pt -78.82 46.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.936 -1.103 . . . . 0.0 111.262 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.37 -110.67 0.53 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.265 1.426 . . . . 0.0 109.401 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.83 -45.74 0.49 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.68 1.592 . . . . 0.0 114.386 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.42 -122.82 6.09 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.84 -75.09 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.9 1.28 . . . . 0.0 112.179 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -51.18 -43.46 61.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.201 1.0 . . . . 0.0 110.417 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -48.27 -59.92 3.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.224 1.41 . . . . 0.0 110.511 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.89 74.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.995 0.518 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 t -64.81 -36.54 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.894 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.7 t -63.83 114.3 13.03 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.15 46.09 2.14 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.352 2.702 . . . . 0.0 110.97 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -164.19 -29.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.739 2.415 . . . . 0.0 109.536 -169.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 m 57.59 58.55 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 110.315 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.59 -20.87 38.91 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.221 1.008 . . . . 0.0 110.673 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.87 116.39 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.1 166.85 12.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -54.26 -39.65 67.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -52.49 -43.63 65.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.073 0.949 . . . . 0.0 112.222 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.57 -34.33 53.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.406 1.082 . . . . 0.0 110.38 -169.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.26 124.17 59.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 118.213 -0.899 . . . . 0.0 109.57 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.67 146.12 56.09 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.01 2.474 . . . . 0.0 112.399 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.5 mp0 -41.75 -44.67 3.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -46.73 -44.01 18.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.592 0.757 . . . . 0.0 110.931 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -101.55 -1.65 32.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.375 1.87 . . . . 0.0 113.246 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.5 mmtm -57.91 -23.96 55.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.454 1.479 . . . . 0.0 108.92 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 p -48.18 -45.36 33.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.717 1.207 . . . . 0.0 110.623 168.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.33 -35.83 82.15 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 121.395 -0.815 . . . . 0.0 111.305 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -46.26 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.76 -44.81 73.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.384 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.39 -45.85 78.62 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.359 0.527 . . . . 0.0 112.047 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 15.0 m-80 -59.61 -41.34 90.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.565 1.146 . . . . 0.0 111.135 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -58.42 -61.21 2.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -52.69 -52.47 55.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.864 2.466 . . . . 0.0 113.359 -170.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -34.99 -47.99 0.39 Allowed 'General case' 0 C--O 1.228 -0.07 0 O-C-N 125.427 1.705 . . . . 0.0 113.466 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.97 -2.84 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.705 0.628 . . . . 0.0 111.894 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -34.1 40.94 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.035 0.834 . . . . 0.0 111.038 -173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -110.35 149.08 30.73 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 117.964 0.347 . . . . 0.0 110.374 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -128.34 139.05 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.179 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.62 140.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 126.553 1.941 . . . . 0.0 107.833 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -129.79 172.44 11.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.163 0.585 . . . . 0.0 111.102 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.8 tt0 -12.71 -59.59 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 129.408 3.083 . . . . 0.0 115.946 171.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.4 -17.74 59.25 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.894 1.712 . . . . 0.0 114.206 -173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.69 -31.82 73.22 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.139 0.882 . . . . 0.0 111.659 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 6' ' ' GLU . 6.9 mt -54.14 101.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.988 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.71 54.42 0.08 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.286 7.1 t 54.99 -160.09 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.134 1.774 . . . . 0.0 113.763 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -77.24 67.02 3.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.347 1.459 . . . . 0.0 111.189 -171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.32 -49.42 77.08 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.27 1.428 . . . . 0.0 110.989 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.86 -127.44 0.75 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.057 0.943 . . . . 0.0 109.329 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 m 75.98 -57.17 0.57 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.209 2.203 . . . . 0.0 110.853 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -57.21 -37.16 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.0 t -54.64 -62.21 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.062 0.945 . . . . 0.0 111.491 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -64.28 6.84 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -168.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.21 -12.06 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.975 1.261 . . . . 0.0 113.418 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.4 t -69.63 130.02 90.84 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.795 1.18 . . . . 0.0 110.7 -171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -57.12 -29.5 83.49 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.947 3.098 . . . . 0.0 113.749 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.4 67.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.214 0.606 . . . . 0.0 109.43 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 6.96 64.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 130.752 3.621 . . . . 0.0 115.354 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 p -116.33 37.51 3.69 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.561 0.744 . . . . 0.0 110.394 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.16 123.51 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 128.056 2.542 . . . . 0.0 105.485 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.32 165.12 25.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.367 1.867 . . . . 0.0 108.643 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -90.41 160.83 15.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.649 0.659 . . . . 0.0 110.351 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 68.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.3 84.01 0.16 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.853 2.061 . . . . 0.0 109.318 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.274 1.1 m-20 47.33 41.43 12.3 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.929 2.092 . . . . 0.0 114.875 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 160.18 28.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.768 2.827 . . . . 0.0 104.195 168.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -102.1 164.07 11.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 123.158 0.287 . . . . 0.0 110.637 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.31 148.62 41.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 106.958 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.2 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.82 123.42 89.2 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 119.621 1.101 . . . . 0.0 109.553 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.87 -28.25 16.78 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.348 1.365 . . . . 0.0 112.961 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -27.46 18.27 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.857 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -81.84 -29.58 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.816 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.32 118.61 9.58 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.428 1.013 . . . . 0.0 110.4 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 pt -88.74 32.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 123.673 0.789 . . . . 0.0 111.336 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 1.6 t70 42.3 52.52 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.953 2.101 . . . . 0.0 111.103 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.5 p -74.35 -44.73 51.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -168.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.85 86.09 1.25 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.64 -59.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.715 0.806 . . . . 0.0 110.65 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -54.97 -48.17 73.6 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.057 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -48.96 70.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.207 1.003 . . . . 0.0 111.422 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.63 77.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.272 0.629 . . . . 0.0 111.768 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.74 2.4 6.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 117.809 -1.091 . . . . 0.0 113.482 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -87.44 102.33 3.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.05 15.59 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.694 2.929 . . . . 0.0 113.112 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.07 -27.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 129.624 3.17 . . . . 0.0 107.343 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 56.83 58.15 4.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.85 1.26 . . . . 0.0 110.15 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -20.1 33.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.187 0.995 . . . . 0.0 110.466 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.75 121.83 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -135.82 168.83 18.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -64.89 142.79 58.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -47.3 -43.91 22.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.09 -39.88 79.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.72 0.808 . . . . 0.0 111.538 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -77.06 -38.9 51.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.56 1.144 . . . . 0.0 110.681 -168.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.88 122.68 14.29 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.191 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.97 146.61 46.46 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.299 2.666 . . . . 0.0 112.668 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.4 mp0 -41.47 -45.5 3.21 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.512 3.125 . . . . 0.0 113.735 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -46.31 -44.73 16.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.851 0.834 . . . . 0.0 110.894 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.93 -0.43 39.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.315 1.846 . . . . 0.0 112.83 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.0 mmtm -59.21 -22.44 61.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.621 1.555 . . . . 0.0 109.341 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 p -48.46 -46.1 37.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.441 1.096 . . . . 0.0 109.764 168.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -62.55 -34.45 76.97 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.322 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.4 -35.53 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 120.849 1.659 . . . . 0.0 109.403 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -62.69 -50.14 72.3 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -48.05 83.51 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.192 0.597 . . . . 0.0 111.384 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -42.25 -47.93 4.84 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 129.591 3.156 . . . . 0.0 112.368 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -61.36 1.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.33 -31.0 65.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.301 1.84 . . . . 0.0 113.616 -170.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.36 17.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.202 0.601 . . . . 0.0 111.828 174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -113.31 -33.25 6.01 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.251 0.621 . . . . 0.0 110.747 -170.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.75 140.9 33.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.67 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -103.92 145.92 29.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.586 0.754 . . . . 0.0 108.981 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG11 HD12 ' A' ' 68' ' ' ILE . 37.4 t -132.36 141.93 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.276 1.031 . . . . 0.0 111.37 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.72 139.8 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.341 1.856 . . . . 0.0 109.177 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.2 p -126.95 174.36 8.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.736 0.815 . . . . 0.0 111.289 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -12.91 -59.62 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.957 2.903 . . . . 0.0 115.577 169.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.09 -12.48 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 121.181 1.458 . . . . 0.0 114.23 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -70.23 -33.86 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.075 0.852 . . . . 0.0 111.951 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.41 127.65 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.527 0.603 . . . . 0.0 109.753 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.6 48.7 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.411 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 19.7 m 52.15 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 116.241 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm 73.9 -64.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.742 2.817 . . . . 0.0 113.247 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 t 60.71 -67.36 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.237 1.415 . . . . 0.0 112.165 -170.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.51 34.32 6.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.364 1.866 . . . . 0.0 113.339 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 m -89.9 -47.72 7.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 111.227 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 p -72.92 69.99 0.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.724 0.773 . . . . 0.0 109.36 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.71 -96.48 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.553 1.141 . . . . 0.0 109.594 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.51 24.71 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.699 1.599 . . . . 0.0 115.133 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.01 -25.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.479 1.512 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.11 121.79 86.03 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.254 0.933 . . . . 0.0 110.765 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.2 -38.17 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 125.261 3.974 . . . . 0.0 114.148 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -116.16 18.77 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.953 0.901 . . . . 0.0 111.804 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t0 42.9 52.25 5.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.699 1.2 . . . . 0.0 112.658 172.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.9 p -107.42 26.95 9.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.765 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.29 126.7 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.364 1.466 . . . . 0.0 109.09 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -136.77 170.28 16.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.892 1.677 . . . . 0.0 107.868 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -100.52 156.74 17.12 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 122.146 0.974 . . . . 0.0 113.209 169.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.87 73.54 0.45 Allowed Glycine 0 N--CA 1.444 -0.77 1 N-CA-C 102.848 -4.101 . . . . 0.0 102.848 167.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 61.98 -66.58 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 131.206 3.803 . . . . 0.0 112.59 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 11' ' ' THR . 22.0 t70 -102.56 -21.14 14.23 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.295 1.438 . . . . 0.0 112.452 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.75 163.68 31.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.221 -169.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -81.41 164.36 22.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 123.574 0.546 . . . . 0.0 110.27 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -143.77 120.6 11.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.516 2.326 . . . . 0.0 106.114 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.09 134.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -77.47 112.33 23.22 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.11 -28.33 41.1 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.74 1.626 . . . . 0.0 110.768 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -78.61 -25.42 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.4 t -89.61 -36.44 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 118.694 0.679 . . . . 0.0 111.868 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.3 t -55.08 136.52 48.04 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.62 1.1 . . . . 0.0 110.722 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.64 38.4 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.476 1.111 . . . . 0.0 111.408 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 44.53 55.47 5.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.438 1.495 . . . . 0.0 112.198 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -159.66 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.705 0.402 . . . . 0.0 111.358 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.47 109.42 0.59 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 169.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -168.63 -66.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.706 1.202 . . . . 0.0 110.094 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.0 p -54.74 -44.44 73.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.99 0.916 . . . . 0.0 111.159 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -50.94 70.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.158 0.583 . . . . 0.0 111.972 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.66 78.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.031 0.532 . . . . 0.0 110.889 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.07 -37.09 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.836 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 t -73.5 106.97 2.77 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 108.706 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.17 -14.0 41.65 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.615 1.544 . . . . 0.0 111.805 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.26 -21.53 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.283 1.433 . . . . 0.0 109.974 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 53.48 58.85 4.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.254 1.022 . . . . 0.0 110.987 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.98 46.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.854 0.862 . . . . 0.0 110.551 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.82 125.08 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.82 167.59 20.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.13 145.4 55.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -48.84 -46.41 42.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.508 0.671 . . . . 0.0 111.048 174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.8 -38.11 60.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.012 1.725 . . . . 0.0 111.109 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -82.77 -41.25 19.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.284 1.034 . . . . 0.0 110.437 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.26 121.81 27.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.752 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.31 147.69 54.73 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.403 2.735 . . . . 0.0 112.531 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.0 mp0 -39.98 -46.6 2.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.517 3.127 . . . . 0.0 113.399 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -45.53 -43.72 12.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.699 0.8 . . . . 0.0 111.148 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -102.11 -0.49 33.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.524 1.93 . . . . 0.0 113.08 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.6 mmtm -57.9 -25.76 61.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.86 1.663 . . . . 0.0 109.23 169.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -46.87 -46.41 21.01 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.029 1.332 . . . . 0.0 110.272 168.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -64.31 -34.89 79.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.656 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.421 HD12 HG11 ' A' ' 3' ' ' VAL . 1.6 mp -62.66 -47.11 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 120.869 1.668 . . . . 0.0 106.952 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -58.75 -43.69 90.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.956 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -64.1 -44.39 92.46 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.367 0.531 . . . . 0.0 111.766 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -59.11 -43.0 91.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.675 1.59 . . . . 0.0 110.497 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -56.7 -60.13 4.01 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.86 -42.06 88.51 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.132 2.573 . . . . 0.0 112.651 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -37.41 -50.41 1.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 112.276 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.18 -21.58 13.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 -170.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 81.62 5.17 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.964 -1.493 . . . . 0.0 108.376 -174.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.79 141.05 33.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.947 0.499 . . . . 0.0 109.998 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.39 143.26 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.836 0.855 . . . . 0.0 110.264 -173.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.08 161.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 110.552 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 p -148.49 174.55 11.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.015 0.926 . . . . 0.0 109.198 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -10.2 -61.71 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 128.661 2.785 . . . . 0.0 116.071 170.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.9 Cg_exo -62.85 -17.16 58.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 CA-C-N 121.494 1.569 . . . . 0.0 113.694 -172.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.67 -31.24 72.15 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.741 0.701 . . . . 0.0 112.03 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.17 91.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.806 0.812 . . . . 0.0 110.14 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.89 85.43 0.16 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.092 2.282 . . . . 0.0 107.639 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.287 6.5 t -6.85 99.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.466 2.706 . . . . 0.0 117.096 -172.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp 56.09 41.62 29.35 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.486 2.314 . . . . 0.0 113.108 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -46.36 -52.11 13.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.741 1.617 . . . . 0.0 112.472 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.04 -121.58 0.72 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.81 0.844 . . . . 0.0 109.229 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m 68.86 -57.38 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.056 1.743 . . . . 0.0 111.634 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.3 p -70.21 64.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 0.0 108.671 169.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.36 152.36 21.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 126.053 1.741 . . . . 0.0 108.0 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 61.12 -10.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.982 2.215 . . . . 0.0 116.982 173.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m -90.55 -24.62 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.812 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -72.76 125.52 91.15 Favored Pre-proline 0 CA--C 1.538 0.512 0 O-C-N 122.211 -0.306 . . . . 0.0 110.19 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.15 -31.54 55.44 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.278 3.318 . . . . 0.0 113.531 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.17 19.92 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.89 0.876 . . . . 0.0 111.853 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.6 t70 41.23 56.39 3.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.065 1.346 . . . . 0.0 113.202 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -110.85 36.19 3.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.681 0.793 . . . . 0.0 111.006 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.41 131.96 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 106.713 176.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -142.1 174.65 10.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.815 1.646 . . . . 0.0 107.749 -169.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -107.94 160.39 15.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.117 0.96 . . . . 0.0 113.095 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.36 67.65 0.56 Allowed Glycine 0 N--CA 1.445 -0.716 1 N-CA-C 102.732 -4.147 . . . . 0.0 102.732 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 64.41 -63.22 0.17 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 131.096 3.758 . . . . 0.0 112.631 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -101.74 -20.5 14.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 112.57 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.45 162.81 38.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.12 -0.987 . . . . 0.0 108.62 -169.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -85.05 162.72 19.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.75 0.656 . . . . 0.0 110.911 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -145.19 131.45 19.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.789 2.436 . . . . 0.0 106.495 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 25' ' ' ILE . 67.6 mt -108.82 129.31 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 13.3 t0 -69.13 113.95 20.06 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.327 0.967 . . . . 0.0 109.192 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -28.94 71.1 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.385 1.39 . . . . 0.0 112.304 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -31.48 23.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.092 -0.48 . . . . 0.0 109.763 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.74 -28.29 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.247 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -58.94 119.53 7.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.946 1.248 . . . . 0.0 111.09 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 pt -91.65 33.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.103 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 43.92 58.98 3.35 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.015 1.326 . . . . 0.0 112.592 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.94 -173.86 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.98 172.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.58 104.4 0.8 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -163.03 -75.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.243 1.017 . . . . 0.0 110.025 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.4 p -50.83 -44.39 59.3 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.601 1.161 . . . . 0.0 112.365 -172.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -39.14 90.54 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.544 -0.722 . . . . 0.0 111.658 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.01 -36.92 67.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.812 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.0 t -65.86 -43.23 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.948 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 t -58.65 112.95 5.67 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 119.272 0.942 . . . . 0.0 108.665 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.28 42.35 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.621 2.881 . . . . 0.0 111.08 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.1 -34.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 128.979 2.911 . . . . 0.0 107.8 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m 57.13 59.85 3.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.276 1.031 . . . . 0.0 110.085 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.65 -23.99 56.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.476 1.51 . . . . 0.0 109.873 169.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.94 116.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.402 1.481 . . . . 0.0 107.008 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -122.87 166.45 15.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.82 145.39 52.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -44.05 62.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.615 -0.678 . . . . 0.0 111.995 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.49 -16.7 63.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.246 1.019 . . . . 0.0 112.597 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -80.8 -38.51 28.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.83 121.07 62.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.822 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -54.03 148.6 38.44 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.717 2.945 . . . . 0.0 112.119 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -52.88 -41.43 64.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.679 1.191 . . . . 0.0 110.728 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -44.34 -47.92 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.067 1.347 . . . . 0.0 111.292 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -95.9 -8.56 33.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.694 1.198 . . . . 0.0 112.08 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -59.95 -16.79 32.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 119.524 1.056 . . . . 0.0 110.869 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -50.56 -47.57 57.73 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.624 -0.673 . . . . 0.0 109.427 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -63.63 -37.34 86.95 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 121.651 -0.656 . . . . 0.0 111.18 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -45.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -55.89 -45.03 78.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -64.07 -45.89 86.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.605 0.639 . . . . 0.0 112.202 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -55.69 -41.58 73.96 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.417 1.487 . . . . 0.0 110.876 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -63.78 -58.44 6.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.1 -46.04 75.5 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.058 1.743 . . . . 0.0 112.833 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -34.76 -53.5 0.55 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.729 1.212 . . . . 0.0 112.298 -173.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -106.71 1.7 25.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 124.438 1.087 . . . . 0.0 112.315 -170.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 11.8 mptt -102.72 -8.65 20.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.778 0.717 . . . . 0.0 112.667 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.563 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -119.7 152.42 37.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.42 0.555 . . . . 0.0 109.704 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 68' ' ' ILE . 46.7 t -131.9 140.6 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.976 0.911 . . . . 0.0 110.613 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 127.344 2.257 . . . . 0.0 107.968 169.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -113.75 -89.97 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -134.46 -52.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -167.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.67 -25.16 74.19 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.935 1.757 . . . . 0.0 113.529 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.12 -37.32 66.74 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.832 0.853 . . . . 0.0 112.294 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.292 3.6 mp -69.01 96.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 122.181 0.991 . . . . 0.0 112.574 -168.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.3 -171.89 14.58 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 103.471 -3.852 . . . . 0.0 103.471 169.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.95 105.33 1.97 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.561 1.944 . . . . 0.0 111.789 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm 62.58 -63.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.638 2.375 . . . . 0.0 115.528 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t 66.03 -89.42 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.827 2.051 . . . . 0.0 112.093 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 96.54 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.341 2.657 . . . . 0.0 108.68 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m 73.92 -57.66 0.61 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.406 2.282 . . . . 0.0 111.584 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.52 -24.47 61.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.34 1.056 . . . . 0.0 111.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.26 7.9 p -72.55 -52.19 24.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 O-C-N 121.345 -0.847 . . . . 0.0 112.27 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -74.13 17.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.46 -20.51 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.68 129.25 94.29 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 120.476 1.489 . . . . 0.0 109.711 -172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.01 -42.32 25.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.801 3.667 . . . . 0.0 113.3 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.72 110.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 25' ' ' ILE . 33.4 t0 -31.01 120.25 0.21 Allowed 'General case' 0 C--O 1.23 0.077 0 C-N-CA 126.101 1.76 . . . . 0.0 114.686 -176.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.7 m -133.7 16.93 3.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 108.036 168.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.62 110.99 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -115.92 145.75 42.64 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -166.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.82 78.08 3.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 122.483 1.135 . . . . 0.0 108.861 169.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.66 97.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.26 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -125.0 -74.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.751 1.221 . . . . 0.0 107.803 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -135.71 -39.25 0.72 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.144 0.978 . . . . 0.0 113.12 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 170.88 8.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.488 1.915 . . . . 0.0 108.954 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.02 127.19 32.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.86 -172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -109.19 117.18 33.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.849 3.26 . . . . 0.0 106.976 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 44.1 mt -82.08 129.09 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.88 0.764 . . . . 0.0 109.487 -175.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.14 112.91 26.23 Favored Pre-proline 0 C--O 1.232 0.181 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.8 -29.74 50.32 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.41 1.407 . . . . 0.0 111.203 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -82.63 -29.64 29.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.293 0.637 . . . . 0.0 109.608 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.94 -33.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.562 0.619 . . . . 0.0 110.932 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.9 t -52.07 120.66 5.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.323 0.965 . . . . 0.0 111.436 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.58 35.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.738 0.815 . . . . 0.0 112.112 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 45.04 50.08 9.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 0.0 113.496 176.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.31 -167.51 1.8 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.55 101.02 0.44 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 169.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.7 -76.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.094 0.947 . . . . 0.0 110.042 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.2 p -48.16 -46.06 34.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.759 1.224 . . . . 0.0 111.844 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -50.9 71.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.956 0.902 . . . . 0.0 112.18 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.34 70.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.15 0.58 . . . . 0.0 110.828 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 t -69.65 -38.81 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.236 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.4 t -57.73 111.67 3.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.753 1.16 . . . . 0.0 109.67 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 -14.26 41.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.501 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.91 -22.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.265 1.426 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m 53.16 57.25 6.47 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 111.258 -171.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.97 -19.85 29.8 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 111.444 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.99 127.99 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 124.989 1.316 . . . . 0.0 107.649 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -139.65 168.45 19.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.21 148.21 52.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -53.28 -42.8 66.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.76 -23.22 60.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.819 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.58 -35.87 52.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.19 125.26 70.12 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.631 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.82 141.91 64.46 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.442 2.761 . . . . 0.0 112.148 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -35.37 -51.3 0.59 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.403 2.681 . . . . 0.0 113.461 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.48 -46.89 14.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.953 0.882 . . . . 0.0 110.617 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -95.18 -3.13 48.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.464 1.506 . . . . 0.0 112.629 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -60.34 -22.53 63.34 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.531 1.514 . . . . 0.0 110.119 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -48.58 -41.75 31.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.317 0.647 . . . . 0.0 110.294 167.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -68.44 -32.49 72.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.245 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.497 HD12 HG11 ' A' ' 3' ' ' VAL . 1.4 mp -61.84 -46.84 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 121.135 1.789 . . . . 0.0 107.365 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.08 -49.12 72.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.017 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -63.71 -43.25 97.15 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -61.32 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.489 1.515 . . . . 0.0 110.297 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -57.23 13.41 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.32 -42.38 99.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 128.375 2.67 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -37.15 -51.84 1.01 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.414 1.086 . . . . 0.0 112.836 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.34 4.14 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.795 0.838 . . . . 0.0 111.503 -170.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 80.63 1.33 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.032 -1.937 . . . . 0.0 107.365 -169.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -90.18 161.59 15.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.195 0.521 . . . . 0.0 111.294 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.19 149.58 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.339 1.055 . . . . 0.0 110.794 -172.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.45 138.71 25.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.979 1.312 . . . . 0.0 109.196 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -128.79 170.84 12.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 111.939 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.25 7.8 tt0 -12.25 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 129.756 3.222 . . . . 0.0 116.657 171.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.66 -19.74 54.66 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 122.559 1.95 . . . . 0.0 114.572 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -68.07 -29.1 67.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.071 0.851 . . . . 0.0 111.895 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.7 mt -44.18 110.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.3 0 C-N-CA 124.576 1.15 . . . . 0.0 113.188 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 38.47 0.07 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.9 m 57.51 -83.63 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.954 2.101 . . . . 0.0 113.258 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -124.86 110.46 14.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.601 0.761 . . . . 0.0 109.556 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -129.76 163.82 25.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.446 2.299 . . . . 0.0 105.242 170.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.71 -130.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.6 m 73.6 -68.17 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.601 2.36 . . . . 0.0 110.569 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 p -59.57 -28.44 67.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.826 0.451 . . . . 0.0 110.392 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.58 -66.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.39 1.076 . . . . 0.0 111.846 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -76.95 38.68 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.782 1.233 . . . . 0.0 113.839 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.45 -33.48 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.17 0.988 . . . . 0.0 113.195 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.03 122.6 73.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 120.064 1.302 . . . . 0.0 112.305 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.73 -31.06 91.5 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.841 3.028 . . . . 0.0 112.842 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.9 16.6 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.332 0.653 . . . . 0.0 112.237 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.8 t0 44.2 56.37 4.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.225 . . . . 0.0 112.405 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.7 p -115.63 32.42 6.08 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.563 0.745 . . . . 0.0 110.943 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.68 114.99 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.572 2.349 . . . . 0.0 107.818 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -128.75 173.8 10.01 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 126.198 1.799 . . . . 0.0 109.72 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -119.89 165.2 14.93 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.009 1.323 . . . . 0.0 113.925 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -128.68 13.67 6.13 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.821 1.677 . . . . 0.0 110.571 167.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 73.9 12.48 4.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.958 2.503 . . . . 0.0 112.774 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -123.54 -48.35 1.94 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 128.789 2.836 . . . . 0.0 109.611 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.83 176.25 10.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.032 2.133 . . . . 0.0 105.371 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.52 166.65 19.11 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.197 0.522 . . . . 0.0 110.269 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -145.39 109.67 4.92 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.767 2.027 . . . . 0.0 107.184 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.89 133.09 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -74.54 111.49 13.21 Favored Pre-proline 0 C--N 1.343 0.301 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 167.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -58.38 -33.53 97.9 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.111 1.207 . . . . 0.0 111.591 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -80.26 -29.83 38.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.705 -0.622 . . . . 0.0 110.599 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.3 -30.68 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.68 125.02 20.4 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.042 0.837 . . . . 0.0 111.308 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 pt -99.05 32.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.258 1.023 . . . . 0.0 111.347 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 46.4 41.7 9.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.78 1.632 . . . . 0.0 113.691 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -21.92 59.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.287 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.44 -139.23 25.33 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.847 1.213 . . . . 0.0 110.682 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.48 -60.55 0.5 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.836 2.054 . . . . 0.0 111.409 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -52.31 -40.46 61.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.911 0.884 . . . . 0.0 111.374 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -46.19 80.73 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.768 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.49 76.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.359 0.663 . . . . 0.0 110.292 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.4 -37.76 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.147 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 t -61.21 116.15 18.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.01 1.277 . . . . 0.0 108.103 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.89 -19.83 49.43 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.1 1.867 . . . . 0.0 112.777 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.27 -19.09 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.305 1.442 . . . . 0.0 110.235 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.0 m 51.9 58.36 5.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.359 1.064 . . . . 0.0 111.137 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.17 -13.4 59.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.071 0.948 . . . . 0.0 111.596 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.11 129.81 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.82 179.45 6.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.431 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 7.8 t-80 -79.51 145.35 33.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -48.31 -42.47 31.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.02 -39.82 87.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.223 0.535 . . . . 0.0 112.274 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -76.88 -32.41 57.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.517 -168.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.72 128.89 80.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.083 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.79 143.55 47.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.157 2.571 . . . . 0.0 112.4 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -44.05 -44.93 7.75 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.603 2.761 . . . . 0.0 112.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -46.77 -47.73 20.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.086 0.954 . . . . 0.0 110.843 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -93.17 -6.2 48.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.402 1.481 . . . . 0.0 112.301 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -59.85 -16.04 25.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.273 1.397 . . . . 0.0 110.869 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 p -52.73 -47.35 67.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.064 -1.022 . . . . 0.0 108.998 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -65.76 -30.16 70.77 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.355 -0.831 . . . . 0.0 111.621 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.04 -49.85 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -54.32 -41.87 69.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.421 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -49.98 66.75 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.624 0.647 . . . . 0.0 112.351 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.22 -42.18 69.51 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.371 1.468 . . . . 0.0 109.71 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -58.55 7.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.1 -44.38 83.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.887 2.475 . . . . 0.0 112.923 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -38.28 -50.99 1.49 Allowed 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.383 1.073 . . . . 0.0 112.664 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -102.74 -15.08 16.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 111.483 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 73.82 8.64 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 116.429 -1.748 . . . . 0.0 107.601 -169.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -108.27 145.21 34.69 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.317 1.447 . . . . 0.0 110.864 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.09 140.54 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.714 1.206 . . . . 0.0 111.51 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -37.92 71.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 C-N-CA 126.123 1.769 . . . . 0.0 112.133 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p 63.36 -108.08 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.712 2.405 . . . . 0.0 114.24 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.92 -52.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -167.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.75 77.64 2.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.014 1.81 . . . . 0.0 111.077 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -178.03 -41.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.238 2.615 . . . . 0.0 108.026 -170.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.94 143.75 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 124.116 0.966 . . . . 0.0 113.024 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.59 32.98 58.89 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 124.954 1.264 . . . . 0.0 112.146 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -161.47 103.24 1.22 Allowed 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.253 1.421 . . . . 0.0 108.097 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -53.16 -39.11 63.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.091 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.9 t 66.71 -68.14 0.15 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 113.756 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.09 42.2 28.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.767 1.627 . . . . 0.0 112.472 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.4 m -100.51 -50.15 3.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.287 0.635 . . . . 0.0 111.228 171.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.3 p -75.16 68.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.762 0.791 . . . . 0.0 109.766 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.95 151.43 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.903 1.681 . . . . 0.0 109.043 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 59.01 29.74 19.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.701 1.6 . . . . 0.0 111.899 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.35 -38.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.366 1.066 . . . . 0.0 111.498 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.11 131.56 93.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.423 0.689 . . . . 0.0 110.201 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -45.95 -36.63 16.0 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 125.274 3.983 . . . . 0.0 114.229 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.71 19.48 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.051 0.94 . . . . 0.0 111.405 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 40.64 44.25 1.77 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 113.316 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.4 p -90.2 46.73 1.37 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.291 1.037 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.63 125.74 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.063 1.745 . . . . 0.0 106.564 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -133.8 166.57 22.34 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 124.791 1.237 . . . . 0.0 107.882 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -98.48 140.75 32.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 120.206 1.366 . . . . 0.0 112.096 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.79 -50.61 4.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 166.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 175.33 -74.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.516 3.126 . . . . 0.0 105.008 168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.32 10.23 7.41 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.057 1.343 . . . . 0.0 113.023 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.84 153.23 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.08 161.99 22.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.857 0.723 . . . . 0.0 110.233 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -134.53 111.89 10.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.861 2.865 . . . . 0.0 105.325 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.52 138.57 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 21.0 t0 -78.9 108.16 7.59 Favored Pre-proline 0 N--CA 1.464 0.268 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -76.67 -3.31 13.64 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.319 1.346 . . . . 0.0 112.479 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' ' HZ2' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -92.89 -38.36 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 109.983 169.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.86 -31.19 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 t -57.19 131.18 49.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.243 0.929 . . . . 0.0 111.211 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.2 pt -103.99 37.19 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.669 1.187 . . . . 0.0 111.53 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 28.0 m-20 52.23 37.06 21.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.393 1.477 . . . . 0.0 114.017 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -20.81 39.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.49 -140.45 24.42 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.03 -57.06 0.57 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 127.359 2.264 . . . . 0.0 111.386 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.2 -37.15 71.76 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.615 0.766 . . . . 0.0 111.188 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -43.28 86.14 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.3 -0.875 . . . . 0.0 110.912 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.17 84.01 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.861 0.464 . . . . 0.0 110.683 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.6 t -67.35 -40.29 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.043 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' HG13 ' A' ' 51' ' ' VAL . 5.6 t -58.38 115.62 12.13 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.95 61.44 7.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.952 3.101 . . . . 0.0 109.14 -172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG13 ' SG ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER 174.93 -36.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.813 2.445 . . . . 0.0 108.593 -167.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m 58.31 53.88 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.086 0.954 . . . . 0.0 110.864 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.285 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.25 121.43 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -118.26 164.13 15.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -71.69 147.28 47.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.79 -36.96 70.48 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.265 1.031 . . . . 0.0 113.183 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.51 -46.21 66.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.307 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -76.48 -36.44 57.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.616 1.167 . . . . 0.0 110.927 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HD11 ' A' ' 68' ' ' ILE . 49.1 t -52.46 122.14 24.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.5 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.03 147.32 64.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.3 2.667 . . . . 0.0 112.81 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 4.6 mp0 -39.69 -47.06 1.96 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.831 3.252 . . . . 0.0 113.537 174.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.06 -43.42 14.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.769 0.828 . . . . 0.0 111.11 172.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -102.13 -1.68 30.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.617 1.967 . . . . 0.0 112.87 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 68' ' ' ILE . 30.5 mmtm -55.52 -28.81 56.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.588 1.54 . . . . 0.0 109.501 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 p -48.78 -45.49 40.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.054 1.342 . . . . 0.0 111.566 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -67.81 -32.68 73.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.549 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 65' ' ' LYS . 10.2 mt -63.94 -47.67 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 120.73 1.605 . . . . 0.0 108.283 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -49.99 -53.67 25.02 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.62 93.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.763 0.256 . . . . 0.0 111.204 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.535 0.734 . . . . 0.0 111.111 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -62.85 -57.89 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.934 1.35 . . . . 0.0 109.202 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.413 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 47.9 t0 -59.64 -38.98 82.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.848 2.859 . . . . 0.0 112.25 -169.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -37.33 -57.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 171.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -97.48 -31.58 12.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.806 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -76.56 81.38 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.998 -1.477 . . . . 0.0 108.007 -169.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -101.47 136.71 40.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.934 1.294 . . . . 0.0 108.604 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.7 142.75 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.367 0.667 . . . . 0.0 111.219 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.11 157.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.187 1.795 . . . . 0.0 111.179 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -145.77 160.08 42.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.341 3.6 tt0 1.2 -66.14 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 130.068 3.347 . . . . 0.0 117.445 169.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.6 Cg_exo -56.04 -25.71 55.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 122.76 2.021 . . . . 0.0 114.633 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 t -57.29 -33.98 68.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 112.177 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.63 83.44 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.646 0.736 . . . . 0.0 111.032 -169.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.88 65.11 0.6 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.148 1.832 . . . . 0.0 108.876 171.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.256 14.2 t 50.13 -156.42 0.1 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.919 1.688 . . . . 0.0 112.435 -175.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -77.4 100.72 6.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.942 0.877 . . . . 0.0 110.56 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.62 177.62 8.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.149 1.78 . . . . 0.0 109.687 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.42 134.33 12.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m 156.42 -68.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.348 2.259 . . . . 0.0 107.412 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.89 40.29 0.24 Allowed 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.564 -0.71 . . . . 0.0 110.876 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.71 -73.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.069 0 O-C-N 120.548 -1.345 . . . . 0.0 107.988 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -80.85 41.5 0.58 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.88 -35.7 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.35 127.91 93.34 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.378 0.99 . . . . 0.0 110.925 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.96 -36.4 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.945 3.763 . . . . 0.0 114.218 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.75 45.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.802 0.841 . . . . 0.0 111.213 -169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 55.62 -115.18 0.91 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.049 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.16 -19.64 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.78 103.26 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.95 1.3 . . . . 0.0 109.824 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.27 142.63 47.29 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.632 1.173 . . . . 0.0 111.823 -169.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -75.8 77.72 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.601 1.091 . . . . 0.0 109.369 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.97 -43.02 96.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.666 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -111.55 -120.72 0.29 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -101.16 -8.79 21.91 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 111.071 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.36 161.87 28.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.425 2.69 . . . . 0.0 108.536 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.49 120.99 25.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.348 0.659 . . . . 0.0 112.255 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 124.14 47.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.441 3.096 . . . . 0.0 106.421 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt -89.34 125.33 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 118.125 -0.94 . . . . 0.0 108.516 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.1 t0 -70.24 113.44 17.97 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 120.134 1.334 . . . . 0.0 108.417 169.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 57.2 Cg_endo -61.9 -31.85 84.86 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 121.277 1.318 . . . . 0.0 110.975 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -79.86 -21.14 44.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.871 -0.518 . . . . 0.0 110.369 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -88.09 -37.55 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.334 0.516 . . . . 0.0 110.706 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.08 148.18 36.73 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.807 0.731 . . . . 0.0 111.207 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 pt -122.62 38.46 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.255 1.422 . . . . 0.0 111.017 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 46.94 39.69 7.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.323 1.849 . . . . 0.0 112.615 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.17 159.0 32.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.829 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.44 63.65 4.38 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.03 174.33 15.38 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 124.373 1.069 . . . . 0.0 108.233 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.283 4.8 p 66.39 -56.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.387 2.275 . . . . 0.0 111.644 -169.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -66.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.992 0.917 . . . . 0.0 111.67 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.83 64.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.261 0.624 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.63 -35.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.555 0.742 . . . . 0.0 109.484 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -60.74 114.07 9.33 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 -2.5 7.72 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.299 2.0 . . . . 0.0 113.026 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -108.8 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.242 1.817 . . . . 0.0 109.894 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.3 m 52.48 55.28 9.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.054 0.942 . . . . 0.0 111.563 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.36 -16.17 50.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 111.058 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.98 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -133.75 167.66 20.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.59 145.15 56.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.58 171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.5 -41.03 65.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.42 -31.42 72.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.806 0.843 . . . . 0.0 110.885 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -81.45 -36.74 29.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.439 0.695 . . . . 0.0 109.945 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -48.92 127.5 14.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.339 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.01 142.51 64.95 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 0.0 112.125 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -41.66 -45.78 3.52 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.755 2.822 . . . . 0.0 112.784 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -47.68 -46.13 28.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.141 0.976 . . . . 0.0 110.882 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -96.19 -6.58 37.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.494 1.518 . . . . 0.0 112.578 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -58.87 -19.9 46.14 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.26 1.391 . . . . 0.0 110.422 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -49.84 -46.71 51.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.705 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -62.7 -35.83 80.97 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.171 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.66 -45.59 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.717 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -65.27 -46.5 80.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.365 0.529 . . . . 0.0 111.654 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 12.3 m-80 -58.24 -42.54 86.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 110.885 175.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -57.81 -61.64 2.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.719 1.208 . . . . 0.0 108.028 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -52.25 -51.74 56.65 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.801 2.44 . . . . 0.0 113.054 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -50.92 0.29 Allowed 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.175 1.79 . . . . 0.0 113.695 -175.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -110.02 -1.14 17.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.715 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.53 -34.31 41.25 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.165 0.893 . . . . 0.0 111.162 -174.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -109.56 142.62 40.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.027 1.331 . . . . 0.0 109.746 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.07 141.04 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.462 1.105 . . . . 0.0 110.705 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -48.37 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 128.433 2.693 . . . . 0.0 114.316 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p 61.19 -165.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.66 1.584 . . . . 0.0 114.065 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.05 -48.93 59.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 129.446 3.099 . . . . 0.0 115.726 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.09 -22.4 74.16 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 CA-C-N 121.322 1.508 . . . . 0.0 113.327 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -58.33 -34.08 70.23 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.444 0.697 . . . . 0.0 112.026 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -71.14 84.15 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.683 0.754 . . . . 0.0 110.814 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.15 58.28 0.7 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.597 2.046 . . . . 0.0 108.608 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.266 14.5 t 49.23 -150.01 0.2 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.022 1.729 . . . . 0.0 113.025 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -66.56 81.62 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.936 1.695 . . . . 0.0 112.157 -172.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.7 t -66.22 151.37 47.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.995 0.918 . . . . 0.0 109.598 169.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.44 44.19 2.31 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.263 1.025 . . . . 0.0 109.508 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -150.49 144.15 25.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.386 5.7 p 74.01 49.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.657 2.383 . . . . 0.0 108.466 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 -43.28 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.624 1.97 . . . . 0.0 109.246 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.07 27.04 2.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.756 2.822 . . . . 0.0 113.498 -168.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.5 -37.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -168.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 t -59.34 123.66 71.27 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.698 1.135 . . . . 0.0 112.535 -168.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.93 -47.21 19.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 1 C-N-CA 125.318 4.012 . . . . 0.0 113.144 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -133.65 84.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -17.37 112.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.984 2.114 . . . . 0.0 114.544 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m -121.97 1.14 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.135 1.374 . . . . 0.0 109.94 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.14 106.4 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.222 0.919 . . . . 0.0 112.433 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -125.95 144.28 50.75 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.081 0.953 . . . . 0.0 110.191 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.39 118.39 17.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 120.157 1.344 . . . . 0.0 111.93 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.66 75.08 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 104.781 -3.327 . . . . 0.0 104.781 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 71.94 -47.83 0.67 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.602 2.761 . . . . 0.0 112.152 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.01 -12.5 1.46 Allowed 'General case' 0 C--N 1.34 0.181 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.97 147.04 34.52 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.06 135.83 49.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 109.989 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 128.74 54.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.066 3.346 . . . . 0.0 104.545 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.0 mt -93.48 124.86 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.78 116.04 33.88 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.056 1.298 . . . . 0.0 108.201 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.91 -20.35 17.17 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.959 1.773 . . . . 0.0 111.605 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -88.39 -30.68 19.32 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.58 -38.6 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.41 171.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.43 146.28 51.86 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.528 0.604 . . . . 0.0 111.352 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.1 pt -120.79 37.9 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.264 1.426 . . . . 0.0 111.098 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.88 42.44 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.724 1.61 . . . . 0.0 111.752 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 161.51 28.92 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.889 -0.507 . . . . 0.0 111.483 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.6 61.19 3.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.98 156.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.257 1.5 p 78.35 -55.68 0.48 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.855 2.462 . . . . 0.0 109.953 -169.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -59.26 0.88 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.859 1.664 . . . . 0.0 113.827 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.64 -10.16 57.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.958 . . . . 0.0 112.494 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.08 -37.26 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.64 0.655 . . . . 0.0 109.447 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.95 114.91 9.51 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.21 -7.64 17.96 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.445 2.097 . . . . 0.0 112.616 -174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.33 -20.47 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.536 1.534 . . . . 0.0 109.865 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m 54.35 51.98 13.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 111.318 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.64 34.76 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.8 mt -64.69 120.88 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -130.64 164.25 25.4 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -65.87 150.08 49.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.99 -43.89 60.78 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -66.05 -29.89 70.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.282 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -82.56 -37.09 25.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.282 0.633 . . . . 0.0 109.887 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -50.89 128.96 28.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.371 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.57 148.15 45.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.17 2.58 . . . . 0.0 113.471 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -45.71 -44.61 13.71 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 129.164 2.986 . . . . 0.0 112.881 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -48.43 -44.45 35.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 111.003 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -97.06 -0.27 47.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.104 1.361 . . . . 0.0 112.441 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -55.42 -29.7 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.777 1.171 . . . . 0.0 108.906 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.19 -44.97 11.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.44 1.096 . . . . 0.0 111.557 169.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -66.39 -34.74 78.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.801 -1.095 . . . . 0.0 111.667 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.12 -43.99 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 120.712 1.596 . . . . 0.0 107.133 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -51.43 69.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -59.19 -42.11 90.09 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.128 -0.982 . . . . 0.0 112.231 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -60.45 -44.16 96.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.138 1.775 . . . . 0.0 110.649 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.05 -55.92 27.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.188 0.995 . . . . 0.0 109.178 174.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.11 -42.02 94.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 129.111 2.964 . . . . 0.0 114.043 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.95 -53.81 0.76 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.705 1.202 . . . . 0.0 112.984 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.2 4.3 31.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.008 0.923 . . . . 0.0 111.497 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 79.85 1.25 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 CA-C-O 116.064 -1.922 . . . . 0.0 107.463 -169.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -103.73 143.06 33.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.279 1.032 . . . . 0.0 110.043 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.36 138.15 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.205 1.002 . . . . 0.0 110.814 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.34 151.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.935 1.694 . . . . 0.0 109.833 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.2 p -138.81 160.17 40.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.923 -0.486 . . . . 0.0 110.574 172.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.331 4.9 tt0 -1.28 -64.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 130.192 3.397 . . . . 0.0 117.418 172.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 52.3 Cg_exo -54.63 -25.42 41.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 122.864 2.059 . . . . 0.0 114.844 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 -35.83 68.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.795 0.838 . . . . 0.0 112.261 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.434 HG13 ' HG2' ' A' ' 31' ' ' GLN 0.273 3.5 mp -70.31 89.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.747 0.784 . . . . 0.0 112.205 -168.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.4 47.44 0.71 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.621 1.581 . . . . 0.0 110.986 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.363 0.9 OUTLIER 51.56 118.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.472 2.709 . . . . 0.0 118.075 174.082 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? 68.09 -63.33 0.33 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.476 2.71 . . . . 0.0 112.588 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t 64.11 -66.3 0.12 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.158 1.783 . . . . 0.0 112.966 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.07 47.79 11.52 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 112.406 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.0 m -110.92 -56.37 2.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.303 0.641 . . . . 0.0 110.703 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -72.95 75.33 1.18 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.993 0.901 . . . . 0.0 109.263 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 m -115.56 -140.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 110.116 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -67.73 17.79 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.65 -28.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -62.41 127.98 90.68 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.52 -34.3 71.85 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.482 3.454 . . . . 0.0 114.637 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.56 24.44 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 122.576 0.351 . . . . 0.0 111.449 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 62.94 -176.28 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.192 0.597 . . . . 0.0 109.454 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.2 p 122.18 -5.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.976 3.71 . . . . 0.0 111.923 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -91.2 110.84 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.556 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.37 141.81 50.97 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 109.877 -170.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.98 113.71 9.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 120.175 1.352 . . . . 0.0 109.823 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.34 64.58 3.76 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 170.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 65.5 -59.11 0.29 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 129.811 3.245 . . . . 0.0 111.163 -172.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.48 -54.29 4.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.535 0.734 . . . . 0.0 112.072 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.434 ' HG2' HG13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -141.8 166.49 24.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.588 1.155 . . . . 0.0 110.215 -169.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.82 133.39 50.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.645 0.736 . . . . 0.0 110.695 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 131.19 53.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 131.002 3.721 . . . . 0.0 104.586 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 25' ' ' ILE . 67.1 mt -99.5 128.41 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.445 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.4 t0 -74.66 111.85 14.93 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 120.037 1.29 . . . . 0.0 107.697 168.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.72 -29.61 69.01 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.563 1.509 . . . . 0.0 111.041 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.27 -24.38 40.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.71 -0.619 . . . . 0.0 110.22 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.06 -35.7 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.5 0.591 . . . . 0.0 110.74 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.2 t -54.71 129.88 38.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.03 0.832 . . . . 0.0 110.743 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.02 35.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 111.378 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.55 37.64 9.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.166 1.787 . . . . 0.0 113.082 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -23.79 46.14 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.55 -141.73 21.39 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.357 0.98 . . . . 0.0 111.772 -169.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.48 -65.01 0.36 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.919 2.088 . . . . 0.0 113.026 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -46.87 -42.37 17.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.61 1.164 . . . . 0.0 109.803 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -40.88 -44.62 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.188 2.195 . . . . 0.0 114.426 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 -28.17 16.63 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 110.19 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -63.42 -38.49 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 119.068 -0.492 . . . . 0.0 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -61.23 113.0 6.76 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.47 29.68 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.448 2.766 . . . . 0.0 112.74 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.15 -29.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 129.42 3.088 . . . . 0.0 108.056 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m 55.54 57.93 4.95 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.503 1.121 . . . . 0.0 110.759 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.51 57.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.819 1.248 . . . . 0.0 110.745 170.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mt -80.85 124.79 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -128.31 167.57 16.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.39 146.24 54.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.46 -36.47 69.11 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.424 1.107 . . . . 0.0 112.882 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.64 -44.14 76.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.132 171.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -78.32 -34.65 48.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.329 1.452 . . . . 0.0 112.022 -168.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 68' ' ' ILE . 40.3 t -50.0 124.31 16.8 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.508 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 143.66 67.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.989 2.459 . . . . 0.0 112.114 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -42.77 -46.89 5.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 128.867 2.867 . . . . 0.0 112.462 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -46.38 -45.14 17.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.14 0.976 . . . . 0.0 110.878 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -97.96 0.49 46.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.702 1.601 . . . . 0.0 112.411 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 68' ' ' ILE . 40.9 mttp -61.3 -19.21 61.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.23 1.377 . . . . 0.0 110.781 170.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -54.07 -42.75 69.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.098 0.959 . . . . 0.0 110.167 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -64.83 -36.62 84.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.064 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 60' ' ' VAL . 11.0 mt -60.36 -44.76 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 120.756 1.616 . . . . 0.0 109.047 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -54.13 -48.22 71.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.427 173.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -61.47 -45.06 95.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.465 0.575 . . . . 0.0 112.064 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -58.89 -43.55 91.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.581 1.152 . . . . 0.0 110.904 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -58.13 -60.46 3.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.893 1.277 . . . . 0.0 107.655 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.14 -51.05 63.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.569 2.748 . . . . 0.0 112.942 -171.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -32.68 -49.6 0.23 Allowed 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 126.581 1.952 . . . . 0.0 113.472 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -114.08 -0.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.804 0.69 . . . . 0.0 111.768 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.11 -34.31 43.56 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.184 0.902 . . . . 0.0 110.873 -174.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.385 0 CA-C-O 115.684 -2.103 . . . . 0.0 106.35 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -97.46 138.91 34.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.401 0.68 . . . . 0.0 109.177 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.42 140.79 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.751 0.786 . . . . 0.0 111.097 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -75.93 152.56 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.686 3.194 . . . . 0.0 111.054 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -146.47 166.71 25.6 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.713 0.405 . . . . 0.0 111.27 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.272 58.4 tt0 -16.2 -60.05 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 129.002 2.921 . . . . 0.0 116.147 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.07 -18.03 41.3 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 121.691 1.64 . . . . 0.0 115.12 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 t -62.36 -40.62 97.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.771 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.86 118.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.024 0.375 . . . . 0.0 110.354 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.42 76.3 0.06 OUTLIER Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.315 3.1 t 64.39 -49.36 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.286 2.634 . . . . 0.0 116.181 170.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 -60.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.981 1.264 . . . . 0.0 111.102 176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.6 -71.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.522 1.929 . . . . 0.0 114.965 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.18 -123.25 0.49 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 109.337 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m 72.29 -55.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.957 2.103 . . . . 0.0 112.783 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.13 -47.98 82.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.389 1.076 . . . . 0.0 110.634 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.79 -41.61 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 O-C-N 121.434 -0.791 . . . . 0.0 112.418 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -68.19 -7.31 29.13 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.63 -22.95 3.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 120.02 1.282 . . . . 0.0 113.665 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -61.87 128.93 91.24 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.45 1.023 . . . . 0.0 110.973 -172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.29 -41.62 13.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 1 C-N-CA 125.327 4.018 . . . . 0.0 114.312 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.18 57.71 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.905 0.882 . . . . 0.0 109.769 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -4.23 104.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.939 2.096 . . . . 0.0 114.689 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -132.14 29.77 4.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.305 171.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.552 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -110.51 113.79 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 -169.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -136.76 140.59 42.68 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -165.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -68.13 160.69 28.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.522 -1.361 . . . . 0.0 112.767 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.63 -52.99 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -112.92 -63.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.586 1.554 . . . . 0.0 109.712 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.8 -54.49 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 109.007 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 145.25 56.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.516 2.327 . . . . 0.0 111.008 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HB3' HG22 ' A' ' 25' ' ' ILE . 69.4 m-85 -86.2 102.69 14.14 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 111.746 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -54.41 110.5 0.63 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.839 2.856 . . . . 0.0 108.505 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -82.97 115.27 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.417 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 9.6 t0 -62.83 117.22 30.08 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.686 1.13 . . . . 0.0 108.544 171.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.88 -24.82 20.66 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 121.493 1.462 . . . . 0.0 112.085 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -36.51 34.18 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.68 -32.02 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.309 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.2 t -59.64 124.22 19.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.215 0.916 . . . . 0.0 110.539 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.91 36.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.998 0.919 . . . . 0.0 111.706 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 39.1 61.9 1.2 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.086 1.755 . . . . 0.0 112.609 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.92 -163.19 1.02 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.862 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 101.87 0.41 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.74 -65.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.06 1.344 . . . . 0.0 110.786 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.1 p -60.37 -52.41 65.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.495 0.718 . . . . 0.0 111.262 -172.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -54.8 24.11 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.757 0.823 . . . . 0.0 111.306 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.98 66.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.02 0.528 . . . . 0.0 112.003 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -41.31 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.349 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.0 t -58.35 111.7 3.93 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.001 0.819 . . . . 0.0 108.877 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.1 22.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.439 2.759 . . . . 0.0 113.038 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -135.09 -28.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 129.871 3.268 . . . . 0.0 107.616 -177.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 54.35 59.53 4.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.623 1.169 . . . . 0.0 110.39 -172.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.14 44.94 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.349 1.06 . . . . 0.0 110.214 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.1 mt -77.67 125.51 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -131.94 171.32 13.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.87 147.18 50.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.141 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -49.11 -41.72 36.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.14 -40.28 89.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.452 0.701 . . . . 0.0 111.461 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -78.79 -34.91 45.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.177 0.991 . . . . 0.0 110.855 -168.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.87 123.99 26.68 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.389 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.76 144.69 53.22 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.066 2.511 . . . . 0.0 112.119 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -41.8 -46.51 3.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.78 2.832 . . . . 0.0 112.497 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -46.89 -46.02 20.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.194 0.997 . . . . 0.0 110.995 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -96.35 -3.02 44.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.713 1.605 . . . . 0.0 112.359 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -61.11 -17.74 54.26 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.478 1.49 . . . . 0.0 110.23 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -51.63 -44.74 63.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.851 0.86 . . . . 0.0 109.189 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -64.79 -32.62 74.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.665 -1.159 . . . . 0.0 111.817 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.72 -47.25 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 121.127 1.785 . . . . 0.0 107.917 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -52.72 -53.99 39.97 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -43.05 99.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.547 0.213 . . . . 0.0 111.082 -171.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.05 -39.17 85.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 111.545 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -51.24 63.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.061 0.934 . . . . 0.0 109.348 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 61.2 t0 -68.86 -47.97 64.63 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.283 2.633 . . . . 0.0 112.54 -169.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -31.11 -56.27 0.23 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.991 1.716 . . . . 0.0 113.053 -175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -98.97 -3.42 35.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.978 0.911 . . . . 0.0 112.543 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 10.8 mptt -104.02 78.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.063 0.945 . . . . 0.0 109.749 -172.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 127.769 2.427 . . . . 0.0 105.872 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -112.27 156.34 22.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.893 0.77 . . . . 0.0 110.625 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 68' ' ' ILE . 11.1 t -132.26 143.43 40.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.846 1.658 . . . . 0.0 109.167 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.19 135.6 25.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.561 1.144 . . . . 0.0 108.666 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 p -127.88 170.78 12.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.222 1.009 . . . . 0.0 111.08 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -14.09 -56.85 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 129.628 3.171 . . . . 0.0 116.553 172.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.49 -21.33 61.18 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 122.25 1.839 . . . . 0.0 114.147 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.53 -27.04 68.69 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.84 0.745 . . . . 0.0 112.094 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 9' ' ' ILE . 81.5 mt -67.02 79.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.811 0.844 . . . . 0.0 110.969 -170.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.67 0.79 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.236 1.874 . . . . 0.0 108.571 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.331 14.6 t 46.83 88.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.326 2.251 . . . . 0.0 114.603 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 73.8 -61.2 0.5 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.703 2.001 . . . . 0.0 114.347 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 t 61.61 -68.6 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 0.0 113.217 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.01 35.01 8.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.399 1.879 . . . . 0.0 114.455 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -106.06 14.69 27.46 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -121.92 54.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.3 -45.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.407 -0.808 . . . . 0.0 111.104 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.5 pm0 -74.84 10.5 1.4 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.183 2.193 . . . . 0.0 114.001 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.64 -24.79 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -70.6 124.53 91.06 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 119.595 1.089 . . . . 0.0 111.198 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.24 -26.76 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.804 3.003 . . . . 0.0 113.161 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.98 38.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.396 0.679 . . . . 0.0 110.004 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 29.97 42.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.079 2.551 . . . . 0.0 116.361 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.1 p -92.18 36.02 0.99 Allowed 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.092 -1.005 . . . . 0.0 110.746 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 120.32 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 126.313 1.845 . . . . 0.0 108.062 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -137.12 171.06 15.06 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.039 1.335 . . . . 0.0 109.607 -169.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.18 172.01 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 119.387 0.994 . . . . 0.0 110.217 168.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.49 -53.9 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.259 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -139.64 58.38 1.61 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.355 0.662 . . . . 0.0 109.27 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 45.76 37.36 3.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.172 1.789 . . . . 0.0 112.578 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 154.25 38.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 172.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -76.41 163.21 27.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.669 0.606 . . . . 0.0 110.707 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.45 110.37 5.63 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 106.057 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.11 132.23 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.81 112.95 22.62 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 167.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.06 -28.97 48.82 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.826 1.684 . . . . 0.0 110.672 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.03 -27.93 29.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.784 0.834 . . . . 0.0 109.804 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.2 t -85.5 -32.27 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.836 0.743 . . . . 0.0 111.122 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.4 t -56.13 130.43 44.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.09 0.859 . . . . 0.0 111.152 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 pt -102.44 35.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.3 1.04 . . . . 0.0 111.184 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 50.65 32.19 6.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.24 1.816 . . . . 0.0 114.636 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -23.08 62.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.13 -132.53 11.27 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -168.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.83 -68.25 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.749 1.62 . . . . 0.0 113.098 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -48.84 -49.99 36.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.324 1.05 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -48.47 -56.2 8.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.255 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.0 68.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.16 0.584 . . . . 0.0 112.465 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.98 -7.73 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.982 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -82.79 111.29 28.38 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.51 41.64 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.237 2.624 . . . . 0.0 111.727 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.7 -27.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 128.346 2.658 . . . . 0.0 109.2 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 55.65 60.18 3.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.847 0.859 . . . . 0.0 110.025 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.55 -25.07 41.75 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.25 1.02 . . . . 0.0 110.169 170.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.9 mt -72.7 117.47 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -127.81 165.16 20.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.29 150.19 40.33 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -54.67 -40.44 69.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.677 -0.64 . . . . 0.0 112.69 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.98 -24.17 63.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.426 -0.796 . . . . 0.0 111.032 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.88 -45.32 43.66 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.915 0.325 . . . . 0.0 110.167 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' HD11 ' A' ' 68' ' ' ILE . 68.0 t -52.69 123.75 32.14 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.792 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.85 149.32 61.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.924 2.416 . . . . 0.0 112.606 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -42.66 -46.25 4.97 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 129.698 3.199 . . . . 0.0 112.258 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.54 -40.44 12.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.11 0.964 . . . . 0.0 111.767 172.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -106.08 7.77 31.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.857 1.663 . . . . 0.0 112.482 -176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.7 mptt -57.89 -27.37 63.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.403 1.001 . . . . 0.0 110.038 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -49.28 -44.53 44.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.165 1.386 . . . . 0.0 111.051 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -67.98 -33.02 73.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.68 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.624 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.6 mt -60.99 -48.18 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 120.803 1.638 . . . . 0.0 108.124 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -53.29 -50.52 64.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -62.8 -43.27 99.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 0.541 . . . . 0.0 111.968 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -58.69 -44.18 90.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.039 1.335 . . . . 0.0 110.763 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -55.55 33.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.163 0.985 . . . . 0.0 109.041 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.68 -45.7 93.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.982 2.513 . . . . 0.0 112.402 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.05 -50.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 113.463 -171.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.2 4.66 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.282 1.033 . . . . 0.0 111.983 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 73.41 0.88 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.685 1.194 . . . . 0.0 109.135 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.142 0 C-N-CA 127.63 2.372 . . . . 0.0 105.916 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 118.351 -0.833 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -105.23 153.86 21.01 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.641 0.655 . . . . 0.0 110.17 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 t -138.13 145.83 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.746 0.818 . . . . 0.0 110.764 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.55 HD11 HD21 ' A' ' 71' ' ' ASN . 2.4 pp -60.81 165.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.237 1.815 . . . . 0.0 111.536 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 p -151.93 168.67 24.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.994 0.918 . . . . 0.0 109.094 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -8.52 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 128.506 2.722 . . . . 0.0 116.336 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 -21.39 71.91 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 121.487 1.567 . . . . 0.0 113.541 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.18 -30.34 71.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.756 0.822 . . . . 0.0 112.177 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.21 90.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.598 0.713 . . . . 0.0 110.385 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.11 60.8 0.67 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.941 1.734 . . . . 0.0 109.92 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t 39.56 73.03 0.12 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.158 1.783 . . . . 0.0 114.307 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 68.94 48.5 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.57 1.148 . . . . 0.0 113.053 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.19 152.42 40.8 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.75 40.12 0.89 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.795 0.725 . . . . 0.0 112.125 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 m -83.89 -37.35 22.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 112.205 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 p -70.04 -13.73 62.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.272 1.429 . . . . 0.0 113.215 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.26 153.85 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 112.431 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 75.86 -40.29 0.4 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.834 2.053 . . . . 0.0 113.038 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.65 -29.11 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.705 -0.622 . . . . 0.0 110.156 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.0 t -65.63 126.58 91.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.949 0.5 . . . . 0.0 110.103 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -39.72 -37.44 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 126.377 4.718 . . . . 0.0 115.407 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.0 m -126.54 21.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.822 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t70 33.2 51.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.702 2.001 . . . . 0.0 113.668 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.5 p -94.57 42.34 1.09 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.298 1.039 . . . . 0.0 110.922 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 132.32 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -133.51 142.13 48.08 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -167.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -83.52 125.15 31.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.309 -0.87 . . . . 0.0 111.627 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.82 -55.07 2.48 Favored Glycine 0 CA--C 1.525 0.69 1 N-CA-C 103.047 -4.021 . . . . 0.0 103.047 166.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -60.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.195 2.198 . . . . 0.0 106.614 168.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.4 -29.17 69.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.266 1.826 . . . . 0.0 114.787 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.18 177.5 11.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.343 0.657 . . . . 0.0 109.476 -168.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.87 116.03 28.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.233 1.013 . . . . 0.0 108.699 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -94.88 119.62 33.74 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 130.441 3.497 . . . . 0.0 109.388 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 54' ' ' ILE . 76.7 mt -81.33 130.13 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 118.878 0.763 . . . . 0.0 109.839 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.39 111.64 18.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.01 -30.98 92.86 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-N 120.98 1.386 . . . . 0.0 111.273 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -79.1 -23.63 43.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -92.1 -32.84 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.276 0.489 . . . . 0.0 110.978 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.56 123.56 16.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.979 0.809 . . . . 0.0 111.45 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.8 pt -89.46 21.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 50.75 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.37 2.268 . . . . 0.0 113.089 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.0 148.41 31.67 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.944 -0.472 . . . . 0.0 110.951 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.72 51.75 4.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.191 -0.943 . . . . 0.0 113.08 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.67 -76.99 0.59 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.363 1.082 . . . . 0.0 111.633 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -47.96 -48.8 31.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.598 1.159 . . . . 0.0 112.497 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.5 -46.55 83.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.171 0.896 . . . . 0.0 111.562 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.14 74.86 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.486 -0.759 . . . . 0.0 110.538 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -74.81 -38.26 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.094 0.557 . . . . 0.0 111.45 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.4 t -64.27 112.41 7.59 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.227 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.48 20.88 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.207 2.604 . . . . 0.0 113.087 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.39 -30.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.103 1.761 . . . . 0.0 109.354 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 t 62.27 81.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 0.0 109.894 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.32 -9.92 0.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' ILE . 77.7 mt -79.82 92.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -109.36 164.57 12.36 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.1 0.96 . . . . 0.0 108.894 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -62.5 146.94 50.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.855 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -40.96 64.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.113 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -73.35 -38.91 65.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -53.76 124.53 43.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.667 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 144.95 52.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.103 2.535 . . . . 0.0 112.191 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -41.49 -47.36 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 128.933 2.893 . . . . 0.0 112.676 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.59 -44.41 26.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.049 0.94 . . . . 0.0 111.063 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -96.71 -6.73 35.73 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.173 1.389 . . . . 0.0 112.424 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -57.99 -22.38 49.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.562 1.528 . . . . 0.0 110.231 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.01 -43.08 40.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.701 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -64.35 -35.06 79.63 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.6 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.35 -46.12 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -56.91 -46.58 81.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.115 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -46.42 90.62 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.427 -0.796 . . . . 0.0 111.631 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.55 HD21 HD11 ' A' ' 4' ' ' ILE . 12.6 m-80 -61.59 -40.0 93.22 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.051 0.94 . . . . 0.0 111.357 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -57.22 -61.86 2.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.43 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 4.0 t70 -52.96 -50.42 64.13 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 128.122 2.569 . . . . 0.0 112.529 -170.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -37.46 -46.35 0.8 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 125.57 1.548 . . . . 0.0 113.432 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -111.39 -3.21 15.33 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.789 0.681 . . . . 0.0 111.447 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -36.67 25.05 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.939 0.791 . . . . 0.0 110.31 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -100.8 147.58 25.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.413 0.685 . . . . 0.0 111.128 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.64 142.29 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.845 1.258 . . . . 0.0 110.708 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.88 168.57 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 125.772 1.629 . . . . 0.0 110.904 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 p -145.02 171.65 14.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -9.82 -61.22 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 128.661 2.785 . . . . 0.0 116.164 169.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.5 Cg_exo -62.59 -15.42 45.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 121.991 1.747 . . . . 0.0 113.635 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.37 -26.09 63.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.851 0.86 . . . . 0.0 112.742 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.15 115.95 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.95 130.31 1.34 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -169.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -60.06 119.57 8.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.957 0.503 . . . . 0.0 112.026 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 36.22 50.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.492 1.917 . . . . 0.0 113.376 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.24 -50.85 72.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.673 0.789 . . . . 0.0 112.616 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.95 -136.01 0.86 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.918 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m 62.7 45.34 5.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.856 1.263 . . . . 0.0 111.878 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 p -176.51 -28.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.162 2.985 . . . . 0.0 109.138 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.75 -44.87 51.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.22 1.008 . . . . 0.0 110.469 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.6 pm0 -67.34 0.3 3.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.399 1.88 . . . . 0.0 114.175 -169.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.03 -16.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.277 1.031 . . . . 0.0 113.136 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -75.36 126.15 88.05 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 119.751 1.16 . . . . 0.0 111.624 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -62.11 141.24 87.88 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.565 2.177 . . . . 0.0 109.227 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.287 11.6 m 45.17 37.09 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 114.217 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 35.92 49.1 0.56 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.335 2.654 . . . . 0.0 114.17 168.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -85.89 30.14 0.68 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.058 -1.027 . . . . 0.0 112.643 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.44 142.13 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -141.55 156.8 45.69 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.086 1.354 . . . . 0.0 107.849 -170.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -91.53 134.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 118.888 0.767 . . . . 0.0 111.254 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.54 -46.96 7.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 104.987 -3.245 . . . . 0.0 104.987 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -175.56 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.245 2.618 . . . . 0.0 104.284 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -98.21 54.1 1.09 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.901 1.81 . . . . 0.0 108.94 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -177.71 137.37 0.2 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 -169.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -102.37 168.41 9.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.889 0.743 . . . . 0.0 109.663 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -146.44 119.82 9.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.192 1.797 . . . . 0.0 107.797 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 57.3 mt -90.38 130.76 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -73.33 114.64 33.38 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -30.85 52.42 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.619 0.879 . . . . 0.0 111.1 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -83.07 -28.43 29.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.279 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.52 -27.63 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.397 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -59.45 120.99 10.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.497 1.044 . . . . 0.0 110.945 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 pt -96.14 34.03 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 46.17 42.31 9.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.574 1.549 . . . . 0.0 113.282 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -23.21 60.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.244 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.75 -138.94 20.9 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.531 1.062 . . . . 0.0 110.934 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.17 -67.51 0.25 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.689 1.596 . . . . 0.0 111.95 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 p -47.98 -50.64 26.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.888 1.275 . . . . 0.0 110.412 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -43.92 -41.25 5.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.714 2.005 . . . . 0.0 113.815 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.47 -34.87 21.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.162 0.985 . . . . 0.0 110.064 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -79.18 -25.57 12.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.94 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -59.84 111.97 4.67 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.413 1.006 . . . . 0.0 108.49 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.12 49.53 3.26 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.857 3.038 . . . . 0.0 110.117 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -169.35 -35.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 128.232 2.613 . . . . 0.0 107.74 -168.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 58.0 58.14 3.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 110.045 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.75 -17.57 50.54 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.665 1.186 . . . . 0.0 110.873 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -77.66 125.42 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.48 170.47 15.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 6.7 t-80 -65.62 146.35 54.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -48.69 -44.12 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.174 0.512 . . . . 0.0 112.058 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.32 -40.22 77.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.177 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -78.96 -34.13 44.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 111.56 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.96 126.55 59.89 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.95 145.5 62.45 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.118 2.545 . . . . 0.0 112.469 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.416 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.6 mp0 -40.91 -45.69 2.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.62 3.168 . . . . 0.0 113.811 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.45 -44.68 12.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.914 0.864 . . . . 0.0 111.093 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -101.26 0.06 36.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.475 1.91 . . . . 0.0 112.945 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 28.3 mmtm -59.27 -21.42 59.61 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.593 1.542 . . . . 0.0 109.456 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 p -50.46 -49.03 56.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.713 1.205 . . . . 0.0 109.896 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -61.91 -35.91 79.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.053 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.45 -50.65 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -54.29 -41.69 69.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.623 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -66.84 -45.58 77.77 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.2 -42.16 94.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.276 1.43 . . . . 0.0 110.587 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -55.76 29.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.84 -48.97 69.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.738 2.815 . . . . 0.0 113.987 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -31.66 -48.92 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.09 1.756 . . . . 0.0 114.942 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -117.12 1.72 12.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.746 0.818 . . . . 0.0 111.985 -170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -40.21 13.24 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.822 0.737 . . . . 0.0 110.814 -169.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.567 2.347 . . . . 0.0 104.682 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.57 150.21 31.67 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.477 0.581 . . . . 0.0 110.612 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.2 140.01 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.287 0.635 . . . . 0.0 111.661 -174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.04 144.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 125.331 1.452 . . . . 0.0 109.93 172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 p -133.65 168.4 18.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 110.332 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -15.49 -57.65 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 129.107 2.963 . . . . 0.0 116.484 173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.26 -21.32 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 CA-C-N 121.774 1.669 . . . . 0.0 114.325 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.7 -32.65 72.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.733 0.697 . . . . 0.0 112.246 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -65.34 86.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.982 0.896 . . . . 0.0 109.943 -172.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 53.11 0.57 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 127.191 2.329 . . . . 0.0 108.256 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.298 12.2 t 53.28 -153.61 0.25 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.624 1.97 . . . . 0.0 113.939 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -73.77 66.96 1.14 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.324 1.45 . . . . 0.0 112.276 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.27 -57.54 8.57 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.722 1.609 . . . . 0.0 111.083 170.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.55 43.93 16.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.476 1.51 . . . . 0.0 112.924 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -98.54 -42.11 7.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.355 0.662 . . . . 0.0 111.564 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -74.28 67.96 1.45 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.006 0.908 . . . . 0.0 108.696 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.43 163.6 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.938 2.095 . . . . 0.0 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 40.93 39.24 0.79 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.627 1.971 . . . . 0.0 114.403 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.61 -39.74 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.423 1.089 . . . . 0.0 111.217 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -65.58 124.98 88.8 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 121.922 -0.486 . . . . 0.0 110.934 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.73 -42.78 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.624 1 C-N-CA 126.012 4.475 . . . . 0.0 115.533 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.5 27.77 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.415 0.686 . . . . 0.0 111.411 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 58.99 -173.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p 124.28 -2.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 130.702 3.601 . . . . 0.0 111.985 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -89.22 115.57 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.708 0.803 . . . . 0.0 109.149 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -134.52 172.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.528 1.531 . . . . 0.0 108.815 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -114.72 177.52 4.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.689 0.757 . . . . 0.0 109.673 168.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.8 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 124.608 1.099 . . . . 0.0 110.692 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -128.94 -94.78 0.42 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.3 58.25 1.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.411 1.101 . . . . 0.0 108.95 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -175.22 2.78 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 128.685 2.794 . . . . 0.0 105.786 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -111.56 159.09 18.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.286 0.494 . . . . 0.0 110.947 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.12 130.86 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.724 2.81 . . . . 0.0 104.444 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -106.06 126.39 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -66.95 114.6 18.73 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 118.022 -1.471 . . . . 0.0 107.516 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.32 -28.46 22.54 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.854 1.703 . . . . 0.0 110.0 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -81.26 -28.77 34.61 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.08 -38.45 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.875 0.761 . . . . 0.0 111.27 169.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.8 t -55.13 124.94 18.52 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 111.838 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 pt -95.23 37.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.111 0.964 . . . . 0.0 111.617 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 38.57 60.33 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.182 2.193 . . . . 0.0 113.691 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 -20.98 16.32 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.1 -132.34 11.4 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.89 -70.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.458 1.503 . . . . 0.0 112.042 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.6 p -48.73 -47.3 41.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.711 1.205 . . . . 0.0 111.197 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.66 -42.64 79.33 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.653 -0.654 . . . . 0.0 111.755 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.74 75.83 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.499 -0.751 . . . . 0.0 110.337 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.72 -40.84 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.596 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -59.55 112.15 4.84 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 119.072 0.851 . . . . 0.0 109.464 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.67 11.66 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.909 2.406 . . . . 0.0 112.862 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -117.14 -26.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 127.679 2.392 . . . . 0.0 108.843 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m 54.39 76.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.483 1.513 . . . . 0.0 111.18 -169.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 6.58 5.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.154 1.382 . . . . 0.0 112.719 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.43 80.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -95.99 162.84 13.39 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -59.35 149.14 29.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.947 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -50.39 -42.42 53.46 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -80.82 -21.59 40.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 119.279 -0.969 . . . . 0.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -71.48 -33.3 69.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -58.36 126.75 79.66 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 119.252 -0.404 . . . . 0.0 109.911 171.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.73 153.17 57.94 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.656 2.904 . . . . 0.0 113.156 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -45.61 -45.12 13.63 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 129.968 3.307 . . . . 0.0 112.747 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -48.79 -46.2 41.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.894 0.878 . . . . 0.0 110.889 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -97.06 -1.19 45.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 0.0 112.525 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -54.46 -27.98 41.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.565 1.075 . . . . 0.0 109.324 169.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -45.86 -46.95 16.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.626 1.17 . . . . 0.0 110.8 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -64.25 -34.36 77.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.766 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.35 -47.55 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 120.698 1.59 . . . . 0.0 107.183 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -57.63 -44.07 85.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -60.56 -51.15 70.63 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 118.682 0.674 . . . . 0.0 111.211 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -56.36 -38.93 72.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.382 1.073 . . . . 0.0 110.733 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -63.28 -58.68 6.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.53 1.132 . . . . 0.0 109.859 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.85 -47.15 87.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.658 2.383 . . . . 0.0 112.936 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.65 -46.32 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.093 1.357 . . . . 0.0 113.954 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.77 3.24 24.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.666 0.786 . . . . 0.0 112.193 -171.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 -60.08 1.93 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.507 1.523 . . . . 0.0 107.913 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.643 3.177 . . . . 0.0 112.738 -174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.209 0.052 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -92.24 136.04 33.52 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.63 142.05 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.473 0.709 . . . . 0.0 110.776 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -65.64 158.26 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 126.728 2.011 . . . . 0.0 110.656 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.7 p -144.9 156.26 43.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.33 0.514 . . . . 0.0 111.687 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.351 3.7 tt0 6.87 -72.05 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 130.108 3.363 . . . . 0.0 117.58 169.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 34.3 Cg_exo -52.95 -26.17 30.62 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.693 1.998 . . . . 0.0 114.905 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -58.46 -36.39 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.699 0.8 . . . . 0.0 112.058 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.07 144.23 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.069 0.462 . . . . 0.0 111.06 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.38 37.87 2.75 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 125.465 1.507 . . . . 0.0 111.315 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -166.87 129.11 1.74 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -70.89 88.01 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.87 167.9 20.52 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.841 0.856 . . . . 0.0 110.939 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.03 71.69 0.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.843 1.657 . . . . 0.0 107.12 173.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.3 m -141.99 -59.0 0.47 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.743 -0.598 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.43 72.63 0.98 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.076 0.941 . . . . 0.0 108.962 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.3 152.56 15.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 108.72 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 62.97 -12.77 0.08 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.28 -24.45 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 120.822 -1.174 . . . . 0.0 110.884 -170.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.71 126.48 92.65 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 122.775 0.43 . . . . 0.0 110.619 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.32 -43.89 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 126.485 4.79 . . . . 0.0 115.975 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.34 7.1 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.868 0.867 . . . . 0.0 112.146 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.2 t0 65.87 149.87 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 111.539 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.9 m -163.06 -102.09 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.509 1.923 . . . . 0.0 106.209 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.255 2.2 pp 13.78 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.785 3.234 . . . . 0.0 116.474 169.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -103.4 138.7 39.79 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.487 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 32.6 mt-10 -76.57 131.84 39.16 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 120.775 -1.203 . . . . 0.0 112.661 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.84 8.63 Favored Glycine 0 CA--C 1.532 1.099 1 N-CA-C 102.886 -4.085 . . . . 0.0 102.886 165.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.44 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.236 3.014 . . . . 0.0 104.286 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.15 -35.88 74.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.661 -0.649 . . . . 0.0 111.584 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.68 146.87 46.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.227 1.411 . . . . 0.0 110.411 -169.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 27' ' ' GLU . 96.9 m-85 -80.44 150.95 29.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.94 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -119.68 114.55 22.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 129.808 3.243 . . . . 0.0 105.554 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -83.95 116.88 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.9 109.07 1.27 Allowed Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 126.868 2.067 . . . . 0.0 111.659 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -67.78 -26.98 38.2 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.039 1.16 . . . . 0.0 111.685 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.15 -41.87 85.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.798 0.839 . . . . 0.0 109.852 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -92.94 -38.31 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.663 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.12 120.01 7.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.107 0.867 . . . . 0.0 111.278 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 pt -89.87 35.58 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.155 0.982 . . . . 0.0 111.572 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.52 60.05 3.04 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.36 1.464 . . . . 0.0 112.905 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.13 -164.75 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.065 0.946 . . . . 0.0 109.03 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.42 -112.15 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 168.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.72 -67.29 0.14 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 126.292 1.837 . . . . 0.0 112.665 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.5 p -62.17 -49.06 77.34 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 137.21 58.22 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 168.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 84.47 -22.24 0.22 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.015 2.526 . . . . 0.0 111.873 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.7 -34.22 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.89 116.76 26.53 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.15 26.78 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.41 2.74 . . . . 0.0 113.03 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.5 -27.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 128.393 2.677 . . . . 0.0 108.331 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.9 m 54.14 62.93 2.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.693 1.197 . . . . 0.0 111.288 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.1 -7.36 45.77 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.276 1.031 . . . . 0.0 111.128 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.4 mt -83.05 124.67 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -134.58 168.51 18.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -64.08 143.51 57.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.517 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.41 -40.82 51.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.33 -38.49 89.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.372 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -77.28 -31.54 54.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.043 -169.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.47 125.38 52.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.635 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.79 144.34 55.0 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.045 2.497 . . . . 0.0 112.043 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -41.91 -47.13 4.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 128.995 2.918 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -46.99 -45.36 20.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.138 0.975 . . . . 0.0 110.863 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -96.72 -4.51 40.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.752 1.621 . . . . 0.0 112.528 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -60.89 -17.2 49.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.156 1.344 . . . . 0.0 109.841 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -51.52 -42.6 61.87 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.628 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -67.82 -31.2 70.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.29 -0.881 . . . . 0.0 111.752 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.77 -45.67 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -55.85 -48.98 74.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.71 0.404 . . . . 0.0 110.032 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.59 73.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.248 0.476 . . . . 0.0 110.497 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.61 -39.61 68.06 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 124.021 0.826 . . . . 0.0 110.568 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -56.15 19.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -50.97 -43.18 60.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.868 2.067 . . . . 0.0 112.526 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -43.84 -44.71 7.03 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.756 0.66 . . . . 0.0 112.151 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -107.95 21.47 17.35 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 111.139 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -132.67 74.51 1.58 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 169.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -169.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.28 144.98 26.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.103 0.961 . . . . 0.0 110.248 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 68' ' ' ILE . 71.3 t -139.85 144.05 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.273 1.029 . . . . 0.0 111.296 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.73 142.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.489 1.515 . . . . 0.0 109.553 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 p -131.42 165.47 23.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.038 0.535 . . . . 0.0 110.237 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -12.21 -58.33 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 129.587 3.155 . . . . 0.0 116.568 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.72 -20.65 69.82 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 CA-C-N 122.115 1.791 . . . . 0.0 114.06 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -62.73 -33.3 74.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.64 0.655 . . . . 0.0 111.532 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.31 3.9 mp -70.58 95.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.965 0.888 . . . . 0.0 112.168 -168.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 151.6 23.34 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 103.784 -3.726 . . . . 0.0 103.784 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -48.07 125.14 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.393 1.877 . . . . 0.0 112.789 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 18.31 72.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.41 2.684 . . . . 0.0 116.037 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -51.01 -58.63 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.577 1.951 . . . . 0.0 112.342 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.0 42.45 32.25 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.265 1.426 . . . . 0.0 113.318 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -103.06 -51.13 3.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.257 0.623 . . . . 0.0 111.583 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 p -75.27 69.66 2.12 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.96 0.886 . . . . 0.0 109.416 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.9 156.44 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.972 1.709 . . . . 0.0 109.324 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 40.76 58.47 2.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.857 . . . . 0.0 112.79 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 p -160.39 -37.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -72.62 141.34 82.46 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -37.29 -36.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.623 4.215 . . . . 0.0 115.575 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.02 29.82 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.297 31.1 m-20 21.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.576 2.351 . . . . 0.0 114.751 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.3 p -86.17 41.58 0.94 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.235 1.014 . . . . 0.0 110.415 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 pp -109.41 126.88 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.864 1.666 . . . . 0.0 108.422 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -141.56 145.46 35.13 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 124.226 1.011 . . . . 0.0 109.991 -169.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.6 115.96 7.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.786 169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.87 -59.32 4.07 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.04 -2.424 . . . . 0.0 107.04 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -124.12 -69.24 0.82 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -128.08 -37.58 1.87 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.538 1.135 . . . . 0.0 113.18 172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.538 ' H ' ' CD ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -87.02 160.2 18.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.986 2.914 . . . . 0.0 110.551 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -76.38 124.9 28.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.613 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 159.07 16.47 Favored 'General case' 0 N--CA 1.444 -0.729 1 C-N-CA 131.835 4.054 . . . . 0.0 104.962 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -116.29 137.19 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.203 1.001 . . . . 0.0 108.369 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.24 112.4 25.54 Favored Pre-proline 0 C--N 1.341 0.222 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 167.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.94 -30.9 67.35 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.052 1.168 . . . . 0.0 110.585 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -80.44 -22.94 40.66 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.477 -0.764 . . . . 0.0 110.223 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -90.03 -29.28 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.47 0.577 . . . . 0.0 111.009 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.6 t -58.52 128.92 39.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.477 1.035 . . . . 0.0 110.568 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 pt -98.31 36.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.342 1.057 . . . . 0.0 111.473 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.6 m-20 42.8 57.32 3.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.96 1.704 . . . . 0.0 112.11 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -176.73 4.3 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.042 0.537 . . . . 0.0 111.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.13 69.16 0.23 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.96 162.39 28.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.019 1.727 . . . . 0.0 106.634 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.27 1.9 p 77.75 -54.76 0.52 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.854 2.862 . . . . 0.0 111.264 -170.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -52.89 15.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.866 0.866 . . . . 0.0 111.998 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.16 62.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.461 1.105 . . . . 0.0 112.025 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.11 -38.2 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.826 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.5 t -61.55 110.37 3.06 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.763 0.71 . . . . 0.0 109.371 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.02 -0.04 6.55 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.999 1.799 . . . . 0.0 112.653 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.19 -23.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.82 1.648 . . . . 0.0 109.837 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 t 60.46 56.97 2.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 110.888 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.95 -22.47 21.94 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.915 0.886 . . . . 0.0 111.062 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -78.68 119.11 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -128.43 167.13 17.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -68.93 144.45 54.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -51.74 -40.99 61.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.18 60.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -82.49 -34.2 28.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.922 0.783 . . . . 0.0 109.814 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.44 127.81 90.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.13 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.98 148.64 37.81 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.546 2.831 . . . . 0.0 112.571 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -51.4 -43.78 62.03 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.865 1.266 . . . . 0.0 111.492 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -41.47 -44.76 2.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.996 1.319 . . . . 0.0 111.267 172.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.41 -1.31 31.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.447 1.499 . . . . 0.0 112.586 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -61.37 -19.45 61.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.473 1.488 . . . . 0.0 110.317 169.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -51.44 -45.02 62.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.339 1.055 . . . . 0.0 109.268 167.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.57 -33.99 77.19 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.678 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.43 HD12 HG11 ' A' ' 3' ' ' VAL . 1.5 mp -63.09 -47.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 120.616 1.553 . . . . 0.0 107.691 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -52.9 -49.85 65.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.925 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -46.46 88.76 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.707 -0.62 . . . . 0.0 111.872 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -57.8 -43.06 85.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.095 1.358 . . . . 0.0 110.589 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -58.68 -60.92 3.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.11 -51.15 62.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.435 2.694 . . . . 0.0 112.001 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -48.46 0.21 Allowed 'General case' 0 C--N 1.337 0.055 0 C-N-CA 126.152 1.781 . . . . 0.0 114.139 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.57 -4.17 14.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.56 0.744 . . . . 0.0 111.296 -170.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -37.24 14.66 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.487 -1.244 . . . . 0.0 107.904 -172.074 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.542 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 119.886 -0.102 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -92.18 146.19 23.91 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.019 0.528 . . . . 0.0 110.245 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.01 143.02 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.013 . . . . 0.0 111.169 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.87 142.26 14.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 126.869 2.068 . . . . 0.0 109.052 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.3 p -133.96 166.43 22.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.059 0.544 . . . . 0.0 111.628 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.282 3.0 tt0 -8.77 -61.4 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 129.776 3.23 . . . . 0.0 116.642 172.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -58.17 -20.03 44.61 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 122.56 1.95 . . . . 0.0 114.619 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 t -61.04 -36.44 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.595 0.634 . . . . 0.0 112.523 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.267 8.6 mt -40.04 113.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.129 0.972 . . . . 0.0 112.066 -169.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.37 130.41 1.41 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -53.82 99.65 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.627 1.571 . . . . 0.0 115.107 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 46.66 56.03 7.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.381 1.873 . . . . 0.0 112.332 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -62.17 95.67 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.451 1.1 . . . . 0.0 110.463 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.41 78.21 9.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 m -128.89 -59.48 1.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.169 0.588 . . . . 0.0 110.876 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 p -74.22 66.71 1.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.79 0.805 . . . . 0.0 109.162 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -120.49 -124.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 109.936 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.6 pm0 -68.52 21.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.68 -27.2 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.158 1.383 . . . . 0.0 109.332 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -67.68 124.05 88.37 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.944 -0.473 . . . . 0.0 110.168 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.99 -45.1 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 125.285 3.99 . . . . 0.0 114.67 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.22 13.61 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.367 -170.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 65.2 t0 59.88 111.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.645 1.578 . . . . 0.0 112.241 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 78.7 m -135.57 4.1 3.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.939 172.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.53 113.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 111.409 -167.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.13 167.08 19.72 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.755 1.222 . . . . 0.0 109.325 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -106.99 177.2 4.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 168.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.38 -43.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -129.77 -97.28 0.36 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -144.08 53.8 1.29 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 123.42 1.581 . . . . 0.0 110.564 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -178.85 6.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.999 2.92 . . . . 0.0 105.022 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.39 164.16 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.56 118.48 16.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.489 2.316 . . . . 0.0 106.177 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.3 mt -90.09 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 113.76 14.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.232 1.378 . . . . 0.0 107.807 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.82 -30.83 40.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.789 1.66 . . . . 0.0 110.582 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -82.82 -28.06 30.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.772 0.829 . . . . 0.0 109.272 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 t -85.38 -31.46 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.752 0.706 . . . . 0.0 111.163 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -58.02 129.89 44.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.387 0.994 . . . . 0.0 111.327 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.7 pt -103.52 33.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.564 1.146 . . . . 0.0 111.391 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 31.2 m-20 46.0 42.68 9.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.967 1.707 . . . . 0.0 113.478 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -23.57 60.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.276 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.69 -141.26 23.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.59 1.09 . . . . 0.0 111.15 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.52 -66.72 0.25 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.132 1.373 . . . . 0.0 111.117 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -49.93 -49.75 48.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.636 1.174 . . . . 0.0 110.352 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -53.97 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.775 2.03 . . . . 0.0 113.096 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.86 65.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.014 0.526 . . . . 0.0 110.568 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.06 -37.81 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.917 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -68.46 108.51 2.93 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 119.934 1.243 . . . . 0.0 108.834 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.64 11.35 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.633 2.222 . . . . 0.0 113.129 -172.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.07 -26.0 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.588 2.355 . . . . 0.0 108.535 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.35 58.92 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.592 0.757 . . . . 0.0 110.51 -170.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.29 -11.69 58.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.744 0.817 . . . . 0.0 111.186 171.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.03 127.37 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.6 1.56 . . . . 0.0 107.276 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -134.83 168.71 18.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -65.78 144.33 56.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -52.93 -39.02 62.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.41 -40.86 79.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.814 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -77.48 -31.32 53.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.518 0.727 . . . . 0.0 110.523 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.22 127.05 69.81 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.695 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 144.84 50.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.163 2.576 . . . . 0.0 112.35 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -43.64 -45.57 6.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 128.734 2.814 . . . . 0.0 112.662 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.21 -48.84 23.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 0.0 110.506 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -90.9 -7.92 50.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.905 1.282 . . . . 0.0 112.456 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -58.05 -21.99 47.99 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 120.629 1.559 . . . . 0.0 110.028 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -49.3 -43.9 43.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.519 -0.738 . . . . 0.0 110.466 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -65.73 -33.57 76.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.504 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.89 -46.04 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 120.906 1.684 . . . . 0.0 107.247 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -56.89 -44.18 82.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.723 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.62 -50.7 72.47 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.352 0.524 . . . . 0.0 111.227 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -57.69 -39.77 77.91 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -60.67 -58.31 9.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.236 1.014 . . . . 0.0 109.003 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.79 -42.2 95.23 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 127.625 2.37 . . . . 0.0 112.957 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.96 -46.26 2.03 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.776 1.23 . . . . 0.0 113.367 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.61 5.47 31.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.649 0.779 . . . . 0.0 111.794 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -170.2 2.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.419 1.887 . . . . 0.0 106.218 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 C-N-CA 128.891 2.877 . . . . 0.0 103.877 168.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 111.331 0.122 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -100.1 143.37 30.39 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.444 1.098 . . . . 0.0 109.132 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.06 145.69 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.38 129.94 44.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 127.601 2.36 . . . . 0.0 107.391 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -110.0 -84.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.961 0.904 . . . . 0.0 112.322 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.95 -63.48 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.394 1.878 . . . . 0.0 113.728 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.79 86.0 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.883 1.722 . . . . 0.0 109.9 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 177.68 -44.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.197 2.599 . . . . 0.0 107.489 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.65 131.35 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.653 0.781 . . . . 0.0 110.944 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.65 72.49 0.02 OUTLIER Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.492 0.568 . . . . 0.0 113.016 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 61.44 -59.4 0.1 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.575 2.75 . . . . 0.0 116.346 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -166.45 148.39 6.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.218 0.917 . . . . 0.0 109.095 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 t -149.94 166.74 28.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.684 1.594 . . . . 0.0 106.953 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -145.83 176.79 9.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.153 2.581 . . . . 0.0 104.038 168.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 49.0 m 117.26 -66.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.334 2.254 . . . . 0.0 109.144 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -74.16 33.19 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.498 -0.751 . . . . 0.0 111.057 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.9 -75.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 O-C-N 120.723 -1.236 . . . . 0.0 108.42 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.09 28.28 0.06 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.22 1.808 . . . . 0.0 115.144 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -130.58 -27.38 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.701 1.2 . . . . 0.0 112.186 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.55 125.73 91.15 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 119.344 0.975 . . . . 0.0 112.267 -169.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.9 121.7 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.911 2.407 . . . . 0.0 108.835 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t 76.25 24.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 111.314 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 36.87 40.69 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.486 2.314 . . . . 0.0 115.067 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.02 44.48 1.18 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 120.672 -1.267 . . . . 0.0 111.176 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.57 122.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.76 2.024 . . . . 0.0 106.14 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.63 143.02 50.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.238 1.415 . . . . 0.0 111.551 -167.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -76.06 135.31 39.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.63 38.23 3.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 105.977 -2.849 . . . . 0.0 105.977 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 65.72 -64.23 0.2 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.756 3.222 . . . . 0.0 110.189 -169.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.41 -27.29 66.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 112.6 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 172.19 18.66 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -91.85 151.35 20.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 125.39 15.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.624 2.77 . . . . 0.0 108.736 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -76.79 142.22 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.763 0.825 . . . . 0.0 109.288 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -80.72 108.92 11.21 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -74.9 -3.14 13.46 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.797 1.665 . . . . 0.0 113.263 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.44 -38.19 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.0 -33.07 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.762 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 t -55.53 123.39 13.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.227 0.921 . . . . 0.0 111.149 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 pt -88.75 35.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.176 0.99 . . . . 0.0 111.672 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.2 m-20 44.83 48.21 9.09 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.325 1.45 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.48 178.22 7.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.08 103.25 0.76 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.45 -56.67 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.08 0.94 . . . . 0.0 111.675 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.3 p -63.51 -43.02 98.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.699 0.8 . . . . 0.0 109.819 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.11 137.14 40.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.59 -0.694 . . . . 0.0 110.023 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.59 -18.33 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.199 1.4 . . . . 0.0 113.052 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.69 -36.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 t -62.76 118.1 38.44 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.33 -23.69 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.101 1.868 . . . . 0.0 112.025 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.39 -22.73 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.139 0.975 . . . . 0.0 110.569 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.6 m 54.05 51.52 14.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.661 1.184 . . . . 0.0 111.87 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.46 -19.64 30.96 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.961 0.904 . . . . 0.0 111.624 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.02 117.72 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -128.87 164.89 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.047 0.939 . . . . 0.0 108.793 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.54 144.89 55.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.07 -40.36 61.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.373 0.606 . . . . 0.0 112.456 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.91 -40.92 77.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.996 1.318 . . . . 0.0 111.854 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -80.09 -36.71 35.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.791 1.237 . . . . 0.0 110.234 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.27 126.41 36.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.493 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.18 144.56 37.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.228 2.618 . . . . 0.0 112.39 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -43.38 -45.87 6.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.407 2.683 . . . . 0.0 112.188 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -46.11 -43.98 15.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.271 1.029 . . . . 0.0 111.245 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -98.6 -6.39 30.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.37 1.868 . . . . 0.0 112.711 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -58.83 -22.32 58.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.437 1.472 . . . . 0.0 110.532 170.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 p -50.41 -44.75 55.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.618 167.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.06 -30.5 70.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.94 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.14 -48.26 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 120.89 1.677 . . . . 0.0 106.81 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -55.87 -47.76 76.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.125 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.37 -46.63 87.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.283 0.492 . . . . 0.0 111.713 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -56.55 -43.08 79.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.056 1.342 . . . . 0.0 109.794 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -61.38 -58.01 9.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 123.109 1.433 . . . . 0.0 108.335 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.36 -39.79 73.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.955 2.102 . . . . 0.0 112.933 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -38.88 -53.73 1.69 Allowed 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.684 1.194 . . . . 0.0 111.61 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.39 -29.55 11.97 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.43 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.7 78.34 4.2 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.431 -1.747 . . . . 0.0 108.02 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -95.96 135.56 37.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.4 t -134.66 139.3 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.035 0.534 . . . . 0.0 110.844 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.49 170.0 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.497 1.919 . . . . 0.0 110.54 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 p -140.74 -107.96 0.15 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -120.86 -54.39 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.4 -23.22 54.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.771 1.647 . . . . 0.0 111.935 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -53.32 -39.61 64.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 112.973 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.13 125.25 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.82 -147.0 4.63 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-O 123.203 1.446 . . . . 0.0 110.931 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 p -89.04 64.35 7.06 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 126.135 1.774 . . . . 0.0 109.429 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.87 0.48 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.919 0.888 . . . . 0.0 110.246 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.16 146.99 52.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.565 0.346 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.03 90.01 1.79 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.491 1.516 . . . . 0.0 107.507 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.4 m -144.14 -55.12 0.36 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.562 -0.711 . . . . 0.0 111.062 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.19 70.54 0.83 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.924 0.868 . . . . 0.0 109.523 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.1 -117.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.545 1.538 . . . . 0.0 108.613 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.02 7.48 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.361 1.864 . . . . 0.0 115.291 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.39 -25.4 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 110.102 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.2 t -69.34 126.09 92.43 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.04 0.382 . . . . 0.0 110.31 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -42.42 -38.21 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.738 4.292 . . . . 0.0 114.543 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -124.47 24.73 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 111.193 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t0 39.29 62.54 1.12 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.559 1.544 . . . . 0.0 113.152 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.1 p -125.17 51.82 1.65 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.523 0.729 . . . . 0.0 110.994 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.56 127.37 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.925 2.09 . . . . 0.0 106.462 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.93 133.45 30.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 119.796 1.18 . . . . 0.0 113.987 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.42 146.86 32.56 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.788 -1.195 . . . . 0.0 112.336 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.18 -50.1 0.43 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -54.67 0.82 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.513 1.525 . . . . 0.0 110.212 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -141.16 -49.66 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.908 2.483 . . . . 0.0 110.813 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.1 137.49 37.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.785 -0.572 . . . . 0.0 111.394 -168.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -75.21 102.14 4.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.838 0.828 . . . . 0.0 109.15 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.65 113.31 3.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.925 2.49 . . . . 0.0 106.911 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mt -78.59 130.96 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.12 119.68 71.63 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.754 0.706 . . . . 0.0 109.254 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.29 -27.05 16.84 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 121.706 1.604 . . . . 0.0 112.56 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -42.6 60.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.14 -33.34 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.795 -0.622 . . . . 0.0 112.243 -172.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -61.55 116.86 5.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.133 1.333 . . . . 0.0 110.998 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -83.23 35.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.974 0.91 . . . . 0.0 111.853 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.39 49.69 6.07 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.654 1.982 . . . . 0.0 113.259 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -161.81 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.609 0.764 . . . . 0.0 109.508 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.6 -125.49 4.46 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.88 -67.51 0.26 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 127.662 2.385 . . . . 0.0 110.408 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.3 p -56.61 -46.56 80.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.103 0.561 . . . . 0.0 110.242 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -44.92 78.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.144 0.978 . . . . 0.0 112.878 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.13 72.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.05 0.54 . . . . 0.0 110.655 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.7 -38.17 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.882 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' VAL . 13.9 t -59.86 114.7 10.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.4 18.91 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.242 2.628 . . . . 0.0 113.139 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.9 m -133.08 -25.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.85 2.86 . . . . 0.0 108.295 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 m 53.2 58.39 5.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.623 1.169 . . . . 0.0 111.242 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.71 -12.6 55.62 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.719 1.208 . . . . 0.0 111.322 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.81 128.5 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.02 170.5 15.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -58.49 143.31 46.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.22 -40.49 58.9 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -74.69 -26.5 59.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.376 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -71.04 -28.9 64.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.65 124.6 73.3 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.12 -0.467 . . . . 0.0 109.753 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.9 149.15 71.79 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.039 3.159 . . . . 0.0 112.573 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.8 mp0 -44.26 -44.91 8.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.578 3.151 . . . . 0.0 113.772 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -48.05 -39.83 21.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.466 0.706 . . . . 0.0 111.472 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -105.79 -1.42 24.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.533 1.933 . . . . 0.0 112.66 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 22.3 mmtm -57.83 -22.51 48.06 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.035 1.288 . . . . 0.0 109.336 169.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.93 -46.37 31.92 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.303 1.441 . . . . 0.0 110.221 168.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.32 -35.18 80.04 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.506 -0.746 . . . . 0.0 110.788 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.63 -37.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.781 1.173 . . . . 0.0 108.39 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -62.71 -46.89 86.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.171 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.5 -49.33 78.19 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.575 -0.703 . . . . 0.0 110.238 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -45.84 -44.7 14.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 127.612 2.365 . . . . 0.0 111.552 169.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -59.51 4.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.56 -44.48 62.73 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.522 1.929 . . . . 0.0 111.524 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -43.2 -42.81 4.39 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -115.51 19.73 15.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.153 0.581 . . . . 0.0 110.855 -174.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 77.99 1.5 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -113.43 142.04 46.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.51 144.38 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.321 1.048 . . . . 0.0 111.815 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.51 161.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.961 2.105 . . . . 0.0 110.916 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 p -148.96 163.73 36.62 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.623 0.725 . . . . 0.0 111.899 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.255 2.8 tt0 -15.1 -62.21 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.805 3.242 . . . . 0.0 116.838 175.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 22.5 Cg_exo -61.53 -25.71 79.87 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 CA-C-N 122.008 1.753 . . . . 0.0 113.451 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -12.3 60.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.352 0.661 . . . . 0.0 111.612 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.09 85.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.268 -0.895 . . . . 0.0 109.204 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.04 58.42 0.57 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.22 1.39 . . . . 0.0 110.131 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.311 14.5 t 38.1 115.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.503 3.121 . . . . 0.0 116.728 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 61.97 -62.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.751 2.021 . . . . 0.0 114.075 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.6 t 66.01 -63.92 0.22 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.859 2.064 . . . . 0.0 112.396 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.94 24.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.004 1.722 . . . . 0.0 113.42 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.0 m -97.31 -48.68 5.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.675 0.39 . . . . 0.0 110.998 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -73.51 71.82 1.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.807 0.813 . . . . 0.0 109.137 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 152.78 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.763 1.625 . . . . 0.0 109.745 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 48.46 21.29 0.37 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.85 -16.92 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.456 0.703 . . . . 0.0 111.718 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -71.98 131.73 85.32 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -172.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -45.44 -37.23 14.37 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.026 3.817 . . . . 0.0 115.084 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 -15.06 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.959 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 t0 99.2 162.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.341 2.657 . . . . 0.0 108.951 -171.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.8 p 154.96 -9.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.608 2.763 . . . . 0.0 112.708 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.91 100.16 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.625 1.102 . . . . 0.0 110.253 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.96 142.52 45.56 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.128 0.971 . . . . 0.0 111.749 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.95 98.59 3.07 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.663 -1.273 . . . . 0.0 111.806 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.43 68.51 2.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 69.91 -59.9 0.49 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 130.066 3.346 . . . . 0.0 111.509 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -141.71 33.52 1.61 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.968 0.89 . . . . 0.0 112.235 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -166.05 140.27 4.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -80.13 114.99 19.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.07 117.93 35.67 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.953 2.501 . . . . 0.0 106.004 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.91 123.19 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.47 113.92 16.6 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.309 0.959 . . . . 0.0 108.589 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 46.9 Cg_endo -61.24 -32.47 90.44 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.801 1.667 . . . . 0.0 110.699 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -77.12 -28.18 54.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -172.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.06 -32.97 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.171 0.441 . . . . 0.0 110.836 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 t -59.54 104.42 0.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.051 0.842 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.7 pt -78.82 46.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.936 -1.103 . . . . 0.0 111.262 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.37 -110.67 0.53 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.265 1.426 . . . . 0.0 109.401 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.83 -45.74 0.49 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.68 1.592 . . . . 0.0 114.386 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.42 -122.82 6.09 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.84 -75.09 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.9 1.28 . . . . 0.0 112.179 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -51.18 -43.46 61.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.201 1.0 . . . . 0.0 110.417 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -48.27 -59.92 3.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.224 1.41 . . . . 0.0 110.511 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.89 74.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.995 0.518 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 t -64.81 -36.54 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.894 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.7 t -63.83 114.3 13.03 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.15 46.09 2.14 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.352 2.702 . . . . 0.0 110.97 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -164.19 -29.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.739 2.415 . . . . 0.0 109.536 -169.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 m 57.59 58.55 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 110.315 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.59 -20.87 38.91 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.221 1.008 . . . . 0.0 110.673 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.87 116.39 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.1 166.85 12.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -54.26 -39.65 67.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -52.49 -43.63 65.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.073 0.949 . . . . 0.0 112.222 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.57 -34.33 53.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.406 1.082 . . . . 0.0 110.38 -169.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.26 124.17 59.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 118.213 -0.899 . . . . 0.0 109.57 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.67 146.12 56.09 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.01 2.474 . . . . 0.0 112.399 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.5 mp0 -41.75 -44.67 3.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -46.73 -44.01 18.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.592 0.757 . . . . 0.0 110.931 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -101.55 -1.65 32.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.375 1.87 . . . . 0.0 113.246 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.5 mmtm -57.91 -23.96 55.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.454 1.479 . . . . 0.0 108.92 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 p -48.18 -45.36 33.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.717 1.207 . . . . 0.0 110.623 168.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.33 -35.83 82.15 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 121.395 -0.815 . . . . 0.0 111.305 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -46.26 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.76 -44.81 73.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.384 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.39 -45.85 78.62 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.359 0.527 . . . . 0.0 112.047 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 15.0 m-80 -59.61 -41.34 90.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.565 1.146 . . . . 0.0 111.135 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -58.42 -61.21 2.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -52.69 -52.47 55.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.864 2.466 . . . . 0.0 113.359 -170.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -34.99 -47.99 0.39 Allowed 'General case' 0 C--O 1.228 -0.07 0 O-C-N 125.427 1.705 . . . . 0.0 113.466 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.97 -2.84 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.705 0.628 . . . . 0.0 111.894 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -34.1 40.94 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.035 0.834 . . . . 0.0 111.038 -173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -110.35 149.08 30.73 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 117.964 0.347 . . . . 0.0 110.374 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -128.34 139.05 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.179 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.62 140.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 126.553 1.941 . . . . 0.0 107.833 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -129.79 172.44 11.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.163 0.585 . . . . 0.0 111.102 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.641 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.8 tt0 -12.71 -59.59 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 129.408 3.083 . . . . 0.0 115.946 171.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.4 -17.74 59.25 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.894 1.712 . . . . 0.0 114.206 -173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.69 -31.82 73.22 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.139 0.882 . . . . 0.0 111.659 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 6' ' ' GLU . 6.9 mt -54.14 101.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.988 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.71 54.42 0.08 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.286 7.1 t 54.99 -160.09 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.134 1.774 . . . . 0.0 113.763 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -77.24 67.02 3.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.347 1.459 . . . . 0.0 111.189 -171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.32 -49.42 77.08 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.27 1.428 . . . . 0.0 110.989 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.86 -127.44 0.75 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.057 0.943 . . . . 0.0 109.329 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 m 75.98 -57.17 0.57 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.209 2.203 . . . . 0.0 110.853 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -57.21 -37.16 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.0 t -54.64 -62.21 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.062 0.945 . . . . 0.0 111.491 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -64.28 6.84 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -168.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.21 -12.06 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.975 1.261 . . . . 0.0 113.418 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.4 t -69.63 130.02 90.84 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.795 1.18 . . . . 0.0 110.7 -171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -57.12 -29.5 83.49 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.947 3.098 . . . . 0.0 113.749 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.4 67.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.214 0.606 . . . . 0.0 109.43 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 6.96 64.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 130.752 3.621 . . . . 0.0 115.354 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 p -116.33 37.51 3.69 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.561 0.744 . . . . 0.0 110.394 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.16 123.51 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 128.056 2.542 . . . . 0.0 105.485 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.32 165.12 25.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.367 1.867 . . . . 0.0 108.643 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -90.41 160.83 15.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.649 0.659 . . . . 0.0 110.351 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 68.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.3 84.01 0.16 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.853 2.061 . . . . 0.0 109.318 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.274 1.1 m-20 47.33 41.43 12.3 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.929 2.092 . . . . 0.0 114.875 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 160.18 28.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.768 2.827 . . . . 0.0 104.195 168.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -102.1 164.07 11.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 123.158 0.287 . . . . 0.0 110.637 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.31 148.62 41.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 106.958 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.2 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.82 123.42 89.2 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 119.621 1.101 . . . . 0.0 109.553 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.87 -28.25 16.78 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.348 1.365 . . . . 0.0 112.961 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -27.46 18.27 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.857 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -81.84 -29.58 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.816 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.32 118.61 9.58 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.428 1.013 . . . . 0.0 110.4 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 pt -88.74 32.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 123.673 0.789 . . . . 0.0 111.336 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 1.6 t70 42.3 52.52 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.953 2.101 . . . . 0.0 111.103 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.5 p -74.35 -44.73 51.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -168.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.85 86.09 1.25 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.64 -59.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.715 0.806 . . . . 0.0 110.65 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -54.97 -48.17 73.6 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.057 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -48.96 70.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.207 1.003 . . . . 0.0 111.422 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.63 77.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.272 0.629 . . . . 0.0 111.768 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.74 2.4 6.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 117.809 -1.091 . . . . 0.0 113.482 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -87.44 102.33 3.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.05 15.59 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.694 2.929 . . . . 0.0 113.112 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.07 -27.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 129.624 3.17 . . . . 0.0 107.343 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 56.83 58.15 4.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.85 1.26 . . . . 0.0 110.15 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -20.1 33.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.187 0.995 . . . . 0.0 110.466 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.75 121.83 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -135.82 168.83 18.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -64.89 142.79 58.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -47.3 -43.91 22.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.09 -39.88 79.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.72 0.808 . . . . 0.0 111.538 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -77.06 -38.9 51.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.56 1.144 . . . . 0.0 110.681 -168.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.88 122.68 14.29 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.191 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.97 146.61 46.46 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.299 2.666 . . . . 0.0 112.668 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.4 mp0 -41.47 -45.5 3.21 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.512 3.125 . . . . 0.0 113.735 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -46.31 -44.73 16.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.851 0.834 . . . . 0.0 110.894 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.93 -0.43 39.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.315 1.846 . . . . 0.0 112.83 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.0 mmtm -59.21 -22.44 61.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.621 1.555 . . . . 0.0 109.341 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 p -48.46 -46.1 37.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.441 1.096 . . . . 0.0 109.764 168.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -62.55 -34.45 76.97 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.322 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.4 -35.53 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 120.849 1.659 . . . . 0.0 109.403 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -62.69 -50.14 72.3 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -48.05 83.51 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.192 0.597 . . . . 0.0 111.384 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -42.25 -47.93 4.84 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 129.591 3.156 . . . . 0.0 112.368 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -61.36 1.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.33 -31.0 65.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.301 1.84 . . . . 0.0 113.616 -170.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.36 17.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.202 0.601 . . . . 0.0 111.828 174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -113.31 -33.25 6.01 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.251 0.621 . . . . 0.0 110.747 -170.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.75 140.9 33.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.67 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -103.92 145.92 29.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.586 0.754 . . . . 0.0 108.981 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG11 HD12 ' A' ' 68' ' ' ILE . 37.4 t -132.36 141.93 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.276 1.031 . . . . 0.0 111.37 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.72 139.8 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.341 1.856 . . . . 0.0 109.177 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.2 p -126.95 174.36 8.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.736 0.815 . . . . 0.0 111.289 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -12.91 -59.62 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.957 2.903 . . . . 0.0 115.577 169.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.09 -12.48 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 121.181 1.458 . . . . 0.0 114.23 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -70.23 -33.86 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.075 0.852 . . . . 0.0 111.951 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.41 127.65 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.527 0.603 . . . . 0.0 109.753 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.6 48.7 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.411 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 19.7 m 52.15 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 116.241 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm 73.9 -64.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.742 2.817 . . . . 0.0 113.247 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 t 60.71 -67.36 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.237 1.415 . . . . 0.0 112.165 -170.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.51 34.32 6.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.364 1.866 . . . . 0.0 113.339 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 m -89.9 -47.72 7.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 111.227 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 p -72.92 69.99 0.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.724 0.773 . . . . 0.0 109.36 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.71 -96.48 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.553 1.141 . . . . 0.0 109.594 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.51 24.71 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.699 1.599 . . . . 0.0 115.133 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.01 -25.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.479 1.512 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.11 121.79 86.03 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.254 0.933 . . . . 0.0 110.765 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.2 -38.17 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 125.261 3.974 . . . . 0.0 114.148 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -116.16 18.77 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.953 0.901 . . . . 0.0 111.804 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t0 42.9 52.25 5.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.699 1.2 . . . . 0.0 112.658 172.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.9 p -107.42 26.95 9.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.765 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.29 126.7 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.364 1.466 . . . . 0.0 109.09 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -136.77 170.28 16.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.892 1.677 . . . . 0.0 107.868 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -100.52 156.74 17.12 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 122.146 0.974 . . . . 0.0 113.209 169.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.87 73.54 0.45 Allowed Glycine 0 N--CA 1.444 -0.77 1 N-CA-C 102.848 -4.101 . . . . 0.0 102.848 167.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 61.98 -66.58 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 131.206 3.803 . . . . 0.0 112.59 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 11' ' ' THR . 22.0 t70 -102.56 -21.14 14.23 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.295 1.438 . . . . 0.0 112.452 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.75 163.68 31.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.221 -169.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -81.41 164.36 22.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 123.574 0.546 . . . . 0.0 110.27 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -143.77 120.6 11.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.516 2.326 . . . . 0.0 106.114 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.09 134.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -77.47 112.33 23.22 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.11 -28.33 41.1 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.74 1.626 . . . . 0.0 110.768 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -78.61 -25.42 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.4 t -89.61 -36.44 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 118.694 0.679 . . . . 0.0 111.868 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.3 t -55.08 136.52 48.04 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.62 1.1 . . . . 0.0 110.722 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.64 38.4 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.476 1.111 . . . . 0.0 111.408 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 44.53 55.47 5.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.438 1.495 . . . . 0.0 112.198 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -159.66 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.705 0.402 . . . . 0.0 111.358 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.47 109.42 0.59 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 169.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -168.63 -66.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.706 1.202 . . . . 0.0 110.094 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.0 p -54.74 -44.44 73.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.99 0.916 . . . . 0.0 111.159 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -50.94 70.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.158 0.583 . . . . 0.0 111.972 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.66 78.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.031 0.532 . . . . 0.0 110.889 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.07 -37.09 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.836 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 t -73.5 106.97 2.77 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 108.706 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.17 -14.0 41.65 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.615 1.544 . . . . 0.0 111.805 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.26 -21.53 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.283 1.433 . . . . 0.0 109.974 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 53.48 58.85 4.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.254 1.022 . . . . 0.0 110.987 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.98 46.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.854 0.862 . . . . 0.0 110.551 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.82 125.08 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.82 167.59 20.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.13 145.4 55.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -48.84 -46.41 42.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.508 0.671 . . . . 0.0 111.048 174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.8 -38.11 60.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.012 1.725 . . . . 0.0 111.109 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -82.77 -41.25 19.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.284 1.034 . . . . 0.0 110.437 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.26 121.81 27.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.752 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.31 147.69 54.73 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.403 2.735 . . . . 0.0 112.531 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.0 mp0 -39.98 -46.6 2.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.517 3.127 . . . . 0.0 113.399 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -45.53 -43.72 12.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.699 0.8 . . . . 0.0 111.148 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -102.11 -0.49 33.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.524 1.93 . . . . 0.0 113.08 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.6 mmtm -57.9 -25.76 61.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.86 1.663 . . . . 0.0 109.23 169.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -46.87 -46.41 21.01 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.029 1.332 . . . . 0.0 110.272 168.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -64.31 -34.89 79.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.656 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.421 HD12 HG11 ' A' ' 3' ' ' VAL . 1.6 mp -62.66 -47.11 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 120.869 1.668 . . . . 0.0 106.952 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -58.75 -43.69 90.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.956 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -64.1 -44.39 92.46 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.367 0.531 . . . . 0.0 111.766 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -59.11 -43.0 91.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.675 1.59 . . . . 0.0 110.497 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -56.7 -60.13 4.01 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.86 -42.06 88.51 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.132 2.573 . . . . 0.0 112.651 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -37.41 -50.41 1.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 112.276 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.18 -21.58 13.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 -170.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 81.62 5.17 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.964 -1.493 . . . . 0.0 108.376 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.79 141.05 33.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.947 0.499 . . . . 0.0 109.998 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.39 143.26 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.836 0.855 . . . . 0.0 110.264 -173.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.08 161.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 110.552 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 p -148.49 174.55 11.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.015 0.926 . . . . 0.0 109.198 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -10.2 -61.71 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 128.661 2.785 . . . . 0.0 116.071 170.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.9 Cg_exo -62.85 -17.16 58.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 CA-C-N 121.494 1.569 . . . . 0.0 113.694 -172.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.67 -31.24 72.15 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.741 0.701 . . . . 0.0 112.03 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.17 91.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.806 0.812 . . . . 0.0 110.14 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.89 85.43 0.16 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.092 2.282 . . . . 0.0 107.639 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.287 6.5 t -6.85 99.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.466 2.706 . . . . 0.0 117.096 -172.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp 56.09 41.62 29.35 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.486 2.314 . . . . 0.0 113.108 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -46.36 -52.11 13.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.741 1.617 . . . . 0.0 112.472 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.04 -121.58 0.72 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.81 0.844 . . . . 0.0 109.229 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m 68.86 -57.38 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.056 1.743 . . . . 0.0 111.634 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.3 p -70.21 64.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 0.0 108.671 169.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.36 152.36 21.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 126.053 1.741 . . . . 0.0 108.0 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 61.12 -10.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.982 2.215 . . . . 0.0 116.982 173.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m -90.55 -24.62 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.812 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -72.76 125.52 91.15 Favored Pre-proline 0 CA--C 1.538 0.512 0 O-C-N 122.211 -0.306 . . . . 0.0 110.19 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.15 -31.54 55.44 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.278 3.318 . . . . 0.0 113.531 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.17 19.92 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.89 0.876 . . . . 0.0 111.853 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.6 t70 41.23 56.39 3.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.065 1.346 . . . . 0.0 113.202 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -110.85 36.19 3.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.681 0.793 . . . . 0.0 111.006 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.41 131.96 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 106.713 176.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -142.1 174.65 10.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.815 1.646 . . . . 0.0 107.749 -169.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -107.94 160.39 15.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.117 0.96 . . . . 0.0 113.095 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.36 67.65 0.56 Allowed Glycine 0 N--CA 1.445 -0.716 1 N-CA-C 102.732 -4.147 . . . . 0.0 102.732 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 64.41 -63.22 0.17 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 131.096 3.758 . . . . 0.0 112.631 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -101.74 -20.5 14.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 112.57 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.45 162.81 38.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.12 -0.987 . . . . 0.0 108.62 -169.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -85.05 162.72 19.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.75 0.656 . . . . 0.0 110.911 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -145.19 131.45 19.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.789 2.436 . . . . 0.0 106.495 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 25' ' ' ILE . 67.6 mt -108.82 129.31 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 13.3 t0 -69.13 113.95 20.06 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.327 0.967 . . . . 0.0 109.192 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -28.94 71.1 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.385 1.39 . . . . 0.0 112.304 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -31.48 23.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.092 -0.48 . . . . 0.0 109.763 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.74 -28.29 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.247 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -58.94 119.53 7.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.946 1.248 . . . . 0.0 111.09 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 pt -91.65 33.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.103 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 43.92 58.98 3.35 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.015 1.326 . . . . 0.0 112.592 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.94 -173.86 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.98 172.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.58 104.4 0.8 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -163.03 -75.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.243 1.017 . . . . 0.0 110.025 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.4 p -50.83 -44.39 59.3 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.601 1.161 . . . . 0.0 112.365 -172.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -39.14 90.54 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.544 -0.722 . . . . 0.0 111.658 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.01 -36.92 67.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.812 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.0 t -65.86 -43.23 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.948 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 t -58.65 112.95 5.67 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 119.272 0.942 . . . . 0.0 108.665 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.28 42.35 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.621 2.881 . . . . 0.0 111.08 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.1 -34.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 128.979 2.911 . . . . 0.0 107.8 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m 57.13 59.85 3.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.276 1.031 . . . . 0.0 110.085 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.65 -23.99 56.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.476 1.51 . . . . 0.0 109.873 169.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.94 116.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.402 1.481 . . . . 0.0 107.008 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -122.87 166.45 15.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.82 145.39 52.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -44.05 62.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.615 -0.678 . . . . 0.0 111.995 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.49 -16.7 63.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.246 1.019 . . . . 0.0 112.597 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -80.8 -38.51 28.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.83 121.07 62.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.822 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -54.03 148.6 38.44 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.717 2.945 . . . . 0.0 112.119 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -52.88 -41.43 64.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.679 1.191 . . . . 0.0 110.728 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -44.34 -47.92 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.067 1.347 . . . . 0.0 111.292 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -95.9 -8.56 33.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.694 1.198 . . . . 0.0 112.08 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -59.95 -16.79 32.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 119.524 1.056 . . . . 0.0 110.869 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -50.56 -47.57 57.73 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.624 -0.673 . . . . 0.0 109.427 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -63.63 -37.34 86.95 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 121.651 -0.656 . . . . 0.0 111.18 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -45.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -55.89 -45.03 78.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -64.07 -45.89 86.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.605 0.639 . . . . 0.0 112.202 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -55.69 -41.58 73.96 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.417 1.487 . . . . 0.0 110.876 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -63.78 -58.44 6.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.1 -46.04 75.5 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.058 1.743 . . . . 0.0 112.833 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -34.76 -53.5 0.55 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.729 1.212 . . . . 0.0 112.298 -173.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -106.71 1.7 25.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 124.438 1.087 . . . . 0.0 112.315 -170.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 11.8 mptt -102.72 -8.65 20.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.778 0.717 . . . . 0.0 112.667 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.563 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -119.7 152.42 37.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.42 0.555 . . . . 0.0 109.704 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 68' ' ' ILE . 46.7 t -131.9 140.6 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.976 0.911 . . . . 0.0 110.613 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 127.344 2.257 . . . . 0.0 107.968 169.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -113.75 -89.97 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -134.46 -52.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -167.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.67 -25.16 74.19 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.935 1.757 . . . . 0.0 113.529 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.12 -37.32 66.74 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.832 0.853 . . . . 0.0 112.294 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.292 3.6 mp -69.01 96.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 122.181 0.991 . . . . 0.0 112.574 -168.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.3 -171.89 14.58 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 103.471 -3.852 . . . . 0.0 103.471 169.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.95 105.33 1.97 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.561 1.944 . . . . 0.0 111.789 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm 62.58 -63.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.638 2.375 . . . . 0.0 115.528 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t 66.03 -89.42 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.827 2.051 . . . . 0.0 112.093 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 96.54 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.341 2.657 . . . . 0.0 108.68 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m 73.92 -57.66 0.61 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.406 2.282 . . . . 0.0 111.584 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.52 -24.47 61.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.34 1.056 . . . . 0.0 111.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.26 7.9 p -72.55 -52.19 24.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 O-C-N 121.345 -0.847 . . . . 0.0 112.27 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -74.13 17.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.46 -20.51 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.68 129.25 94.29 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 120.476 1.489 . . . . 0.0 109.711 -172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.01 -42.32 25.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.801 3.667 . . . . 0.0 113.3 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.72 110.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 25' ' ' ILE . 33.4 t0 -31.01 120.25 0.21 Allowed 'General case' 0 C--O 1.23 0.077 0 C-N-CA 126.101 1.76 . . . . 0.0 114.686 -176.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.7 m -133.7 16.93 3.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 108.036 168.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.62 110.99 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -115.92 145.75 42.64 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -166.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.82 78.08 3.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 122.483 1.135 . . . . 0.0 108.861 169.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.66 97.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.26 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -125.0 -74.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.751 1.221 . . . . 0.0 107.803 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -135.71 -39.25 0.72 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.144 0.978 . . . . 0.0 113.12 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 170.88 8.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.488 1.915 . . . . 0.0 108.954 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.02 127.19 32.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.86 -172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -109.19 117.18 33.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.849 3.26 . . . . 0.0 106.976 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 44.1 mt -82.08 129.09 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.88 0.764 . . . . 0.0 109.487 -175.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.14 112.91 26.23 Favored Pre-proline 0 C--O 1.232 0.181 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.8 -29.74 50.32 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.41 1.407 . . . . 0.0 111.203 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -82.63 -29.64 29.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.293 0.637 . . . . 0.0 109.608 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.94 -33.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.562 0.619 . . . . 0.0 110.932 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.9 t -52.07 120.66 5.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.323 0.965 . . . . 0.0 111.436 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.58 35.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.738 0.815 . . . . 0.0 112.112 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 45.04 50.08 9.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 0.0 113.496 176.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.31 -167.51 1.8 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.55 101.02 0.44 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 169.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.7 -76.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.094 0.947 . . . . 0.0 110.042 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.2 p -48.16 -46.06 34.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.759 1.224 . . . . 0.0 111.844 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -50.9 71.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.956 0.902 . . . . 0.0 112.18 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.34 70.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.15 0.58 . . . . 0.0 110.828 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 t -69.65 -38.81 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.236 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.4 t -57.73 111.67 3.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.753 1.16 . . . . 0.0 109.67 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 -14.26 41.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.501 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.91 -22.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.265 1.426 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m 53.16 57.25 6.47 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 111.258 -171.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.97 -19.85 29.8 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 111.444 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.99 127.99 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 124.989 1.316 . . . . 0.0 107.649 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -139.65 168.45 19.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.21 148.21 52.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -53.28 -42.8 66.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.76 -23.22 60.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.819 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.58 -35.87 52.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.19 125.26 70.12 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.631 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.82 141.91 64.46 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.442 2.761 . . . . 0.0 112.148 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -35.37 -51.3 0.59 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.403 2.681 . . . . 0.0 113.461 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.48 -46.89 14.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.953 0.882 . . . . 0.0 110.617 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -95.18 -3.13 48.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.464 1.506 . . . . 0.0 112.629 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -60.34 -22.53 63.34 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.531 1.514 . . . . 0.0 110.119 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -48.58 -41.75 31.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.317 0.647 . . . . 0.0 110.294 167.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -68.44 -32.49 72.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.245 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.497 HD12 HG11 ' A' ' 3' ' ' VAL . 1.4 mp -61.84 -46.84 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 121.135 1.789 . . . . 0.0 107.365 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.08 -49.12 72.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.017 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -63.71 -43.25 97.15 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -61.32 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.489 1.515 . . . . 0.0 110.297 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -57.23 13.41 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.32 -42.38 99.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 128.375 2.67 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -37.15 -51.84 1.01 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.414 1.086 . . . . 0.0 112.836 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.34 4.14 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.795 0.838 . . . . 0.0 111.503 -170.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 80.63 1.33 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.032 -1.937 . . . . 0.0 107.365 -169.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -90.18 161.59 15.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.195 0.521 . . . . 0.0 111.294 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.19 149.58 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.339 1.055 . . . . 0.0 110.794 -172.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.45 138.71 25.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.979 1.312 . . . . 0.0 109.196 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -128.79 170.84 12.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 111.939 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.25 7.8 tt0 -12.25 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 129.756 3.222 . . . . 0.0 116.657 171.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.66 -19.74 54.66 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 122.559 1.95 . . . . 0.0 114.572 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -68.07 -29.1 67.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.071 0.851 . . . . 0.0 111.895 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.7 mt -44.18 110.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.3 0 C-N-CA 124.576 1.15 . . . . 0.0 113.188 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 38.47 0.07 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.9 m 57.51 -83.63 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.954 2.101 . . . . 0.0 113.258 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -124.86 110.46 14.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.601 0.761 . . . . 0.0 109.556 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -129.76 163.82 25.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.446 2.299 . . . . 0.0 105.242 170.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.71 -130.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.6 m 73.6 -68.17 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.601 2.36 . . . . 0.0 110.569 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 p -59.57 -28.44 67.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.826 0.451 . . . . 0.0 110.392 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.58 -66.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.39 1.076 . . . . 0.0 111.846 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -76.95 38.68 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.782 1.233 . . . . 0.0 113.839 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.45 -33.48 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.17 0.988 . . . . 0.0 113.195 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.03 122.6 73.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 120.064 1.302 . . . . 0.0 112.305 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.73 -31.06 91.5 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.841 3.028 . . . . 0.0 112.842 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.9 16.6 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.332 0.653 . . . . 0.0 112.237 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.8 t0 44.2 56.37 4.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.225 . . . . 0.0 112.405 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.7 p -115.63 32.42 6.08 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.563 0.745 . . . . 0.0 110.943 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.68 114.99 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.572 2.349 . . . . 0.0 107.818 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -128.75 173.8 10.01 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 126.198 1.799 . . . . 0.0 109.72 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -119.89 165.2 14.93 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.009 1.323 . . . . 0.0 113.925 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -128.68 13.67 6.13 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.821 1.677 . . . . 0.0 110.571 167.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 73.9 12.48 4.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.958 2.503 . . . . 0.0 112.774 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -123.54 -48.35 1.94 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 128.789 2.836 . . . . 0.0 109.611 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.83 176.25 10.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.032 2.133 . . . . 0.0 105.371 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.52 166.65 19.11 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.197 0.522 . . . . 0.0 110.269 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -145.39 109.67 4.92 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.767 2.027 . . . . 0.0 107.184 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.89 133.09 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -74.54 111.49 13.21 Favored Pre-proline 0 C--N 1.343 0.301 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 167.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -58.38 -33.53 97.9 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.111 1.207 . . . . 0.0 111.591 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -80.26 -29.83 38.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.705 -0.622 . . . . 0.0 110.599 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.3 -30.68 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.68 125.02 20.4 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.042 0.837 . . . . 0.0 111.308 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 pt -99.05 32.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.258 1.023 . . . . 0.0 111.347 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 46.4 41.7 9.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.78 1.632 . . . . 0.0 113.691 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -21.92 59.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.287 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.44 -139.23 25.33 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.847 1.213 . . . . 0.0 110.682 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.48 -60.55 0.5 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.836 2.054 . . . . 0.0 111.409 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -52.31 -40.46 61.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.911 0.884 . . . . 0.0 111.374 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -46.19 80.73 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.768 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.49 76.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.359 0.663 . . . . 0.0 110.292 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.4 -37.76 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.147 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 t -61.21 116.15 18.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.01 1.277 . . . . 0.0 108.103 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.89 -19.83 49.43 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.1 1.867 . . . . 0.0 112.777 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.27 -19.09 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.305 1.442 . . . . 0.0 110.235 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.0 m 51.9 58.36 5.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.359 1.064 . . . . 0.0 111.137 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.17 -13.4 59.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.071 0.948 . . . . 0.0 111.596 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.11 129.81 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.82 179.45 6.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.431 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 7.8 t-80 -79.51 145.35 33.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -48.31 -42.47 31.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.02 -39.82 87.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.223 0.535 . . . . 0.0 112.274 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -76.88 -32.41 57.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.517 -168.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.72 128.89 80.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.083 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.79 143.55 47.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.157 2.571 . . . . 0.0 112.4 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -44.05 -44.93 7.75 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.603 2.761 . . . . 0.0 112.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -46.77 -47.73 20.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.086 0.954 . . . . 0.0 110.843 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -93.17 -6.2 48.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.402 1.481 . . . . 0.0 112.301 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -59.85 -16.04 25.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.273 1.397 . . . . 0.0 110.869 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 p -52.73 -47.35 67.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.064 -1.022 . . . . 0.0 108.998 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -65.76 -30.16 70.77 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.355 -0.831 . . . . 0.0 111.621 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.04 -49.85 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -54.32 -41.87 69.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.421 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -49.98 66.75 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.624 0.647 . . . . 0.0 112.351 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.22 -42.18 69.51 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.371 1.468 . . . . 0.0 109.71 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -58.55 7.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.1 -44.38 83.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.887 2.475 . . . . 0.0 112.923 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -38.28 -50.99 1.49 Allowed 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.383 1.073 . . . . 0.0 112.664 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -102.74 -15.08 16.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 111.483 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 73.82 8.64 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 116.429 -1.748 . . . . 0.0 107.601 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -108.27 145.21 34.69 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.317 1.447 . . . . 0.0 110.864 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.09 140.54 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.714 1.206 . . . . 0.0 111.51 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -37.92 71.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 C-N-CA 126.123 1.769 . . . . 0.0 112.133 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p 63.36 -108.08 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.712 2.405 . . . . 0.0 114.24 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.92 -52.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -167.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.75 77.64 2.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.014 1.81 . . . . 0.0 111.077 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -178.03 -41.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.238 2.615 . . . . 0.0 108.026 -170.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.94 143.75 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 124.116 0.966 . . . . 0.0 113.024 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.59 32.98 58.89 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 124.954 1.264 . . . . 0.0 112.146 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -161.47 103.24 1.22 Allowed 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.253 1.421 . . . . 0.0 108.097 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -53.16 -39.11 63.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.091 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.9 t 66.71 -68.14 0.15 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 113.756 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.09 42.2 28.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.767 1.627 . . . . 0.0 112.472 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.4 m -100.51 -50.15 3.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.287 0.635 . . . . 0.0 111.228 171.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.3 p -75.16 68.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.762 0.791 . . . . 0.0 109.766 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.95 151.43 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.903 1.681 . . . . 0.0 109.043 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 59.01 29.74 19.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.701 1.6 . . . . 0.0 111.899 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.35 -38.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.366 1.066 . . . . 0.0 111.498 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.11 131.56 93.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.423 0.689 . . . . 0.0 110.201 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -45.95 -36.63 16.0 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 125.274 3.983 . . . . 0.0 114.229 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.71 19.48 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.051 0.94 . . . . 0.0 111.405 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 40.64 44.25 1.77 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 113.316 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.4 p -90.2 46.73 1.37 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.291 1.037 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.63 125.74 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.063 1.745 . . . . 0.0 106.564 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -133.8 166.57 22.34 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 124.791 1.237 . . . . 0.0 107.882 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -98.48 140.75 32.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 120.206 1.366 . . . . 0.0 112.096 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.79 -50.61 4.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 166.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 175.33 -74.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.516 3.126 . . . . 0.0 105.008 168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.32 10.23 7.41 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.057 1.343 . . . . 0.0 113.023 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.84 153.23 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.08 161.99 22.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.857 0.723 . . . . 0.0 110.233 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -134.53 111.89 10.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.861 2.865 . . . . 0.0 105.325 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.52 138.57 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 21.0 t0 -78.9 108.16 7.59 Favored Pre-proline 0 N--CA 1.464 0.268 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -76.67 -3.31 13.64 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.319 1.346 . . . . 0.0 112.479 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' ' HZ2' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -92.89 -38.36 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 109.983 169.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.86 -31.19 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 t -57.19 131.18 49.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.243 0.929 . . . . 0.0 111.211 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.2 pt -103.99 37.19 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.669 1.187 . . . . 0.0 111.53 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 28.0 m-20 52.23 37.06 21.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.393 1.477 . . . . 0.0 114.017 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -20.81 39.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.49 -140.45 24.42 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.03 -57.06 0.57 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 127.359 2.264 . . . . 0.0 111.386 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.2 -37.15 71.76 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.615 0.766 . . . . 0.0 111.188 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -43.28 86.14 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.3 -0.875 . . . . 0.0 110.912 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.17 84.01 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.861 0.464 . . . . 0.0 110.683 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.6 t -67.35 -40.29 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.043 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' HG13 ' A' ' 51' ' ' VAL . 5.6 t -58.38 115.62 12.13 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.95 61.44 7.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.952 3.101 . . . . 0.0 109.14 -172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG13 ' SG ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER 174.93 -36.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.813 2.445 . . . . 0.0 108.593 -167.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m 58.31 53.88 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.086 0.954 . . . . 0.0 110.864 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.285 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.25 121.43 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -118.26 164.13 15.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -71.69 147.28 47.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.79 -36.96 70.48 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.265 1.031 . . . . 0.0 113.183 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.51 -46.21 66.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.307 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -76.48 -36.44 57.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.616 1.167 . . . . 0.0 110.927 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HD11 ' A' ' 68' ' ' ILE . 49.1 t -52.46 122.14 24.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.5 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.03 147.32 64.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.3 2.667 . . . . 0.0 112.81 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 4.6 mp0 -39.69 -47.06 1.96 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.831 3.252 . . . . 0.0 113.537 174.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.06 -43.42 14.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.769 0.828 . . . . 0.0 111.11 172.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -102.13 -1.68 30.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.617 1.967 . . . . 0.0 112.87 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 68' ' ' ILE . 30.5 mmtm -55.52 -28.81 56.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.588 1.54 . . . . 0.0 109.501 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 p -48.78 -45.49 40.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.054 1.342 . . . . 0.0 111.566 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -67.81 -32.68 73.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.549 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 65' ' ' LYS . 10.2 mt -63.94 -47.67 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 120.73 1.605 . . . . 0.0 108.283 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -49.99 -53.67 25.02 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.62 93.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.763 0.256 . . . . 0.0 111.204 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.535 0.734 . . . . 0.0 111.111 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -62.85 -57.89 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.934 1.35 . . . . 0.0 109.202 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.413 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 47.9 t0 -59.64 -38.98 82.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.848 2.859 . . . . 0.0 112.25 -169.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -37.33 -57.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 171.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -97.48 -31.58 12.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.806 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -76.56 81.38 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.998 -1.477 . . . . 0.0 108.007 -169.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -101.47 136.71 40.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.934 1.294 . . . . 0.0 108.604 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.7 142.75 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.367 0.667 . . . . 0.0 111.219 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.11 157.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.187 1.795 . . . . 0.0 111.179 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -145.77 160.08 42.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.341 3.6 tt0 1.2 -66.14 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 130.068 3.347 . . . . 0.0 117.445 169.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.6 Cg_exo -56.04 -25.71 55.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 122.76 2.021 . . . . 0.0 114.633 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 t -57.29 -33.98 68.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 112.177 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.63 83.44 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.646 0.736 . . . . 0.0 111.032 -169.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.88 65.11 0.6 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.148 1.832 . . . . 0.0 108.876 171.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.256 14.2 t 50.13 -156.42 0.1 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.919 1.688 . . . . 0.0 112.435 -175.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -77.4 100.72 6.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.942 0.877 . . . . 0.0 110.56 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.62 177.62 8.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.149 1.78 . . . . 0.0 109.687 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.42 134.33 12.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m 156.42 -68.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.348 2.259 . . . . 0.0 107.412 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.89 40.29 0.24 Allowed 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.564 -0.71 . . . . 0.0 110.876 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.71 -73.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.069 0 O-C-N 120.548 -1.345 . . . . 0.0 107.988 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -80.85 41.5 0.58 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.88 -35.7 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.35 127.91 93.34 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.378 0.99 . . . . 0.0 110.925 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.96 -36.4 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.945 3.763 . . . . 0.0 114.218 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.75 45.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.802 0.841 . . . . 0.0 111.213 -169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 55.62 -115.18 0.91 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.049 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.16 -19.64 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.78 103.26 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.95 1.3 . . . . 0.0 109.824 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.27 142.63 47.29 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.632 1.173 . . . . 0.0 111.823 -169.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -75.8 77.72 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.601 1.091 . . . . 0.0 109.369 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.97 -43.02 96.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.666 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -111.55 -120.72 0.29 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -101.16 -8.79 21.91 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 111.071 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.36 161.87 28.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.425 2.69 . . . . 0.0 108.536 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.49 120.99 25.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.348 0.659 . . . . 0.0 112.255 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 124.14 47.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.441 3.096 . . . . 0.0 106.421 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt -89.34 125.33 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 118.125 -0.94 . . . . 0.0 108.516 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.1 t0 -70.24 113.44 17.97 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 120.134 1.334 . . . . 0.0 108.417 169.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 57.2 Cg_endo -61.9 -31.85 84.86 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 121.277 1.318 . . . . 0.0 110.975 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -79.86 -21.14 44.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.871 -0.518 . . . . 0.0 110.369 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -88.09 -37.55 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.334 0.516 . . . . 0.0 110.706 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.08 148.18 36.73 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.807 0.731 . . . . 0.0 111.207 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 pt -122.62 38.46 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.255 1.422 . . . . 0.0 111.017 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 46.94 39.69 7.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.323 1.849 . . . . 0.0 112.615 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.17 159.0 32.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.829 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.44 63.65 4.38 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.03 174.33 15.38 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 124.373 1.069 . . . . 0.0 108.233 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.283 4.8 p 66.39 -56.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.387 2.275 . . . . 0.0 111.644 -169.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -66.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.992 0.917 . . . . 0.0 111.67 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.83 64.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.261 0.624 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.63 -35.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.555 0.742 . . . . 0.0 109.484 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -60.74 114.07 9.33 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 -2.5 7.72 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.299 2.0 . . . . 0.0 113.026 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -108.8 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.242 1.817 . . . . 0.0 109.894 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.3 m 52.48 55.28 9.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.054 0.942 . . . . 0.0 111.563 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.36 -16.17 50.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 111.058 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.98 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -133.75 167.66 20.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.59 145.15 56.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.58 171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.5 -41.03 65.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.42 -31.42 72.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.806 0.843 . . . . 0.0 110.885 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -81.45 -36.74 29.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.439 0.695 . . . . 0.0 109.945 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -48.92 127.5 14.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.339 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.01 142.51 64.95 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 0.0 112.125 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -41.66 -45.78 3.52 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.755 2.822 . . . . 0.0 112.784 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -47.68 -46.13 28.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.141 0.976 . . . . 0.0 110.882 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -96.19 -6.58 37.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.494 1.518 . . . . 0.0 112.578 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -58.87 -19.9 46.14 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.26 1.391 . . . . 0.0 110.422 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -49.84 -46.71 51.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.705 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -62.7 -35.83 80.97 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.171 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.66 -45.59 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.717 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -65.27 -46.5 80.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.365 0.529 . . . . 0.0 111.654 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 12.3 m-80 -58.24 -42.54 86.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 110.885 175.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -57.81 -61.64 2.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.719 1.208 . . . . 0.0 108.028 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -52.25 -51.74 56.65 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.801 2.44 . . . . 0.0 113.054 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -50.92 0.29 Allowed 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.175 1.79 . . . . 0.0 113.695 -175.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -110.02 -1.14 17.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.715 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.53 -34.31 41.25 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.165 0.893 . . . . 0.0 111.162 -174.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -109.56 142.62 40.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.027 1.331 . . . . 0.0 109.746 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.07 141.04 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.462 1.105 . . . . 0.0 110.705 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -48.37 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 128.433 2.693 . . . . 0.0 114.316 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p 61.19 -165.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.66 1.584 . . . . 0.0 114.065 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.05 -48.93 59.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 129.446 3.099 . . . . 0.0 115.726 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.09 -22.4 74.16 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 CA-C-N 121.322 1.508 . . . . 0.0 113.327 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -58.33 -34.08 70.23 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.444 0.697 . . . . 0.0 112.026 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -71.14 84.15 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.683 0.754 . . . . 0.0 110.814 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.15 58.28 0.7 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.597 2.046 . . . . 0.0 108.608 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.266 14.5 t 49.23 -150.01 0.2 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.022 1.729 . . . . 0.0 113.025 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -66.56 81.62 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.936 1.695 . . . . 0.0 112.157 -172.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.7 t -66.22 151.37 47.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.995 0.918 . . . . 0.0 109.598 169.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.44 44.19 2.31 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.263 1.025 . . . . 0.0 109.508 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -150.49 144.15 25.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.386 5.7 p 74.01 49.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.657 2.383 . . . . 0.0 108.466 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 -43.28 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.624 1.97 . . . . 0.0 109.246 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.07 27.04 2.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.756 2.822 . . . . 0.0 113.498 -168.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.5 -37.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -168.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 t -59.34 123.66 71.27 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.698 1.135 . . . . 0.0 112.535 -168.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.93 -47.21 19.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 1 C-N-CA 125.318 4.012 . . . . 0.0 113.144 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -133.65 84.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -17.37 112.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.984 2.114 . . . . 0.0 114.544 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m -121.97 1.14 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.135 1.374 . . . . 0.0 109.94 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.14 106.4 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.222 0.919 . . . . 0.0 112.433 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -125.95 144.28 50.75 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.081 0.953 . . . . 0.0 110.191 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.39 118.39 17.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 120.157 1.344 . . . . 0.0 111.93 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.66 75.08 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 104.781 -3.327 . . . . 0.0 104.781 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 71.94 -47.83 0.67 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.602 2.761 . . . . 0.0 112.152 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.01 -12.5 1.46 Allowed 'General case' 0 C--N 1.34 0.181 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.04 34.52 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.06 135.83 49.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 109.989 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 128.74 54.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.066 3.346 . . . . 0.0 104.545 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.0 mt -93.48 124.86 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.78 116.04 33.88 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.056 1.298 . . . . 0.0 108.201 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.91 -20.35 17.17 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.959 1.773 . . . . 0.0 111.605 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -88.39 -30.68 19.32 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.58 -38.6 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.41 171.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.43 146.28 51.86 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.528 0.604 . . . . 0.0 111.352 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.1 pt -120.79 37.9 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.264 1.426 . . . . 0.0 111.098 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.88 42.44 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.724 1.61 . . . . 0.0 111.752 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 161.51 28.92 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.889 -0.507 . . . . 0.0 111.483 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.6 61.19 3.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.98 156.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.257 1.5 p 78.35 -55.68 0.48 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.855 2.462 . . . . 0.0 109.953 -169.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -59.26 0.88 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.859 1.664 . . . . 0.0 113.827 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.64 -10.16 57.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.958 . . . . 0.0 112.494 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.08 -37.26 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.64 0.655 . . . . 0.0 109.447 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.95 114.91 9.51 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.21 -7.64 17.96 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.445 2.097 . . . . 0.0 112.616 -174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.33 -20.47 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.536 1.534 . . . . 0.0 109.865 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m 54.35 51.98 13.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 111.318 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.64 34.76 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.8 mt -64.69 120.88 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -130.64 164.25 25.4 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -65.87 150.08 49.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.99 -43.89 60.78 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -66.05 -29.89 70.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.282 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -82.56 -37.09 25.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.282 0.633 . . . . 0.0 109.887 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -50.89 128.96 28.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.371 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.57 148.15 45.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.17 2.58 . . . . 0.0 113.471 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -45.71 -44.61 13.71 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 129.164 2.986 . . . . 0.0 112.881 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -48.43 -44.45 35.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 111.003 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -97.06 -0.27 47.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.104 1.361 . . . . 0.0 112.441 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -55.42 -29.7 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.777 1.171 . . . . 0.0 108.906 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.19 -44.97 11.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.44 1.096 . . . . 0.0 111.557 169.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -66.39 -34.74 78.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.801 -1.095 . . . . 0.0 111.667 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.12 -43.99 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 120.712 1.596 . . . . 0.0 107.133 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -51.43 69.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -59.19 -42.11 90.09 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.128 -0.982 . . . . 0.0 112.231 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -60.45 -44.16 96.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.138 1.775 . . . . 0.0 110.649 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.05 -55.92 27.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.188 0.995 . . . . 0.0 109.178 174.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.11 -42.02 94.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 129.111 2.964 . . . . 0.0 114.043 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.95 -53.81 0.76 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.705 1.202 . . . . 0.0 112.984 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.2 4.3 31.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.008 0.923 . . . . 0.0 111.497 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 79.85 1.25 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 CA-C-O 116.064 -1.922 . . . . 0.0 107.463 -169.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -103.73 143.06 33.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.279 1.032 . . . . 0.0 110.043 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.36 138.15 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.205 1.002 . . . . 0.0 110.814 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.34 151.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.935 1.694 . . . . 0.0 109.833 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.2 p -138.81 160.17 40.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.923 -0.486 . . . . 0.0 110.574 172.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.331 4.9 tt0 -1.28 -64.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 130.192 3.397 . . . . 0.0 117.418 172.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 52.3 Cg_exo -54.63 -25.42 41.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 122.864 2.059 . . . . 0.0 114.844 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 -35.83 68.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.795 0.838 . . . . 0.0 112.261 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.434 HG13 ' HG2' ' A' ' 31' ' ' GLN 0.273 3.5 mp -70.31 89.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.747 0.784 . . . . 0.0 112.205 -168.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.4 47.44 0.71 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.621 1.581 . . . . 0.0 110.986 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.363 0.9 OUTLIER 51.56 118.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.472 2.709 . . . . 0.0 118.075 174.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? 68.09 -63.33 0.33 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.476 2.71 . . . . 0.0 112.588 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t 64.11 -66.3 0.12 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.158 1.783 . . . . 0.0 112.966 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.07 47.79 11.52 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 112.406 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.0 m -110.92 -56.37 2.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.303 0.641 . . . . 0.0 110.703 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -72.95 75.33 1.18 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.993 0.901 . . . . 0.0 109.263 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 m -115.56 -140.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 110.116 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -67.73 17.79 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.65 -28.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -62.41 127.98 90.68 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.52 -34.3 71.85 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.482 3.454 . . . . 0.0 114.637 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.56 24.44 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 122.576 0.351 . . . . 0.0 111.449 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 62.94 -176.28 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.192 0.597 . . . . 0.0 109.454 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.2 p 122.18 -5.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.976 3.71 . . . . 0.0 111.923 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -91.2 110.84 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.37 141.81 50.97 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 109.877 -170.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.98 113.71 9.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 120.175 1.352 . . . . 0.0 109.823 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.34 64.58 3.76 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 170.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 65.5 -59.11 0.29 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 129.811 3.245 . . . . 0.0 111.163 -172.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.48 -54.29 4.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.535 0.734 . . . . 0.0 112.072 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.434 ' HG2' HG13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -141.8 166.49 24.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.588 1.155 . . . . 0.0 110.215 -169.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.82 133.39 50.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.645 0.736 . . . . 0.0 110.695 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 131.19 53.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 131.002 3.721 . . . . 0.0 104.586 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 25' ' ' ILE . 67.1 mt -99.5 128.41 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.445 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.4 t0 -74.66 111.85 14.93 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 120.037 1.29 . . . . 0.0 107.697 168.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.72 -29.61 69.01 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.563 1.509 . . . . 0.0 111.041 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.27 -24.38 40.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.71 -0.619 . . . . 0.0 110.22 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.06 -35.7 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.5 0.591 . . . . 0.0 110.74 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.2 t -54.71 129.88 38.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.03 0.832 . . . . 0.0 110.743 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.02 35.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 111.378 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.55 37.64 9.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.166 1.787 . . . . 0.0 113.082 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -23.79 46.14 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.55 -141.73 21.39 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.357 0.98 . . . . 0.0 111.772 -169.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.48 -65.01 0.36 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.919 2.088 . . . . 0.0 113.026 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -46.87 -42.37 17.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.61 1.164 . . . . 0.0 109.803 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -40.88 -44.62 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.188 2.195 . . . . 0.0 114.426 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 -28.17 16.63 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 110.19 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -63.42 -38.49 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 119.068 -0.492 . . . . 0.0 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -61.23 113.0 6.76 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.47 29.68 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.448 2.766 . . . . 0.0 112.74 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.15 -29.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 129.42 3.088 . . . . 0.0 108.056 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m 55.54 57.93 4.95 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.503 1.121 . . . . 0.0 110.759 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.51 57.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.819 1.248 . . . . 0.0 110.745 170.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mt -80.85 124.79 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -128.31 167.57 16.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.39 146.24 54.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.46 -36.47 69.11 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.424 1.107 . . . . 0.0 112.882 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.64 -44.14 76.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.132 171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -78.32 -34.65 48.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.329 1.452 . . . . 0.0 112.022 -168.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 68' ' ' ILE . 40.3 t -50.0 124.31 16.8 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.508 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 143.66 67.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.989 2.459 . . . . 0.0 112.114 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -42.77 -46.89 5.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 128.867 2.867 . . . . 0.0 112.462 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -46.38 -45.14 17.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.14 0.976 . . . . 0.0 110.878 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -97.96 0.49 46.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.702 1.601 . . . . 0.0 112.411 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 68' ' ' ILE . 40.9 mttp -61.3 -19.21 61.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.23 1.377 . . . . 0.0 110.781 170.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -54.07 -42.75 69.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.098 0.959 . . . . 0.0 110.167 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -64.83 -36.62 84.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.064 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 60' ' ' VAL . 11.0 mt -60.36 -44.76 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 120.756 1.616 . . . . 0.0 109.047 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -54.13 -48.22 71.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.427 173.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -61.47 -45.06 95.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.465 0.575 . . . . 0.0 112.064 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -58.89 -43.55 91.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.581 1.152 . . . . 0.0 110.904 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -58.13 -60.46 3.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.893 1.277 . . . . 0.0 107.655 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.14 -51.05 63.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.569 2.748 . . . . 0.0 112.942 -171.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -32.68 -49.6 0.23 Allowed 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 126.581 1.952 . . . . 0.0 113.472 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -114.08 -0.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.804 0.69 . . . . 0.0 111.768 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.11 -34.31 43.56 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.184 0.902 . . . . 0.0 110.873 -174.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.385 0 CA-C-O 115.684 -2.103 . . . . 0.0 106.35 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -97.46 138.91 34.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.401 0.68 . . . . 0.0 109.177 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.42 140.79 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.751 0.786 . . . . 0.0 111.097 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -75.93 152.56 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.686 3.194 . . . . 0.0 111.054 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -146.47 166.71 25.6 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.713 0.405 . . . . 0.0 111.27 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.272 58.4 tt0 -16.2 -60.05 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 129.002 2.921 . . . . 0.0 116.147 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.07 -18.03 41.3 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 121.691 1.64 . . . . 0.0 115.12 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 t -62.36 -40.62 97.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.771 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.86 118.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.024 0.375 . . . . 0.0 110.354 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.42 76.3 0.06 OUTLIER Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.315 3.1 t 64.39 -49.36 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.286 2.634 . . . . 0.0 116.181 170.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 -60.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.981 1.264 . . . . 0.0 111.102 176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.6 -71.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.522 1.929 . . . . 0.0 114.965 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.18 -123.25 0.49 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 109.337 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m 72.29 -55.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.957 2.103 . . . . 0.0 112.783 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.13 -47.98 82.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.389 1.076 . . . . 0.0 110.634 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.79 -41.61 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 O-C-N 121.434 -0.791 . . . . 0.0 112.418 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -68.19 -7.31 29.13 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.63 -22.95 3.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 120.02 1.282 . . . . 0.0 113.665 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -61.87 128.93 91.24 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.45 1.023 . . . . 0.0 110.973 -172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.29 -41.62 13.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 1 C-N-CA 125.327 4.018 . . . . 0.0 114.312 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.18 57.71 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.905 0.882 . . . . 0.0 109.769 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -4.23 104.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.939 2.096 . . . . 0.0 114.689 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -132.14 29.77 4.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.305 171.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.552 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -110.51 113.79 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 -169.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -136.76 140.59 42.68 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -165.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -68.13 160.69 28.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.522 -1.361 . . . . 0.0 112.767 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.63 -52.99 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -112.92 -63.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.586 1.554 . . . . 0.0 109.712 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.8 -54.49 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 109.007 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 145.25 56.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.516 2.327 . . . . 0.0 111.008 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HB3' HG22 ' A' ' 25' ' ' ILE . 69.4 m-85 -86.2 102.69 14.14 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 111.746 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -54.41 110.5 0.63 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.839 2.856 . . . . 0.0 108.505 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -82.97 115.27 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.417 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 9.6 t0 -62.83 117.22 30.08 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.686 1.13 . . . . 0.0 108.544 171.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.88 -24.82 20.66 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 121.493 1.462 . . . . 0.0 112.085 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -36.51 34.18 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.68 -32.02 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.309 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.2 t -59.64 124.22 19.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.215 0.916 . . . . 0.0 110.539 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.91 36.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.998 0.919 . . . . 0.0 111.706 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 39.1 61.9 1.2 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.086 1.755 . . . . 0.0 112.609 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.92 -163.19 1.02 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.862 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 101.87 0.41 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.74 -65.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.06 1.344 . . . . 0.0 110.786 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.1 p -60.37 -52.41 65.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.495 0.718 . . . . 0.0 111.262 -172.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -54.8 24.11 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.757 0.823 . . . . 0.0 111.306 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.98 66.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.02 0.528 . . . . 0.0 112.003 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -41.31 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.349 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.0 t -58.35 111.7 3.93 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.001 0.819 . . . . 0.0 108.877 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.1 22.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.439 2.759 . . . . 0.0 113.038 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -135.09 -28.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 129.871 3.268 . . . . 0.0 107.616 -177.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 54.35 59.53 4.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.623 1.169 . . . . 0.0 110.39 -172.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.14 44.94 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.349 1.06 . . . . 0.0 110.214 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.1 mt -77.67 125.51 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -131.94 171.32 13.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.87 147.18 50.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.141 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -49.11 -41.72 36.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.14 -40.28 89.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.452 0.701 . . . . 0.0 111.461 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -78.79 -34.91 45.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.177 0.991 . . . . 0.0 110.855 -168.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.87 123.99 26.68 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.389 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.76 144.69 53.22 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.066 2.511 . . . . 0.0 112.119 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -41.8 -46.51 3.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.78 2.832 . . . . 0.0 112.497 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -46.89 -46.02 20.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.194 0.997 . . . . 0.0 110.995 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -96.35 -3.02 44.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.713 1.605 . . . . 0.0 112.359 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -61.11 -17.74 54.26 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.478 1.49 . . . . 0.0 110.23 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -51.63 -44.74 63.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.851 0.86 . . . . 0.0 109.189 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -64.79 -32.62 74.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.665 -1.159 . . . . 0.0 111.817 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.72 -47.25 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 121.127 1.785 . . . . 0.0 107.917 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -52.72 -53.99 39.97 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -43.05 99.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.547 0.213 . . . . 0.0 111.082 -171.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.05 -39.17 85.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 111.545 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -51.24 63.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.061 0.934 . . . . 0.0 109.348 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 61.2 t0 -68.86 -47.97 64.63 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.283 2.633 . . . . 0.0 112.54 -169.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -31.11 -56.27 0.23 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.991 1.716 . . . . 0.0 113.053 -175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -98.97 -3.42 35.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.978 0.911 . . . . 0.0 112.543 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 10.8 mptt -104.02 78.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.063 0.945 . . . . 0.0 109.749 -172.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 127.769 2.427 . . . . 0.0 105.872 168.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -112.27 156.34 22.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.893 0.77 . . . . 0.0 110.625 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 68' ' ' ILE . 11.1 t -132.26 143.43 40.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.846 1.658 . . . . 0.0 109.167 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.19 135.6 25.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.561 1.144 . . . . 0.0 108.666 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 p -127.88 170.78 12.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.222 1.009 . . . . 0.0 111.08 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -14.09 -56.85 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 129.628 3.171 . . . . 0.0 116.553 172.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.49 -21.33 61.18 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 122.25 1.839 . . . . 0.0 114.147 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.53 -27.04 68.69 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.84 0.745 . . . . 0.0 112.094 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 9' ' ' ILE . 81.5 mt -67.02 79.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.811 0.844 . . . . 0.0 110.969 -170.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.67 0.79 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.236 1.874 . . . . 0.0 108.571 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.331 14.6 t 46.83 88.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.326 2.251 . . . . 0.0 114.603 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 73.8 -61.2 0.5 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.703 2.001 . . . . 0.0 114.347 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 t 61.61 -68.6 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 0.0 113.217 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.01 35.01 8.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.399 1.879 . . . . 0.0 114.455 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -106.06 14.69 27.46 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -121.92 54.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.3 -45.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.407 -0.808 . . . . 0.0 111.104 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.5 pm0 -74.84 10.5 1.4 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.183 2.193 . . . . 0.0 114.001 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.64 -24.79 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -70.6 124.53 91.06 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 119.595 1.089 . . . . 0.0 111.198 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.24 -26.76 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.804 3.003 . . . . 0.0 113.161 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.98 38.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.396 0.679 . . . . 0.0 110.004 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 29.97 42.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.079 2.551 . . . . 0.0 116.361 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.1 p -92.18 36.02 0.99 Allowed 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.092 -1.005 . . . . 0.0 110.746 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 120.32 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 126.313 1.845 . . . . 0.0 108.062 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -137.12 171.06 15.06 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.039 1.335 . . . . 0.0 109.607 -169.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.18 172.01 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 119.387 0.994 . . . . 0.0 110.217 168.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.49 -53.9 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.259 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -139.64 58.38 1.61 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.355 0.662 . . . . 0.0 109.27 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 45.76 37.36 3.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.172 1.789 . . . . 0.0 112.578 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 154.25 38.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 172.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -76.41 163.21 27.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.669 0.606 . . . . 0.0 110.707 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.45 110.37 5.63 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 106.057 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.11 132.23 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.81 112.95 22.62 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 167.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.06 -28.97 48.82 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.826 1.684 . . . . 0.0 110.672 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.03 -27.93 29.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.784 0.834 . . . . 0.0 109.804 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.2 t -85.5 -32.27 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.836 0.743 . . . . 0.0 111.122 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.4 t -56.13 130.43 44.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.09 0.859 . . . . 0.0 111.152 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 pt -102.44 35.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.3 1.04 . . . . 0.0 111.184 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 50.65 32.19 6.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.24 1.816 . . . . 0.0 114.636 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -23.08 62.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.13 -132.53 11.27 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -168.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.83 -68.25 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.749 1.62 . . . . 0.0 113.098 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -48.84 -49.99 36.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.324 1.05 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -48.47 -56.2 8.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.255 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.0 68.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.16 0.584 . . . . 0.0 112.465 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.98 -7.73 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.982 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -82.79 111.29 28.38 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.51 41.64 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.237 2.624 . . . . 0.0 111.727 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.7 -27.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 128.346 2.658 . . . . 0.0 109.2 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 55.65 60.18 3.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.847 0.859 . . . . 0.0 110.025 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.55 -25.07 41.75 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.25 1.02 . . . . 0.0 110.169 170.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.9 mt -72.7 117.47 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -127.81 165.16 20.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.29 150.19 40.33 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -54.67 -40.44 69.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.677 -0.64 . . . . 0.0 112.69 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.98 -24.17 63.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.426 -0.796 . . . . 0.0 111.032 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.88 -45.32 43.66 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.915 0.325 . . . . 0.0 110.167 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' HD11 ' A' ' 68' ' ' ILE . 68.0 t -52.69 123.75 32.14 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.792 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.85 149.32 61.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.924 2.416 . . . . 0.0 112.606 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -42.66 -46.25 4.97 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 129.698 3.199 . . . . 0.0 112.258 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.54 -40.44 12.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.11 0.964 . . . . 0.0 111.767 172.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -106.08 7.77 31.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.857 1.663 . . . . 0.0 112.482 -176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.7 mptt -57.89 -27.37 63.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.403 1.001 . . . . 0.0 110.038 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -49.28 -44.53 44.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.165 1.386 . . . . 0.0 111.051 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -67.98 -33.02 73.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.68 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.624 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.6 mt -60.99 -48.18 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 120.803 1.638 . . . . 0.0 108.124 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -53.29 -50.52 64.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -62.8 -43.27 99.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 0.541 . . . . 0.0 111.968 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -58.69 -44.18 90.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.039 1.335 . . . . 0.0 110.763 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -55.55 33.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.163 0.985 . . . . 0.0 109.041 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.68 -45.7 93.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.982 2.513 . . . . 0.0 112.402 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.05 -50.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 113.463 -171.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.2 4.66 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.282 1.033 . . . . 0.0 111.983 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 73.41 0.88 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.685 1.194 . . . . 0.0 109.135 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.142 0 C-N-CA 127.63 2.372 . . . . 0.0 105.916 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 118.351 -0.833 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -105.23 153.86 21.01 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.641 0.655 . . . . 0.0 110.17 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 t -138.13 145.83 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.746 0.818 . . . . 0.0 110.764 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.55 HD11 HD21 ' A' ' 71' ' ' ASN . 2.4 pp -60.81 165.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.237 1.815 . . . . 0.0 111.536 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 p -151.93 168.67 24.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.994 0.918 . . . . 0.0 109.094 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -8.52 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 128.506 2.722 . . . . 0.0 116.336 170.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.59 -21.39 71.91 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 CA-C-N 121.487 1.567 . . . . 0.0 113.541 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.18 -30.34 71.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.756 0.822 . . . . 0.0 112.177 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.21 90.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.598 0.713 . . . . 0.0 110.385 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.11 60.8 0.67 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.941 1.734 . . . . 0.0 109.92 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 t 39.56 73.03 0.12 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.158 1.783 . . . . 0.0 114.307 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 68.94 48.5 0.71 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.57 1.148 . . . . 0.0 113.053 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.19 152.42 40.8 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.75 40.12 0.89 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.795 0.725 . . . . 0.0 112.125 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 m -83.89 -37.35 22.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 112.205 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 p -70.04 -13.73 62.35 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.272 1.429 . . . . 0.0 113.215 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.26 153.85 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 112.431 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 75.86 -40.29 0.4 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.834 2.053 . . . . 0.0 113.038 169.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -72.65 -29.11 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.705 -0.622 . . . . 0.0 110.156 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.0 t -65.63 126.58 91.89 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.949 0.5 . . . . 0.0 110.103 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -39.72 -37.44 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 126.377 4.718 . . . . 0.0 115.407 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.0 m -126.54 21.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.822 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t70 33.2 51.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.702 2.001 . . . . 0.0 113.668 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.5 p -94.57 42.34 1.09 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.298 1.039 . . . . 0.0 110.922 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 132.32 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -133.51 142.13 48.08 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -167.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -83.52 125.15 31.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.309 -0.87 . . . . 0.0 111.627 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.82 -55.07 2.48 Favored Glycine 0 CA--C 1.525 0.69 1 N-CA-C 103.047 -4.021 . . . . 0.0 103.047 166.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.64 -60.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.195 2.198 . . . . 0.0 106.614 168.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -66.4 -29.17 69.28 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.266 1.826 . . . . 0.0 114.787 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -158.18 177.5 11.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.343 0.657 . . . . 0.0 109.476 -168.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.87 116.03 28.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.233 1.013 . . . . 0.0 108.699 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -94.88 119.62 33.74 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 130.441 3.497 . . . . 0.0 109.388 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 54' ' ' ILE . 76.7 mt -81.33 130.13 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 118.878 0.763 . . . . 0.0 109.839 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -77.39 111.64 18.5 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.01 -30.98 92.86 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-N 120.98 1.386 . . . . 0.0 111.273 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -79.1 -23.63 43.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -92.1 -32.84 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.276 0.489 . . . . 0.0 110.978 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.56 123.56 16.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.979 0.809 . . . . 0.0 111.45 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.8 pt -89.46 21.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 50.75 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.37 2.268 . . . . 0.0 113.089 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -147.0 148.41 31.67 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.944 -0.472 . . . . 0.0 110.951 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.72 51.75 4.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.191 -0.943 . . . . 0.0 113.08 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.67 -76.99 0.59 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.363 1.082 . . . . 0.0 111.633 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.2 p -47.96 -48.8 31.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.598 1.159 . . . . 0.0 112.497 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -57.5 -46.55 83.64 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.171 0.896 . . . . 0.0 111.562 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.14 74.86 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.486 -0.759 . . . . 0.0 110.538 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -74.81 -38.26 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.094 0.557 . . . . 0.0 111.45 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.4 t -64.27 112.41 7.59 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.227 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.48 20.88 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.207 2.604 . . . . 0.0 113.087 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.39 -30.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 126.103 1.761 . . . . 0.0 109.354 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 t 62.27 81.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 0.0 109.894 -170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.32 -9.92 0.65 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' ILE . 77.7 mt -79.82 92.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -109.36 164.57 12.36 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.1 0.96 . . . . 0.0 108.894 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -62.5 146.94 50.39 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.855 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -40.96 64.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.113 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -73.35 -38.91 65.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -53.76 124.53 43.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.667 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 144.95 52.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.103 2.535 . . . . 0.0 112.191 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -41.49 -47.36 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 128.933 2.893 . . . . 0.0 112.676 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.59 -44.41 26.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.049 0.94 . . . . 0.0 111.063 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -96.71 -6.73 35.73 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.173 1.389 . . . . 0.0 112.424 -176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -57.99 -22.38 49.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.562 1.528 . . . . 0.0 110.231 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.01 -43.08 40.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.701 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -64.35 -35.06 79.63 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.6 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.35 -46.12 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -56.91 -46.58 81.86 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.115 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -46.42 90.62 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.427 -0.796 . . . . 0.0 111.631 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.55 HD21 HD11 ' A' ' 4' ' ' ILE . 12.6 m-80 -61.59 -40.0 93.22 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.051 0.94 . . . . 0.0 111.357 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -57.22 -61.86 2.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 4.0 t70 -52.96 -50.42 64.13 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 128.122 2.569 . . . . 0.0 112.529 -170.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -37.46 -46.35 0.8 Allowed 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 125.57 1.548 . . . . 0.0 113.432 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -111.39 -3.21 15.33 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 123.789 0.681 . . . . 0.0 111.447 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -36.67 25.05 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.939 0.791 . . . . 0.0 110.31 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -100.8 147.58 25.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.413 0.685 . . . . 0.0 111.128 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.64 142.29 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.845 1.258 . . . . 0.0 110.708 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.88 168.57 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.351 0 C-N-CA 125.772 1.629 . . . . 0.0 110.904 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 p -145.02 171.65 14.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -9.82 -61.22 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 128.661 2.785 . . . . 0.0 116.164 169.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.5 Cg_exo -62.59 -15.42 45.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 121.991 1.747 . . . . 0.0 113.635 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HA ' ' S1 ' ' A' ' 78' ' ' SF4 . 15.2 t -70.37 -26.09 63.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.851 0.86 . . . . 0.0 112.742 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -51.15 115.95 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.95 130.31 1.34 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -169.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 t -60.06 119.57 8.05 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.957 0.503 . . . . 0.0 112.026 -170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm 36.22 50.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.492 1.917 . . . . 0.0 113.376 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.24 -50.85 72.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.673 0.789 . . . . 0.0 112.616 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.95 -136.01 0.86 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.918 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m 62.7 45.34 5.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.856 1.263 . . . . 0.0 111.878 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 p -176.51 -28.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.162 2.985 . . . . 0.0 109.138 -173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.75 -44.87 51.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 C-N-CA 124.22 1.008 . . . . 0.0 110.469 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.6 pm0 -67.34 0.3 3.0 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.399 1.88 . . . . 0.0 114.175 -169.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.03 -16.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.277 1.031 . . . . 0.0 113.136 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -75.36 126.15 88.05 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 119.751 1.16 . . . . 0.0 111.624 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -62.11 141.24 87.88 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.565 2.177 . . . . 0.0 109.227 169.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.287 11.6 m 45.17 37.09 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.371 1.868 . . . . 0.0 114.217 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 35.92 49.1 0.56 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.335 2.654 . . . . 0.0 114.17 168.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -85.89 30.14 0.68 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.058 -1.027 . . . . 0.0 112.643 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.44 142.13 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -141.55 156.8 45.69 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.086 1.354 . . . . 0.0 107.849 -170.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -91.53 134.04 35.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 118.888 0.767 . . . . 0.0 111.254 170.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.54 -46.96 7.06 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 104.987 -3.245 . . . . 0.0 104.987 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -175.56 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.245 2.618 . . . . 0.0 104.284 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -98.21 54.1 1.09 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.901 1.81 . . . . 0.0 108.94 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -177.71 137.37 0.2 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 -169.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -102.37 168.41 9.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.889 0.743 . . . . 0.0 109.663 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -146.44 119.82 9.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.192 1.797 . . . . 0.0 107.797 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 57.3 mt -90.38 130.76 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -73.33 114.64 33.38 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -30.85 52.42 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 120.619 0.879 . . . . 0.0 111.1 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -83.07 -28.43 29.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.279 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.52 -27.63 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.397 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -59.45 120.99 10.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.497 1.044 . . . . 0.0 110.945 173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 pt -96.14 34.03 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.075 0.95 . . . . 0.0 111.46 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 46.17 42.31 9.79 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.574 1.549 . . . . 0.0 113.282 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -23.21 60.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.244 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.75 -138.94 20.9 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.531 1.062 . . . . 0.0 110.934 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.17 -67.51 0.25 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.689 1.596 . . . . 0.0 111.95 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 p -47.98 -50.64 26.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.888 1.275 . . . . 0.0 110.412 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -43.92 -41.25 5.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.714 2.005 . . . . 0.0 113.815 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.47 -34.87 21.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.162 0.985 . . . . 0.0 110.064 -174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -79.18 -25.57 12.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.94 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' S4 ' ' A' ' 78' ' ' SF4 . 12.2 t -59.84 111.97 4.67 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.413 1.006 . . . . 0.0 108.49 171.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.12 49.53 3.26 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.857 3.038 . . . . 0.0 110.117 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -169.35 -35.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 128.232 2.613 . . . . 0.0 107.74 -168.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 58.0 58.14 3.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 110.045 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.75 -17.57 50.54 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.665 1.186 . . . . 0.0 110.873 172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -77.66 125.42 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.48 170.47 15.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 6.7 t-80 -65.62 146.35 54.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -48.69 -44.12 37.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.174 0.512 . . . . 0.0 112.058 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.32 -40.22 77.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.177 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -78.96 -34.13 44.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.075 0.95 . . . . 0.0 111.56 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -54.96 126.55 59.89 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.95 145.5 62.45 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.118 2.545 . . . . 0.0 112.469 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.416 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.6 mp0 -40.91 -45.69 2.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.62 3.168 . . . . 0.0 113.811 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.45 -44.68 12.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.914 0.864 . . . . 0.0 111.093 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -101.26 0.06 36.66 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.475 1.91 . . . . 0.0 112.945 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 28.3 mmtm -59.27 -21.42 59.61 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 120.593 1.542 . . . . 0.0 109.456 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 p -50.46 -49.03 56.22 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.713 1.205 . . . . 0.0 109.896 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -61.91 -35.91 79.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 118.23 -0.891 . . . . 0.0 111.053 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.45 -50.65 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -54.29 -41.69 69.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.623 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -66.84 -45.58 77.77 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.2 -42.16 94.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.276 1.43 . . . . 0.0 110.587 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -55.76 29.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.84 -48.97 69.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.738 2.815 . . . . 0.0 113.987 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -31.66 -48.92 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 126.09 1.756 . . . . 0.0 114.942 -169.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -117.12 1.72 12.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.746 0.818 . . . . 0.0 111.985 -170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -40.21 13.24 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 118.822 0.737 . . . . 0.0 110.814 -169.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.567 2.347 . . . . 0.0 104.682 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . 0.448 ' S1 ' ' HA ' ' A' ' 8' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -112.57 150.21 31.67 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 118.477 0.581 . . . . 0.0 110.612 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.2 140.01 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.287 0.635 . . . . 0.0 111.661 -174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.04 144.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 125.331 1.452 . . . . 0.0 109.93 172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.6 p -133.65 168.4 18.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 110.332 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -15.49 -57.65 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 129.107 2.963 . . . . 0.0 116.484 173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.26 -21.32 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 CA-C-N 121.774 1.669 . . . . 0.0 114.325 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.7 -32.65 72.87 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.733 0.697 . . . . 0.0 112.246 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -65.34 86.97 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.982 0.896 . . . . 0.0 109.943 -172.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 53.11 0.57 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 127.191 2.329 . . . . 0.0 108.256 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.298 12.2 t 53.28 -153.61 0.25 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.624 1.97 . . . . 0.0 113.939 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -73.77 66.96 1.14 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.324 1.45 . . . . 0.0 112.276 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -51.27 -57.54 8.57 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.722 1.609 . . . . 0.0 111.083 170.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.55 43.93 16.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.476 1.51 . . . . 0.0 112.924 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.9 m -98.54 -42.11 7.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.355 0.662 . . . . 0.0 111.564 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -74.28 67.96 1.45 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.006 0.908 . . . . 0.0 108.696 172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.43 163.6 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 126.938 2.095 . . . . 0.0 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 40.93 39.24 0.79 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.627 1.971 . . . . 0.0 114.403 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.61 -39.74 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.423 1.089 . . . . 0.0 111.217 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -65.58 124.98 88.8 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 121.922 -0.486 . . . . 0.0 110.934 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.73 -42.78 4.31 Favored 'Trans proline' 0 N--CA 1.457 -0.624 1 C-N-CA 126.012 4.475 . . . . 0.0 115.533 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.5 27.77 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.415 0.686 . . . . 0.0 111.411 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 58.99 -173.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p 124.28 -2.18 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 130.702 3.601 . . . . 0.0 111.985 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -89.22 115.57 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.708 0.803 . . . . 0.0 109.149 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -134.52 172.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.528 1.531 . . . . 0.0 108.815 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -114.72 177.52 4.62 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.689 0.757 . . . . 0.0 109.673 168.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.8 -38.31 0.03 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 124.608 1.099 . . . . 0.0 110.692 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -128.94 -94.78 0.42 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.3 58.25 1.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.411 1.101 . . . . 0.0 108.95 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -175.22 2.78 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 128.685 2.794 . . . . 0.0 105.786 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -111.56 159.09 18.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.286 0.494 . . . . 0.0 110.947 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.12 130.86 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.724 2.81 . . . . 0.0 104.444 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -106.06 126.39 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -66.95 114.6 18.73 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 118.022 -1.471 . . . . 0.0 107.516 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.32 -28.46 22.54 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.854 1.703 . . . . 0.0 110.0 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -81.26 -28.77 34.61 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.08 -38.45 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.875 0.761 . . . . 0.0 111.27 169.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.8 t -55.13 124.94 18.52 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.367 0.985 . . . . 0.0 111.838 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.1 pt -95.23 37.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.111 0.964 . . . . 0.0 111.617 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 38.57 60.33 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.182 2.193 . . . . 0.0 113.691 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 -20.98 16.32 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.1 -132.34 11.4 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.89 -70.64 0.11 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.458 1.503 . . . . 0.0 112.042 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.6 p -48.73 -47.3 41.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.711 1.205 . . . . 0.0 111.197 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.66 -42.64 79.33 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.653 -0.654 . . . . 0.0 111.755 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.74 75.83 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.499 -0.751 . . . . 0.0 110.337 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.72 -40.84 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.596 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.2 t -59.55 112.15 4.84 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 119.072 0.851 . . . . 0.0 109.464 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.67 11.66 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.909 2.406 . . . . 0.0 112.862 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -117.14 -26.53 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 127.679 2.392 . . . . 0.0 108.843 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.5 m 54.39 76.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.483 1.513 . . . . 0.0 111.18 -169.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 6.58 5.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.154 1.382 . . . . 0.0 112.719 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.43 80.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -95.99 162.84 13.39 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -59.35 149.14 29.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.947 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -50.39 -42.42 53.46 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -80.82 -21.59 40.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 119.279 -0.969 . . . . 0.0 111.833 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -71.48 -33.3 69.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.7 t -58.36 126.75 79.66 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-O 119.252 -0.404 . . . . 0.0 109.911 171.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.73 153.17 57.94 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.656 2.904 . . . . 0.0 113.156 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -45.61 -45.12 13.63 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 129.968 3.307 . . . . 0.0 112.747 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -48.79 -46.2 41.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.894 0.878 . . . . 0.0 110.889 172.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -97.06 -1.19 45.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 0.0 112.525 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -54.46 -27.98 41.25 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.565 1.075 . . . . 0.0 109.324 169.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -45.86 -46.95 16.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.626 1.17 . . . . 0.0 110.8 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -64.25 -34.36 77.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.766 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.35 -47.55 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 120.698 1.59 . . . . 0.0 107.183 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -57.63 -44.07 85.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -60.56 -51.15 70.63 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 118.682 0.674 . . . . 0.0 111.211 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -56.36 -38.93 72.07 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.382 1.073 . . . . 0.0 110.733 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -63.28 -58.68 6.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.53 1.132 . . . . 0.0 109.859 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -60.85 -47.15 87.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.658 2.383 . . . . 0.0 112.936 -169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.65 -46.32 0.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.093 1.357 . . . . 0.0 113.954 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.77 3.24 24.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.666 0.786 . . . . 0.0 112.193 -171.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 -60.08 1.93 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.507 1.523 . . . . 0.0 107.913 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.643 3.177 . . . . 0.0 112.738 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.209 0.052 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -92.24 136.04 33.52 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.63 142.05 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.473 0.709 . . . . 0.0 110.776 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -65.64 158.26 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 126.728 2.011 . . . . 0.0 110.656 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.7 p -144.9 156.26 43.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.33 0.514 . . . . 0.0 111.687 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.351 3.7 tt0 6.87 -72.05 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 130.108 3.363 . . . . 0.0 117.58 169.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 34.3 Cg_exo -52.95 -26.17 30.62 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.693 1.998 . . . . 0.0 114.905 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.3 t -58.46 -36.39 73.62 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.699 0.8 . . . . 0.0 112.058 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -79.07 144.23 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.069 0.462 . . . . 0.0 111.06 -169.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.38 37.87 2.75 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 125.465 1.507 . . . . 0.0 111.315 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -166.87 129.11 1.74 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -70.89 88.01 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.8 t -73.87 167.9 20.52 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.841 0.856 . . . . 0.0 110.939 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.03 71.69 0.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.843 1.657 . . . . 0.0 107.12 173.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.3 m -141.99 -59.0 0.47 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.743 -0.598 . . . . 0.0 111.124 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.43 72.63 0.98 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.076 0.941 . . . . 0.0 108.962 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.3 152.56 15.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 126.361 1.864 . . . . 0.0 108.72 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 62.97 -12.77 0.08 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -93.28 -24.45 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 O-C-N 120.822 -1.174 . . . . 0.0 110.884 -170.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.71 126.48 92.65 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 122.775 0.43 . . . . 0.0 110.619 -172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.32 -43.89 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 126.485 4.79 . . . . 0.0 115.975 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.34 7.1 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.868 0.867 . . . . 0.0 112.146 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.2 t0 65.87 149.87 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 111.539 -170.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.9 m -163.06 -102.09 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.509 1.923 . . . . 0.0 106.209 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . 0.255 2.2 pp 13.78 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.785 3.234 . . . . 0.0 116.474 169.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -103.4 138.7 39.79 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.487 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 32.6 mt-10 -76.57 131.84 39.16 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 120.775 -1.203 . . . . 0.0 112.661 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.84 8.63 Favored Glycine 0 CA--C 1.532 1.099 1 N-CA-C 102.886 -4.085 . . . . 0.0 102.886 165.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.44 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.236 3.014 . . . . 0.0 104.286 167.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.15 -35.88 74.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.661 -0.649 . . . . 0.0 111.584 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.68 146.87 46.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.227 1.411 . . . . 0.0 110.411 -169.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 27' ' ' GLU . 96.9 m-85 -80.44 150.95 29.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.94 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -119.68 114.55 22.36 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 129.808 3.243 . . . . 0.0 105.554 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -83.95 116.88 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -52.9 109.07 1.27 Allowed Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 126.868 2.067 . . . . 0.0 111.659 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -67.78 -26.98 38.2 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.039 1.16 . . . . 0.0 111.685 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.15 -41.87 85.34 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.798 0.839 . . . . 0.0 109.852 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -92.94 -38.31 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.663 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.6 t -58.12 120.01 7.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.107 0.867 . . . . 0.0 111.278 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 pt -89.87 35.58 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.155 0.982 . . . . 0.0 111.572 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 44.52 60.05 3.04 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.36 1.464 . . . . 0.0 112.905 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.13 -164.75 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.065 0.946 . . . . 0.0 109.03 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.42 -112.15 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 168.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.72 -67.29 0.14 Allowed 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 126.292 1.837 . . . . 0.0 112.665 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.5 p -62.17 -49.06 77.34 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 137.21 58.22 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 168.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 84.47 -22.24 0.22 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.015 2.526 . . . . 0.0 111.873 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.7 -34.22 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 t -62.89 116.76 26.53 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.15 26.78 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.41 2.74 . . . . 0.0 113.03 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.5 -27.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 128.393 2.677 . . . . 0.0 108.331 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.9 m 54.14 62.93 2.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.693 1.197 . . . . 0.0 111.288 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.1 -7.36 45.77 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.276 1.031 . . . . 0.0 111.128 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.4 mt -83.05 124.67 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -134.58 168.51 18.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -64.08 143.51 57.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.517 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.41 -40.82 51.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.33 -38.49 89.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.372 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -77.28 -31.54 54.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.043 -169.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -54.47 125.38 52.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.635 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.79 144.34 55.0 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.045 2.497 . . . . 0.0 112.043 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -41.91 -47.13 4.23 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 128.995 2.918 . . . . 0.0 112.38 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -46.99 -45.36 20.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.138 0.975 . . . . 0.0 110.863 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -96.72 -4.51 40.6 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.752 1.621 . . . . 0.0 112.528 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -60.89 -17.2 49.31 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 120.156 1.344 . . . . 0.0 109.841 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.7 p -51.52 -42.6 61.87 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.628 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -67.82 -31.2 70.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.29 -0.881 . . . . 0.0 111.752 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.77 -45.67 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -55.85 -48.98 74.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.71 0.404 . . . . 0.0 110.032 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.59 73.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.248 0.476 . . . . 0.0 110.497 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.61 -39.61 68.06 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 124.021 0.826 . . . . 0.0 110.568 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -56.15 19.14 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -50.97 -43.18 60.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.868 2.067 . . . . 0.0 112.526 -174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -43.84 -44.71 7.03 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.756 0.66 . . . . 0.0 112.151 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -107.95 21.47 17.35 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 111.139 -174.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -132.67 74.51 1.58 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 169.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -169.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -97.28 144.98 26.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.103 0.961 . . . . 0.0 110.248 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 68' ' ' ILE . 71.3 t -139.85 144.05 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.273 1.029 . . . . 0.0 111.296 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.73 142.68 14.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.489 1.515 . . . . 0.0 109.553 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.9 p -131.42 165.47 23.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.038 0.535 . . . . 0.0 110.237 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -12.21 -58.33 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 129.587 3.155 . . . . 0.0 116.568 172.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.72 -20.65 69.82 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 CA-C-N 122.115 1.791 . . . . 0.0 114.06 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -62.73 -33.3 74.84 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.64 0.655 . . . . 0.0 111.532 173.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.31 3.9 mp -70.58 95.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.965 0.888 . . . . 0.0 112.168 -168.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.32 151.6 23.34 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 103.784 -3.726 . . . . 0.0 103.784 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -48.07 125.14 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.393 1.877 . . . . 0.0 112.789 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.7 mttp 18.31 72.07 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 128.41 2.684 . . . . 0.0 116.037 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -51.01 -58.63 5.58 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.577 1.951 . . . . 0.0 112.342 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.0 42.45 32.25 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.265 1.426 . . . . 0.0 113.318 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.2 m -103.06 -51.13 3.32 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.257 0.623 . . . . 0.0 111.583 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.5 p -75.27 69.66 2.12 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.96 0.886 . . . . 0.0 109.416 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.9 156.44 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.972 1.709 . . . . 0.0 109.324 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 40.76 58.47 2.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.857 . . . . 0.0 112.79 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.3 p -160.39 -37.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -72.62 141.34 82.46 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -37.29 -36.93 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 1 C-N-CA 125.623 4.215 . . . . 0.0 115.575 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.02 29.82 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.297 31.1 m-20 21.55 61.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.576 2.351 . . . . 0.0 114.751 -176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.3 p -86.17 41.58 0.94 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.235 1.014 . . . . 0.0 110.415 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 pp -109.41 126.88 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.864 1.666 . . . . 0.0 108.422 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -141.56 145.46 35.13 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 124.226 1.011 . . . . 0.0 109.991 -169.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.6 115.96 7.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.786 169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.87 -59.32 4.07 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 107.04 -2.424 . . . . 0.0 107.04 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -124.12 -69.24 0.82 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -128.08 -37.58 1.87 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.538 1.135 . . . . 0.0 113.18 172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.538 ' H ' ' CD ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -87.02 160.2 18.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.986 2.914 . . . . 0.0 110.551 178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -76.38 124.9 28.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.613 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 159.07 16.47 Favored 'General case' 0 N--CA 1.444 -0.729 1 C-N-CA 131.835 4.054 . . . . 0.0 104.962 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.1 mt -116.29 137.19 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.203 1.001 . . . . 0.0 108.369 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.24 112.4 25.54 Favored Pre-proline 0 C--N 1.341 0.222 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 167.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.94 -30.9 67.35 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.052 1.168 . . . . 0.0 110.585 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -80.44 -22.94 40.66 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.477 -0.764 . . . . 0.0 110.223 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -90.03 -29.28 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.47 0.577 . . . . 0.0 111.009 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.6 t -58.52 128.92 39.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.477 1.035 . . . . 0.0 110.568 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 pt -98.31 36.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.342 1.057 . . . . 0.0 111.473 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.6 m-20 42.8 57.32 3.62 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.96 1.704 . . . . 0.0 112.11 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -176.73 4.3 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.042 0.537 . . . . 0.0 111.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.13 69.16 0.23 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -161.96 162.39 28.99 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.019 1.727 . . . . 0.0 106.634 172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.27 1.9 p 77.75 -54.76 0.52 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.854 2.862 . . . . 0.0 111.264 -170.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.38 -52.89 15.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.866 0.866 . . . . 0.0 111.998 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.16 62.79 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.461 1.105 . . . . 0.0 112.025 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -75.11 -38.2 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.826 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.5 t -61.55 110.37 3.06 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 118.763 0.71 . . . . 0.0 109.371 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.02 -0.04 6.55 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.999 1.799 . . . . 0.0 112.653 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.19 -23.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.82 1.648 . . . . 0.0 109.837 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 t 60.46 56.97 2.96 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 110.888 -170.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.95 -22.47 21.94 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.915 0.886 . . . . 0.0 111.062 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.7 mt -78.68 119.11 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -128.43 167.13 17.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -68.93 144.45 54.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -51.74 -40.99 61.23 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.18 60.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -82.49 -34.2 28.09 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.922 0.783 . . . . 0.0 109.814 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.44 127.81 90.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.13 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.98 148.64 37.81 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.546 2.831 . . . . 0.0 112.571 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -51.4 -43.78 62.03 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.865 1.266 . . . . 0.0 111.492 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -41.47 -44.76 2.99 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.996 1.319 . . . . 0.0 111.267 172.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.41 -1.31 31.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.447 1.499 . . . . 0.0 112.586 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -61.37 -19.45 61.88 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.473 1.488 . . . . 0.0 110.317 169.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 p -51.44 -45.02 62.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.339 1.055 . . . . 0.0 109.268 167.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -65.57 -33.99 77.19 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.678 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.43 HD12 HG11 ' A' ' 3' ' ' VAL . 1.5 mp -63.09 -47.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 120.616 1.553 . . . . 0.0 107.691 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -52.9 -49.85 65.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.925 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.24 -46.46 88.76 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.707 -0.62 . . . . 0.0 111.872 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -57.8 -43.06 85.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.095 1.358 . . . . 0.0 110.589 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -58.68 -60.92 3.06 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.11 -51.15 62.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.435 2.694 . . . . 0.0 112.001 -171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -48.46 0.21 Allowed 'General case' 0 C--N 1.337 0.055 0 C-N-CA 126.152 1.781 . . . . 0.0 114.139 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.57 -4.17 14.21 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.56 0.744 . . . . 0.0 111.296 -170.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -37.24 14.66 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.487 -1.244 . . . . 0.0 107.904 -172.074 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.542 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 119.886 -0.102 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -92.18 146.19 23.91 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.019 0.528 . . . . 0.0 110.245 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -138.01 143.02 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.013 . . . . 0.0 111.169 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.9 mt -80.87 142.26 14.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 126.869 2.068 . . . . 0.0 109.052 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.3 p -133.96 166.43 22.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.059 0.544 . . . . 0.0 111.628 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.282 3.0 tt0 -8.77 -61.4 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 129.776 3.23 . . . . 0.0 116.642 172.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.1 Cg_exo -58.17 -20.03 44.61 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 122.56 1.95 . . . . 0.0 114.619 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 t -61.04 -36.44 79.56 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.595 0.634 . . . . 0.0 112.523 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.267 8.6 mt -40.04 113.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 124.129 0.972 . . . . 0.0 112.066 -169.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.37 130.41 1.41 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -53.82 99.65 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.627 1.571 . . . . 0.0 115.107 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 46.66 56.03 7.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.381 1.873 . . . . 0.0 112.332 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -62.17 95.67 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.451 1.1 . . . . 0.0 110.463 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.41 78.21 9.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 m -128.89 -59.48 1.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.169 0.588 . . . . 0.0 110.876 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 p -74.22 66.71 1.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.79 0.805 . . . . 0.0 109.162 171.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -120.49 -124.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 109.936 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.6 pm0 -68.52 21.05 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.68 -27.2 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.158 1.383 . . . . 0.0 109.332 169.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -67.68 124.05 88.37 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.944 -0.473 . . . . 0.0 110.168 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.99 -45.1 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 125.285 3.99 . . . . 0.0 114.67 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.22 13.61 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.367 -170.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 65.2 t0 59.88 111.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.645 1.578 . . . . 0.0 112.241 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 78.7 m -135.57 4.1 3.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.939 172.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.53 113.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.028 0.931 . . . . 0.0 111.409 -167.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.13 167.08 19.72 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.755 1.222 . . . . 0.0 109.325 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -106.99 177.2 4.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 168.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.38 -43.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -129.77 -97.28 0.36 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -144.08 53.8 1.29 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-O 123.42 1.581 . . . . 0.0 110.564 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -178.85 6.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.999 2.92 . . . . 0.0 105.022 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.39 164.16 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -135.56 118.48 16.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.489 2.316 . . . . 0.0 106.177 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.3 mt -90.09 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.88 113.76 14.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 120.232 1.378 . . . . 0.0 107.807 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.82 -30.83 40.18 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.789 1.66 . . . . 0.0 110.582 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -82.82 -28.06 30.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.772 0.829 . . . . 0.0 109.272 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 t -85.38 -31.46 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.752 0.706 . . . . 0.0 111.163 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.0 t -58.02 129.89 44.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.387 0.994 . . . . 0.0 111.327 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.7 pt -103.52 33.21 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.564 1.146 . . . . 0.0 111.391 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 31.2 m-20 46.0 42.68 9.71 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.967 1.707 . . . . 0.0 113.478 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.15 -23.57 60.48 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.276 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.69 -141.26 23.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.59 1.09 . . . . 0.0 111.15 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.52 -66.72 0.25 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.132 1.373 . . . . 0.0 111.117 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -49.93 -49.75 48.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.636 1.174 . . . . 0.0 110.352 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.83 -53.97 2.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.775 2.03 . . . . 0.0 113.096 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.48 -33.86 65.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.014 0.526 . . . . 0.0 110.568 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.06 -37.81 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.917 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -68.46 108.51 2.93 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 119.934 1.243 . . . . 0.0 108.834 172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.64 11.35 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.633 2.222 . . . . 0.0 113.129 -172.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.07 -26.0 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.588 2.355 . . . . 0.0 108.535 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.35 58.92 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.592 0.757 . . . . 0.0 110.51 -170.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.29 -11.69 58.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.744 0.817 . . . . 0.0 111.186 171.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.03 127.37 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.6 1.56 . . . . 0.0 107.276 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -134.83 168.71 18.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -65.78 144.33 56.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -52.93 -39.02 62.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -57.41 -40.86 79.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.814 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -77.48 -31.32 53.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.518 0.727 . . . . 0.0 110.523 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.22 127.05 69.81 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.408 -0.806 . . . . 0.0 109.695 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -53.57 144.84 50.4 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.163 2.576 . . . . 0.0 112.35 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -43.64 -45.57 6.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 128.734 2.814 . . . . 0.0 112.662 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.21 -48.84 23.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.752 0.821 . . . . 0.0 110.506 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -90.9 -7.92 50.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.905 1.282 . . . . 0.0 112.456 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -58.05 -21.99 47.99 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 120.629 1.559 . . . . 0.0 110.028 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -49.3 -43.9 43.72 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.519 -0.738 . . . . 0.0 110.466 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -65.73 -33.57 76.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.504 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.89 -46.04 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 120.906 1.684 . . . . 0.0 107.247 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -56.89 -44.18 82.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.723 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.62 -50.7 72.47 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.352 0.524 . . . . 0.0 111.227 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -57.69 -39.77 77.91 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.539 0.736 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -60.67 -58.31 9.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.236 1.014 . . . . 0.0 109.003 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.79 -42.2 95.23 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 127.625 2.37 . . . . 0.0 112.957 -169.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -39.96 -46.26 2.03 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.776 1.23 . . . . 0.0 113.367 -175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -105.61 5.47 31.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.649 0.779 . . . . 0.0 111.794 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.09 -170.2 2.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.419 1.887 . . . . 0.0 106.218 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.051 0 C-N-CA 128.891 2.877 . . . . 0.0 103.877 168.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 111.331 0.122 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -100.1 143.37 30.39 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.444 1.098 . . . . 0.0 109.132 172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.5 t -136.06 145.69 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.38 129.94 44.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 127.601 2.36 . . . . 0.0 107.391 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 p -110.0 -84.28 0.56 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.961 0.904 . . . . 0.0 112.322 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -133.95 -63.48 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.394 1.878 . . . . 0.0 113.728 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -68.79 86.0 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 121.883 1.722 . . . . 0.0 109.9 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 177.68 -44.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.197 2.599 . . . . 0.0 107.489 -169.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -49.65 131.35 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.653 0.781 . . . . 0.0 110.944 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.65 72.49 0.02 OUTLIER Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.492 0.568 . . . . 0.0 113.016 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 61.44 -59.4 0.1 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.575 2.75 . . . . 0.0 116.346 169.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -166.45 148.39 6.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.218 0.917 . . . . 0.0 109.095 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.3 t -149.94 166.74 28.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.684 1.594 . . . . 0.0 106.953 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -145.83 176.79 9.4 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.153 2.581 . . . . 0.0 104.038 168.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 49.0 m 117.26 -66.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.334 2.254 . . . . 0.0 109.144 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 p -74.16 33.19 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.498 -0.751 . . . . 0.0 111.057 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.9 -75.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 O-C-N 120.723 -1.236 . . . . 0.0 108.42 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.09 28.28 0.06 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.22 1.808 . . . . 0.0 115.144 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -130.58 -27.38 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.701 1.2 . . . . 0.0 112.186 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.55 125.73 91.15 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 119.344 0.975 . . . . 0.0 112.267 -169.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.9 121.7 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.911 2.407 . . . . 0.0 108.835 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 t 76.25 24.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 111.314 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 36.87 40.69 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.486 2.314 . . . . 0.0 115.067 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.3 p -87.02 44.48 1.18 Allowed 'General case' 0 C--O 1.232 0.181 0 O-C-N 120.672 -1.267 . . . . 0.0 111.176 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.57 122.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.76 2.024 . . . . 0.0 106.14 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -130.63 143.02 50.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.238 1.415 . . . . 0.0 111.551 -167.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -76.06 135.31 39.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.63 38.23 3.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 105.977 -2.849 . . . . 0.0 105.977 166.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 65.72 -64.23 0.2 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.756 3.222 . . . . 0.0 110.189 -169.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.41 -27.29 66.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.935 0.894 . . . . 0.0 112.6 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 172.19 18.66 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -169.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -91.85 151.35 20.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 168.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 125.39 15.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.624 2.77 . . . . 0.0 108.736 -172.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -76.79 142.22 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 123.763 0.825 . . . . 0.0 109.288 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -80.72 108.92 11.21 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 168.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -74.9 -3.14 13.46 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.797 1.665 . . . . 0.0 113.263 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -94.44 -38.19 11.06 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.71 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.0 -33.07 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.762 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 t -55.53 123.39 13.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.227 0.921 . . . . 0.0 111.149 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 pt -88.75 35.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.176 0.99 . . . . 0.0 111.672 -175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.2 m-20 44.83 48.21 9.09 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.325 1.45 . . . . 0.0 112.362 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.48 178.22 7.81 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.607 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.08 103.25 0.76 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.45 -56.67 0.06 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.08 0.94 . . . . 0.0 111.675 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.3 p -63.51 -43.02 98.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.699 0.8 . . . . 0.0 109.819 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.11 137.14 40.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.59 -0.694 . . . . 0.0 110.023 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 72.59 -18.33 0.35 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.199 1.4 . . . . 0.0 113.052 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.69 -36.93 48.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.3 t -62.76 118.1 38.44 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.33 -23.69 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.101 1.868 . . . . 0.0 112.025 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.39 -22.73 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.139 0.975 . . . . 0.0 110.569 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.6 m 54.05 51.52 14.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.661 1.184 . . . . 0.0 111.87 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.46 -19.64 30.96 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.961 0.904 . . . . 0.0 111.624 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 85.3 mt -66.02 117.72 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -128.87 164.89 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.047 0.939 . . . . 0.0 108.793 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.54 144.89 55.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 173.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.07 -40.36 61.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.373 0.606 . . . . 0.0 112.456 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.91 -40.92 77.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.996 1.318 . . . . 0.0 111.854 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.4 m-30 -80.09 -36.71 35.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.791 1.237 . . . . 0.0 110.234 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.27 126.41 36.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.493 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.18 144.56 37.89 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.228 2.618 . . . . 0.0 112.39 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -43.38 -45.87 6.31 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.407 2.683 . . . . 0.0 112.188 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -46.11 -43.98 15.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.271 1.029 . . . . 0.0 111.245 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -98.6 -6.39 30.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.37 1.868 . . . . 0.0 112.711 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -58.83 -22.32 58.49 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.437 1.472 . . . . 0.0 110.532 170.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 p -50.41 -44.75 55.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.618 167.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.06 -30.5 70.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 117.976 -1.012 . . . . 0.0 111.94 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.14 -48.26 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 120.89 1.677 . . . . 0.0 106.81 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -55.87 -47.76 76.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.125 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.37 -46.63 87.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.283 0.492 . . . . 0.0 111.713 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -56.55 -43.08 79.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.056 1.342 . . . . 0.0 109.794 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -61.38 -58.01 9.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 123.109 1.433 . . . . 0.0 108.335 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.36 -39.79 73.47 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.955 2.102 . . . . 0.0 112.933 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -38.88 -53.73 1.69 Allowed 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 124.684 1.194 . . . . 0.0 111.61 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.39 -29.55 11.97 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.43 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.7 78.34 4.2 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.431 -1.747 . . . . 0.0 108.02 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -95.96 135.56 37.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.4 t -134.66 139.3 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.035 0.534 . . . . 0.0 110.844 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.49 170.0 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.497 1.919 . . . . 0.0 110.54 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.5 p -140.74 -107.96 0.15 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -120.86 -54.39 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.4 -23.22 54.14 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.771 1.647 . . . . 0.0 111.935 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -53.32 -39.61 64.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.92 1.288 . . . . 0.0 112.973 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.13 125.25 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.82 -147.0 4.63 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-O 123.203 1.446 . . . . 0.0 110.931 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 p -89.04 64.35 7.06 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 126.135 1.774 . . . . 0.0 109.429 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.0 72.87 0.48 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.919 0.888 . . . . 0.0 110.246 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.16 146.99 52.0 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.565 0.346 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.03 90.01 1.79 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.491 1.516 . . . . 0.0 107.507 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.4 m -144.14 -55.12 0.36 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.562 -0.711 . . . . 0.0 111.062 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 p -72.19 70.54 0.83 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.924 0.868 . . . . 0.0 109.523 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 t -125.1 -117.32 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.545 1.538 . . . . 0.0 108.613 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -64.02 7.48 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.361 1.864 . . . . 0.0 115.291 -171.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.39 -25.4 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 110.102 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.2 t -69.34 126.09 92.43 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.04 0.382 . . . . 0.0 110.31 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -42.42 -38.21 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.738 4.292 . . . . 0.0 114.543 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.2 m -124.47 24.73 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.108 0.963 . . . . 0.0 111.193 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t0 39.29 62.54 1.12 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.559 1.544 . . . . 0.0 113.152 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.1 p -125.17 51.82 1.65 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.523 0.729 . . . . 0.0 110.994 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.56 127.37 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.925 2.09 . . . . 0.0 106.462 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.93 133.45 30.17 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 119.796 1.18 . . . . 0.0 113.987 -168.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.42 146.86 32.56 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 120.788 -1.195 . . . . 0.0 112.336 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.18 -50.1 0.43 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -54.67 0.82 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.513 1.525 . . . . 0.0 110.212 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -141.16 -49.66 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.908 2.483 . . . . 0.0 110.813 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.1 137.49 37.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.785 -0.572 . . . . 0.0 111.394 -168.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -75.21 102.14 4.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.838 0.828 . . . . 0.0 109.15 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -64.65 113.31 3.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.925 2.49 . . . . 0.0 106.911 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mt -78.59 130.96 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.12 119.68 71.63 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.754 0.706 . . . . 0.0 109.254 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.29 -27.05 16.84 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 121.706 1.604 . . . . 0.0 112.56 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -42.6 60.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.14 -33.34 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.795 -0.622 . . . . 0.0 112.243 -172.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 t -61.55 116.86 5.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.133 1.333 . . . . 0.0 110.998 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -83.23 35.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.974 0.91 . . . . 0.0 111.853 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.39 49.69 6.07 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.654 1.982 . . . . 0.0 113.259 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -161.81 0.82 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.609 0.764 . . . . 0.0 109.508 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.6 -125.49 4.46 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 108.449 -1.861 . . . . 0.0 108.449 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 73.88 -67.51 0.26 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 127.662 2.385 . . . . 0.0 110.408 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.3 p -56.61 -46.56 80.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.103 0.561 . . . . 0.0 110.242 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -44.92 78.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.144 0.978 . . . . 0.0 112.878 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.57 -35.13 72.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.05 0.54 . . . . 0.0 110.655 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 t -68.7 -38.17 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 118.891 -0.576 . . . . 0.0 110.882 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' VAL . 13.9 t -59.86 114.7 10.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.4 18.91 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.242 2.628 . . . . 0.0 113.139 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.9 m -133.08 -25.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.85 2.86 . . . . 0.0 108.295 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 m 53.2 58.39 5.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.623 1.169 . . . . 0.0 111.242 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.71 -12.6 55.62 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.719 1.208 . . . . 0.0 111.322 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.81 128.5 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.02 170.5 15.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -58.49 143.31 46.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.22 -40.49 58.9 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -74.69 -26.5 59.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.376 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -71.04 -28.9 64.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.65 124.6 73.3 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.12 -0.467 . . . . 0.0 109.753 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.9 149.15 71.79 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.039 3.159 . . . . 0.0 112.573 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.8 mp0 -44.26 -44.91 8.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.578 3.151 . . . . 0.0 113.772 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -48.05 -39.83 21.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.466 0.706 . . . . 0.0 111.472 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -105.79 -1.42 24.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.533 1.933 . . . . 0.0 112.66 -175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 22.3 mmtm -57.83 -22.51 48.06 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.035 1.288 . . . . 0.0 109.336 169.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.93 -46.37 31.92 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.303 1.441 . . . . 0.0 110.221 168.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -64.32 -35.18 80.04 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.506 -0.746 . . . . 0.0 110.788 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.63 -37.17 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.781 1.173 . . . . 0.0 108.39 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -62.71 -46.89 86.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.171 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.5 -49.33 78.19 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.575 -0.703 . . . . 0.0 110.238 -177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -45.84 -44.7 14.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 127.612 2.365 . . . . 0.0 111.552 169.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -59.51 4.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.56 -44.48 62.73 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 126.522 1.929 . . . . 0.0 111.524 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -43.2 -42.81 4.39 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -115.51 19.73 15.21 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.153 0.581 . . . . 0.0 110.855 -174.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 77.99 1.5 Allowed 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -113.43 142.04 46.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.51 144.38 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.321 1.048 . . . . 0.0 111.815 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.51 161.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.961 2.105 . . . . 0.0 110.916 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.6 p -148.96 163.73 36.62 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.623 0.725 . . . . 0.0 111.899 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.255 2.8 tt0 -15.1 -62.21 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.805 3.242 . . . . 0.0 116.838 175.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 22.5 Cg_exo -61.53 -25.71 79.87 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 CA-C-N 122.008 1.753 . . . . 0.0 113.451 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -12.3 60.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.352 0.661 . . . . 0.0 111.612 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.09 85.29 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.268 -0.895 . . . . 0.0 109.204 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.04 58.42 0.57 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.22 1.39 . . . . 0.0 110.131 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.311 14.5 t 38.1 115.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.503 3.121 . . . . 0.0 116.728 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 61.97 -62.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.751 2.021 . . . . 0.0 114.075 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.6 t 66.01 -63.92 0.22 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.859 2.064 . . . . 0.0 112.396 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.94 24.87 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.004 1.722 . . . . 0.0 113.42 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.0 m -97.31 -48.68 5.23 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.675 0.39 . . . . 0.0 110.998 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.3 p -73.51 71.82 1.35 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.807 0.813 . . . . 0.0 109.137 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 152.78 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.763 1.625 . . . . 0.0 109.745 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 48.46 21.29 0.37 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.3 m -111.85 -16.92 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.456 0.703 . . . . 0.0 111.718 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -71.98 131.73 85.32 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -172.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -45.44 -37.23 14.37 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.026 3.817 . . . . 0.0 115.084 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 -15.06 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.959 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 t0 99.2 162.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.341 2.657 . . . . 0.0 108.951 -171.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.8 p 154.96 -9.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 128.608 2.763 . . . . 0.0 112.708 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -81.91 100.16 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.625 1.102 . . . . 0.0 110.253 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.96 142.52 45.56 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.128 0.971 . . . . 0.0 111.749 -169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -73.95 98.59 3.07 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 120.663 -1.273 . . . . 0.0 111.806 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.43 68.51 2.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 106.424 -2.671 . . . . 0.0 106.424 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 69.91 -59.9 0.49 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 130.066 3.346 . . . . 0.0 111.509 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -141.71 33.52 1.61 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.968 0.89 . . . . 0.0 112.235 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -166.05 140.27 4.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -80.13 114.99 19.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.07 117.93 35.67 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.953 2.501 . . . . 0.0 106.004 -172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.91 123.19 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.47 113.92 16.6 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.309 0.959 . . . . 0.0 108.589 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 46.9 Cg_endo -61.24 -32.47 90.44 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.801 1.667 . . . . 0.0 110.699 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -77.12 -28.18 54.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -172.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.06 -32.97 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.171 0.441 . . . . 0.0 110.836 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.8 t -59.54 104.42 0.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.051 0.842 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.7 pt -78.82 46.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.936 -1.103 . . . . 0.0 111.262 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 52.37 -110.67 0.53 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.265 1.426 . . . . 0.0 109.401 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.83 -45.74 0.49 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.68 1.592 . . . . 0.0 114.386 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.42 -122.82 6.09 Favored Glycine 0 CA--C 1.535 1.316 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 63.84 -75.09 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.9 1.28 . . . . 0.0 112.179 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -51.18 -43.46 61.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.201 1.0 . . . . 0.0 110.417 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -48.27 -59.92 3.06 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.224 1.41 . . . . 0.0 110.511 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.89 74.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.995 0.518 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 t -64.81 -36.54 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.894 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.7 t -63.83 114.3 13.03 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.15 46.09 2.14 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.352 2.702 . . . . 0.0 110.97 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -164.19 -29.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 127.739 2.415 . . . . 0.0 109.536 -169.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 m 57.59 58.55 3.69 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 110.315 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.59 -20.87 38.91 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.221 1.008 . . . . 0.0 110.673 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.87 116.39 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -120.1 166.85 12.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -54.26 -39.65 67.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -52.49 -43.63 65.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.073 0.949 . . . . 0.0 112.222 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.57 -34.33 53.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.406 1.082 . . . . 0.0 110.38 -169.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.26 124.17 59.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 118.213 -0.899 . . . . 0.0 109.57 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.67 146.12 56.09 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.01 2.474 . . . . 0.0 112.399 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.5 mp0 -41.75 -44.67 3.3 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 129.278 3.031 . . . . 0.0 113.912 176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -46.73 -44.01 18.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.592 0.757 . . . . 0.0 110.931 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -101.55 -1.65 32.45 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.375 1.87 . . . . 0.0 113.246 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.5 mmtm -57.91 -23.96 55.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.454 1.479 . . . . 0.0 108.92 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 p -48.18 -45.36 33.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.717 1.207 . . . . 0.0 110.623 168.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.33 -35.83 82.15 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 121.395 -0.815 . . . . 0.0 111.305 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -46.26 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.76 -44.81 73.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.384 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -66.39 -45.85 78.62 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.359 0.527 . . . . 0.0 112.047 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 15.0 m-80 -59.61 -41.34 90.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.565 1.146 . . . . 0.0 111.135 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -58.42 -61.21 2.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -52.69 -52.47 55.87 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.864 2.466 . . . . 0.0 113.359 -170.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -34.99 -47.99 0.39 Allowed 'General case' 0 C--O 1.228 -0.07 0 O-C-N 125.427 1.705 . . . . 0.0 113.466 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.97 -2.84 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.705 0.628 . . . . 0.0 111.894 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -34.1 40.94 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.035 0.834 . . . . 0.0 111.038 -173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -110.35 149.08 30.73 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 117.964 0.347 . . . . 0.0 110.374 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -128.34 139.05 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.474 1.109 . . . . 0.0 110.179 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.62 140.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 126.553 1.941 . . . . 0.0 107.833 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -129.79 172.44 11.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.163 0.585 . . . . 0.0 111.102 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.8 tt0 -12.71 -59.59 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 129.408 3.083 . . . . 0.0 115.946 171.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -62.4 -17.74 59.25 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.894 1.712 . . . . 0.0 114.206 -173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.69 -31.82 73.22 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.139 0.882 . . . . 0.0 111.659 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 6' ' ' GLU . 6.9 mt -54.14 101.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.078 0.551 . . . . 0.0 111.988 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.71 54.42 0.08 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.286 7.1 t 54.99 -160.09 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.134 1.774 . . . . 0.0 113.763 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -77.24 67.02 3.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.347 1.459 . . . . 0.0 111.189 -171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 t -61.32 -49.42 77.08 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.27 1.428 . . . . 0.0 110.989 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.86 -127.44 0.75 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.057 0.943 . . . . 0.0 109.329 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 m 75.98 -57.17 0.57 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.209 2.203 . . . . 0.0 110.853 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -57.21 -37.16 71.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.0 t -54.64 -62.21 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.062 0.945 . . . . 0.0 111.491 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -64.28 6.84 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -168.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -128.21 -12.06 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 119.975 1.261 . . . . 0.0 113.418 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.4 t -69.63 130.02 90.84 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.795 1.18 . . . . 0.0 110.7 -171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -57.12 -29.5 83.49 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.947 3.098 . . . . 0.0 113.749 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.4 67.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.214 0.606 . . . . 0.0 109.43 -172.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 6.96 64.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 130.752 3.621 . . . . 0.0 115.354 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 p -116.33 37.51 3.69 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.561 0.744 . . . . 0.0 110.394 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.16 123.51 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 128.056 2.542 . . . . 0.0 105.485 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.32 165.12 25.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.367 1.867 . . . . 0.0 108.643 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -90.41 160.83 15.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.649 0.659 . . . . 0.0 110.351 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 68.26 0.3 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.3 84.01 0.16 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.853 2.061 . . . . 0.0 109.318 176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.274 1.1 m-20 47.33 41.43 12.3 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.929 2.092 . . . . 0.0 114.875 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.75 160.18 28.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 128.768 2.827 . . . . 0.0 104.195 168.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -102.1 164.07 11.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 123.158 0.287 . . . . 0.0 110.637 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.31 148.62 41.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.105 2.162 . . . . 0.0 106.958 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.2 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.82 123.42 89.2 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 119.621 1.101 . . . . 0.0 109.553 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.87 -28.25 16.78 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.348 1.365 . . . . 0.0 112.961 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.44 -27.46 18.27 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.857 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -81.84 -29.58 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.816 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.6 t -65.32 118.61 9.58 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.428 1.013 . . . . 0.0 110.4 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 pt -88.74 32.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 123.673 0.789 . . . . 0.0 111.336 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 1.6 t70 42.3 52.52 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.953 2.101 . . . . 0.0 111.103 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.5 p -74.35 -44.73 51.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -168.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.85 86.09 1.25 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.64 -59.75 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.715 0.806 . . . . 0.0 110.65 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 p -54.97 -48.17 73.6 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.057 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -48.96 70.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.207 1.003 . . . . 0.0 111.422 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.63 77.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.272 0.629 . . . . 0.0 111.768 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.74 2.4 6.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 117.809 -1.091 . . . . 0.0 113.482 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.9 t -87.44 102.33 3.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.05 15.59 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.694 2.929 . . . . 0.0 113.112 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.07 -27.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 129.624 3.17 . . . . 0.0 107.343 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 56.83 58.15 4.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.85 1.26 . . . . 0.0 110.15 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -20.1 33.59 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.187 0.995 . . . . 0.0 110.466 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.75 121.83 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -135.82 168.83 18.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -64.89 142.79 58.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -47.3 -43.91 22.93 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.09 -39.88 79.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.72 0.808 . . . . 0.0 111.538 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -77.06 -38.9 51.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.56 1.144 . . . . 0.0 110.681 -168.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -49.88 122.68 14.29 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.191 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.97 146.61 46.46 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.299 2.666 . . . . 0.0 112.668 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.4 mp0 -41.47 -45.5 3.21 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.512 3.125 . . . . 0.0 113.735 175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -46.31 -44.73 16.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.851 0.834 . . . . 0.0 110.894 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.93 -0.43 39.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.315 1.846 . . . . 0.0 112.83 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 30.0 mmtm -59.21 -22.44 61.05 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.621 1.555 . . . . 0.0 109.341 169.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 p -48.46 -46.1 37.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.441 1.096 . . . . 0.0 109.764 168.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -62.55 -34.45 76.97 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.322 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.4 -35.53 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 120.849 1.659 . . . . 0.0 109.403 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -62.69 -50.14 72.3 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -48.05 83.51 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.192 0.597 . . . . 0.0 111.384 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -42.25 -47.93 4.84 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 129.591 3.156 . . . . 0.0 112.368 169.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -61.36 1.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -57.33 -31.0 65.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.301 1.84 . . . . 0.0 113.616 -170.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.36 17.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.202 0.601 . . . . 0.0 111.828 174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -113.31 -33.25 6.01 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.251 0.621 . . . . 0.0 110.747 -170.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.75 140.9 33.99 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 176.67 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -103.92 145.92 29.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.586 0.754 . . . . 0.0 108.981 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG11 HD12 ' A' ' 68' ' ' ILE . 37.4 t -132.36 141.93 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.276 1.031 . . . . 0.0 111.37 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.72 139.8 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.341 1.856 . . . . 0.0 109.177 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.2 p -126.95 174.36 8.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.736 0.815 . . . . 0.0 111.289 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -12.91 -59.62 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 128.957 2.903 . . . . 0.0 115.577 169.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -65.09 -12.48 34.9 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 CA-C-N 121.181 1.458 . . . . 0.0 114.23 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -70.23 -33.86 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.075 0.852 . . . . 0.0 111.951 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.41 127.65 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.527 0.603 . . . . 0.0 109.753 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.6 48.7 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.411 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 19.7 m 52.15 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 116.241 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm 73.9 -64.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 128.742 2.817 . . . . 0.0 113.247 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 t 60.71 -67.36 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.237 1.415 . . . . 0.0 112.165 -170.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.51 34.32 6.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.364 1.866 . . . . 0.0 113.339 172.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 m -89.9 -47.72 7.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 111.227 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 p -72.92 69.99 0.99 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.724 0.773 . . . . 0.0 109.36 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.71 -96.48 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.553 1.141 . . . . 0.0 109.594 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.51 24.71 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.699 1.599 . . . . 0.0 115.133 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.01 -25.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.479 1.512 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.11 121.79 86.03 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.254 0.933 . . . . 0.0 110.765 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.2 -38.17 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 125.261 3.974 . . . . 0.0 114.148 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 m -116.16 18.77 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.953 0.901 . . . . 0.0 111.804 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t0 42.9 52.25 5.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.699 1.2 . . . . 0.0 112.658 172.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.9 p -107.42 26.95 9.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.319 0.648 . . . . 0.0 111.765 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.29 126.7 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.364 1.466 . . . . 0.0 109.09 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -136.77 170.28 16.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.892 1.677 . . . . 0.0 107.868 -169.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -100.52 156.74 17.12 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 122.146 0.974 . . . . 0.0 113.209 169.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.87 73.54 0.45 Allowed Glycine 0 N--CA 1.444 -0.77 1 N-CA-C 102.848 -4.101 . . . . 0.0 102.848 167.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 61.98 -66.58 0.07 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 131.206 3.803 . . . . 0.0 112.59 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 11' ' ' THR . 22.0 t70 -102.56 -21.14 14.23 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.295 1.438 . . . . 0.0 112.452 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.75 163.68 31.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.538 1.063 . . . . 0.0 108.221 -169.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -81.41 164.36 22.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 123.574 0.546 . . . . 0.0 110.27 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -143.77 120.6 11.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.516 2.326 . . . . 0.0 106.114 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mt -89.09 134.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -77.47 112.33 23.22 Favored Pre-proline 0 C--O 1.234 0.25 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.11 -28.33 41.1 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 121.74 1.626 . . . . 0.0 110.768 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -78.61 -25.42 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.4 t -89.61 -36.44 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 118.694 0.679 . . . . 0.0 111.868 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.3 t -55.08 136.52 48.04 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.62 1.1 . . . . 0.0 110.722 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.64 38.4 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.476 1.111 . . . . 0.0 111.408 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 44.53 55.47 5.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.438 1.495 . . . . 0.0 112.198 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.42 -159.66 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.705 0.402 . . . . 0.0 111.358 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.47 109.42 0.59 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 169.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -168.63 -66.07 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.706 1.202 . . . . 0.0 110.094 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.0 p -54.74 -44.44 73.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.99 0.916 . . . . 0.0 111.159 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -50.94 70.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.158 0.583 . . . . 0.0 111.972 178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.41 -37.66 78.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.031 0.532 . . . . 0.0 110.889 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.07 -37.09 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.836 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.6 t -73.5 106.97 2.77 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 108.706 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.17 -14.0 41.65 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.615 1.544 . . . . 0.0 111.805 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -87.26 -21.53 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.283 1.433 . . . . 0.0 109.974 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m 53.48 58.85 4.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.254 1.022 . . . . 0.0 110.987 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.38 -20.98 46.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.854 0.862 . . . . 0.0 110.551 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.4 mt -80.82 125.08 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -133.82 167.59 20.29 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 176.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.13 145.4 55.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -48.84 -46.41 42.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.508 0.671 . . . . 0.0 111.048 174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.8 -38.11 60.73 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.012 1.725 . . . . 0.0 111.109 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -82.77 -41.25 19.4 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.284 1.034 . . . . 0.0 110.437 -169.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.0 t -53.26 121.81 27.03 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.752 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.31 147.69 54.73 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.403 2.735 . . . . 0.0 112.531 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 5.0 mp0 -39.98 -46.6 2.1 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.517 3.127 . . . . 0.0 113.399 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -45.53 -43.72 12.07 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.699 0.8 . . . . 0.0 111.148 172.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -102.11 -0.49 33.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.524 1.93 . . . . 0.0 113.08 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 62' ' ' GLU . 29.6 mmtm -57.9 -25.76 61.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.86 1.663 . . . . 0.0 109.23 169.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -46.87 -46.41 21.01 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.029 1.332 . . . . 0.0 110.272 168.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -64.31 -34.89 79.18 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.656 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.421 HD12 HG11 ' A' ' 3' ' ' VAL . 1.6 mp -62.66 -47.11 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 120.869 1.668 . . . . 0.0 106.952 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -58.75 -43.69 90.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.956 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -64.1 -44.39 92.46 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.367 0.531 . . . . 0.0 111.766 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -59.11 -43.0 91.87 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.675 1.59 . . . . 0.0 110.497 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -56.7 -60.13 4.01 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.86 -42.06 88.51 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.132 2.573 . . . . 0.0 112.651 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -37.41 -50.41 1.07 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.861 0.864 . . . . 0.0 112.276 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.18 -21.58 13.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 -170.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 81.62 5.17 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.964 -1.493 . . . . 0.0 108.376 -174.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.79 141.05 33.12 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.947 0.499 . . . . 0.0 109.998 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.39 143.26 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.836 0.855 . . . . 0.0 110.264 -173.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.08 161.23 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 110.552 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 p -148.49 174.55 11.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.015 0.926 . . . . 0.0 109.198 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . 0.5 OUTLIER -10.2 -61.71 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 128.661 2.785 . . . . 0.0 116.071 170.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 37.9 Cg_exo -62.85 -17.16 58.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 CA-C-N 121.494 1.569 . . . . 0.0 113.694 -172.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 t -65.67 -31.24 72.15 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.741 0.701 . . . . 0.0 112.03 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -66.17 91.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.806 0.812 . . . . 0.0 110.14 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.89 85.43 0.16 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 127.092 2.282 . . . . 0.0 107.639 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.287 6.5 t -6.85 99.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.466 2.706 . . . . 0.0 117.096 -172.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp 56.09 41.62 29.35 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.486 2.314 . . . . 0.0 113.108 169.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -46.36 -52.11 13.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.741 1.617 . . . . 0.0 112.472 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 62.04 -121.58 0.72 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.81 0.844 . . . . 0.0 109.229 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.7 m 68.86 -57.38 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.056 1.743 . . . . 0.0 111.634 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.3 p -70.21 64.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 0.0 108.671 169.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.36 152.36 21.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 126.053 1.741 . . . . 0.0 108.0 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 61.12 -10.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.982 2.215 . . . . 0.0 116.982 173.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 m -90.55 -24.62 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.812 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -72.76 125.52 91.15 Favored Pre-proline 0 CA--C 1.538 0.512 0 O-C-N 122.211 -0.306 . . . . 0.0 110.19 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.15 -31.54 55.44 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.278 3.318 . . . . 0.0 113.531 -174.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.17 19.92 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.89 0.876 . . . . 0.0 111.853 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.6 t70 41.23 56.39 3.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.065 1.346 . . . . 0.0 113.202 174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -110.85 36.19 3.23 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.681 0.793 . . . . 0.0 111.006 -177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.41 131.96 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 126.12 1.768 . . . . 0.0 106.713 176.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -142.1 174.65 10.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.815 1.646 . . . . 0.0 107.749 -169.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -107.94 160.39 15.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.117 0.96 . . . . 0.0 113.095 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.36 67.65 0.56 Allowed Glycine 0 N--CA 1.445 -0.716 1 N-CA-C 102.732 -4.147 . . . . 0.0 102.732 167.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 64.41 -63.22 0.17 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 131.096 3.758 . . . . 0.0 112.631 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -101.74 -20.5 14.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.124 1.37 . . . . 0.0 112.57 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.45 162.81 38.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.12 -0.987 . . . . 0.0 108.62 -169.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -85.05 162.72 19.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 123.75 0.656 . . . . 0.0 110.911 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -145.19 131.45 19.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.789 2.436 . . . . 0.0 106.495 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.517 HG12 HG22 ' A' ' 25' ' ' ILE . 67.6 mt -108.82 129.31 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 13.3 t0 -69.13 113.95 20.06 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.327 0.967 . . . . 0.0 109.192 173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.46 -28.94 71.1 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.385 1.39 . . . . 0.0 112.304 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -31.48 23.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 119.092 -0.48 . . . . 0.0 109.763 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.6 t -85.74 -28.29 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.247 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -58.94 119.53 7.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.946 1.248 . . . . 0.0 111.09 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 pt -91.65 33.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.227 1.011 . . . . 0.0 112.103 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 43.92 58.98 3.35 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.015 1.326 . . . . 0.0 112.592 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.94 -173.86 3.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.98 172.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.58 104.4 0.8 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 171.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -163.03 -75.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.243 1.017 . . . . 0.0 110.025 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.4 p -50.83 -44.39 59.3 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.601 1.161 . . . . 0.0 112.365 -172.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -39.14 90.54 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.544 -0.722 . . . . 0.0 111.658 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.01 -36.92 67.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.812 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.0 t -65.86 -43.23 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.948 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.8 t -58.65 112.95 5.67 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 119.272 0.942 . . . . 0.0 108.665 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -80.28 42.35 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.621 2.881 . . . . 0.0 111.08 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.1 -34.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 128.979 2.911 . . . . 0.0 107.8 -169.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.8 m 57.13 59.85 3.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.276 1.031 . . . . 0.0 110.085 -174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.65 -23.99 56.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.476 1.51 . . . . 0.0 109.873 169.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.94 116.97 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.402 1.481 . . . . 0.0 107.008 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -122.87 166.45 15.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.82 145.39 52.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -44.05 62.63 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 121.615 -0.678 . . . . 0.0 111.995 -178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.49 -16.7 63.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.246 1.019 . . . . 0.0 112.597 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -80.8 -38.51 28.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.83 121.07 62.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.822 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -54.03 148.6 38.44 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.717 2.945 . . . . 0.0 112.119 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -52.88 -41.43 64.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.679 1.191 . . . . 0.0 110.728 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -44.34 -47.92 9.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.067 1.347 . . . . 0.0 111.292 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -95.9 -8.56 33.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.694 1.198 . . . . 0.0 112.08 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -59.95 -16.79 32.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 119.524 1.056 . . . . 0.0 110.869 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 p -50.56 -47.57 57.73 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.624 -0.673 . . . . 0.0 109.427 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -63.63 -37.34 86.95 Favored 'General case' 0 C--O 1.22 -0.454 0 O-C-N 121.651 -0.656 . . . . 0.0 111.18 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -45.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -55.89 -45.03 78.73 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -64.07 -45.89 86.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.605 0.639 . . . . 0.0 112.202 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -55.69 -41.58 73.96 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.417 1.487 . . . . 0.0 110.876 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -63.78 -58.44 6.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.1 -46.04 75.5 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.058 1.743 . . . . 0.0 112.833 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -34.76 -53.5 0.55 Allowed 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.729 1.212 . . . . 0.0 112.298 -173.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -106.71 1.7 25.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 124.438 1.087 . . . . 0.0 112.315 -170.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 11.8 mptt -102.72 -8.65 20.7 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.778 0.717 . . . . 0.0 112.667 -170.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.563 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -119.7 152.42 37.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 118.42 0.555 . . . . 0.0 109.704 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG11 HD12 ' A' ' 68' ' ' ILE . 46.7 t -131.9 140.6 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.976 0.911 . . . . 0.0 110.613 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.41 140.45 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 127.344 2.257 . . . . 0.0 107.968 169.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.3 p -113.75 -89.97 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -134.46 -52.48 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -167.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.67 -25.16 74.19 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.935 1.757 . . . . 0.0 113.529 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.12 -37.32 66.74 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.832 0.853 . . . . 0.0 112.294 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.292 3.6 mp -69.01 96.53 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 122.181 0.991 . . . . 0.0 112.574 -168.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.3 -171.89 14.58 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 103.471 -3.852 . . . . 0.0 103.471 169.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.95 105.33 1.97 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.561 1.944 . . . . 0.0 111.789 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm 62.58 -63.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.638 2.375 . . . . 0.0 115.528 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t 66.03 -89.42 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.827 2.051 . . . . 0.0 112.093 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 96.54 -138.03 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.341 2.657 . . . . 0.0 108.68 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.7 m 73.92 -57.66 0.61 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.406 2.282 . . . . 0.0 111.584 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.52 -24.47 61.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.34 1.056 . . . . 0.0 111.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.26 7.9 p -72.55 -52.19 24.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 O-C-N 121.345 -0.847 . . . . 0.0 112.27 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -74.13 17.92 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.46 -20.51 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.68 129.25 94.29 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 120.476 1.489 . . . . 0.0 109.711 -172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.01 -42.32 25.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.801 3.667 . . . . 0.0 113.3 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.72 110.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 25' ' ' ILE . 33.4 t0 -31.01 120.25 0.21 Allowed 'General case' 0 C--O 1.23 0.077 0 C-N-CA 126.101 1.76 . . . . 0.0 114.686 -176.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.7 m -133.7 16.93 3.93 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 108.036 168.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -120.62 110.99 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -169.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -115.92 145.75 42.64 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -166.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.82 78.08 3.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 122.483 1.135 . . . . 0.0 108.861 169.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.34 -43.66 97.16 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.26 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -125.0 -74.05 0.62 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.751 1.221 . . . . 0.0 107.803 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -135.71 -39.25 0.72 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.144 0.978 . . . . 0.0 113.12 175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 170.88 8.84 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.488 1.915 . . . . 0.0 108.954 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.02 127.19 32.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.86 -172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -109.19 117.18 33.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.849 3.26 . . . . 0.0 106.976 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 25' ' ' ILE . 44.1 mt -82.08 129.09 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.88 0.764 . . . . 0.0 109.487 -175.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.14 112.91 26.23 Favored Pre-proline 0 C--O 1.232 0.181 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.8 -29.74 50.32 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.41 1.407 . . . . 0.0 111.203 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -82.63 -29.64 29.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.293 0.637 . . . . 0.0 109.608 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.94 -33.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.562 0.619 . . . . 0.0 110.932 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.9 t -52.07 120.66 5.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.323 0.965 . . . . 0.0 111.436 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.58 35.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.738 0.815 . . . . 0.0 112.112 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 45.04 50.08 9.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.812 1.645 . . . . 0.0 113.496 176.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.31 -167.51 1.8 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.55 101.02 0.44 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 169.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.7 -76.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.094 0.947 . . . . 0.0 110.042 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.2 p -48.16 -46.06 34.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.759 1.224 . . . . 0.0 111.844 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -50.9 71.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.956 0.902 . . . . 0.0 112.18 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.34 70.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.15 0.58 . . . . 0.0 110.828 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 t -69.65 -38.81 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.236 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.4 t -57.73 111.67 3.77 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.753 1.16 . . . . 0.0 109.67 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 -14.26 41.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.501 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.91 -22.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.265 1.426 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m 53.16 57.25 6.47 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 111.258 -171.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.97 -19.85 29.8 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.141 0.977 . . . . 0.0 111.444 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 83.3 mt -79.99 127.99 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 124.989 1.316 . . . . 0.0 107.649 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -139.65 168.45 19.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.21 148.21 52.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -53.28 -42.8 66.92 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.76 -23.22 60.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.819 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.58 -35.87 52.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.19 125.26 70.12 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.631 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.82 141.91 64.46 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.442 2.761 . . . . 0.0 112.148 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -35.37 -51.3 0.59 Allowed 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.403 2.681 . . . . 0.0 113.461 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -45.48 -46.89 14.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.953 0.882 . . . . 0.0 110.617 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -95.18 -3.13 48.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.464 1.506 . . . . 0.0 112.629 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -60.34 -22.53 63.34 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 120.531 1.514 . . . . 0.0 110.119 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -48.58 -41.75 31.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.317 0.647 . . . . 0.0 110.294 167.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -68.44 -32.49 72.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.245 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.497 HD12 HG11 ' A' ' 3' ' ' VAL . 1.4 mp -61.84 -46.84 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 121.135 1.789 . . . . 0.0 107.365 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.08 -49.12 72.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.017 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -63.71 -43.25 97.15 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -61.32 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.489 1.515 . . . . 0.0 110.297 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -57.23 13.41 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.32 -42.38 99.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 128.375 2.67 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -37.15 -51.84 1.01 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.414 1.086 . . . . 0.0 112.836 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -105.34 4.14 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.795 0.838 . . . . 0.0 111.503 -170.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 80.63 1.33 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.032 -1.937 . . . . 0.0 107.365 -169.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' N ' ' NE2' ' A' ' 56' ' ' HIS . . . . . . . . 0 C--O 1.233 0.208 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -90.18 161.59 15.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.195 0.521 . . . . 0.0 111.294 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.19 149.58 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.339 1.055 . . . . 0.0 110.794 -172.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.45 138.71 25.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.979 1.312 . . . . 0.0 109.196 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -128.79 170.84 12.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 111.939 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.25 7.8 tt0 -12.25 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 129.756 3.222 . . . . 0.0 116.657 171.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.66 -19.74 54.66 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 122.559 1.95 . . . . 0.0 114.572 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -68.07 -29.1 67.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.071 0.851 . . . . 0.0 111.895 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.7 mt -44.18 110.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.3 0 C-N-CA 124.576 1.15 . . . . 0.0 113.188 -170.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.82 38.47 0.07 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.9 m 57.51 -83.63 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.954 2.101 . . . . 0.0 113.258 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -124.86 110.46 14.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.601 0.761 . . . . 0.0 109.556 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -129.76 163.82 25.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.446 2.299 . . . . 0.0 105.242 170.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.71 -130.51 0.29 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.6 m 73.6 -68.17 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.601 2.36 . . . . 0.0 110.569 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 p -59.57 -28.44 67.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.826 0.451 . . . . 0.0 110.392 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.58 -66.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 124.39 1.076 . . . . 0.0 111.846 176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -76.95 38.68 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.782 1.233 . . . . 0.0 113.839 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -143.45 -33.48 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.17 0.988 . . . . 0.0 113.195 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -62.03 122.6 73.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 120.064 1.302 . . . . 0.0 112.305 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.73 -31.06 91.5 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.841 3.028 . . . . 0.0 112.842 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.9 16.6 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.332 0.653 . . . . 0.0 112.237 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.8 t0 44.2 56.37 4.9 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.764 1.225 . . . . 0.0 112.405 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.7 p -115.63 32.42 6.08 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.563 0.745 . . . . 0.0 110.943 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -113.68 114.99 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.572 2.349 . . . . 0.0 107.818 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -128.75 173.8 10.01 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 126.198 1.799 . . . . 0.0 109.72 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -119.89 165.2 14.93 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.009 1.323 . . . . 0.0 113.925 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -128.68 13.67 6.13 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.821 1.677 . . . . 0.0 110.571 167.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 73.9 12.48 4.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.958 2.503 . . . . 0.0 112.774 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -123.54 -48.35 1.94 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 128.789 2.836 . . . . 0.0 109.611 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -162.83 176.25 10.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.032 2.133 . . . . 0.0 105.371 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.52 166.65 19.11 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.197 0.522 . . . . 0.0 110.269 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -145.39 109.67 4.92 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.767 2.027 . . . . 0.0 107.184 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.9 mt -78.89 133.09 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -74.54 111.49 13.21 Favored Pre-proline 0 C--N 1.343 0.301 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 167.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -58.38 -33.53 97.9 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.111 1.207 . . . . 0.0 111.591 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -80.26 -29.83 38.36 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.705 -0.622 . . . . 0.0 110.599 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.3 -30.68 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.68 125.02 20.4 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.042 0.837 . . . . 0.0 111.308 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 pt -99.05 32.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.258 1.023 . . . . 0.0 111.347 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 46.4 41.7 9.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.78 1.632 . . . . 0.0 113.691 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -21.92 59.4 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.287 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.44 -139.23 25.33 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.847 1.213 . . . . 0.0 110.682 -169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.48 -60.55 0.5 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 126.836 2.054 . . . . 0.0 111.409 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -52.31 -40.46 61.89 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.911 0.884 . . . . 0.0 111.374 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -46.19 80.73 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.768 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.49 76.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.359 0.663 . . . . 0.0 110.292 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -74.4 -37.76 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.147 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.9 t -61.21 116.15 18.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.01 1.277 . . . . 0.0 108.103 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.89 -19.83 49.43 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.1 1.867 . . . . 0.0 112.777 -176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.27 -19.09 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.305 1.442 . . . . 0.0 110.235 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.0 m 51.9 58.36 5.54 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.359 1.064 . . . . 0.0 111.137 -170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.17 -13.4 59.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.071 0.948 . . . . 0.0 111.596 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.11 129.81 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.82 179.45 6.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.431 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 7.8 t-80 -79.51 145.35 33.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -48.31 -42.47 31.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.02 -39.82 87.17 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.223 0.535 . . . . 0.0 112.274 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -76.88 -32.41 57.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.517 -168.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.72 128.89 80.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.083 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.79 143.55 47.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.157 2.571 . . . . 0.0 112.4 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -44.05 -44.93 7.75 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.603 2.761 . . . . 0.0 112.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -46.77 -47.73 20.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.086 0.954 . . . . 0.0 110.843 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -93.17 -6.2 48.38 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.402 1.481 . . . . 0.0 112.301 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -59.85 -16.04 25.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.273 1.397 . . . . 0.0 110.869 170.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 p -52.73 -47.35 67.43 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.064 -1.022 . . . . 0.0 108.998 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -65.76 -30.16 70.77 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.355 -0.831 . . . . 0.0 111.621 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -63.04 -49.85 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -54.32 -41.87 69.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.421 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.6 -49.98 66.75 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.624 0.647 . . . . 0.0 112.351 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -54.22 -42.18 69.51 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.371 1.468 . . . . 0.0 109.71 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -58.55 7.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.1 -44.38 83.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.887 2.475 . . . . 0.0 112.923 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -38.28 -50.99 1.49 Allowed 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 124.383 1.073 . . . . 0.0 112.664 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -102.74 -15.08 16.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 111.483 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 73.82 8.64 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 175.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.176 0 CA-C-O 116.429 -1.748 . . . . 0.0 107.601 -169.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -108.27 145.21 34.69 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.317 1.447 . . . . 0.0 110.864 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.09 140.54 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.714 1.206 . . . . 0.0 111.51 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -37.92 71.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 C-N-CA 126.123 1.769 . . . . 0.0 112.133 -175.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p 63.36 -108.08 0.23 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 127.712 2.405 . . . . 0.0 114.24 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.92 -52.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -167.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.75 77.64 2.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.014 1.81 . . . . 0.0 111.077 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.2 t -178.03 -41.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.238 2.615 . . . . 0.0 108.026 -170.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.94 143.75 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 C-N-CA 124.116 0.966 . . . . 0.0 113.024 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.59 32.98 58.89 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 124.954 1.264 . . . . 0.0 112.146 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.1 m -161.47 103.24 1.22 Allowed 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.253 1.421 . . . . 0.0 108.097 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -53.16 -39.11 63.32 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.091 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.9 t 66.71 -68.14 0.15 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 113.756 169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.09 42.2 28.65 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.767 1.627 . . . . 0.0 112.472 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.4 m -100.51 -50.15 3.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.287 0.635 . . . . 0.0 111.228 171.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.3 p -75.16 68.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.762 0.791 . . . . 0.0 109.766 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.95 151.43 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.903 1.681 . . . . 0.0 109.043 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 59.01 29.74 19.38 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.701 1.6 . . . . 0.0 111.899 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -139.35 -38.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.366 1.066 . . . . 0.0 111.498 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.11 131.56 93.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.423 0.689 . . . . 0.0 110.201 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -45.95 -36.63 16.0 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 125.274 3.983 . . . . 0.0 114.229 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.71 19.48 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.051 0.94 . . . . 0.0 111.405 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 40.64 44.25 1.77 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.502 1.921 . . . . 0.0 113.316 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.4 p -90.2 46.73 1.37 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.291 1.037 . . . . 0.0 110.159 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.63 125.74 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.063 1.745 . . . . 0.0 106.564 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -133.8 166.57 22.34 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 124.791 1.237 . . . . 0.0 107.882 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -98.48 140.75 32.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 120.206 1.366 . . . . 0.0 112.096 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.79 -50.61 4.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 166.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 175.33 -74.43 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.516 3.126 . . . . 0.0 105.008 168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.32 10.23 7.41 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.057 1.343 . . . . 0.0 113.023 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.84 153.23 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.08 161.99 22.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 123.857 0.723 . . . . 0.0 110.233 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -134.53 111.89 10.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.861 2.865 . . . . 0.0 105.325 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 66.4 mt -76.52 138.57 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 21.0 t0 -78.9 108.16 7.59 Favored Pre-proline 0 N--CA 1.464 0.268 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -76.67 -3.31 13.64 Favored 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 121.319 1.346 . . . . 0.0 112.479 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' ' HZ2' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -92.89 -38.36 11.76 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.954 -1.091 . . . . 0.0 109.983 169.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.86 -31.19 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.8 t -57.19 131.18 49.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.243 0.929 . . . . 0.0 111.211 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.2 pt -103.99 37.19 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.669 1.187 . . . . 0.0 111.53 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 28.0 m-20 52.23 37.06 21.01 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.393 1.477 . . . . 0.0 114.017 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -20.81 39.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.49 -140.45 24.42 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.03 -57.06 0.57 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 127.359 2.264 . . . . 0.0 111.386 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.2 -37.15 71.76 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.615 0.766 . . . . 0.0 111.188 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -43.28 86.14 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.3 -0.875 . . . . 0.0 110.912 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.17 84.01 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.861 0.464 . . . . 0.0 110.683 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.6 t -67.35 -40.29 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.043 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' HG13 ' A' ' 51' ' ' VAL . 5.6 t -58.38 115.62 12.13 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.95 61.44 7.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.952 3.101 . . . . 0.0 109.14 -172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG13 ' SG ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER 174.93 -36.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.813 2.445 . . . . 0.0 108.593 -167.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.0 m 58.31 53.88 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.086 0.954 . . . . 0.0 110.864 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.3 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.285 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.25 121.43 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -118.26 164.13 15.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -71.69 147.28 47.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -56.79 -36.96 70.48 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 122.265 1.031 . . . . 0.0 113.183 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.51 -46.21 66.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.307 171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -76.48 -36.44 57.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.616 1.167 . . . . 0.0 110.927 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HD11 ' A' ' 68' ' ' ILE . 49.1 t -52.46 122.14 24.31 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.5 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.03 147.32 64.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.3 2.667 . . . . 0.0 112.81 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' HA ' ' CG ' ' A' ' 65' ' ' LYS . 4.6 mp0 -39.69 -47.06 1.96 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.831 3.252 . . . . 0.0 113.537 174.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.06 -43.42 14.54 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.769 0.828 . . . . 0.0 111.11 172.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -102.13 -1.68 30.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.617 1.967 . . . . 0.0 112.87 -175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 68' ' ' ILE . 30.5 mmtm -55.52 -28.81 56.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.588 1.54 . . . . 0.0 109.501 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.4 p -48.78 -45.49 40.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.054 1.342 . . . . 0.0 111.566 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -67.81 -32.68 73.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.549 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 65' ' ' LYS . 10.2 mt -63.94 -47.67 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 120.73 1.605 . . . . 0.0 108.283 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -49.99 -53.67 25.02 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.62 93.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.763 0.256 . . . . 0.0 111.204 -174.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.535 0.734 . . . . 0.0 111.111 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -62.85 -57.89 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.934 1.35 . . . . 0.0 109.202 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.413 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 47.9 t0 -59.64 -38.98 82.83 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.848 2.859 . . . . 0.0 112.25 -169.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -37.33 -57.66 0.88 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 171.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -97.48 -31.58 12.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.806 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -76.56 81.38 3.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 175.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.998 -1.477 . . . . 0.0 108.007 -169.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -101.47 136.71 40.86 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.934 1.294 . . . . 0.0 108.604 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -138.7 142.75 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.367 0.667 . . . . 0.0 111.219 -176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.11 157.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.187 1.795 . . . . 0.0 111.179 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.5 p -145.77 160.08 42.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.341 3.6 tt0 1.2 -66.14 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 130.068 3.347 . . . . 0.0 117.445 169.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 50.6 Cg_exo -56.04 -25.71 55.5 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 CA-C-N 122.76 2.021 . . . . 0.0 114.633 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 t -57.29 -33.98 68.22 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 112.177 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.63 83.44 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.646 0.736 . . . . 0.0 111.032 -169.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.88 65.11 0.6 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 126.148 1.832 . . . . 0.0 108.876 171.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.256 14.2 t 50.13 -156.42 0.1 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.919 1.688 . . . . 0.0 112.435 -175.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -77.4 100.72 6.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.942 0.877 . . . . 0.0 110.56 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.62 177.62 8.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.149 1.78 . . . . 0.0 109.687 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.42 134.33 12.09 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 168.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m 156.42 -68.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.348 2.259 . . . . 0.0 107.412 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.89 40.29 0.24 Allowed 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.564 -0.71 . . . . 0.0 110.876 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.71 -73.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.069 0 O-C-N 120.548 -1.345 . . . . 0.0 107.988 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -80.85 41.5 0.58 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.0 113.061 -169.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.88 -35.7 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.35 127.91 93.34 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.378 0.99 . . . . 0.0 110.925 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.96 -36.4 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.945 3.763 . . . . 0.0 114.218 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.75 45.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.802 0.841 . . . . 0.0 111.213 -169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t70 55.62 -115.18 0.91 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.049 173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.16 -19.64 0.17 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 169.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.78 103.26 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.95 1.3 . . . . 0.0 109.824 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.27 142.63 47.29 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.632 1.173 . . . . 0.0 111.823 -169.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -75.8 77.72 2.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.601 1.091 . . . . 0.0 109.369 169.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.97 -43.02 96.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.666 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -111.55 -120.72 0.29 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -101.16 -8.79 21.91 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 111.071 172.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.36 161.87 28.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.425 2.69 . . . . 0.0 108.536 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.49 120.99 25.2 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.348 0.659 . . . . 0.0 112.255 -169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 124.14 47.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.441 3.096 . . . . 0.0 106.421 -177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt -89.34 125.33 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 118.125 -0.94 . . . . 0.0 108.516 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.1 t0 -70.24 113.44 17.97 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 120.134 1.334 . . . . 0.0 108.417 169.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 71' ' ' ASN . 57.2 Cg_endo -61.9 -31.85 84.86 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 121.277 1.318 . . . . 0.0 110.975 178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -79.86 -21.14 44.44 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.871 -0.518 . . . . 0.0 110.369 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -88.09 -37.55 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.334 0.516 . . . . 0.0 110.706 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -60.08 148.18 36.73 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.807 0.731 . . . . 0.0 111.207 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 pt -122.62 38.46 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.255 1.422 . . . . 0.0 111.017 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 46.94 39.69 7.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.323 1.849 . . . . 0.0 112.615 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.17 159.0 32.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.623 -0.673 . . . . 0.0 111.829 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.44 63.65 4.38 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -158.03 174.33 15.38 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 124.373 1.069 . . . . 0.0 108.233 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.283 4.8 p 66.39 -56.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.387 2.275 . . . . 0.0 111.644 -169.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -66.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.992 0.917 . . . . 0.0 111.67 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.83 64.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.261 0.624 . . . . 0.0 112.25 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.63 -35.32 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 123.555 0.742 . . . . 0.0 109.484 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -60.74 114.07 9.33 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 -2.5 7.72 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.299 2.0 . . . . 0.0 113.026 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -108.8 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.242 1.817 . . . . 0.0 109.894 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.3 m 52.48 55.28 9.32 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.054 0.942 . . . . 0.0 111.563 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.36 -16.17 50.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.875 0.87 . . . . 0.0 111.058 173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.98 129.14 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -133.75 167.66 20.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.59 145.15 56.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.58 171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -53.5 -41.03 65.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.42 -31.42 72.5 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 123.806 0.843 . . . . 0.0 110.885 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -81.45 -36.74 29.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.439 0.695 . . . . 0.0 109.945 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -48.92 127.5 14.36 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.339 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -54.01 142.51 64.95 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.026 2.484 . . . . 0.0 112.125 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -41.66 -45.78 3.52 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.755 2.822 . . . . 0.0 112.784 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -47.68 -46.13 28.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.141 0.976 . . . . 0.0 110.882 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -96.19 -6.58 37.86 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.494 1.518 . . . . 0.0 112.578 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -58.87 -19.9 46.14 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.26 1.391 . . . . 0.0 110.422 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 p -49.84 -46.71 51.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 109.705 168.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -62.7 -35.83 80.97 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.171 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.66 -45.59 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.717 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 tptp -65.27 -46.5 80.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.365 0.529 . . . . 0.0 111.654 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 12.3 m-80 -58.24 -42.54 86.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 110.885 175.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -57.81 -61.64 2.38 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.719 1.208 . . . . 0.0 108.028 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -52.25 -51.74 56.65 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.801 2.44 . . . . 0.0 113.054 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -32.98 -50.92 0.29 Allowed 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 126.175 1.79 . . . . 0.0 113.695 -175.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -110.02 -1.14 17.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.715 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.53 -34.31 41.25 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.165 0.893 . . . . 0.0 111.162 -174.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -109.56 142.62 40.39 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.027 1.331 . . . . 0.0 109.746 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.07 141.04 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.462 1.105 . . . . 0.0 110.705 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.82 -48.37 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 128.433 2.693 . . . . 0.0 114.316 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 p 61.19 -165.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.66 1.584 . . . . 0.0 114.065 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.05 -48.93 59.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 129.446 3.099 . . . . 0.0 115.726 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.09 -22.4 74.16 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 CA-C-N 121.322 1.508 . . . . 0.0 113.327 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -58.33 -34.08 70.23 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.444 0.697 . . . . 0.0 112.026 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 mp -71.14 84.15 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.683 0.754 . . . . 0.0 110.814 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.15 58.28 0.7 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.597 2.046 . . . . 0.0 108.608 171.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.266 14.5 t 49.23 -150.01 0.2 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.022 1.729 . . . . 0.0 113.025 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -66.56 81.62 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.936 1.695 . . . . 0.0 112.157 -172.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.7 t -66.22 151.37 47.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.995 0.918 . . . . 0.0 109.598 169.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.44 44.19 2.31 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.263 1.025 . . . . 0.0 109.508 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.3 m -150.49 144.15 25.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.386 5.7 p 74.01 49.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.657 2.383 . . . . 0.0 108.466 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.42 -43.28 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.624 1.97 . . . . 0.0 109.246 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.07 27.04 2.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.756 2.822 . . . . 0.0 113.498 -168.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.5 -37.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -168.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.9 t -59.34 123.66 71.27 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.698 1.135 . . . . 0.0 112.535 -168.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.93 -47.21 19.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 1 C-N-CA 125.318 4.012 . . . . 0.0 113.144 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.7 t -133.65 84.32 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -17.37 112.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.984 2.114 . . . . 0.0 114.544 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m -121.97 1.14 9.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.135 1.374 . . . . 0.0 109.94 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.14 106.4 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.222 0.919 . . . . 0.0 112.433 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -125.95 144.28 50.75 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 124.081 0.953 . . . . 0.0 110.191 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.39 118.39 17.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 120.157 1.344 . . . . 0.0 111.93 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.66 75.08 2.41 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 104.781 -3.327 . . . . 0.0 104.781 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 71.94 -47.83 0.67 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.602 2.761 . . . . 0.0 112.152 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -138.01 -12.5 1.46 Allowed 'General case' 0 C--N 1.34 0.181 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.04 34.52 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -169.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.06 135.83 49.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 109.989 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 128.74 54.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 130.066 3.346 . . . . 0.0 104.545 -175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.0 mt -93.48 124.86 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.78 116.04 33.88 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.056 1.298 . . . . 0.0 108.201 169.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.91 -20.35 17.17 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.959 1.773 . . . . 0.0 111.605 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -88.39 -30.68 19.32 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.089 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.58 -38.6 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.41 171.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.43 146.28 51.86 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.528 0.604 . . . . 0.0 111.352 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.1 pt -120.79 37.9 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.264 1.426 . . . . 0.0 111.098 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.88 42.44 16.14 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.724 1.61 . . . . 0.0 111.752 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 161.51 28.92 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.889 -0.507 . . . . 0.0 111.483 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.6 61.19 3.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.98 156.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.257 1.5 p 78.35 -55.68 0.48 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.855 2.462 . . . . 0.0 109.953 -169.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.12 -59.26 0.88 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.859 1.664 . . . . 0.0 113.827 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.64 -10.16 57.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.094 0.958 . . . . 0.0 112.494 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.9 t -74.08 -37.26 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.64 0.655 . . . . 0.0 109.447 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.95 114.91 9.51 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.21 -7.64 17.96 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.445 2.097 . . . . 0.0 112.616 -174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.33 -20.47 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.536 1.534 . . . . 0.0 109.865 177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.2 m 54.35 51.98 13.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 111.318 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.05 -30.64 34.76 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.139 0.976 . . . . 0.0 110.754 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.8 mt -64.69 120.88 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -130.64 164.25 25.4 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -65.87 150.08 49.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.985 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.99 -43.89 60.78 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -66.05 -29.89 70.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.282 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -82.56 -37.09 25.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.282 0.633 . . . . 0.0 109.887 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -50.89 128.96 28.41 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.371 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.57 148.15 45.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.17 2.58 . . . . 0.0 113.471 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -45.71 -44.61 13.71 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 129.164 2.986 . . . . 0.0 112.881 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -48.43 -44.45 35.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 111.003 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -97.06 -0.27 47.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.104 1.361 . . . . 0.0 112.441 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -55.42 -29.7 59.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.777 1.171 . . . . 0.0 108.906 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.19 -44.97 11.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.44 1.096 . . . . 0.0 111.557 169.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -66.39 -34.74 78.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 117.801 -1.095 . . . . 0.0 111.667 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -61.12 -43.99 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 120.712 1.596 . . . . 0.0 107.133 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -51.43 69.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -59.19 -42.11 90.09 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.128 -0.982 . . . . 0.0 112.231 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -60.45 -44.16 96.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.138 1.775 . . . . 0.0 110.649 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.05 -55.92 27.07 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.188 0.995 . . . . 0.0 109.178 174.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.11 -42.02 94.37 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 129.111 2.964 . . . . 0.0 114.043 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.95 -53.81 0.76 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.705 1.202 . . . . 0.0 112.984 -175.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.2 4.3 31.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.008 0.923 . . . . 0.0 111.497 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 79.85 1.25 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 CA-C-O 116.064 -1.922 . . . . 0.0 107.463 -169.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 110.72 -0.104 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -103.73 143.06 33.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.279 1.032 . . . . 0.0 110.043 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.36 138.15 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.205 1.002 . . . . 0.0 110.814 -176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.34 151.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.935 1.694 . . . . 0.0 109.833 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.2 p -138.81 160.17 40.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.923 -0.486 . . . . 0.0 110.574 172.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 7' ' ' PRO 0.331 4.9 tt0 -1.28 -64.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 130.192 3.397 . . . . 0.0 117.418 172.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 6' ' ' GLU . 52.3 Cg_exo -54.63 -25.42 41.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 CA-C-N 122.864 2.059 . . . . 0.0 114.844 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 -35.83 68.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.795 0.838 . . . . 0.0 112.261 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.434 HG13 ' HG2' ' A' ' 31' ' ' GLN 0.273 3.5 mp -70.31 89.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.747 0.784 . . . . 0.0 112.205 -168.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.4 47.44 0.71 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.621 1.581 . . . . 0.0 110.986 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.363 0.9 OUTLIER 51.56 118.04 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.472 2.709 . . . . 0.0 118.075 174.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? 68.09 -63.33 0.33 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.476 2.71 . . . . 0.0 112.588 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t 64.11 -66.3 0.12 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.158 1.783 . . . . 0.0 112.966 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.07 47.79 11.52 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 112.406 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.0 m -110.92 -56.37 2.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.303 0.641 . . . . 0.0 110.703 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.3 p -72.95 75.33 1.18 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.993 0.901 . . . . 0.0 109.263 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 m -115.56 -140.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 110.116 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -67.73 17.79 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -71.65 -28.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 169.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -62.41 127.98 90.68 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.52 -34.3 71.85 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 124.482 3.454 . . . . 0.0 114.637 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.56 24.44 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 122.576 0.351 . . . . 0.0 111.449 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 62.94 -176.28 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.192 0.597 . . . . 0.0 109.454 -174.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.2 p 122.18 -5.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.976 3.71 . . . . 0.0 111.923 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -91.2 110.84 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.37 141.81 50.97 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 125.126 1.37 . . . . 0.0 109.877 -170.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -71.98 113.71 9.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 120.175 1.352 . . . . 0.0 109.823 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.34 64.58 3.76 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 170.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 65.5 -59.11 0.29 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 129.811 3.245 . . . . 0.0 111.163 -172.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.48 -54.29 4.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.535 0.734 . . . . 0.0 112.072 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.434 ' HG2' HG13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -141.8 166.49 24.58 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.588 1.155 . . . . 0.0 110.215 -169.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.82 133.39 50.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.645 0.736 . . . . 0.0 110.695 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 131.19 53.79 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 131.002 3.721 . . . . 0.0 104.586 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 25' ' ' ILE . 67.1 mt -99.5 128.41 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.445 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 36.4 t0 -74.66 111.85 14.93 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 120.037 1.29 . . . . 0.0 107.697 168.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.72 -29.61 69.01 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.563 1.509 . . . . 0.0 111.041 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -80.27 -24.38 40.1 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 121.71 -0.619 . . . . 0.0 110.22 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.9 t -90.06 -35.7 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.5 0.591 . . . . 0.0 110.74 172.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.2 t -54.71 129.88 38.49 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.03 0.832 . . . . 0.0 110.743 175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.02 35.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 111.378 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.55 37.64 9.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.166 1.787 . . . . 0.0 113.082 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -23.79 46.14 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.55 -141.73 21.39 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.357 0.98 . . . . 0.0 111.772 -169.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.48 -65.01 0.36 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.919 2.088 . . . . 0.0 113.026 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.9 p -46.87 -42.37 17.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.61 1.164 . . . . 0.0 109.803 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -40.88 -44.62 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.188 2.195 . . . . 0.0 114.426 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -92.92 -28.17 16.63 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.515 1.126 . . . . 0.0 110.19 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -63.42 -38.49 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 119.068 -0.492 . . . . 0.0 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.1 t -61.23 113.0 6.76 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.47 29.68 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.448 2.766 . . . . 0.0 112.74 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -146.15 -29.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 129.42 3.088 . . . . 0.0 108.056 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.4 m 55.54 57.93 4.95 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.503 1.121 . . . . 0.0 110.759 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.08 -13.51 57.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.819 1.248 . . . . 0.0 110.745 170.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 mt -80.85 124.79 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -128.31 167.57 16.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.39 146.24 54.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.46 -36.47 69.11 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.424 1.107 . . . . 0.0 112.882 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.64 -44.14 76.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.132 171.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -78.32 -34.65 48.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.329 1.452 . . . . 0.0 112.022 -168.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 68' ' ' ILE . 40.3 t -50.0 124.31 16.8 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.508 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 143.66 67.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.989 2.459 . . . . 0.0 112.114 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -42.77 -46.89 5.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 128.867 2.867 . . . . 0.0 112.462 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -46.38 -45.14 17.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.14 0.976 . . . . 0.0 110.878 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 50.6 m0 -97.96 0.49 46.51 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.702 1.601 . . . . 0.0 112.411 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 68' ' ' ILE . 40.9 mttp -61.3 -19.21 61.51 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 120.23 1.377 . . . . 0.0 110.781 170.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 p -54.07 -42.75 69.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.098 0.959 . . . . 0.0 110.167 167.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -64.83 -36.62 84.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.064 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 60' ' ' VAL . 11.0 mt -60.36 -44.76 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 120.756 1.616 . . . . 0.0 109.047 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -54.13 -48.22 71.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.427 173.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -61.47 -45.06 95.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.465 0.575 . . . . 0.0 112.064 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -58.89 -43.55 91.0 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.581 1.152 . . . . 0.0 110.904 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -58.13 -60.46 3.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.893 1.277 . . . . 0.0 107.655 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.14 -51.05 63.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.569 2.748 . . . . 0.0 112.942 -171.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -32.68 -49.6 0.23 Allowed 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 126.581 1.952 . . . . 0.0 113.472 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -114.08 -0.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.804 0.69 . . . . 0.0 111.768 -169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HZ1' ' CG ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -79.11 -34.31 43.56 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.184 0.902 . . . . 0.0 110.873 -174.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.385 0 CA-C-O 115.684 -2.103 . . . . 0.0 106.35 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -97.46 138.91 34.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.401 0.68 . . . . 0.0 109.177 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.42 140.79 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.751 0.786 . . . . 0.0 111.097 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -75.93 152.56 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.686 3.194 . . . . 0.0 111.054 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.1 p -146.47 166.71 25.6 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.713 0.405 . . . . 0.0 111.27 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.272 58.4 tt0 -16.2 -60.05 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 129.002 2.921 . . . . 0.0 116.147 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.07 -18.03 41.3 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 121.691 1.64 . . . . 0.0 115.12 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 t -62.36 -40.62 97.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.771 171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.86 118.83 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.024 0.375 . . . . 0.0 110.354 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.42 76.3 0.06 OUTLIER Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.315 3.1 t 64.39 -49.36 0.3 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.286 2.634 . . . . 0.0 116.181 170.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 -60.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.981 1.264 . . . . 0.0 111.102 176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t 60.6 -71.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.522 1.929 . . . . 0.0 114.965 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 64.18 -123.25 0.49 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 109.337 -168.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.9 m 72.29 -55.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.957 2.103 . . . . 0.0 112.783 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -62.13 -47.98 82.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.389 1.076 . . . . 0.0 110.634 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.79 -41.61 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 O-C-N 121.434 -0.791 . . . . 0.0 112.418 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -68.19 -7.31 29.13 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.63 -22.95 3.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 120.02 1.282 . . . . 0.0 113.665 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -61.87 128.93 91.24 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 119.45 1.023 . . . . 0.0 110.973 -172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.29 -41.62 13.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 1 C-N-CA 125.327 4.018 . . . . 0.0 114.312 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.18 57.71 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.905 0.882 . . . . 0.0 109.769 -175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -4.23 104.74 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.939 2.096 . . . . 0.0 114.689 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -132.14 29.77 4.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.305 171.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.552 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -110.51 113.79 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 -169.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -136.76 140.59 42.68 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 117.082 2.253 . . . . 0.0 117.082 -165.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -68.13 160.69 28.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.522 -1.361 . . . . 0.0 112.767 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.63 -52.99 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -112.92 -63.17 1.48 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.586 1.554 . . . . 0.0 109.712 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.8 -54.49 0.08 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 109.007 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 145.25 56.21 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.516 2.327 . . . . 0.0 111.008 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HB3' HG22 ' A' ' 25' ' ' ILE . 69.4 m-85 -86.2 102.69 14.14 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 111.746 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -54.41 110.5 0.63 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.839 2.856 . . . . 0.0 108.505 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.8 mt -82.97 115.27 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.417 ' OD2' ' NZ ' ' A' ' 76' ' ' LYS . 9.6 t0 -62.83 117.22 30.08 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.686 1.13 . . . . 0.0 108.544 171.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.88 -24.82 20.66 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 121.493 1.462 . . . . 0.0 112.085 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.31 -36.51 34.18 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.68 -32.02 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.309 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.2 t -59.64 124.22 19.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.215 0.916 . . . . 0.0 110.539 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 pt -93.91 36.97 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.998 0.919 . . . . 0.0 111.706 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 39.1 61.9 1.2 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.086 1.755 . . . . 0.0 112.609 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -94.92 -163.19 1.02 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.862 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 101.87 0.41 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -160.74 -65.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.06 1.344 . . . . 0.0 110.786 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 28.1 p -60.37 -52.41 65.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.495 0.718 . . . . 0.0 111.262 -172.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 -54.8 24.11 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.757 0.823 . . . . 0.0 111.306 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.98 66.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.02 0.528 . . . . 0.0 112.003 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.47 -41.31 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.349 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' VAL . 10.0 t -58.35 111.7 3.93 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.001 0.819 . . . . 0.0 108.877 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.1 22.24 0.43 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.439 2.759 . . . . 0.0 113.038 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -135.09 -28.11 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 129.871 3.268 . . . . 0.0 107.616 -177.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 54.35 59.53 4.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.623 1.169 . . . . 0.0 110.39 -172.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.14 44.94 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.349 1.06 . . . . 0.0 110.214 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.1 mt -77.67 125.51 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -131.94 171.32 13.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -62.87 147.18 50.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.141 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -49.11 -41.72 36.75 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.14 -40.28 89.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.452 0.701 . . . . 0.0 111.461 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -78.79 -34.91 45.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.177 0.991 . . . . 0.0 110.855 -168.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.3 t -51.87 123.99 26.68 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.389 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -53.76 144.69 53.22 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.066 2.511 . . . . 0.0 112.119 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -41.8 -46.51 3.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 128.78 2.832 . . . . 0.0 112.497 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -46.89 -46.02 20.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.194 0.997 . . . . 0.0 110.995 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -96.35 -3.02 44.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.713 1.605 . . . . 0.0 112.359 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -61.11 -17.74 54.26 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.478 1.49 . . . . 0.0 110.23 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -51.63 -44.74 63.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.851 0.86 . . . . 0.0 109.189 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -64.79 -32.62 74.4 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.665 -1.159 . . . . 0.0 111.817 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.72 -47.25 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 121.127 1.785 . . . . 0.0 107.917 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -52.72 -53.99 39.97 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.17 -43.05 99.7 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.547 0.213 . . . . 0.0 111.082 -171.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.05 -39.17 85.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.673 1.189 . . . . 0.0 111.545 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -51.24 63.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.061 0.934 . . . . 0.0 109.348 177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 77' ' ' LYS . 61.2 t0 -68.86 -47.97 64.63 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.283 2.633 . . . . 0.0 112.54 -169.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -31.11 -56.27 0.23 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.991 1.716 . . . . 0.0 113.053 -175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -98.97 -3.42 35.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.978 0.911 . . . . 0.0 112.543 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' NZ ' ' OD2' ' A' ' 35' ' ' ASP . 10.8 mptt -104.02 78.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.063 0.945 . . . . 0.0 109.749 -172.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 127.769 2.427 . . . . 0.0 105.872 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -112.27 156.34 22.55 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.893 0.77 . . . . 0.0 110.625 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 68' ' ' ILE . 11.1 t -132.26 143.43 40.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 125.846 1.658 . . . . 0.0 109.167 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.19 135.6 25.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.561 1.144 . . . . 0.0 108.666 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.9 p -127.88 170.78 12.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.222 1.009 . . . . 0.0 111.08 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -14.09 -56.85 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 129.628 3.171 . . . . 0.0 116.553 172.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.49 -21.33 61.18 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 122.25 1.839 . . . . 0.0 114.147 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.3 t -64.53 -27.04 68.69 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.84 0.745 . . . . 0.0 112.094 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 9' ' ' ILE . 81.5 mt -67.02 79.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.811 0.844 . . . . 0.0 110.969 -170.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.67 0.79 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 126.236 1.874 . . . . 0.0 108.571 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.331 14.6 t 46.83 88.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.326 2.251 . . . . 0.0 114.603 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm 73.8 -61.2 0.5 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.703 2.001 . . . . 0.0 114.347 169.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 t 61.61 -68.6 0.05 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 0.0 113.217 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.01 35.01 8.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.399 1.879 . . . . 0.0 114.455 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -106.06 14.69 27.46 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.6 p -121.92 54.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.3 -45.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.407 -0.808 . . . . 0.0 111.104 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 1.5 pm0 -74.84 10.5 1.4 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 127.183 2.193 . . . . 0.0 114.001 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.64 -24.79 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -70.6 124.53 91.06 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 119.595 1.089 . . . . 0.0 111.198 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.24 -26.76 83.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.804 3.003 . . . . 0.0 113.161 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.98 38.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.396 0.679 . . . . 0.0 110.004 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 29.97 42.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 128.079 2.551 . . . . 0.0 116.361 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.1 p -92.18 36.02 0.99 Allowed 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.092 -1.005 . . . . 0.0 110.746 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.0 120.32 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 126.313 1.845 . . . . 0.0 108.062 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -137.12 171.06 15.06 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 125.039 1.335 . . . . 0.0 109.607 -169.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.18 172.01 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 119.387 0.994 . . . . 0.0 110.217 168.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.49 -53.9 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.259 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -139.64 58.38 1.61 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.355 0.662 . . . . 0.0 109.27 -172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 t0 45.76 37.36 3.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.172 1.789 . . . . 0.0 112.578 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.71 154.25 38.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 172.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -76.41 163.21 27.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 123.669 0.606 . . . . 0.0 110.707 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -143.45 110.37 5.63 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 106.057 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.11 132.23 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.81 112.95 22.62 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 167.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.06 -28.97 48.82 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.826 1.684 . . . . 0.0 110.672 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.03 -27.93 29.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.784 0.834 . . . . 0.0 109.804 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.2 t -85.5 -32.27 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 118.836 0.743 . . . . 0.0 111.122 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.4 t -56.13 130.43 44.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.09 0.859 . . . . 0.0 111.152 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 pt -102.44 35.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.3 1.04 . . . . 0.0 111.184 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 50.65 32.19 6.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.24 1.816 . . . . 0.0 114.636 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -23.08 62.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.13 -132.53 11.27 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -168.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.83 -68.25 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.749 1.62 . . . . 0.0 113.098 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -48.84 -49.99 36.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.324 1.05 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -48.47 -56.2 8.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.084 0.954 . . . . 0.0 110.255 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.2 -31.0 68.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.16 0.584 . . . . 0.0 112.465 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.98 -7.73 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.982 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -82.79 111.29 28.38 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.51 41.64 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.237 2.624 . . . . 0.0 111.727 -173.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.7 -27.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 128.346 2.658 . . . . 0.0 109.2 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m 55.65 60.18 3.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.847 0.859 . . . . 0.0 110.025 -171.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.55 -25.07 41.75 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.25 1.02 . . . . 0.0 110.169 170.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.9 mt -72.7 117.47 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 172.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -127.81 165.16 20.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.29 150.19 40.33 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -54.67 -40.44 69.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.677 -0.64 . . . . 0.0 112.69 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -69.98 -24.17 63.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.426 -0.796 . . . . 0.0 111.032 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -74.88 -45.32 43.66 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.915 0.325 . . . . 0.0 110.167 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.624 ' HB ' HD11 ' A' ' 68' ' ' ILE . 68.0 t -52.69 123.75 32.14 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.792 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.85 149.32 61.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.924 2.416 . . . . 0.0 112.606 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -42.66 -46.25 4.97 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 129.698 3.199 . . . . 0.0 112.258 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -46.54 -40.44 12.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.11 0.964 . . . . 0.0 111.767 172.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -106.08 7.77 31.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.857 1.663 . . . . 0.0 112.482 -176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.7 mptt -57.89 -27.37 63.23 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.403 1.001 . . . . 0.0 110.038 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 p -49.28 -44.53 44.08 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.165 1.386 . . . . 0.0 111.051 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -67.98 -33.02 73.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.68 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.624 HD11 ' HB ' ' A' ' 60' ' ' VAL . 3.6 mt -60.99 -48.18 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 120.803 1.638 . . . . 0.0 108.124 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -53.29 -50.52 64.72 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 tptp -62.8 -43.27 99.24 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 0.541 . . . . 0.0 111.968 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -58.69 -44.18 90.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.039 1.335 . . . . 0.0 110.763 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -55.55 33.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.163 0.985 . . . . 0.0 109.041 176.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.68 -45.7 93.15 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.982 2.513 . . . . 0.0 112.402 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -35.05 -50.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 113.463 -171.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -105.2 4.66 31.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.282 1.033 . . . . 0.0 111.983 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.22 73.41 0.88 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.685 1.194 . . . . 0.0 109.135 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.142 0 C-N-CA 127.63 2.372 . . . . 0.0 105.916 169.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_